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ABSTRACT 
 
Type-2 diabetes is a serious metabolic disease that currently affects 9.3% of the U.S. 
population and is aggravated by diets low in fruit and vegetable intake leading to postprandial 
oxidative stress and inflammation [1, 2]. Berries are one of the richest dietary sources of 
polyphenolic compounds associated with decreased markers of chronic inflammation and 
decreased risk for type-2 diabetes [3,4], specifically anthocyanins
 
[5] (ANC) and 
proanthocyanidins (PAC), polymerized forms of ANC and other phenolics [6]. Fermentation is a 
feasible way to increase phenolic content of berry juice products, and fermented products may be 
more bioactive than their unfermented counterparts, thus increasing the potential for health 
benefits [7]. Our long-term goal, as outlined in Chapter 1, was to fill the gap of knowledge in 
understanding the mechanisms by which dietary bioactives found in fermented berry beverages 
contribute to the management of type-2 diabetes using in vitro enzymatic kinetics, analytical 
assays, computational modeling, in vitro cell culture, and in vivo animal feeding trials. A review 
of the literature focusing on the role of berries to reduce diabetes is presented in Chapter 2.  
Our research focused on the evaluation and potential mechanisms of action of alcohol-
free blueberry (Vaccinium corymbosum) and blackberry (Rubus spp.) fermented beverages and 
their bioactive ANC and PAC components to reduce inflammation and type-2 diabetes in vitro 
and in vivo through the aims introduced in Chapter 3. First we prepared blueberry and blackberry 
wines that were comparable to those commercially available (Chapter 4), and found that 
blueberries and their wine, especially when fermented at cold temperature, contain phenolic 
compounds that act as antioxidants and potential inhibitory factors of starch-cleaving enzymes 
that could be used to limit glucose absorption (Chapter 5). We then generated ANC- and PAC-
enriched fractions and found that blueberry and blackberry ANC and PAC inhibited expression 
of proteins in the NF-κB-mediated pathway in macrophages, indicating potential to reduce 
chronic inflammation associated with hyperglycemia (Chapter 6). ANC were found to bind 
strongly within active pockets of dipeptidyl-peptidase IV (DPP-IV), an incretin-cleaving target 
of diabetes therapy, to effectively reduce its activity (IC50 = 4.0 μM) (Chapter 7). ANC were also 
able to reduce the inflammatory cross-talk between macrophages and adipocytes (Chapter 8). 
Further, ANC increased insulin secretion from pancreatic β-cells by 233 and 100 µIU insulin/mL 
directly and after epithelial transport, respectively, due to reduced DPP-IV expression and up-
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regulated insulin-receptor associated genes and proteins (Chapter 9). Lastly, in Chapter 10 we 
established the role of phenolic compounds in 30:70% blueberry-blackberry alcohol-free 
fermented beverage to reduce body weight (BW) gain (10.3 vs. 16.7 g), fat mass (18.0 vs. 31.3% 
BW), and fasting blood glucose (184 vs. 222 mg/dL), in diet-induced obese C57BL/6j mice 
consuming ANC beverage vs. water, (p < 0.05). There were some adverse effects noted at the 
highest dose, warranting future studies into the optimal dose of phenolic compounds extracted 
and concentrated from the alcohol-free fermented blueberry-blackberry beverage. These results, 
as summarized in Chapter 11, suggest that ANC in blueberry and blackberry fermented 
beverages are beneficial sources of antioxidants, decrease glucose absorption, and inhibit 
inflammation and DPP-IV, and therefore could be used in the management of type-2 diabetes. 
 
1. National diabetes fact sheet: national estimates and general information on diabetes and 
prediabetes in the United States, 2014. Atlanta, GA: U.S. DHHS, Centers for Disease 
Control and Prevention, 2014. 
2. Jennings A, Welch AA, Spector T, Macgregor A, Cassidy A. (2014) Intakes of anthocyanins 
and flavones are associated with biomarkers of insulin resistance and inflammation in 
women. J Nutr 144(2):202-8. 
3. Ley SH, Hamdy O, Mohan V, Hu FB. (2014) Prevention and management of type 2 diabetes: 
dietary components and nutritional strategies. Lancet 383(9933):1999-2007. 
4. van Dam RM, Naidoo N, Landberg R. (2013) Dietary flavonoids and the development of 
type 2 diabetes and cardiovascular diseases: review of recent findings. Curr Opin Lipidol 
24(1):25-33. 
5. Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE, Prior RL. (2006) 
Concentrations of anthocyanins in common foods in the United States and estimates of 
normal consumption. J Agric Food Chem. 54, 4069-4075. 
6. Wedick NM, Pan A, Cassidy A, Rimm EB, Sampson L, Rosner B, Willett W, Hu FB, Sun Q, 
van Dam RM. (2012) Dietary flavonoid intakes and risk of type 2 diabetes in US men and 
women. Am J Clin Nutr 95: 925-33. 
7. Su MS, Chien PJ. (2007) Antioxidant activity, anthocyanins, and phenolics of rabbiteye 
blueberry (Vaccinium ashei) fluid products as affected by fermentation. Food Chem 104:182-
187. 
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CHAPTER 1 
OVERALL HYPOTHESES AND OBJECTIVES 
 
Long Term Goal 
 Fill the gap of knowledge in understanding the mechanisms by which dietary bioactives 
found in fermented berry beverages contribute to the management of type-2 diabetes using in 
vitro enzymatic kinetics, analytical assays, computational modeling, in vitro cell culture, and in 
vivo animal feeding trials.  
 
Overall Objective  
 To evaluate and determine the potential mechanism of action of berry phenolic 
compounds from dealcoholized blueberry-blackberry fermented beverages for their effect on 
markers of inflammation, carbohydrate utilization, incretin action and insulin secretion in vitro 
and in vivo.  
 
Central Hypothesis 
 Anthocyanins (ANC) and proanthocyanidins (PAC) present in blueberry-blackberry 
fermented beverages can reduce dysfunctional glucose metabolism through their antioxidant and 
anti-inflammatory action and their ability to inhibit the activity of glucosidases and DPP-IV, and 
therefore improve incretin and insulin function.  
     
 Image 1.1. Overall aims graphic.  
Dixon Springs, IL 
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GENERAL INTRODUCTION 
 
Type-2 diabetes is a serious metabolic disease that currently affects 9.3% of the U.S. 
population, with 1.7 million new cases diagnosed in 2012 [1]. It occurs when the body loses the 
capacity to deal with excess glucose as a result of insulin resistance or beta-cell dysfunction. This 
inability to control blood glucose increases the risk of serious complications such as heart 
disease, stroke, kidney failure, lower-limb amputations and non-alcoholic fatty liver diseases, 
among others. As a result, diabetes was the 7
th
 leading cause of death in 2010. The economic 
burden of diabetes is staggering with $176 billion for direct medical costs and $69 billion due to 
reduced productivity [1]. Current obesity trends and modern sedentary lifestyle along with diets 
low in fruit and vegetable intake lead to postprandial oxidative stress and inflammation in the 
body, contributing to insulin resistance and development of metabolic syndrome and diabetes 
[8].  
Oral medications and interventions such as insulin pumps are needed if healthy diet and 
exercise are not enough to regulate glucose levels. One therapeutic approach for management of 
type-2 diabetes involves reducing glucose absorption by inhibiting enzymes α-amylase and α-
glucosidase, as well as to increase insulin secretion. The incretin hormone glucagon-like peptide-
1 (GLP-1) is able to stimulate insulin release; however, it is rapidly degraded to inactive 
metabolites by dipeptidyl peptidase-IV (DPP-IV) [2], a current target for type-2 diabetes therapy. 
Natural sources of inhibitors of these enzymes would be beneficial for those with diabetes to 
avoid any potential side effects and to reduce the economic cost. Because berries have been 
found to be one of the best dietary sources of phenolic compounds, they have potential impact 
for the management of type-2 diabetes [14]. There is a need for new therapeutic interventions 
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and experimental models to determine the efficacy and health implications of new solutions to 
manage diabetes. 
Increased phenolic intake has been seen to correlate with a decreased incidence of several 
obesity-associated diseases, including metabolic syndrome [8] and diabetes [3, 9]. Recent studies 
have shown a link between increased consumption of anthocyanins (ANC) and anthocyanin-
containing foods, such as blueberries, with a decreased risk for type-2 diabetes [2-4]. Blueberries 
and blackberries are a rich source of ANC, the water-soluble pigments which give berries their 
red, blue, and purple color [5]. Berries also contain proanthocyanidins, the polymerized form of 
anthocyanidins, and non-hydrolyzable tannins [6]. The consumption of anthocyanins is among 
the highest of all flavonoids due to their wide distribution in foods [7]. Regardless of the low 
bioavailability of anthocyanins, clinical trials have shown the anti-diabetic effect of these 
compounds [10-13]. Data from mechanistic studies supports the role of flavonoids such as 
anthocyanins to be beneficial on insulin sensitivity, to decrease blood glucose levels, and to 
improve insulin secretion.  
 Some fermented juices and wines from berries inhibit inflammatory protein production or 
expression more than their unfermented counterparts when consumed [18-23]. Fermentation is 
known to increase the phenolic content of berry juice products through increased extraction of 
these compounds from the skins, including ANC [15]; this extraction technique may then also 
increase their antioxidant capacity [16] and potential health benefits. Dietary flavonoids have 
been linked to anti-inflammatory pathways [17]; therefore anthocyanins have potential for 
clinical efficacy in prevention and management of type-2 diabetes by inhibiting the inflammatory 
response. Due to the wide variety of phenolic compounds present in berry fruits as well as other 
foods, the benefits of bioactive compounds from berries may not be attributable to just one type 
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but to a combination. The optimal dose and efficiency of well-characterized phenolic extracts 
from berry products and their potential benefits may lead to specific recommendations to 
promote consumption of berries and berry products for type-2 diabetes management. Thus, there 
is a great need to further investigate the health benefits of specific phenolic compounds from 
berry fruits and fermented berry beverages and elucidate their role in diabetes and inflammation. 
To test the central hypothesis that anthocyanins (ANC) and proanthocyanidins (PAC) 
present in blueberry-blackberry fermented beverages can help to manage type-2 diabetes through 
their antioxidant and anti-inflammatory action and their ability to alter glucose metabolism, 
fermented beverages were produced from Illinois-grown blueberry (Vaccinium corymbosum) and 
blackberry (Rubus spp.) beverages. Our laboratory has shown that wines produced from 
blueberries and blackberries have high total polyphenolic and anthocyanin concentrations that 
correlate with their antioxidant capacity [23]. These phenolic compounds isolated from the 
blueberry-blackberry beverages were further tested and found to reduce LPS-induced 
inflammatory response via the NFκB-mediated pathway [24], and to inhibit carbohydrate 
utilizing enzymes alpha-glucosidase and alpha-amylase. Dipeptidyl peptidase-IV (DPP-IV) is a 
serine aminopeptidase that is a novel target for type-2 diabetes therapy [25]. DPP-IV rapidly 
cleaves incretin hormones into their inactive metabolites, preventing their activation of insulin 
secretion. We found that anthocyanins are able to bind within the catalytic site of DPP-IV and 
strongly inhibit its activity, thus providing a potential mechanism that anthocyanins may reduce 
hyperglycemia and therefore type-2 diabetes. These in vitro enzymatic kinetics, analytical 
assays, computational modeling, and cell culture experiments indicated that phenolic compounds 
from blueberry and blackberry alcohol-free fermented beverages have the potential to reduce 
complications associated with chronic inflammatory diseases such as type-2 diabetes through 
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antioxidant and anti-inflammatory mechanisms. The overall objective was to evaluate and 
determine the potential mechanism of action of phenolic compounds from dealcoholized 
blueberry-blackberry fermented beverages to affect markers of inflammation, glucose utilization, 
and insulin secretion both in vitro and in vivo. The goal of my integrated thesis research is to fill 
the gap of knowledge in understanding the mechanisms by which dietary bioactives found in 
fermented berry beverages contribute to the management of type-2 diabetes using in vitro 
enzymatic kinetics, analytical chemical assays, computational modeling, cell culture, and in vivo 
animal feeding trials, as indicated in the diagram below. 
Figure 1.1: Integration of Aims 1-5, as follows. 
 
I. Aim 1: Evaluate commercially available blueberry and blackberry juices and wines 
produced in the state of Illinois.  
II. Aim 2: Determine the effect of fermentation on the chemical composition and quality of 
blueberry and blackberry fermented beverages.  
III. Aim 3: Assess the potential of combinations of blueberry-blackberry fermented 
beverages for antioxidant capacity, and determine their ability to reduce activity of key 
enzymes related to diabetes and to modulate inflammation using in vitro and 
computational studies.  
IV. Aim 4: Evaluate the insulin secretory effect of phenolic compounds found in fermented 
berry beverages in vitro using a simulated absorption model of epithelial and 
physiologically-relevant pancreatic β-cells. 
V. Aim 5: Establish the role of anthocyanins in fermented berry beverages to reduce diet-
induced obesity and hyperglycemia in C57Bl/6j mice.  
 
Insulin Secretion 
(Aim 4) 
(Aim 3) 
Phenolic 
Compounds in 
Berry Wine 
(Aim 1, Aim 2) 
3.1: Glucose 
Absorption, Oxidative 
Stress & Inflammation 
 
3.3: Adipogenesis 
& Inflammation 
3.2: DPP-IV Activity Type-2 Diabetes 
ress 
Diet-induced 
Obesity and 
Hyperglycemia 
(Aim 5) 
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Research Aims 
Type of Study Aim Publication 
Evaluation of 
commercially 
available fermented 
berry beverages 
Aim 1: Evaluate commercially 
available blueberry and 
blackberry juices and wines 
produced in the state of Illinois. 
Michelle Johnson, Elvira G. de Mejia. 
Comparison of chemical composition and 
antioxidant capacity of commercially available 
blueberry and blackberry wines in Illinois. J. Food 
Sci. 2012, 77(1): C141-8. 
Evaluation of 
fermentation on 
phenolic compounds 
Aim 2: Determine the effect of 
fermentation on the chemical 
composition and quality of 
blueberry and blackberry 
fermented beverages.  
Michelle Johnson, Tessa Meyer, Anita Lucius, 
Elvira G. de Mejia. Cultivar evaluation and effect 
of fermentation on antioxidant capacity and in 
vitro inhibition of α-amylase and α-glucosidase by 
Highbush blueberry (Vaccinium corombosum). J. 
Agric. Food Chem. 2011, 59 (16): 8923-8930. 
In vitro, enzymatic & 
computational 
analysis of enzyme 
targets and markers 
related to 
inflammation and 
adipogenesis  
Aim 3: Assess the potential of 
ANC and PAC extracted from 
blueberry-blackberry fermented 
beverages for: 
 
3.1: Antioxidant capacity and 
inhibition of starch-degrading 
enzymes, DPP-IV (dipeptidyl-
peptidase IV), and inflammation.  
 
3.2 Ability to bind to the 
active sites of DPP-IV to inhibit 
DPP-IV enzyme activity. 
 
 
3.3 Reduction in the 
inflammatory cross-talk between 
macrophages and adipocytes. 
1. Michelle H. Johnson, Elvira Gonzalez de 
Mejia, Junfeng Fan, Mary Ann Lila, Gad G 
Yousef. Anthocyanins and proanthocyanidins from 
blueberry-blackberry fermented beverages inhibit 
markers of inflammation in RAW 264.7 
macrophages and carbohydrate-utilizing enzymes 
in vitro. Mol. Nutr. Food Res. 2013, 57: 1182-
1197. doi: 10.1002/mnfr.201200678. 
 
2. Junfeng Fan, Michelle H. Johnson, Mary Ann 
Lila, Gad Yousef, Elvira Gonzalez de Mejia. Berry 
and citrus flavonoids inhibit dipeptidyl peptidase 
IV, implications in diabetes management. Evid. 
Based Complement. Alternat. Med. 2013, No. 
479505. dx.doi.org/10.1155/2013/479505. 
 
3. Diego Garcia-Diaz, Michelle Johnson, Elvira 
Gonzalez de Mejia. Anthocyanins from blueberry-
blackberry fermented blends inhibit the pathogenic 
interaction between adipocytes and macrophages. 
J. Functional Foods. 18(4):489-96. 
doi:10.1089/jmf.2014.0039. 
In vitro, Caco-2 and 
iNS-1E β-cells 
Aim 4: Evaluate the insulin 
secretory effect of phenolic 
compounds found in fermented 
berry beverages in vitro using a 
simulated absorption model of 
epithelial and physiologically-
relevant β-cells. 
Johnson MH, de Mejia EG. Anthocyanins from 
fermented berry beverages increased insulin 
secretion from pancreatic beta cells in vitro beyond 
their ability to reduce dipeptidyl peptidase IV. 
Food and Function. [Submitted for publication, 
April 2015]. 
 
In vivo, obesity-
induced 
hyperglycemia in 
C57BL/6J mice 
Aim 5: Establish the in vivo 
potential of a fermented berry 
beverage and effective dose of its 
phenolic compounds to reduce 
obesity and hyperglycemia 
utilizing mice fed a high-fat diet. 
Johnson MH, Wallig M, Luna Vital DA, de Mejia 
EG. Alcohol-free fermented blueberry-blackberry 
beverage phenolics reduce diet-induced obesity 
and blood glucose in C57BL/6J mice. Journal of 
Nutritional Biochemistry. [In preparation].  
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CHAPTER 2 
LITERATURE REVIEW: 
DIABETES AND BERRIES
1
 
 
Summary 
 
Diets insufficient in the consumption of fruits and vegetables and that are low in 
flavonoids have been associated with higher incidence of inflammatory-related chronic diseases. 
Worldwide, the number of people with diabetes is projected to increase to over 360 million by 
2030. Type 2 diabetes mellitus occurs when the body loses the capacity to deal with excess 
glucose as a consequence of insulin resistance or beta-cell dysfunction, resulting in high blood 
glucose levels. Anthocyanins belong to the flavonoid family, a class of compounds considered to 
provide antioxidant activity. Found naturally in a number of foods, anthocyanins are the 
pigments that give berries, grapes, pomegranates and kidney beans their rich colors. In addition, 
anthocyanins are natural pigments that may provide anti-inflammatory and anti-diabetes benefits. 
The present chapter offers an overview of the effect of anthocyanins on the reduction of 
inflammation and diabetes complications in human subjects, in animal models, and their 
potential mechanisms of action.  
In this chapter, the botanical definitions of popular berry fruits, their common uses, and 
the major class of berry pigments, anthocyanins, will be introduced. An overview of absorption, 
metabolism, and antioxidant capacity of anthocyanins will be presented, followed by an 
overview of what causes inflammatory diseases and diabetes, and the biological activities 
associated with anthocyanins that can overcome these health concerns. The objective is to 
present an up to date overview of science-based evidence on the chemistry and health benefits of 
anthocyanins from berries and their roles in prevention of inflammation and diabetes. Other 
health benefits of anthocyanins will be briefly introduced. 
 
                                                             
1
 Portions from ANTHOCYANINS FROM BERRIES: CHEMISTRY AND ROLES IN 
INFLAMMATION AND DIABETES, Elvira Gonzalez de Mejia, Michelle H. Johnson, (2013), in 
Nutraceuticals and Fundamental Foods , [Ed. G.K.Jayaprakasha and Dr.Bhimangouda S.Patil], in 
Encyclopedia of Life Support Systems(EOLSS), Developed under the Auspices of the UNESCO, Eolss 
Publishers, Paris, France, [http://www.eolss.net], with permission from UNESCO-Encyclopedia of Life 
Support Systems (EOLSS). © UNESCO-Encyclopedia of Life Support Systems (EOLSS). 
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1. Introduction to Berries 
The purpose of this section is to clarify the definition of ‘berry’, to evaluate the 
horticultural significance and uses of major berry crops, and to explain the geographical 
significance of berries around the world. Berry fruits are of interest due to recent health claims 
and promotion for increased fruit and vegetable consumption in the human diet. In general, 
berries are readily available for consumption by many groups of people around the world. 
Usually consumed fresh or in processed forms, minimal preparation and varied recipe choices 
make berries a quick and easy addition to daily eating. Native people in many parts of the world 
have consumed berries throughout history. Today, berries are a common commercial crop with 
worldwide demand and potential for health benefits. These plants have been used historically for 
medicinal purposes especially in rural areas, and have traditionally been consumed as treatment 
for diarrhea or dysentery. Locally harvested fruits are being used in traditional medicine in India, 
Bangladesh, and China. In the Amazon region, in addition to being used for nourishment, açai 
berry oil has been used for its anti-diarrheic action, and the root for its anti-malarial activity. The 
Chilean maqui berry has been used as an anti-inflammatory agent and as treatment for kidney 
pains, fever, and stomach ulcers and tumors. 
There are currently many areas in the world without access to modern pharmaceutical 
solutions to chronic diseases that would benefit from increased evaluation of the potential for 
berry fruits to prevent the pathogenesis of chronic diseases. Investigating the composition of 
berries and their role as antioxidants helps to establish the basis for their potential health benefits. 
It is important to understand the scientific background that provides the basis to promote berry 
fruit consumption for the potential health benefits and use of anthocyanins as functional foods.  
 
1.1. Botanical and Common Definitions  
 
In broad terms, a fruit is the structure of a plant that contains its seeds. Figure 2.1 
presents maps indicating the cultivated areas and yields of fruits around the world. When 
investigating the health benefits and claims attributed to berries, it is important to first define 
which fruits qualify as a ‘berry’. Botanically, true berries are those which have edible pulp 
produced from a single ovary. Major ‘berry’ crops are defined as those produced on a shrub or 
vine that have economic importance. For the purpose of this review, berries will be considered as 
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those in common parlance, as small fruits that can be eaten whole. These include the true berries: 
black currant, red currant, and gooseberry; the “false” or epigenous berries: cranberry and 
blueberry; the aggregate berries: blackberry, raspberry, and hybrid boysenberry (Rubus ursinus x 
idaeus, Rosaceae); and the multiple berry mulberry (Morus atropurpurea Roxb., Moracea). 
Blackberry, black raspberry, blueberry, cranberry, and red raspberry are the most commonly 
consumed berries in North America. Also, berries commonly consumed in other parts of the 
world or consumed by traditional tribal communities will be discussed. These include açai 
(Euterpe oleracea, Arecaceae), Andean mora berry (Rubus glaucus Benth, Rosaceae), Chilean 
maqui berry (Aristotelia chilensis, Elaeocarpaceae), bilberry (Vaccinium myrtillus L., Ericaceae), 
chokeberry (Aronia melanocarpa, Rosaceae), elderberry (Sambucus canadensis L. and nigra L., 
Caprifoliaceae), mortiño (Vaccinium floribundum Kunth, Ericaceae), sea buckthorn (Hippophae 
rhamnoides, Elaeagnaceae), and wolfberry, also called goji berry (Lycium barbarum, 
Solanaceae). These commonly consumed berries or exotic berry-type fruits have seen an increase 
in consumption that may have potential to improve human health. Berries positively modulate 
chronic diseases such as cardiovascular disease, neurodegeneration, cancer, and diseases related 
to aging because they contain vitamins, minerals, folate, and fiber in addition to several 
phytochemicals. It is important to first look at the horticultural and geographical significance of 
berries commonly consumed in North America and around the world before discussing berry 
composition and biological activity that suggests their benefits to human health. 
 
A. Fruits areas. 
Figure 2.1. Availability of fruit crops worldwide: A. areas and B. yields  
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Figure 2.1 (contd.) B. Fruits yields.  
Adapted from: Monfreda et al., 2008. 
 
1.2. Horticulture and Geographical Significance: Berries around the World (Figure 2.2)  
 
True berries are simple fruits produced from a single ovary having seeds and an edible 
pulp, and contain the Ribes genus of berries. Generally, the entire ovary wall of the fruit ripens 
into an edible outer layer. True berries include black currant, red currant and gooseberry, and 
have been widely adapted to grow in many soil types and regions. They have been used both 
fresh and processed into juice, jellies, preserves or pies. Black currants (Ribes nigrum L., 
Grossulariaceae) are perennial plants native to central and Northern Europe and Northern Asia. 
They grow on a small shrub reaching 1-2 m in height. Most commonly, blackcurrants are used in 
juice, jellies, and purees, and have a distinctive sharp sweet taste. ‘Superfruit’ is a marketing 
term used to refer to fruits with appealing taste and exceptionally high nutrient richness and 
antioxidant quality. Black currants have this special status among consumers, with many health 
benefits attributed to their high antioxidant levels. Red currants (Ribes rubrum L., 
Grossulariaceae) are similar to the black currant but are bright red translucent berries. The red 
currant is mostly used in juice, jelly and purees. This small deciduous shrub is native to parts of 
Western Europe, though Poland is a large producer. Gooseberry (Ribes uva-crispa L., 
Grossulariaceae) grows on a bush from 1-3 m tall with sharp spines on the branches. 
Gooseberries are usually green and slightly hairy, but may also be deep purple in color. They are 
indigenous to Europe and Western Asia, growing naturally in thickets and rocky woods in many 
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countries. Though there are many uses in foods and cakes, gooseberries have a slightly sour taste 
and are recently losing sales. The Indian gooseberry (Phyllanthus emblica, Euphorbiaceae) is 
also a botanically true berry, having light green to yellow fruit that is sour, bitter and fibrous. 
The epigenous or false berries include the Vaccinium species of cranberry and blueberry. 
These are termed false berries as they are not true berries botanically speaking due to the fact 
that there are many seeds inside, rather than just one. Cranberries (Vaccinium macrocarpon Ait., 
Ericaceae) grow on evergreen creeping shrubs or vines growing to 2 m long and 5-20 cm tall in 
cooler parts of the Northern hemisphere. The berry turns deep red when ripe and is slightly 
acidic, leading to almost all being processed into products such as juice, sauce, and sweetened 
dried cranberries. Sales have increased recently due to recognition of the potential for health 
benefits, making cranberries a commercially important crop grown mostly in the United States 
and Canada. Blueberry (Vaccinium corymbosum L., angusifolium Ait., ashei Reade, Ericaceae) 
fruits are round blue berries with flared crowns at the end, and grow on shrubs that vary in size 
depending on the variety. They are native to North America but are also cultivated in Argentina, 
Chile, Australia, and New Zealand. American blueberries include the low-bush, or “wild” 
blueberry and the high-bush or “cultivated” blueberry. Blueberries can be used in many 
applications due to their sweet taste, including beverages and snack foods, and are perceived to 
be generally healthy. Cranberries and blueberries were widely used in the New England area for 
trading between Native Americans and Colonial settlers. 
Aggregate berries include blackberries, raspberries and boysenberries. Aggregate berries 
are composed of many small individual drupes, called druplets, which are the small fleshy parts 
forming around individual ovules of the fruit. There are many varieties of blackberries (Rubus 
sp. Rosaceae), which have naturally sharp spines that reach 3-6 m in height, and grow throughout 
the Northern hemisphere. Blackberries are one of the most widely available and widespread 
berries, having many species and hybrids, and are becoming one of the most economically 
important berries following more common strawberry (Fragaria × ananassa Duch.), blueberry 
(Vaccinium spp.), and red raspberry (R. idaeus L.) (Finn and Clark 2011). Mostly popular for its 
use in desserts, jams, and jellies, blackberries can also be made into wine. Raspberries (Rubus 
idaeus, Rosaceae) are similar to blackberries but are smaller, softer, and have a different color. 
They can be easily grown in many parts of the world and are commercially important for the 
fresh fruit market and for processing into frozen products, juices, or dried fruit. Fruits of the 
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raspberry plant grow on woody brambles and are usually red in color, but may also be black or 
yellow. Black raspberries (Rubus occidentalis L., Rosaceae) are not the same species as the red 
raspberry, but are a North American species grown mostly in the state of Oregon and used for 
juice and jam production. Boysenberries (Rubus ursinus x idaeus, Rosaceae) are a hybrid 
between a red raspberry and a blackberry, which was discovered in California and is now widely 
produced in the state of Oregon, as well as in New Zealand. The berry has similar fruit to 
blackberries with purple fruit, though their fruits are usually are larger and have larger druplets. 
The last group of berries used in common parlance are multiple fruit berries, which 
include mulberries (Morus atropurpurea Roxb., Moracea). Black mulberry (Morus nigra, 
Moracea) is native to western Asia but has been cultivated in Europe for hundreds of years. The 
fruits are 2-3 cm long and are found on medium sized deciduous trees growing to 10-15 m tall. 
The fruit is usually eaten fresh. As they are in high demand by birds they may be important when 
considering the horticultural production of other berry fruits. 
The berries just discussed are the most commonly referred to as berries; however, there 
are many exotic or rare berries less common to North American consumers with unique 
characteristics and horticultural interest. Some of these berries have become more common to the 
general public due to the introduction to grocery stores of the popular marketing term 
‘superfruits’. One very popular berry in the market today is açai (Euterpe oleracea, Arecaceae). 
This berry is the fruit of the açai palm that grows in tropical Central and South America mainly 
in floodplains and swamps. The palm is a small bushy evergreen similar to cherry trees growing 
to 15 m or more, and the berries are dark purple fruits. Known mostly because of its antioxidant 
properties, açai berries are used mostly in processed form or as juice or preserves because of 
poor shelf-life. 
 
1.3. Berry Composition 
In addition to fiber, minerals, and vitamins C, E, and A, berries contain phytochemicals 
with many potential benefits to prevent inflammation and diabetes. These phytochemicals are the 
bioactive phenolic compounds, which are categorized chemically into hydrolysable tannins and 
phenylpropanoids, such as lignins, flavonoids and condensed tannins. Phenolic phytochemicals 
are ubiquitous in plants and serve many biological functions, including roles in growth and 
development of the plant, and in defense mechanisms against insects and UV radiation. 
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Black currant (Ribes nigrum L., 
Grossulariaceae) 
 
vivekamexports.com 
Blackberry (Rubus sp. Rosaceae) 
 
Berries in the world. A report prepared for 
SITRA/Lapinnova Oy by: Invenire 
Market Intelligence. Finland. June 2008. 
Andes berry (Rubus glaucus Benth) 
 
biolib.cz 
Red currant (Ribes rubrum L.) 
nutritionkey.wordpress.com 
Raspberry (Rubus idaeus) 
 
bbcgoodfood.com 
Acerola (Malphighia emarginata) 
 
bewellbuzz.com 
Gooseberry (Indian Gooseberry: 
Emblica officinalis Gaertn.) 
 
pickyourown.org 
Boysenberry (Rubus ursinus x 
idaeus) 
 
gourmetsleuth.com 
Bilberry (Vaccinium myrtillus) 
 
herbalextracts.net 
Cranberry (Vaccinium 
macrocarpon Ait.) 
hunnylovins.blogspot.com 
Mulberry (Morus atropurpurea 
Roxb.) 
 
fruitdirectory.com 
Chokeberry (Aronia spp.) 
 
fruitdirectory.com 
Blueberry (Vaccinium 
corymbosum L., angusifolium 
Ait., ashei Reade) 
 
wrensoft.com 
Elderberry (Sambucus canadensis 
and S. nigra) 
blog.biottajuices.com 
Crowberry (Empetrum spp.) 
 
fruitipedia.com 
Maqui berry (Aristotelia 
chilensis) 
 
maquiberrytruth.com 
Mortiño (Vaccinium floribundum 
Kunth.) 
 
my.englishclub.com 
Marionberry (Rubus hybrid) 
 
fruitsinfo.com 
Figure 2.2. Images of berries found around the world. Berry (Scientific name) and Image Source. 
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Polyphenolic structures are characterized by one or more aromatic six-carbon rings and 
two or more phenolic hydroxyl groups. Anthocyanidins belong to the polyphenolic group of 
flavonoids, which are secondary metabolites synthesized by plants and are found in fruits along 
with ellagitannins, flavan-3-ols, procyanidins, flavonols, and hydroxybenzoate derivatives. 
Anthocyanidins are the aglycones of anthocyanins, which contain a sugar group or groups. 
Berries are one of the richest sources of anthocyanins, the largest group of water soluble 
pigments in nature that give fruits and vegetables their distinctive red, blue or purple color. The 
word ‘anthocyanin’ is derived from the Greek words anthos meaning flowers and kyanos 
meaning dark blue (Anderson and Jordheim 2006). Berries also contain proanthocyanidins, the 
polymerized form of anthocyanidins, along with non-hydrolyzable tannins. Proanthocyanidins, a 
major group of phenolic compounds occurring in plants, are the second most abundant natural 
phenolic after lignin (Gu 2004). Berries may also contain other phenolic compounds including 
phenolic acids, hydroxycinnamic acids, lignans or phytoestrogens, and stilbenoids, as well as 
terpenes or isoprenoids. The location of phenolic compounds in fruit varies depending on the 
type: phenolic acids are mostly found in the pulp, anthocyanins and stilbenes are found in the 
skin and other phenols including catechins and proanthocyanidins are found in the skin and 
seeds. Anthocyanins are important to plants because their rich colors attract animals, which 
allows for seed dispersal and pollination.  
Compared to other flavonoids, the dietary consumption of anthocyanins and 
proanthocyanidins is high due to their wide distribution in plants. Dark colored fruits such as 
blueberries, raspberries and black currants are major sources of anthocyanins in the human diet. 
Estimated daily intake of anthocyanins in the United States is between 180-215 mg, but may be 
as low as 12.5 mg per day, according to a USDA report in 2006 (Wu 2006). In addition to fresh 
fruit consumption, anthocyanins are also used as food pigments in the beverage industry, which 
increases their daily consumption and availability. Mean daily intake of proanthocyanidins in the 
U.S. population is estimated to be 57.7 mg/person, with major sources being apples, chocolate, 
and grapes (Gu 2004). These intake levels support the potential for these phenolic compounds to 
have health benefits.  
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1.4. Structure of Main Anthocyanins and Proanthocyanidins in Berries 
 
The biological activity to lower risk of diseases, the structural stability, and the 
bioavailability of anthocyanins and proanthocyanidins depend on their chemical structures. 
Polyphenolic flavonoids contain two benzyl rings (known as the A- and B-rings) separated by a 
heterocyclic ring (the C-ring) (Figure 2.3). Flavonoids, phenolic acids, lignans, and tannins 
differ structurally by the types and levels of oxidation on their heterocyclic rings and 
glycosylation by various sugars. The sub-classes of flavonoids, including flavonols, flavanols, 
anthocyanins, flavanones, flavones, and isoflavones differ based on the presence or absence of 
double bonds or carbonyl groups on the C-ring. There are more than 600 anthocyanins that have 
been identified in nature, and though the human diet provides hundreds of anthocyanins (the 
glycosylated form), only six anthocyanidins (the aglycone forms) are predominant and therefore 
important to the human diet. The phenolic profile and relative color varies greatly depending on 
the type of fruit, with cyanidin derivatives being the most common anthocyanin present in berry 
fruits.  
The six main anthocyanidins are cyanidin, malvidin, delphinidin, peonidin, petunidin, 
and pelargonidin, with diversity from the position and number of hydroxyl and methoxy groups 
attached at the R1 and R2 position on the B-ring of the anthocyanin skeleton (Figure 2.3). The 
hydroxyl groups may be substituted to form O-linked conjugates off the C-ring with many sugars 
in the form of 3-monoglycosides, often with a single sugar linked to the 3-position of the C-ring, 
and 3,5-diglycosides, with a sugar attached at both the 3- and 5-positions (Miguel 2011). 
Glycosylation increases water solubility and stability due to hydrogen bonding, so the more 
unstable aglycone form is rarely found in nature. More than 90% of anthocyanins contain 
glucose and are the nonmethylated anthocyanidins, which are cyanidin, delphindin and 
pelargonidin. Anthocyanins have also the ability to form resonating structures in response to 
changes in pH, which is responsible for their relative color. Anthocyanins are unique from other 
flavonoid compounds due to their capacity to form flavylium cations (McGhie 2007). In very 
acidic conditions, this flavylium cation is the predominant form which results in red color 
formation due to the presence of conjugated double bonds with positive charge, while the blue-
purple quinoidal base is formed at pH 7-8 with the loss of protons (Domitrovik 2011). Many of 
the biological activities reported for anthocyanins and proanthocyanidins, and their metabolites, 
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are due to their antioxidant activity from the resulting positively charged oxygen atom in the C-
ring. The hydrogen-donating antioxidant capacity of anthocyanins and their ability for electron 
delocalization make them more effective antioxidants than other flavonoid compounds. 
Anthocyanidin Skeleton                    Anthocyanin (Cyanidin-3-O-glucoside) 
 
 
 
 
 
 
 
 
Figure 2.3. Blueberries, blackberries, and raspberries and their anthocyanidins and anthocyanins. 
 
1.5. Main Anthocyanins in Berries  
 
The anthocyanin profile varies greatly depending on the type of fruit, with the most 
common anthocyanin present in berry fruits being cyanidin derivatives. The relative color of 
berries is also due to the types of anthocyanins present and in what amounts. Table 2.1 presents 
the chemical composition of phenolics, anthocyanins, and proanthocyanidins in different berries 
as well as their antioxidant capacity. Blueberry, bilberry, and blackcurrant contain a wide array 
of anthocyanins while red currant and elderberry contain only one type, cyanidin. Malvidin-3-O-
arabinosides and 3-O-galactosides of cyanidin, delphinidin, petunidin and malvidin are the main 
components of blueberry. Major anthocyanins in blackberry and red raspberry are derivatives of 
cyanidin, with blackberry having much higher levels of anthocyanins than red raspberry, and 
therefore darker colors (Seeram 2008). Three cyanidin glycosides have been detected in red 
Anthocyanidin R1 R2 Color 
Pelargonidin H H Orange to orange-red 
Cyanidin OH H Red to orange-red 
Delphinidin OH OH Pink 
Peonidin OCH3 H Bluish-purple 
Petunidin OCH3 OH Purple  
Malvidin OCH3 OCH3 Red-purple 
C 
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currant extracts, while 3-O-glucosides and 3-O-rutinosides of delphinidin and cyanidin are the 
dominant anthocyanins in blackcurrants. Cranberries have cyanidin- and peonidin-based 
anthocyanin compounds. The major anthocyanin pigments in the Colombian Andes berry are 
cyanidin-3-rutinoside and cyanidin-3-glucoside. Main anthocyanins in the Chilean maqui berry 
are delphinidin and cyanidin glucoside derivatives. Açai berry contains cyanidin-3-O-rutinoside 
and cyanidin-O-glucoside as the main anthocyanin constituents, while acerola has cyanidin-3-α-
o-rhamnoside as its major anthocyanin, and mortiño berries contain predominantly cyanidin-3-
glucosides. Anthocyanins are the major class of phenolics used to characterize several types of 
berries, especially Vaccinium and Ribes species. The potential health benefits from berries differ 
based on the specific compounds present in each berry fruit. Therefore, it is important to 
understand which phenolic compounds are present.   
 Color differences seen in different berry types are due to different anthocyanins present. 
 Anthocyanins may act as antioxidants due to their ability to form a flavylium cation. 
 Predominant anthocyanins from berries are cyanidin derivatives. 
 
              
Proanthocyanins are polymers of anthocyanins with multiple units of flavan-3-ols such as 
catechins and epicatechin that are most commonly linked at the 4 and 8 positions. When this 
carbon-carbon interflavanyl bond is cleaved under strongly acidic conditions, anthocyanidins are 
formed. Proanthocyanidins can be found in many plants, including apples, grape skin and seeds, 
as well as berries like bilberry, cranberry, and black currant. Other foods such as green tea, black 
tea, red wine and cocoa beans, as well as the bark of plants contain polymeric flavonoids. In 
berries, complex tannin composition is composed of highly polymerized compounds. The size of 
these compounds is described as degree of polymerization. Blueberries are known to contain, in 
addition to monomers, proanthocyanidin oligomers and polymers ranging from 2- to 14-units of 
catechin/epicatechin. Flavanols are able to polymerize due to the nucleophilicity of the A-rings, 
susceptibility of the heterocyclic rings to cleavage and therefore subsequent rearrangements, and 
susceptibility to phenol oxidative degradation (Ferreira 2006). Oligomeric proanthocyanidins 
found in skins of peanuts, grapes, and apples, are the di- and tri-mers of catechins. Hydrolyzable 
tannins are gallo- or ellagi- tannins, having structure as seen in Figure 2.4, and the term 
‘complex tannins’ is used to describe polyphenols where there is a proanthocyanidin connected 
to a hydrolyzable tannin through carbon-carbon linkage.  
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Figure 2.4: Basic chemical structures of polymeric phytochemicals found in blueberry and 
blackberry. Condensed proanthocyanidins: catechin and epicatechin; hydrolyzable tannins: 
gallic acid, ellagic acid. 
 
2. Absorption, Distribution, Metabolism, and Excretion of Anthocyanins and 
Proanthocyanidins in Humans  
 
It is helpful to understand the process that anthocyanins follow once they enter the body 
to exert their biological effects, and to understand the mechanism behind their antioxidant 
potential. The positive impact of anthocyanins found in berry fruits on both inflammation and 
diabetes will be presented following a brief introduction of the pathophysiology and biological 
processes that lead to these states in the body. Bioavailability is the proportion of an ingested 
substance that reaches the systemic circulation and thus is available to reach a target tissue. The 
bioavailability of anthocyanins and proanthocyanidins differs from other flavonoids; however, 
they follow a similar pathway. After consumption of flavonoid-rich foods, chewing starts the 
release of compounds from the food matrix. Under certain conditions, the absorption of 
anthocyanins has been determined to start in the stomach, so these compounds may appear 
rapidly in the blood, although the small intestine is the major site of absorption of parent ANC 
(McGhie 2007, Matuschek 2006). 
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Table 2.1. Total phenolics, proanthocyanidins and anthocyanins, and antioxidant capacity of berries based on data available since 2013. 
Berry (Scientific 
name) 
Total Phenolics Proanthocyanidin 
Content 
Anthocyanin 
Content 
Antioxidant 
Capacity 
 
References 
Black currant (Ribes 
nigrum L.) 
 
 
333 mg / 100 g fruit 
1 
 
21.3 ± 8.0 mg CAE /g 
FW 
2 
 
187.7 - 207.8 mg / 100 
g FW
4 
 
11.80 ± 0.60 mg GAE/g 
DW
5
 
1478 ± 280 mg/kg 
FW 
3
 
354 mg / 100 g fruit 
1 
 
162.8 – 180.4 mg / 
100 g FW 
4 
 
93.5± 0.6 mg /100 g 
DW 
5
 
ORAC: 34.5 ± 1.9 
mg TE /g FW, 
DPPH: 25.0 ± 4.1 mg 
TE /g FW 
2
 
1Lugasi A, Hóvári J, Kádár G, 
Dénes F. 2011. Acta Alimentaria, 
40: 52-64.  
2Tarbart J, Franck T, Kevers C. 
2011. Food Chem, 131: 1116-
1122. 3Gu L, Kelm MA. 2004. J 
Nutr, 134: 613-617. 
Red currant (Ribes 
rubrum L.) 
 
192 mg / 100 g 
1 
 
17.97 – 18.1 mg / 100 g 
FW 
4
 
608 mg/kg FW 
6
 46 mg / 100 g 
1 
 
14.7 – 15.9 mg / 100 
g FW 
4
 
 
4Gavrilova V, Kajdz M. 2011. J. 
Agric. Food Chem. 59: 4009–
4018. 
Indian Gooseberry 
(Emblica officinalis 
Gaertn.) 
188.8 – 237.0 mg GA/g 
DW 
7
 
   
5Samappito S, Butkhup L. 2010. 
Int J Fruit Sci, 10: 264-280. 
Cranberry (Vaccinium 
macrocarpon Ait) 
192.3 mg/100 g FW 
8
 4188 ± 750 mg/kg 
FW 
3
 
83.3 mg / 100 g FW 
8
  
6Wu X, Gu L. 2004. J Agric Food 
Chem, 52: 7846-7856. 
Blueberry (Vaccinium 
corymbosum L., 
angusifolium Ait., 
ashei Reade) 
 
2269 – 3699 mg / kg 
FW 
9 
 
48.9 ± 2.41 – 362 ± 
29.9 mg GAE / g FW 
10 
 
11.30± 0.23 mg GAE/g 
DW 
5
 
1798 ± 508 mg/kg 
FW 
3
 
116 ± 12.2 – 197 ± 
19.8 mg / 100 g FW 
10 
 
80.16 ± 0.26 mg 
/100g DW 
5
 
ORAC: 36.7 – 77.6 
mmol TE / kg FW 
11 
 
ORAC: 44.4 ± 2.14 – 
55.7 ± 2.94 µmol TE 
/ g FW 
12
 
 
7Polantov, EA, Shikov AN, 
Dorman HJD. 2009. Phytother 
Res, 23: 1309-15.  
 8Viskelis P, Rubinskiene M., 
Jasutiene I. 2009. J Food Sci, 74: 
C157-C161. 
Blackberry (Rubus sp.) 
 
2922 - 4464 mg / kg 
FW 
9
 
379 mg / 100 g fruit 
1
 
270 ± 170 mg/kg 
FW 
3
 
145 mg / 100 g 
1
 ORAC: 49.4 – 76.1 
mmol TE / kg FW 
9
 
9Cho M, Luke R Howard L, Prior 
R, Clark J. 2005. J Sci Food 
Agric, 85 (13): 2149-2158. 
Raspberry (Rubus 
idaeus) 
219 -244 mg / 100 g 
1 
 
4.2 ± 0.4 mg GAE/g 
DW 
5
 
302 ± 230 mg/kg 
FW 
3
 
1.0-41.9  mg / 100 g 
1 
 
79.2 mg /100 g FW 
12
 
 
17.9 ± 0.2 mg /100 g 
DW
5
 
12.8 -48.8 µmol TE / 
g seed oil 
11
 
10You Q, Chen F, Huang Z. 2011. 
Food Chem, 125: 201-208.  
11Parry J, Su L., Luther M. 2005. 
J Agric Food Chem, 53(3): 566-
573. 
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DPPH: 2,2-diphenyl-1-picrylhydrazyl; ORAC: Oxygen Radical Absorbance Capacity; GAE: Gallic acid equivalents; C3G: cyanidin-3-glucoside 
equivalents; CE: Catechin equivalents; DW: dry weight; FW: fresh weight; FRAP: ferric reducing antioxidant power; TE: trolox equivalents; 
TEAC: Trolox equivalent antioxidant capacity.    
Table 2.1 (contd.) 
 
    
 
Boysenberry (Rubus 
ursinus x idaeus) 
  1514 µg /g FW 
13
 21.1 – 77.9 µmol TE 
/ g seed oil 
11
 
12Koponen JM, Happonen, A. M. 
2007. J Agric Food Chem, 55: 
1612–1619. 
Mulberry (Morus 
atropurpurea Roxb.) 
13.14 ± 0.09 mg GAE/g 
DW 
14
 
 228.78 ± 1.08 mg 
/100g DW 
14
 
 
13Scalzo J, Currie A. 2008. 
BioFactors, 34: 13-21. 
Elderberry (Sambucus 
canadensis and S. 
nigra) 
277 – 582 mg GAE / 
100 g berries 
15 
 
2240 mg GAE /L juice 
16
 
 106 – 444 mg C3G / 
100 g berries
15 
 
700 mg / 400 mL 
juice 
16
 
TEAC: 9.2 mmol / 
400 mL juice, TRAP: 
16.8 mmol / 400 mL 
juice 
16
 
14Wu X, Liang, L.  Zou, Y. 2011. 
Food Chem, 129: 443-453. 
Andes berry (Rubus 
glaucus Benth) 
294 ± 37.2 mg GAE / 
100 g FW 
17
 
 45 ± 7.1 mg / 100 g 
FW 
17
 
FRAP: 4.5 ± 1.2 
mmol TE / 100 g FW 
17
 
15Lee J, Finn C. 2007. J Sci Food 
Agric, 87: 2665–2675. 
Acerola (Malphighia 
emarginata) 
  3.8 to 59.74 mg/100 
g pulp 
18
 
 
16Netzel M, Strass G., Herbst M. 
2005. Food Res Int, 38: 905-910. 
Bilberry (Vaccinium 
myrtillus) 
  955.7 mg/100 g FW 
12
 
 
17Garzon GA, Riedl KM. 2009. J 
Food Sci, 74: C227–C232. 
Chokeberry (Aronia 
spp.) 
714.1 ± 7.4 mg/g 
extract 
19
 
 695.3 mg/ 100 g FW 
12
 
404.5 ± 4.9 
19
 
 
18Lima VLAG, Melo EA, Maciel 
MIS, Lima DES. 2003.   Ciênc. 
Tecnol. Aliment. 23:101–103.  
Crowberry (Empetrum 
spp.) 
  609.6 mg/100g FW 
12
  
19Frejnagel, S. 2007. Pol J Food 
Nutr Sci. 57: 83-86. 
Maqui berry 
(Aristotelia chilensis) 
17879 ± 755.9 µmol CE 
/g extract 
20
 
 137.6 ± 0.4 mg / 100 
g FW 
21
 
ORAC: 8941.5 – 
31926.5 µmol TE/ g 
extract 
20
 
20Cespedes C, Valdez-Morales M, 
Avila JG, El-Hadifi M, Alarcon J, 
Paredes-Lopez O. 2010. Food 
Chem, 119: 886-895. 
Mortiño (Vaccinium 
floribundum Kunth.) 
882 mg GAE / 100 g 
FW 
22
 
 345 mg cyanidin / 
100 g FW 
22
 
1200 mg TE / 100 g 
FW 
22
 
21Escribano-Bailon MT, Alcalde-
Eon C. 2008. Phytochem Anal, 
17: 8-14. 
Marionberry (Rubus 
hybrid) 
   3.9 – 17.2 µmol TE / 
g seed oil 
11
 
22Vasco C., Riihinen K, Ruales J, 
Kamal-Eldin A. 2009. J Agric 
Food Chem, 57: 8274-81. 
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Recent evidence has indicated that the major metabolites of ANC are produced due to 
fermentation by the gut microbiota and their subsequent absorption in the colon (Del Rio 2010, 
McGhie and Walton 2007). Many phenolic compounds that reach the lower intestines intact are 
then hydrolyzed by the cecal microflora glycosidases and subsequently absorbed. Glucosidases 
are enzymes involved to release the aglycone form from the sugar attachment, primarily to 
release glucose. As the free aglycones have sugar groups removed, they are much smaller than 
the glycosides and are able to be absorbed through the epithelial layer of the intestines passively. 
The major metabolites have been identified as protocatechuic acid (PCA), along with other 
phenolic acids that have been identified in plasma following ANC consumption such as vanillic 
acid, syringic acid, caffeic acid, and ferulic acid (Vitaglione 2007, deFerrars 2014a).  
Bioavailability of proanthocyanidins is largely dependent on the degree of 
polymerization. Oligomeric proanthocyanidins are generally poorly absorbed across the 
intestine, and may be hydrolyzed to monomers, dimers, and trimers, especially in acidic 
environment such as the stomach (Ou and Gu 2013). The dimers and trimers of 
proanthocyanidins may be absorbed intact, or further degraded to their flavan-3-ol monomers in 
the intestinal lumen. Intact glycosides are absorbed by the sodium-dependent glucose transporter 
(SGLT1) and in some part by inefficient passive diffusion. Differing from other flavonoids that 
have their sugar moiety removed before being absorbed, human studies and animal models have 
shown that anthocyanins in the glycosidic form can be rapidly absorbed in the jejunal portion of 
the small intestine (Matuschek 2006). Acylated flavonoids do not have a free sugar available to 
bind glucose transporters, have a lower affinity for the bilitranslocase transporter, and are not 
recognized for absorption in the small intestine and therefore these unabsorbed flavonoid 
molecules may be absorbed farther downstream (Passamonti 2005). In the colon, anthocyanins 
may undergo hydrolysis by colonic bacteria which releases the sugar moiety and the aglycone for 
marginal absorption (Keppler and Humpf 2005). The aglycone may then be further degraded to 
phenolic acids, and other conjugated metabolites, which may be absorbed, reenter the jejunum 
with bile, and enter circulation again. Proanthocyanidins may be partially metabolized by 
intestinal microbiota to phenolic acids and other derivatives. Following absorption, anthocyanins 
and proanthocyanidins are transported to the liver via portal circulation and undergo phase II 
metabolism, where they form glucuronide and sulfate or methyl conjugates. 
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Unabsorbed flavonoid molecules are then excreted through feces, with intact 
anthocyanins and aglycone anthocyanidins largely excreted in urine. Overall, the percentage of 
anthocyanins excreted in urine is low, but the excretion of metabolites that are produced in the 
colon can be important to producing beneficial effects attributed to anthocyanins. Recent studies 
utilizing a 
13
C-labelled ANC have indicated that the relative bioavailability of C3G may in fact 
be closer to 12% based on recovery in urine or breath. This indicates that given the degradation 
of the parent compound that occurs, the low Cmax (ranging from 1.4 to 547 nM) and the short t1/2 
(between 0.5-1.5 h), most observed benefits from consumption of ANC are probably due to the 
metabolites such as PCA which are present in circulation at much higher concentrations (Czank 
2013, de Ferrars 2014b). Many studies suggest anthocyanins are able to cross the blood-brain 
barrier and the blood-retinal barrier, thereby providing protection to these tissues. 
Proanthocyanidins may be distributed to tissues including the kidney, lung, spleen, and 
connective tissue (Ferreira 2006). Low levels of tissue dispersion and accumulation indicate that 
potential for toxicity is very low, making these polyphenols valuable compounds to exert health 
benefits. Only intact anthocyanins glycosides have been detected in urine and plasma, possibly 
due to low detection of the large amount of metabolites that form. Anthocyanins, 
proanthocyanidins, and their metabolites may be excreted in urine, feces, bile, or via respiration 
(Netzel 2005, Czank 2013). 
 Human consumption of anthocyanins is among the highest of all flavonoids as they are 
pigments widely found in fruits and vegetables. 
 Absorption occurs in the stomach, and mainly in the small intestine with very efficient 
epithelial tissue uptake. 
 Bioavailability of anthocyanins in terms of transport into plasma and excretion appears to be 
limited and dependent on the chemical nature of the compound. 
 
3. Antioxidant Capacity  
 
One of the most important benefits of consuming berries is the antioxidant capacity of the 
anthocyanins. Oxidative stress in the body from accumulation of reactive oxidative species leads 
to the oxidation of necessary enzymes and proteins in the body, which can lead to chronic 
diseases. Anthocyanins reduce some chronic diseases by scavenging these free radicals and 
therefore reducing the oxidative stress in the body. This antioxidant activity may occur through 
several processes: decreasing oxygen concentrations, preventing initiation of reactive oxygen or 
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nitrogen species, or binding of metal ions, decomposing peroxides, and scavenging intermediate 
radicals that may form during normal metabolism (Miguel 2011). Significant increases in plasma 
antioxidant activity have been seen after humans consume berry juices. There are several assays 
to study the potential antioxidant and free-radical scavenging activity of berries after 
consumption. One assay to measure the antioxidant capacity is the Trolox equivalent antioxidant 
capacity (TEAC) assay, which is based on the ability of a compound to quench a long-lived 
radical as compared to Trolox, a vitamin E analog. Similar is the oxygen radical absorbance 
capacity (ORAC) assay, based on hydrogen-transfer ability. Another assay is the ferric reducing 
ability/power assay, otherwise known as FRAP, based on the ability of the compound to reduce 
Fe
3+
 to the ferrous form as a marker of reducing ability of an antioxidant. There is also the 2,2-
diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay, based on electron transfer. The 
ability of anthocyanins to support an unpaired electron or donate a hydroxyl group to a free 
radical differs between anthocyanins and is dependent on the structure. Generally, anthocyanins 
with more hydroxyl groups or fewer sugar units are associated with having a greater antioxidant 
capacity. Much of the data for the antioxidant capacity is from in vitro studies and may not lead 
to the same conclusions for anthocyanins studied after in vivo human consumption, so it is 
important to consider results from both types of studies. Once the antioxidant activity has been 
determined using in vitro models, feeding trials using animal models, or human studies can 
determine if there are similar effects after everyday consumption.  
Anthocyanins have been able to increase plasma antioxidant levels, though it seems clear 
that the metabolites rather than the parent compounds are responsible for these effects. However, 
after elderberry juice consumption, a direct association was found between plasma antioxidant 
capacity and total phenolics through the detection of unchanged glycosylated anthocyanins in 
healthy human volunteers vi HPLC spectrophotometry (Netzel et al. 2002). Also, an increase in 
plasma antioxidant capacity 2 h after oral consumption of black currant anthocyanins was 
observed. Consumption of berry fruits over several weeks has been shown to significantly 
increase plasma antioxidant capacity in elderly individuals. These human feeding studies that 
show an increase in plasma antioxidant capacity is also supported by numerous animal studies, 
and in vitro studies of anthocyanin antioxidant capacity. The antioxidant capacity exhibited by 
berry fruits attributed to their anthocyanins has a positive impact on the overall health. 
Antioxidant capacity may be especially important for preventing or delaying complications 
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associated with specific physiological states that occur during inflammation, diabetes and 
cardiovascular disease through the reduction of oxidative processes.  
 
4. Health Benefits: Anti-inflammatory Effect 
 
Inflammation is a normal part of the immune response to tissue injury and is necessary 
for defense mechanisms; however, prolonged and uncontrolled inflammation can result in a 
number of diseases. Reactive oxygen and nitrogen species, which include superoxide anions, 
hydroxyl radicals, hydrogen peroxides, nitric oxide, and singlet oxygen, are generated by 
inflammatory cells. In response to inflammatory state, many proteins such as cytokines are 
released by macrophages to deal with the stress on the cell. These proteins and inflammatory 
chemicals may injure important molecules such as proteins and lipids and attack normal tissues, 
resulting in harmful oxidative damage and thus inflammation. Several human diseases have 
recently been linked with this resulting chronic inflammatory state and include neurological 
disorders, cancers, cardiovascular diseases, obesity, metabolic diseases, and skeletal or muscular 
disorders. Chronic inflammatory diseases have been inversely correlated with the consumption 
of fruits and vegetables that are rich in flavonoids. Many types of flavonoids including 
anthocyanins may exert anti-inflammatory potential through their effect on molecular 
mechanisms and signally pathways involved with inflammation.  
Through in vitro studies of the inhibition of these inflammatory markers using cell 
culture, the potential for berries and berry compounds and their mechanism of action can be 
determined and later used for more in depth studies involving animals or humans. Anthocyanins 
from berry fruits have been seen to affect both acute and chronic inflammation through exerting 
their antioxidant effects. Cyclooxygenases convert the polyunsaturated fatty acid arachidonic 
acid to prostaglandins that stimulate inflammation, so the inhibition of these compounds is very 
important for decreasing inflammation. Nitric oxide synthases (NOSs) are multidomain 
metalloproteins responsible for the synthesis of the agent nitric oxide (NO). Highly selective 
inhibitors of inducible NOS (iNOS) have been identified and some of these have potential in the 
treatment of inflammatory conditions in which iNOS has been implicated. Anthocyanins have 
been found to inhibit several of these inflammatory markers including cyclooxygenase-2 (COX-
2) expression or inhibiting inducible nitric oxide (iNOS). Açai berries have been found to inhibit 
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the activity of cyclooxygenases (COX) -1 and -2 in vitro, and extracts have been seen to have 
direct action to inhibit the production of nitric oxide (NO) in cultured cells, with possible 
involvement on both acute and chronic processes. Incorrect regulation of the nuclear factor 
kappa enhancer of activated B cells (NF-κB) protein complex pathway, which controls the 
transcription of DNA, is involved with inflammation and cancers. Human studies with 
polyphenol-rich foods have shown decreases in plasma concentrations of inflammatory 
mediators associated with NF-κB activation. 
  Correlations have been suggested between obesity and inflammation, and the role of 
berries to improve inflammatory responses associated with obese or overweight humans has also 
been studied. Increased adipose tissue associated with obesity leads to the secretion of pro-
inflammatory factors. Elevated levels of the pro-inflammatory cytokine tumor necrosis factor-
alpha (TNF-α) synthesized in adipocytes during obese states is also associated with insulin 
resistance (Tzanavari 2010). Compared to a control group fed no blueberries, fresh blueberries 
and blueberry puree fed to obese children decreased oxidant species and slightly reduced clinical 
and chronic inflammatory markers (Giongo 2011). Intervention strategies involving fresh fruit 
high in antioxidants, such as blueberries, show promise to reduce the potential onset of morbidity 
in overweight and obese individuals during childhood. Consumption of black currant 
anthocyanins by healthy individuals before exercise alleviated the exercise-induced oxidative 
stress, usually resulting in an acute inflammatory response (Lyall et. al. 2009). Berries have been 
found to reduce inflammatory responses in a variety of obese conditions in humans. Along with 
obesity, chronic low grade inflammation is a characteristic feature of metabolic syndrome, and is 
a major risk factor for developing type 2 diabetes.  
 Anthocyanins from berries can inhibit markers of inflammation. 
 Berries have been seen to reduce inflammatory responses and reduce the potential morbidity 
associated with inflammation due to obesity. 
 
5. Diabetes Pathology and Current Treatments 
 
Type-2 diabetes mellitus occurs when the body loses the ability to uptake blood glucose 
as a result of insulin resistance or beta-cell dysfunction, resulting in hyperglycemia. Normally, 
insulin is synthesized and secreted from the beta-cells in the pancreas that acts to reduce glucose 
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production and output in the liver. Insulin also facilitates glucose uptake in skeletal muscle and 
decreases lipolysis in adipose tissues. Both obesity and diabetes contribute to the metabolic 
syndrome, which is characterized by low-grade inflammation, oxidative stress, hyperlipidemia, 
impaired glucose tolerance, and insulin resistance. Increases of glucose and fatty acid in skeletal 
muscle, liver, and adipose tissue occurs due to insulin resistance and results in metabolic 
disorders such as fatty liver diseases, type-2 diabetes, chronic kidney disease, and heart diseases. 
Severe end-stage diabetes may result in long-term complications such as poor circulation, 
diabetic retinopathy, stroke, heart disease, kidney failure, or even death. Glycated hemoglobin 
that forms due to glycation of proteins during chronic hyperglycemia is a diagnostic marker for 
type-2 diabetes along with fasting blood glucose and impaired glucose tolerance levels. 
There are many currently available pharmacological treatments to correct dysfunctions 
that lead to type-2 diabetes, insulin resistance and impaired insulin secretion (Cuny 2012). Oral 
medications include insulin sensitizers (metformin and thiazolidinediones) and insulin 
secretagogues (sulfonylureas, glinides, and recent incretin mimetics). Digestive enzyme targets 
include alpha-amylase and alpha-glucosidase; α-amylase is secreted by the pancreas and is 
involved in starch hydrolysis, while α-glucosidase is an intestinal enzyme involved in the 
absorption of glucose. Inhibition of glucosidase enzymes results in decreased postprandial 
hyperglycemia, the increase in blood glucose levels seen after a meal. Because secretion of 
insulin may be impaired due to the dysfunction of the beta cells, drugs called sulfonylureas act to 
increase insulin production by binding to ATP-potassium channels on the cell membrane of 
pancreatic beta cells in addition to lowering the glucose uptake. However, this pharmaceutical 
treatment can eventually lead to hypoglycemia; therefore it is desirable to search for natural 
compounds that increase insulin secretion without this adverse recovery effect. Natural inhibitors 
of enzymes and promoters of insulin secretion from fruits would be able to control postprandial 
hyperglycemia, the increase in blood glucose levels seen after a meal, without side effects of 
digestive problems or hypoglycemic incidents that may be associated with current therapeutic 
drugs. Berries included in a healthy diet are able to affect these clinical targets of diabetes in a 
non-synthetic way.  
Current dietary recommendations for people with diabetes are to follow a healthy diet, as 
is recommended for a general healthy population. Unfortunately, fruit and vegetable intake 
among people with diabetes tends to be low due to the misperception of adverse effects from 
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fruit sugars on blood glucose levels. The American Diabetes Association suggests that people 
with diabetes incorporate whole grains, vegetables, and fruits into a diet containing moderate salt 
and sugar and that is low in fat, especially saturated fats and trans- fats. Besides the many 
vitamins, minerals, and fiber, fruits also contain carbohydrates. These carbohydrates make fruits 
important to include in meal planning for people with diabetes in exchange for other 
carbohydrates such as starches, grains or dairy. One serving of fruit, equivalent to ¾ to 1 cup of 
berries, has about 15 g of carbohydrate. Fruit consumption is encouraged to increase the average 
consumption of fruits and vegetables by the U.S. consumer who is currently consuming less than 
2 cups per day. Due to their convenience and cost, fresh or freshly frozen common berry fruits 
including blackberries, blueberries, and raspberries are an ideal fruit choice to include in meal 
planning.  
 
5.1. In Vitro Clinical Targets  
 
Inhibition of starch degrading and glucose absorbing enzymes results in decreased 
glucose available to the body, making it easier for the body to handle glucose already present in 
insulin resistance states that occurs with the development of type 2 diabetes. The mechanism of 
inhibition of alpha-glucosidase by anthocyanins is not clear, but it is thought to be a competition 
between the normal substrate and the glucosyl groups linked to the anthocyanins. This structural 
similarity allows anthocyanins to bind to the enzyme, but not be hydrolyzed, and is the method 
employed by acarbose, a pharmaceutical drug for hyperglycemic management. The effects of 
berry compounds have been studied and are summarized in in vitro models (Table 2.2). 
Cranberry powders have been shown to inhibit alpha-glucosidase while having a lowered alpha-
amylase inhibition, resulting in fewer undesirable gastrointestinal side effects associated with 
excessive alpha-amylase inhibition. Additionally, there may be a synergistic effect between 
acarbose and cyanidin-3-galactoside, which could lead to a reduced dose of acarbose needed for 
the treatment of type 2 diabetes. Anthocyanins from raspberries and other berry fruits have 
shown potential to improve glucose control in diabetics through interacting with alpha-amylases 
(McDougall 2005) and through inducing insulin secretion (Jayaprakasam 2005). The 
anthocyanins abundant in fruits, especially pelargonidin, promote the secretion of insulin by the 
body and may represent a beneficial role in preventing type 2 diabetes.  
 28 
 
Inflammatory markers may have increased expression with the development of type 2 
diabetes, and are likely to contribute to the development of insulin resistance. An excess of pro-
inflammatory cytokines including CRP, IL-1, IL-6, and TNF-α, can result in beta-cell 
dysfunction, affecting both insulin secretion and reduced insulin-dependent signaling, resulting 
in insulin resistance. A study with humans at risk for cardiovascular disease  found that plasma 
concentrations of pro-inflammatory cytokines including CRP, and IL-6, and IL-15, and 
monokine induced by INF-γ (MIG) were all significantly decreased in those receiving bilberry 
juice for 4 weeks compared to the group receiving water (Karlsen et al. 2010). As these are all 
target genes of NF-κB, the transcription factor crucial for initiating inflammatory responses that 
lead to insulin resistance, consumption of berries can be seen to positively impact inflammation 
related to diabetes in humans. Flavonoids like anthocyanins interfere with the pro-inflammatory 
cytokines to decrease their production and their induced beta-cell dysfunction or degradation that 
leads to reduced insulin output. They also work to up-regulate the insulin-dependent signaling 
and improve glucose uptake in many cell and tissue types. Severe end-stage diabetes may result 
in long term complications such as diabetic retinopathy or death. Therefore, it is important to 
investigate the potential for berry consumption to reduce metabolic disease precursors including 
obesity and insulin resistance.  
 
5.2. Anti-Diabetic Studies Using Animal Models  
 
There are many studies investigating the anti-diabetic properties of berries in animal 
studies. The effects of anthocyanins on health have also been studied and are summarized for 
their anti-inflammatory and anti-diabetic properties in animal models (Table 2.3). One study 
found decreased whole-body insulin resistance in mice fed blueberry powder. Anthocyanins may 
protect beta-cells from glucose-induced oxidative effects, as seen by protective effects of 
boysenberry on diabetic rats. Black chokeberry ingestion has been seen to improve antioxidant 
status in a rat model of prediabetes, resulting in hypoglycemic actions, and may be a promising 
supplemental option for the prevention and treatment of metabolic syndrome and related 
diseases. The lowered blood glucose concentrations in this study were attributed partly to the 
inhibition of maltase and sucrose enzymes, similar to the action seen by inhibition of the alpha-
glucosidase enzyme in several studies.  
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Table 2.2. Other health beneficial properties or in vitro results attributed to berries and berry compounds. 
Berry Dose of Treatment Proposed target Model Results Reference 
Black currant 
(Ribes nigrum L.) 
 
 
1 µg/mL black currant juice Endothelial nitric oxide 
synthase (eNOS) 
activation 
 
Human umbilical vein 
endothelial cells 
(HUVECs) 
 
Significant increase in 
phosphorylation of Akt 
and eNOS 
Edirisingh I, Banaszewski. 
(2011). J Agric Food Chem, 
59: 8616–8624.  
0.5–10 mg/mL blackcurrant total 
polyphenolic extract (BC-T), 
enriched anthocyanin sub-extract 
(BC-A) or enriched 
proanthocyanidin sub-extract 
(BC-P)  
 
Airway inflammation 
related to asthma via IL-
4-stimulated eotaxin-3 
(CCL26) 
Human alveolar 
endothelial cell line 
(A549) 
Procyanidins (but not 
anthocyanins) in 
blackcurrant suppressed 
both IL-4 and IL-13 
stimulated CCL26 
secretion, a factor in 
eosinophil recruitment 
Hurst SM, McGhie TK, 
Cooney JM. (2010). Mol 
Nutr Food Res, 54 Suppl 
2:S159-70. 
 
 
Dietary black currant skin extract 
for 4 wks before initiation and 22 
wks after 
Chemoprevention 
 
Rat liver carcinogenesis 
 
Up-regulation of Bax 
and down-regulation of 
Bcl-2 expression which 
encourages the 
development of 
chemopreventative 
agents 
Bishayee A, Mbimba T, 
Thoppil RJ, Haznagy-Radnai 
E, et. al. (2011). J Nut 
Biochem, 22: 1035-1046. 
Cranberry 
(Vaccinium spp.) 
1-200 mg/mL cranberry powders Postprandial reduction in 
glucose via inhibition of 
starch breakdown 
In vitro assays for 
inhibition of α-amylase, 
α-glucosidase, and 
angiotensin I-converting 
enzyme (ACE) 
High α-glucosidase 
inhibition with limited α-
amylase inhibition at 5 
mg/mL, significant ACE 
inhibition at 100-200 
mg/mL   
da Silva-Pinto, MS, Shetty 
K. (2010). American 
Chemical Society: 
Washington, DC, Ch. 8. 
 
 
Vaccinium arctostaphylos berry 
anthocyanin 
In vitro diabetes models Pancreatic alpha-amylase 
inhibition 
 
The IC50 of alpha-
amylase inhibition was 
1.91 (1.89-1.94) mg/mL 
Nickavar B, Amin G. (2011). 
Iranian J Pharm Res. 
65:567-70. 
Blueberry 
(Vaccinium  
corymbosum) 
 
100, 200, or 300 mg/kg crude 
alcoholic extract of Vaccinium  
corymbosum 
 
Anti-inflammatory and 
antinociceptive properties 
Male Wistar rats, n=6 
(200-250 g) and male 
Swiss mice,  (40-45 g) 
 
Dose-dependently 
reduced rat paw edema 
and inhibited 
myeloperoxidase 
activity, related to 
inhibition of pain and 
inflammation 
Torri E, Lemos M, Caliari V. 
(2007). J Pharm Pharmacol., 
59:591-6. 
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Table 2.2 (contd.)      
Blackberry (Rubus 
sp. Rosaceae) 
 
3.8 μmol anthocyanins/g diet 
using a) 5% whole BRB powder, 
b) anthocyanin-rich fraction, c) an 
organic solvent-soluble extract, or 
d) an organic-insoluble fraction 
(containing 0.02 μmol 
anthocyanins/g diet) 
Esophageal tumors  F344 rats 
 
Anthocyanins in 
blackberry suppressed 
tumor growth 
Wang SL, Hecht SS, 
Carmella SG. (2009). 
Cancer Prev Res (Phila) 
2:84-93. 
 
 
Maqui berry 
(Aristoltelia 
Chilensis) and 
Mortiño 
(Vaccinium 
floribundum)  
100 µmol/ L (C3G or epicatechin 
equivalent) phenolic extracts from 
both berries, treatment for 24 h 
Cardiovascular risk 
factors such as 
adiopogenesis and lipid 
accumulation 
3T3-L1 adipocytes and 
RAW 264.7 macrophage 
Inhibited lipid 
accumulation by 4.0 – 
10.8%, decreased 
production of 
inflammatory markers 
NO, PGE2, iNOS, and 
COX-2  
Schreckinger M, Wang J, 
Yousef G, de Mejia E. 
(2010). J Agric Food Chem, 
58: 8966-8976. 
Elderberry 
(Sambucus nigra 
L.) 
200, 300 or 400 mL of elderberry 
juice (containing 361, 541 and 
722 mg total anthocyanins) 
Excretion & biological 
activity of anthocyanin 
Healthy humans (4 men 
and 4 women) 
Most absorption was 
through the stomach and 
intestines, skin is able to 
easily take up 
anthocyanins, small 
amounts are excreted in 
urine. 
Netzel M, Strass G, Herbst 
M. (2005). Food Res Int, 38: 
905-910. 
 
Serviceberry 
(Amelanchier 
alnifolia), 
cranberry 
(Viburnum 
trilobum), 
chokeberry 
(Prunus 
virginiana) and 
buffaloberry 
(Shepherdia 
arentea) 
5 μg/mL of berry samples 
dissolved in DMSO; frozen 
berries were lyophilized, dried, 
and extracted with 80% ethanol  
Diabetic microvascular 
complications, 
hyperglycemia, pro-
inflammatory gene 
expression, metabolic 
syndrome symptoms 
L6 cells, a cell model for 
studying insulin action 
Polar constituents 
(phenolic acids, 
anthocyanins and 
proanthocyanidins) were 
hypoglycemic agents and 
strong inhibitors of IL-
1βand COX-2 gene 
expression 
Burns Kraft TF, Dey M, 
Rogers RB, Ribnicky DM et 
al. (2008). J Agric Food 
Chem, 56:654-60. 
 
 
Akt: protein kinase B, Bcl-2: B-cell lymphoma 2, Bax: Bcl-2-associated X protein, COX-2: cyclooxygenase 2, DMSO: dimethyl sulfoxide, IC50: half maximal 
inhibitory concentration, IL-4: interleukin-4, IL-13: interleukin-13, IL-1β: interleukin-1 beta, iNOS: inducible nitric oxide synthase, NO: nitric oxide, PGE2: 
prostaglandin E2.
 31 
 
Table 2.3. Anti-inflammatory or anti-diabetic properties attributed to berries and berry compounds in in vivo animal studies. 
Berry Dose of Treatment Proposed target Model Results Reference 
Black currant 
(Ribes nigrum L.) 
 
 
Single-dose black currant 
anthocyanin 
Absorption & 
Excretion 
 
20 male WHHL 
hyperlipidemic rabbits, 6 
wks old 
Higher absorption from juice than 
from anthocyanin fraction extract, 
WHHL rabbits are comparable to 
humans and are useful models of 
CVD development 
Nielsen ILF, Dragsted LO, 
Ravin-Haren G. (2003). J 
Agric Food Chem, 51: 
2813-2820. 
 
Red currant (Rhus 
chirindensis) 
 
 
RCE, 50–800 mg/kg i.p., DIC, 
100 mg/kg i.p., distilled water 
as control for inflammation; 
STZ, (75 mg/kg, in 0.1 mol/l 
citrate buffer at pH 6.3), and 
distilled water as control for 
diabetes 
Inflammation and 
diabetes 
Balb C male and female 
mice and Wistar rats with 
induced diabetes mellitus 
through injections of 
streptozotocin (STZ). 
Pretreatment with high doses of 
stem-bark extract significantly 
reduced blood glucose 
concentrations of fasted normal 
and fasted diabetic rats. 
Ojewole JAO. (2005). J 
Ethnopharmacol, 113: 
338-345. 
 
Indian Gooseberry 
(Emblica offcinalis) 
 
 
1 mL/kg/orally/day fruit juice 
(541.3 mg GAE/1 g extract) 
for eight weeks 
Diabetes-induced 
myocardial 
dysfunction 
STZ-induced type 1 
diabetic male Wistar rats 
(200-250 g) 
Fruit juice treatment decreased 
serum glucose and myocardial 
damage associated with type 1 
diabetes mellitus (attributed to 
concentration of polyphenols) 
Patel SS, Goyal RK. 
(2011). Exp Clin Cardiol, 
16:87-91. 
Blueberry 
(Vaccinium spp.) 
 
 
Single dose oral administration 
of ethanolic extract of 
Vaccinium arctostaphylos 
Antidiabetic effect Alloxan-diabetic male 
Wistar rats 
 
47% and 56% inhibitory effects of 
the extract on activity of intestinal 
maltase and sucrase enzymes 
Feshani AM, Kouhsari 
SM, Mohammadi S. 
(2011). J Ethnopharmacol, 
133:67-74. 
Low-fat, high-fat, or high-fat 
+BB (with 4% wt:wt blueberry 
(V. ashei and V. corymbosum) 
powder (14.5 MJ/kg) for 8 wks 
 
Obesity-associated 
pathology of 
adipocyte death and 
inflammation 
High fat fed male 
C57BI/6j mice, n=8/diet 
 
 
Shift of global upregulation of 
inflammatory genes (TNF-α, IL-6, 
MCP1, iNOS) from high fat diet 
was attenuated or nonexistent with 
+BB diet 
Defuria J, Bennett G, 
Strissel KJ. (2009). J Nutr, 
139:1510-6. 
1% freeze-dried lowbush 
blueberries (BB) in a AIN-93G 
diet for 20 weeks and 5 weeks 
CD36 and SR-A 
scavenger 
promoters and foam 
cell formation 
ApoE-/- mice, female, 4 
wk old 
Fewer oxidized LDL-induced foam 
cells, lower gene and protein levels 
of PPARγ, showing athero-
protective effects of BB 
Xie C, Kang J, Chen J, 
Lazarenko O. (2011). 
Food and Function, 2:588-
94. 
Mulberry (Morus 
Lhou Koidz.) 
 
 
Mulberry methanol 
extracts(ME), authentic 
anthocyanin (10 mg C3G/ kg 
BW) 
Inflammation-
related 
hematological 
parameters 
32  male Sprague-Dawley 
rats (180 ± 1 g) injected 
with carageenan 
Anti-inflammatory effects of ME’s 
when administered prior to 
caregeenan treatment and similar 
C3G treatment 
Kim AJ, Park S. (2006). J 
Med Food, 9:431-5. 
Açai (Euterpe 
oleracea) 
500, 1000 and 1500 mg/kg 
(Euterpe oleracea oil) OEO  
orally 
 
Inflammation and 
hyperalgesia 
Male albino Wistar rats 
(180-200 g) and male 
albino Swiss mice (20-25 
g) 
Significantly inhibited the 
granuloma test, a chronic 
inflammatory model, and 
decreased histamine action, 
showing the effect on the acute 
inflammatory process 
Favacho Hugo AS, 
Oliveira Bianca R. Santos 
Kelem C. (2011). 
Brazilian J 
Pharmacognosy, 21: 105-
114. 
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Table 2.3 (contd.)     
Chilean wild 
blackberry 
(Aristotelia 
chilensis) 
 Aristotelia chilensis Mol 
(Stuntz.) subfractions,  
Inflammation and 
carageenan-induced 
rat paw edema & 
gastro protection 
Adult male Wistar rats, 4-
5 wks old, 200-250 g 
Extracts have anti-inflammatory, 
anti-edema, and reduction in 
gastric lesion number, length, and 
amounts 
Céspedes C, Alarcon J, 
Avila G, El-Hafidi M. 
(2010). Boletín 
Latinoamericano y del 
Caribe de Plantas 
Medicinales y Aromáticas, 
9: 432-439. 
Omija (schizandra 
chilensis) 
Omija pulp/seed extract (OPE) 
treatment at 0.5 g/kg  
Hyperglycemia 
induced by sucrose 
loading 
Sprague-Dawley rat 
model and in vitro assays 
for enzyme inhibition 
Potent α-amylase inhibition, potent 
α-glucosidase inhibition, 
significant decrease of blood 
glucose 
Jo SH, Ha KS, Moon KS. 
(2011). Int J Mol Sci., 
12:1359-70. 
Black choke berry 
(Aronia 
melanocarpa) 
Fruit juice 10 and 20 ml/kg  Glycaemia and 
lipidemia 
Streptozotocin-induced 
diabetic rats 
Significant reduction in plasma 
glucose and triglycerides 
Valcheva-Kuzmanova S, 
Kuzmanov K, Tancheva S. 
(2007). Methods Find Exp 
Clin Pharmacol, 29:101-5. 
Bilberry (Vaccinium 
myrtillis) 
0.02% bilberry anthocyanin-
rich extract 
 
Inflammation and 
cardiovascular 
disease 
Apo-E deficient mice Reduced plasmatic total 
cholesterol and hepatic triglyceride 
levels, but the plasmatic 
antioxidant status remained 
unchanged. 
Mauray A, Felgines C, 
Morand C. (2010). Genes 
Nutr, 5: 343–353. 
Daily dosage of 40 
mg/kg Vaccinium myrtillis in 5 
mL drinking water 
Capillary filtration 
of albumin (CFA), 
skeletal muscle 
permeability 
Male Wistar 
streptozotocin-induced 
diabetic rats 
Albumin retention was decreased 
significantly, anthocyanosides 
prevent the increase in CFA and 
failure of lymphatic uptake of 
interstitial albumin in diabetic 
animals 
Cohen-Boulakia F, 
Valensi PE, Boulahdour 
H. (2000). Metabolism, 
49:880-5. 
Chokeberry (Aronia 
spp.) 
Black chokeberry extract 
(0.2%) over 4 weeks, added to 
a standard casein diet with 8% 
lard and 65% fructose 
Antioxidant and 
hypoglycemic 
properties 
24 male Wistar rats, 161 ± 
8 g,  streptozotocin 
induced diabetes 
Decrease in serum ACL level and 
serum glucose levels by the extract 
compared to the high-fructose diet 
without it.  
Jurgoński A, Juśkiewicz J, 
Zduńczyk Z. (2008). Plant 
Foods Hum Nutr, 63:176-
82. 
Turkey berry 
(Solanum torvum 
Swartz) 
10, 20 and 40 mg/kg Hyperlipidemia and 
diabetes 
Streptozotocin-induced 
rats 
Methyl caffeate isolate has 
antihyperglycemic and anti-
diabetic effects 
Gandhi GR, Ignacimuthu 
S, Paulraj M. (2011). 
European J Pharmacol, 
670: 623-631. 
Chinese 
magnolivine 
(Fructus 
schisandrae) 
 
200mg/kg BW ethanol extract 
fractions given orally for 8 
weeks 
PPARγ activity and 
glucose stimulated 
insulin secretion 
90% pancreatized male 
Sprague-Dawley diabetic 
rats, 231 ± 25 g and 3T3-
L1 fibroblasts 
Lignan-rich fractions improved 
glucose dispersal rates as much as 
rosiglitazone, and enhanced 
hepatic insulin sensitivity 
Kwon DY, Kim da S, 
Yang HJ, Park S. (2011). J 
Ethnopharmacol. 135:455-
62. 
 
ACL: antioxidant capacity of lipophilic substances, ApoE: Apolipoprotein E, Balb C: albino mouse line, C3G: cyanidin-3-glucoside, CD36: cluster of 
differentiation 36, DIC: diclofenac, GAE: gallic acid equivalents, IL-6: interleukin-6, iNOS: nitric oxide synthase, MCP-1: monocyte chemotactic protein-1, 
PPARγ: peroxisome proliferator activated receptor gamma, RCE: redcurrant extract, SR-A: scavenger receptor class A, STZ: streptozotocin, TNF-α: tumor 
necrosis factor-alpha, WHHL: Watanabe heritable hyperlipidemic. 
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A side effect of diabetes mellitus is the increased risk of cardiomyopathy and heart failure 
from the resulting stiffness and impaired contractility of blood vessels due to the increased 
glycation of interstitial proteins such as collagen. Treatment with fruit juice from Indian 
gooseberry in type 1 diabetic rats was seen to improve the glycemic response and reduce 
oxidative stress through increasing antioxidant enzymes in the heart and to decrease blood 
triglycerides and total cholesterol levels in the rats. The decrease in the glucose level was seen 
without an increase in insulin output, indicating that the fruit juice polyphenols were able to 
increase the sensitivity of the peripheral tissue to insulin. These and many other animal studies 
with beneficial effects due to berry or anthocyanin consumption provide the basis for human 
feeding trials and clinical studies, and provide a link to the potential mechanism of action 
determined with in vitro studies. 
 
5.3 Anti-Diabetic Human Studies  
 
While animal feeding trials are much easier to control or design than those involving 
humans, it is the clinical and epidemiological studies of berry consumption which provide the 
most relevant information to elucidate the beneficial effects to improve inflammatory diseases 
such as diabetes. Diabetes is associated with oxidative stress that results from the imbalance of 
free radical production and antioxidants in the system. Through their antioxidant activity, 
anthocyanins may be able to reduce oxidative stress that occurs due to the glycation reactions 
from hyperglycemia, thereby protecting beta-cells from damage. The effects of berry compounds 
on health have been studied and are summarized for their anti-inflammatory and anti-diabetic 
properties in humans (Table 2.4). Gooseberry phenolic compounds significantly improved 
antioxidant defense and diabetic indices in patients with diabetes (Chen 2011). Young healthy 
adults fed bilberry extract experienced a decrease in postprandial insulin demand, with a larger 
amount of bilberries consumed decreasing the glycemic response further (Granfeldt 2011). This 
study supports the thought that bilberries are able to cause an increased uptake of glucose into 
the peripheral cells, allowing for enhanced insulin sensitivity in type 2 diabetics. Bilberry extract 
has also been seen to reduce blood glucose levels through activation of an AMP-activated protein 
kinase, an enzyme that is crucial for the regulation of tissue fuel preference. A similar activation 
of this kinase was seen following treatment of fermented blueberry juice, having improved 
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glucose uptake and therefore decreased hyperglycemia. Exotic berries also have the potential to 
improve inflammation or diabetes management. Açai berry preparations are able to reduce 
reactive oxygen species to assist in normalizing metabolic pathways leading to metabolic 
syndrome, a precursor to diabetes. Following the twice-daily feeding of 100 g of açai pulp for a 
month, overweight adults had a reduction of fasting glucose and plasma insulin (Udani 2011), 
warranting more large-scale studies to improve metabolic parameters following berry 
consumption. 
Low glycemic index (GI) fruit consumption by patients with type 2 diabetes, who were 
taking oral agents to control diabetes, showed significant changes in the measures of glycemic 
control, including a negative association with berry intake and glucose levels (Jenkins 2011). 
Two additional daily servings of low GI temperate climate fruit with a GI value of <70, which 
includes berries, has been associated with a significant benefit in glycemic control by reducing 
the blood glucose levels after a meal, and such consumption should be encouraged in the 
management of type 2 diabetes. One study following consumption of a bilberry drink showed the 
beneficial metabolic properties of a low glycemic diet through lower insulin response or 
increased insulin sensitivity, where there was a low insulin demand. Consumption of 45 g/day of 
berries may be considered high for some; however, due to the potential of berries to decrease the 
risk of obesity, metabolic syndrome, and type 2 diabetes, increasing consumption to this modest 
amount is extremely important.  
 Human feeding trials with berry anthocyanins were able to increase plasma antioxidant status and 
reduce oxidative stress. 
 Anthocyanins may protect beta-cells, increase the secretion of insulin, and reduce the digestion of 
sugars in the small intestine. 
 Anthocyanins have multiple and simultaneous anti-diabetic effects, including reducing blood glucose 
and preventing free radical production. 
 Berry consumption may reduce postprandial blood glucose increase and improve insulin resistance, 
beneficial for those with type 2 diabetes mellitus. 
 
6. Other Health Benefits 
 
It is worth mentioning some other health beneficial effects of berry or berry components 
(Table 2.2). Berries have been found to inhibit tumor initiation, promotion, and progression, 
indicating potential and have been reported to play a major role in prevention of cardiovascular 
disease. There is also research into other anticancer properties, cardioprotection, and inhibition 
of lipid peroxidation, neuroprotection, and anti-atherosclerosis ability of berry fruits.  
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Table 2.4. Anti-inflammatory and/or diabetes-improving properties attributed to berries and berry compounds in clinical and epidemiological 
studies in humans. 
 
Berry Dose of Treatment Proposed target Participants Results Reference 
Black currant (Ribes 
nigrum L.) 
 
 
8 g/kg BW either diluted sweetened 
juice (1239 or 716 mg 
anthocyanins) or control sugar water 
drink, or 716 mg drink and a rice 
cake 
 
Cardiovascular 
disease 
17 healthy 
normolipidemic 
females, 19-48 years 
old, BMI = 23.0 kg/m2 
Protective effects of anthocyanins 
on atherosclerosis development 
Nielsen ILF, Dragsted LO, 
Ravin-Haren G. (2003). J 
Agric Food Chem, 51: 
2813-2820. 
 
3 wk double-blind crossover study 
with 48 g of blackcurrant extract or 
sugar placebo encapsulated in 
gelatin 
Oxidative stress 
following 30-min 
row exercise 
 
Exercise, healthy 
individuals (five males 
and five females) 
between 37 and 63 
yrs. old 
Anthocyanins from the extract 
were effective antioxidants in 
reducing oxidative stress 
following exercise 
Lyall KA, Hurst SM, 
Cooney J. (2009). Am J 
Physiol Regul Integr 
Comp Physiol., 297:R70-
81.  
Gooseberry (Ribes 
uva-crispa L.) 
 
Mixture of (-)-epigallocatechin 
gallate (EGCG) and Indian 
gooseberry (amla) extract (AE) 
Diabetes-induced 
oxidative stress 
Uremic patients with 
diabetes 
Significantly improved 
antioxidant defense and diabetic 
and atherogenic indices in uremic 
patients with diabetes 
Chen TS, Liou SY, Wu 
HC. (2011). J Medicinal 
Food, 14: 718-723. 
Cranberry 
(Vaccinium 
macrocarpon Ait.) 
 
Single cross-over design: 
unsweetened low-calorie CBJ 
(LCCBJ; 19 Cal/240 mL), 
carbohydrate sweetened normal 
calorie CBJ (NCCBJ; 120 Cal/240 
mL), isocaloric low-calorie sugar 
water control (LCC), and isocaloric 
normal calorie sugar water control 
(NCC) interventions 
Glycemic response  6 male and 6 female 
type 2 diabetics, 65.3 
± 2.3 yrs. old, BMI 
34.7 ± 1.6  
Low calorie interventions had no 
significant increase in blood 
glucose or plasma insulin and 
therefore should be used instead 
of normal calorie preparations 
Wilson T, Meyers SL, 
Singh AP. (2008). J Food 
Sci., 73:H241-5. 
One of six treatments: WB (57 g, 
160 cal, 1 g fiber), RC (55 g, 21 cal, 
1 g fiber), SDC (40 g, 138 cal, 2.1 g 
fiber), and SDC containing less 
sugar (SDC-LS, 40 g, 113 cal, 1.8 g 
fiber + 10 g polydextrose)  
Plasma insulin and 
blood glucose 0, 30, 
60, 120, and 180 
minutes after 
consumption 
187 healthy 
participants (149 
women and 9 men), 
non-diabetic; 19.7 ± 
0.13 yrs. old, 67.96 ± 
1.03 kg BW 
Consumption of a low calorie 
cranberry juice rich in phenolics 
is associated with a favorable 
glycemic response 
Wilson T, Singh AP, 
Vorsa N, Goettl CD, 
Kittleson KM, Roe CM, 
Kastello GM, Ragsdale 
FR. (2010). J Med Food, 
11:46-54. 
Blueberry 
(Vaccinium 
corymbosum L., 
angusifolium Ait., 
ashei Reade) 
 
Single-blinded controlled study of 
50 g freeze-dried blueberries 
reconstituted in 480 mL water 
CVD risk factors 66 obese men and 
women with metabolic 
syndrome, age 50.0 ± 
3.0 y 
Decrease in risk factors including 
blood pressure and plasma 
oxidized LDL, no effect on serum 
glucose concentration 
Basu A, Du M, Jeyva M. 
(2010). J Nutr, 140: 1582-
1587. 
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Table 2.4 (contd.)     
Blueberry 
(Vaccinium 
corymbosum L., 
angusifolium Ait., 
ashei Reade) contd. 
 
375 g/wk fresh blueberries, 375 g/ 
wk fresh blueberry purée, control 
was no blueberries 
Markers of 
inflammation and 
oxidative stress  
24 overweight and 
obese children (8-13 
years) 
Increased consumption of 
blueberries increased intake 
antioxidant, and had a positive 
effect to reduce markers of 
inflammation and oxidative stress 
Giongo L, Bozza E., 
Caciagli P. (2011). Berry 
Research, 1: 147-158. 
100 g freeze-dried wild blueberry 
powder with high-fat meal 
Post-prandial serum 
AC 
Eight middle-aged 
male subjects (38-54 
years) 
Increase in serum antioxidant 
capacity 
Kay CD, Holub BJ (2002). 
Br J Nutr, 88: 389-397. 
Açai (Euterpe 
oleracea Mart.) 
100 g açai pulp twice daily for 1 
month 
Metabolic 
parameters 
10 overweight adults 
(BMI ≥ 25 kg/m2 and 
≤ 30 kg/m2) 
Significant reductions in fasting 
glucose and insulin levels 
compared to baseline, 
ameliorating post-prandial 
increase in plasma glucose 
Udani JK, Singh BB, 
Singh VJ, Barrett ML. 
(2011). Nutr J, 12:45. 
Bilberry (Vaccinium 
Myrtillus) 
330 mL bilberry juice/day (diluted 
to 1 L using 
tap water) for 4 weeks  
Plasma 
concentration of NF-
κB inflammatory 
markers 
Male and female 
subjects at risk for 
cardiovascular disease 
(n=31 / group) 
Significant decreases in CRP, IL-
6, IL-15 and MIG 
Karlsen A, Paur I, Bohn S. 
(2010). Eur J Nutr, 49: 
345-355. 
 
Fermented oatmeal drinks (FOMD), 
with 10% bilberry (BFOMD, 270.3 
g), enriched to 47% bilberry 
(BBFOMD, 307.7 g), and 70.0 g 
reference bread 
Glycemic and 
insulinemic 
responses 
Young (26.2  ± 4.6  
years) healthy adults 
(7 women and 4 men), 
BMI 23.5 ± 2.9 kg/m2 
Insulin demand and insulin index 
was significantly lower after the 
BFOMD, with BBFOMD having 
a low insulin demand, and 
lowered glycaemia compared to 
FOMD 
Granfeldt YE, Bjorck 
IME. (2011). Nutr J 
10:57. 
Sea buckthorn 
(Hippophae 
rhamnoides L.) 
Three sea buckthorn meals on four 
distinct study day, dried and crushed 
whole berries 
 
Postprandial 
metabolism 
Ten healthy normal-
weight male 
Postprandial metabolism was 
improved 
Lehtonen HM, Järvinen R, 
Linderborg K. (2010). Eur 
J Clin Nutr, 64:1465-71. 
Sea buckthorn (28 g daily, frozen 
puree), randomized, double-blind, 
placebo-controlled trial, 90 day 
observation 
Infections and CRP 
levels, a marker of 
inflammation and a 
risk factor for 
cardiovascular 
disease 
233 healthy 19-50 
year-old men and 
women 
Significant decrease of serum 
CRP in the sea buckthorn group. 
No significant reductions in 
common cold, digestive, or 
urinary tract infections. 
Larmo P, Alin J, Salminen 
E, Kallio H, Tahvonen R. 
(2008). Eur J Clin Nutr, 
62:1123-30. 
Randomized cross-over study of 4 
diets with equivalent doses of 100 g 
fresh sea buckthorn (SB), extracts 
(SBo, SBe) or bilberry (BB) 
Type 2 diabetes and 
atherosclerotic 
cardiovascular 
diseases 
110 overweight and 
obese (BMI 26-34 
kg/m2) female 
Small decrease in fasting plasma 
glucose after SB, TNF-α level 
decreased with BB, SB, and SBe  
Lehtonen HM, Suomela 
JP, Tahvonen R. (2011). 
Eur J Clin Nutr, 65:394-
401. 
AC: antioxidant capacity, BFOMD: bilberry fermented oatmeal drink, BBFOMD: enriched bilberry fermented oatmeal drink, CRP: C-reactive protein, LCCBJ: 
low-calorie cranberry juice, IL-6: interleukin-6, IL-15: interleukin-15, LDL: low density lipoprotein, MIG: monokine induced by INF-γ, NCCBJ: normal calorie 
cranberry juice, RC: raw cranberries, SDC: sweetened dry cranberries, WB: white bread. 
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In a study of obese men and women with metabolic syndrome, no effect was seen on 
serum glucose concentration or lipid profiles; however decreases in blood pressure and plasma 
LDL were greater in the group receiving blueberries. This study by Basu et al. indicated that 
though human studies are limited, blueberries may improve selected features of metabolic 
syndrome, and supports the favorable effects of blueberries on metabolic syndrome and type 2 
diabetes seen by animal obesity models. Phytochemicals in berries may prevent oxidation of 
cellular lipids and repair DNA oxidative damage, impact the cell cycle, inhibit oxidant enzymes, 
induce endogenous antioxidant enzymes to scavenge free radicals, and modulate signal 
transduction and intercellular communication (Paredes-Lopez 2010). Black currant concentrates 
and the main anthocyanins of black currant fruit juices have been shown to phosphorylate eNOS 
via activation of a kinase-signaling pathway. This induction leads to activation of cell signaling 
molecules relevant to maintaining endothelial function and therefore reducing the risk for 
cardiovascular diseases. Whole mulberry extracts, historically known for their anti-inflammatory 
properties, were able to reduce the acute inflammatory response through fluid accumulation 
indicative of arthritic damage. Effectiveness of whole fruit extracts rather than individual 
components provide a prediction of the potential effects due to whole fruit consumption. A 
clinical study of diets with equivalent doses of 100 g fresh sea buckthorn or bilberries found 
positive effects on the associated variables of obesity-related diseases. Due to the potential of 
berries to decrease the risk of obesity, metabolic syndrome, and type 2 diabetes, consumption of 
berry fruits available around the world should be increased. 
 
7. Concluding Remarks 
 
Berry fruits are a major dietary source of anthocyanins. Anthocyanins show promising 
benefits to general health and for the reduction of inflammation and diabetes. More 
understanding of the benefits of berry compounds like anthocyanins will provide increased 
awareness of their health potential and promote consumption of berries as functional foods. 
Anthocyanins are generally regarded as a safe food component. Toxicological studies on pure 
anthocyanins are limited; however, mixtures of anthocyanins extracted from different fruits 
indicated that they are safe and possess very low toxicity to humans (Crozier et al. 2009). 
Anthocyanins have potential for clinical efficiency in prevention and treatment of type 2 diabetes 
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and improving the inflammatory response. Regardless of the low bioavailability of anthocyanins, 
clinical trials have shown the efficacy of these compounds (Nielsen 2003, Lyall 2009, Basu 
2010, Giongo 2011, and Udani 2011). It will be helpful for future studies on anthocyanins to 
identify the specific structural and chemical properties of anthocyanins, which impacts the 
mechanism of action. Anthocyanins may be isolated and purified from berry fruits to carry out 
further in vivo experiments and clinical evaluations. With the papers available to date, it can be 
seen that berry fruits and their anthocyanin pigments may have favorable effects on type 2 
diabetes. The effects on stimulating insulin secretion and protection of beta cells through reduced 
oxidative stress improves insulin resistance and leads to decreased postprandial glucose levels. 
Studies are needed to determine which specific anthocyanins are most appropriate for a 
particular purpose or target for treatment of diabetes and related inflammation. It would be 
beneficial for future researchers to analyze the effects and the composition of berries to properly 
attribute any benefits to a specific compound. Beyond the health benefits studied by researchers, 
it will also be important to promote the daily consumption of berry crops to consumers. The 
benefits of anthocyanins from berries may not be attributable to just one type, therefore the wide 
variety of anthocyanins present in berry fruits and other foods makes them ideal to promote for 
use in everyday diet. The optimal dose and efficiency of extracts from berries and levels of foods 
rich in these compounds can determine which berries to promote for consumption. Additionally, 
improved horticultural techniques and new cultivar development will further the commercial 
application for berries and increase their availability. As seen by the USDA Horticulture 
National Berry Crop Initiative, “Berry crops have the potential to improve vision, fight cancer, 
and treat infections, but more research, education, and extension efforts are needed to determine 
the potential health benefits of these crops and to help inform producers and consumers about the 
benefits.” There is a great need to further investigate the health benefits of anthocyanins from 
berry fruits and their roles in diabetes and inflammation, and to propagate this knowledge to 
consumers to promote berry fruit consumption as functional foods. 
 Berry fruits are potent antioxidants due to the high amounts of anthocyanins present, and 
anthocyanins may act to increase plasma antioxidant status in humans. 
 Berry extracts, or anthocyanin treatment, have been shown to reduce inflammation-related 
parameters in human studies, animal studies, and in vitro cellular models. 
 Berry fruits have been studied for parameters related to type 2 diabetes; therefore consumption 
to gain these beneficial effects should be advocated to people with diabetes. 
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 More studies are needed to investigate the clinical and epidemiological role of berry 
consumption and the role of anthocyanins from berries in improving or preventing 
inflammation-related chronic diseases. 
 
Glossary 
 
Aglycone: the non-sugar compound; the resulting anthocyanidin form after replacement of the glycosyl group by a 
hydrogen atom in the glycoside anthocyanin form 
Acylation: adding an acyl group (the function group derived from removal of one or more hydroxyl groups from an 
oxygen-containing species) to a compound 
Arachidonic acid: also referred to as AA or ARA, a omega-6 fatty acid in phospholipids of membranes in the body 
Cardiomyopathy: deterioration of the function of the myocardium, the heart muscle, which puts one at risk for 
sudden cardiac arrest 
Ellagitannins: the class of hydrolysable tannins, a group of polyphenols 
Endogenous: originating from within an organism or tissue 
Flavonols: a class of flavonoids with a 3-hydroxyflavone backbone containing a ketone group, different from 
flavanals, or flavan-3-ols  
Flavan-3-ols: a class of flavonoids that are the building blocks of proanthocyanidins, and lack the ketone group on 
the 4-carbon of the C-ring, contain catechin and epicatechin 
Flavylium cation: the ion 2-phenylchromenylium cation, containing a positive oxygen  
Glycation: non-enzymatic glycosylation, covalent bonding of a protein or lipid with a sugar molecule without the 
control of an enzyme 
Glycemic index: a measure of the effects of carbohydrates on blood sugar levels, high GI carbohydrates break down 
quickly during digestion and release glucose rapidly into the bloodstream 
Glycosylation: a reaction where a carbohydrate is attached to a hydroxyl or another functional group on another 
molecule 
Hydroxybenzoate: a part of parabens, a class of chemicals use as preservatives 
Isoprenoids: also called terpenoids, a large diverse class of compounds derived from the combination of several 5-
carbon isoprene units  
Jejunum: the middle section of the small intestine, lying between the duodenum and the ileum 
Lipid peroxidation: the oxidative degradation of lipids in which free radicals take electrons from lipids in cell 
membranes, resulting in cellular damage. 
Nutraceuticals: a food or food product with reported health and medical benefits that can be included in the 
prevention and treatment of disease, from “nutrition” and “pharmaceutical” 
Postprandial: occurring after consuming a meal 
Procyanidins: members of the proanthocyanidin class of flavonoids that form from flavan-3-ols molecules 
Stilbenoids: hydroxylated derivatives of stilbene, secondary products in plants (a common example is resveratrol) 
Terpenes: derived from units of isoprene, oxidized or rearranged into terpenoids 
 
 
Annotated Bibliography 
 
Anderson OM, Jordheim M, in Anderson OM, Markham KR (Editors), Flavonoids Chemistry, Biochemistry 
and Applications, CRC Press, Taylor and Francis, Boca Raton, 2006, pp. 471-551.  
Basu A, Du M, Jeyva M. (2010) Blueberries decrease cardiovascular risk factors in obese men and women with 
metabolic syndrome. Journal of Nutrition 140(9): 1582-1587. [Used in Table 4 as a reference for blueberry 
beverage clinical trial].  
Bishayee A, Mbimba T, Thoppil RJ, Haznagy-Radnai E, Sipos P, Darvesh AS, Folkesson HG, Hohmann J. 
(2011). Anthocyanin-rich black currant (Ribes nigrum L.) extract affords chemoprevention against 
diethylnitrosamine-induced hepatocellular carcinogenesis in rats. Journal of Nutritional Biochemistry 22: 1035-
1046. [Used in Table 2 to indicate the role of black currant skin extract on chemoprevention in rat liver cells]. 
 40 
 
Burns Kraft TF, Dey M, Rogers RB, Ribnicky DM, Gipp DM, Cefalu WT, Raskin I, Lila MA. (2008) 
Phytochemical composition and metabolic performance-enhancing activity of dietary berries traditionally used 
by Native North Americans. Journal of Agricultural and Food Chemistry 56(3):654-60. [Included in Table 2 to 
indicate the hypoglycemic and anti-inflammatory properties of serviceberry, cranberry, chokeberry and buffalo 
berry phenolic extracts, and a referee article on historical berry uses in North America]. 
Céspedes C, Alarcon J, Avila G, El-Hafidi M. (2010) Anti-inflammatory, antioedema and gastroprotective 
activities of Aristotelia chilensis extracts, Part 2. Boletín Latinoamericano y del Caribe de Plantas Medicinales 
y Aromáticas 9(6): 432-439. [Used in Table 3 as a reference for Chilean wild blackberry fractions on 
inflammation in rats]. 
Céspedes C, Valdez-Morales M, Avila JG, El-Hadifi M, Alarcon J, Paredes-Lopez O. (2010) Phytochemical 
profile and the antioxidant activity of Chilean wild black-berry fruits, Aristotelia chilensis (Mol) Stuntz 
(Elaeocarpaceae). Food Chemistry 119:886-895. [Used in Table 1 as a reference for Maqui berry total 
phenolics and antioxidant capacity]. 
Chen TS, Liou SY, Wu HC. (2011) Efficacy of epigallocatechin-3-gallate and Amla (Emblica officinalis) 
extract for the treatment of diabetic-uremic patients. Journal of Medicinal Food 14: 718-723. [A referee journal 
article that demonstrates anti diabetic properties, included in Table 4 as a reference for gooseberry extract in 
reducing oxidative stress in uremic patients with diabetes]. 
Cho M, Luke R, Howard L, Prior R, Clark J. (2005) Flavonol glycosides and antioxidant capacity of various 
blackberry and blueberry genotypes determined by high-performance liquid chromatography/mass 
spectrometry. Journal of the Science of Food and Agriculture 85 (13): 2149-2158. [Used in Table 1 as a 
reference for blueberry and blackberry total phenolics]. 
Crozier A, Jaganath IB, Clifford MN. (2009) Dietary phenolics: chemistry, bioavailability and effects on 
health. Natural Product Reports 26 (8): 1001-1043. [A referee journal article on dietary phenolics, containing a 
comprehensive review of chemistry and bioavailability of anthocyanins, and health effects]. 
Cohen-Boulakia F, Valensi PE, Boulahdour H. (2000) In vivo sequential study of skeletal muscle capillary 
permeability in diabetic rats: effect of anthocyanosides. Metabolism 49(7):880-5. [Used in Table 3 as a 
reference for bilberry in water of diabetes-induced rats]. 
Cuny T. Guerci B, Cariou B. (2012) New avenues for the pharmacological management of type 2 diabetes: An 
update. Annals of Endocrinology 73: 459-468. 
Czank C, Cassidy A, Zhang Q, Morrison DJ, Preston T, Kroon PA, Botting NP, Kay CD. (2013) Human 
metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: a (13)C-tracer study. Am J Clin Nutr 
97(5):995-1003. doi: 10.3945/ajcn.112.049247. 
da Silva-Pinto, MS, Shetty K. (2010) Chapter 8: Health benefits of berries for potential management of 
hyperglycemia and hypertension. In: Flavor and Health Benefits of Small Fruits; Qian M, et. al, ACS 
Symposium Series; American Chemical Society. Washington, DC. [Used in Table 2 to show the role of 
cranberry powder on reducing postprandial glucose in vitro]. 
de Ferrars RM, Cassidy A, Curtis P, Kay CD. (2014a) Phenolic metabolites of anthocyanins following a dietary 
intervention study in post-menopausal women. Mol Nutr Food Res 58(3):490-502. doi: 
10.1002/mnfr.201300322. 
de Ferrars RM, Czank C, Zhang Q, Botting NP, Kroon PA, Cassidy A, Kay CD. (2014b) The pharmacokinetics 
of anthocyanins and their metabolites in humans. Br J Pharmacol. 171(13):3268-82. doi: 10.1111/bph.12676. 
Defuria J, Bennett G, Strissel KJ. (2009) Dietary blueberry attenuates whole-body insulin resistance in high fat-
fed mice by reducing adipocyte death and its inflammatory sequelae. Journal of Nutrition 139(8):1510-6. [Used 
in Table 3 as a reference for obesity-associated pathology of blueberry powder in high fat fed mice]. 
Del Rio D, Borges G, Crozier A. (2010) Berry flavanoids and phenolics: bioavailability and evidence of 
protective effects. British Journal of Nutrition 104: S67-S90. [A referee journal article that demonstrates 
availability of flavanoids]. 
 41 
 
Domitrovic R. (2011) The molecular basis for the pharmacological activity of anthocyans. Curr Med Chem 
18(29):4454-4469. 
Edirisingh I, Banaszewski. (2011) Effect of black currant anthocyanins on the activation of endothelial nitric 
oxide synthase (eNOS) in vitro in human endothelial cells. Journal of Agricultural and Food Chemistry 59 
(16): 8616–8624. [Used in Table 2 as a reference for black currant juice eNOS activation in human umbilical 
vein endothelial cells]. 
Escribano-Bailon MT, Alcalde-Eon C. (2008) Anthocyanins in berries of Maqui (Aristotelia chilensis (Mol.) 
Stuntz). Phytochemical Analysis 17 (1): 8-14. [Used in Table 1 as a reference for Maqui berry total 
anthocanins]. 
Favacho HAS, Oliveira BR, Santos KC, Medeiros BJL, Sousa PJC, Perazzo FF, Carvalho JCT. (2011) Anti-
inflammatory and antinociceptive activities of Euterpe oleracea oil. Brazilian Journal of Pharmacognosy 21(1): 
105-114. [Used in Table 3 as a reference for Açai oil on inflammation and hyperalgesia in rats and mice]. 
Ferreira D, Slade D, Marais JPJ. (2006) Flavans and Proanthocyanidins. In: Flavonoids: Chemistry, 
Biochemistry, and Applications. Anderson OM and Markham KR. Taylor & Francis Group, Boca Raton, FL. 
Feshani AM, Kouhsari SM, Mohammadi S. (2011) Vaccinium arctostaphylos, a common herbal medicine in 
Iran: molecular and biochemical study of its antidiabetic effects on alloxan-diabetic Wistar rats. Journal of 
Ethnopharmacology 133(1):67-74. [Used in Table 3 as a reference for anti-diabetic effect of ethanolic extract 
from blueberry in rats]. 
Finn CE, Clark JR. (2011) Emergence of Blackberry as a World Crop. Chronica Horticulturae 51 (3): 13-18. 
[A horticultural science news article on the role of blackberries as an emerging world crop]. 
Frejnagel, S. (2007) Comparison of polyphenolic composition of extracts from honeysuckle, chokeberries and 
green tea – A short report. Polish Journal of Food and Nutrition Sciences 57: 83-86. [Used in Table 1 as a 
reference for chokeberry total phenolics and total anthocyanins]. 
Gandhi GR, Ignacimuthu S, Paulraj MG, Sasikumar P. (2011) Antihyperglycemic activity and antidiabetic 
effect of methyl caffeate isolated from Solanum torvum Swartz. fruit in streptozotocin induced diabetic rats. 
European Journal of Pharmacology 670 (2-3): 623-631. [Used in Table 3 as a reference for turkey berry on 
hyperlipidemia in diabetes-induced rats]. 
Garzon GA, Riedl KM. (2009) Determination of anthocyanins, total phenolic content, and antioxidant activity 
in Andes berry (Rubus glaucus Benth). Journal of Food Science 74 (3): C227–C232. [A referee journal article 
that provides numbers on post-harvest loses, used in Table 1 as a reference for Andes berry total phenolics, 
total anthocyanins, and antioxidant capacity]. 
Gavrilova V, Kajdz M. (2011) Separation, characterization and quantification of phenolic compounds in 
blueberries and red and black currants by HPLC−DAD−ESI-MS. Journal of Agricultural and Food Chemistry 
59 (8): 4009–4018. [Used in Table 1 as a reference for black and red currant total phenolics and total 
anthocyanins]. 
Giongo L, Bozza E, Caciagli P. (2011) Short-term blueberry intake enhances biological antioxidant potential 
and modulates inflammation markers in overweight and obese children. Journal of Berry Research 1 (3):147-
158. [A referee journal article that demonstrates modulation of inflammation, used in Table 4 as a reference for 
fresh blueberry intake in children clinical trial]. 
Granfeldt YE, Bjorck IME. (2011) A bilberry drink with fermented oatmeal decreases postprandial insulin 
demand in young healthy adults. Nutrition Journal 10: 57. [A referee journal article that demonstrates the effect 
of a berry on diabetes, used in Table 4 as a reference for bilberry-enriched fermented oatmeal drink clinical 
trial]. 
Gu L, Kelm MA. (2004) Concentrations of proanthocyanidins in common foods and estimations of normal 
consumption. Journal of Nutrition, 134: 613-617. [Used in Table 1 as a reference for black currant, cranberry, 
blueberry, blackberry, and raspberry total proanthocyanidins]. 
 42 
 
Hurst SM, McGhie TK, Cooney JM, Jensen DJ, Gould EM, Lyall KA, Hurst RD. (2010) Blackcurrant 
proanthocyanidins augment IFN-gamma-induced suppression of IL-4 stimulated CCL26 secretion in alveolar 
epithelial cells. Molecular Nutrition and Food Research 54:S159-S170. [Used in Table 2 as a reference for 
black currant extract effect on airway inflammation in human endothelial cells]. 
Jayaprakasam B, Vareed SK. (2005) Insulin secretion by bioactive anthocyanins and anthocyanidins present in 
fruits. Journal of Agricultural and Food Chemistry 53: 28-31. [A comprehensive assessment of role of 
anthocyanins on insulin secretion]. 
Jenkins DJ, Srichaikul K, Kendall CW. (2011) The relation of low glycaemic index fruit consumption to 
glycaemic control and risk factors for coronary heart disease in type 2 diabetes. Diabetologia 54:271-9 [A 
referee journal article that provides an assessment of the glycemic index of berries and diabetes]. 
Jo SH, Ha KS, Moon KS. (2011) In vitro and in vivo anti-hyperglycemic effects of Omija (Schizandra 
chinensis) fruit. International Journal of Molecular Sciences 12(2):1359-70. [Used in Table 3 as a reference for 
Omija pulp/seed extract treatment on hyperglycemia in rats]. 
Jurgoński A, Juśkiewicz J, Zduńczyk Z. (2008) Ingestion of black chokeberry fruit extract leads to intestinal 
and systemic changes in a rat model of prediabetes and hyperlipidemia. Plant Foods for Human Nutrition 
63(4):176-82. [Used in Table 3 as a reference for black chokeberry extract effect on antioxidant and 
hypoglycemic properties in diabetes-induced rats]. 
Kay CD, Holub BJ. (2002) The effect of wild blueberry (Vaccinium angustifolium) consumption on 
postprandial serum antioxidant status in human subjects. British Journal of Nutrition 88: 389-397. [Used in 
Table 4 as a reference for freeze-dried blueberry powder clinical trial]. 
Karlsen A, Paur I, Bohn SK, Sakhi AK, Borge GI, Serafini M, Erlund I, Laake P, Tonstad S, Blomhoff R. 
(2010) Bilberry juice modulates plasma concentration of NF-κB related inflammatory markers in subjects at 
increased risk of CVD. European Journal of Nutrition 49 (6):345-355. [A referee journal article that relates 
berry consumption and inflammation reduction, used in Table 4 as a reference for bilberry juice clinical trial]. 
Keppler K and Humpf HU. (2005) Metabolism of anthocyanins and their phenolic degradation products by the 
intestinal microflora. Bioorg and Med Chem 13: 5195-5205. 
Kim AJ, Park S. (2006) Mulberry extract supplements ameliorate the inflammation-related hematological 
parameters in carrageenan-induced arthritic rats. Journal of Medicinal Food, 9(3):431-5. [Used in Table 3 as a 
reference for mulberry methanol extracts on inflammation in rats]. 
Koponen JM, Happonen, AM. (2007) Contents of anthocyanins and ellagitannin in selected foods consumed in 
Finland. Journal of Agricultural and Food Chemistry 55, 1612–1619. [Used in Table 1 as a reference for 
mulberry in vitro trial]. 
Kwon DY, Kim da S, Yang HJ, Park S. (2011) The lignan-rich fractions of Fructus Schisandrae improve 
insulin sensitivity via the PPAR-γ pathways in in vitro and in vivo studies. Journal of Ethnopharmacology 
135(2):455-62. [Used in Table 3 as a reference for Chinese magnolivine ethanol extract on insulin secretion in 
diabetic rats]. 
Larmo P, Alin J, Salminen E, Kallio H, Tahvonen R. (2008) Effects of sea buckthorn berries on infections and 
inflammation: a double-blind, randomized, placebo-controlled trial. European Journal of Clinical Nutrition 
62(9):1123-30. [Used in Table 4 for sea buckthorn frozen puree clinical trial in healthy adults]. 
Lee J, Finn C. (2007) Anthocyanins and other polyphenolics in American elderberry (Sambucus canadensis) 
and European elderberry (S. nigra) cultivars. Journal of the Science of Food and Agriculture 87(14): 2665–
2675. [Used in Table 1 as a reference for elderberry total phenolics and total anthocyanins]. 
Lehtonen HM, Järvinen R, Linderborg K. (2010) Postprandial hyperglycemia and insulin response are affected 
by sea buckthorn (Hippophaë rhamnoides ssp. turkestanica) berry and its ethanol-soluble metabolites. 
European Journal of Clinical Nutrition 64(12):1465-71. [Used in Table 4 as a reference for sea buckthorn 
berry clinical study]. 
 43 
 
Lehtonen HM, Suomela JP, Tahvonen R. (2011) Different berries and berry fractions have various but slightly 
positive effects on the associated variables of metabolic diseases on overweight and obese women. Journal of 
Clinical Nutrition 65(3):394-401. [Randomized cross-over study used in Table 4 as a reference for fresh sea 
buckthorn or extracts]. 
Lima VLAG, Melo EA, Maciel MIS, Lima DES. (2003) Evaluation of total anthocyanins in frozen acerola pulp 
from fruits of 12 different trees acerola (Malpighia emarginata DC). Ciência e Tecnologia de Alimentos 
23:101–103. [Used in Table 1 as a reference for acerola total anthocyanins]. 
Lyall KA, Hurst SM, Cooney J. (2009) Short-term blackcurrant extract consumption modulates exercise-
induced oxidative stress and lipopolysaccharide-stimulated inflammatory responses. American Journal of 
Physiology – Regulatory, Integrative and Comparative Physiology 297 (1): R70-81. [A referee journal article 
that provides evidence of the role of anthocyanin in humans and reduction of inflammation, used in Table 4 as 
a reference for black currant extract clinical study on oxidative stress]. 
Lugasi A , Hóvári J, Kádár G, Dénes F. (2011) Phenolics in raspberry, blackberry and currant cultivars grown 
in Hungary. Acta Alimentaria 40(1): 52-64. [Used in Table 1 as a reference for black currant, red currant, 
blackberry, and raspberry total phenolics and total anthocyanins]. 
Matuschek MC, Hendriks WH, McGhie TK, Reynolds GW. (2006) The jejunum is the main site of absorption 
for anthocyanins in mice. J Nut Biochem 17: 31-36. 
Mauray A, Felgines C, Morand C. (2010) Nutrigenomic analysis of the protective effects of bilberry 
anthocyanin-rich extract in apo E-deficient mice. Genes and Nutrition 5(4): 343–353. [Used in Table 3 as a 
reference for bilberry anthocyanin extract on inflammation and CVD in mice]. 
McDougall GJ, Stewart D. (2005) The inhibitory effects of berry polyphenols on digestive enzymes. Biofactors 
23:189-95. [A referee journal article that relates anthocyanins from berries and enzymes related to diabetes]. 
McGhie T, Walton M. (2007) The bioavailability and absorption of anthocyanins: Towards a better 
understanding. Mol Nutr Food Res 51: 702-713. 
Miguel MG. (2011) Anthocyanins: Antioxidant and/or anti-inflammatory activities. Journal of Applied 
Pharmacology Sciences 6:07-15. [A standard reference that covers all aspects of anthocyanins, antioxidant 
capacity and prevention of inflammation]. 
Netzel M, Strass G, Herbst M. (2005) The excretion and biological antioxidant activity of elderberry 
antioxidants in healthy humans. Food Research International 38(8-9): 905-910. [Used in Table 1 as a reference 
for elderberry total phenolics, total anthocyanins, and antioxidant capacity, used in Table 2 to exhibit elderberry 
juice anthocyanin excretion in humans]. 
Netzel M, Strass G, Kaul C. (2002) In vivo antioxidant capacity of a composite berry juice. Food Research 
International 35: 213-216. [A standard reference that relays the presence of anthocyanins in humans after berry 
juice consumption] 
Nickavar B, Amin G. (2011) Bioassay-guided separation of an alpha-amylase inhibitor anthocyanin from 
Vaccinium arctostaphylos berries. Zeitschrift fur Naturforsch C: A Journal of Biosciences 65(9-10):567-70. 
[Used in Table 2 to indicate cranberry anthocyanin in vitro alpha-amylase inhibition]. 
Nielsen ILF, Dragsted LO, Ravin-Haren G. (2003) Absorption and excretion of black currant anthocyanins in 
humans and watanabe heritable hyperlipidemic rabbits. Journal of Agricultural and Food Chemistry 51: 2813-
2820. [Used in Table 4 as a reference for black currant juice clinical trial on atherosclerosis development]. 
Novotny JA, Clevidence BA, Kurilich AC. (2011) Anthocyanin kinetics are dependent on anthocyanin 
structure. British Journal of Nutrition 107:504-509. [A referee journal on the kinetics of anthocyanin 
absorption].  
Ojewole JAO. (2005) Analgesic, anti-inflammatory and hypoglycaemic effects of Rhus chirindensis (Baker F.) 
[Anacardiaceae] stem-bark aqueous extract in mice and rats. Journal of Ethnopharmacology 113(2): 338-345. 
[Used in Table 3 as a reference for red currant extract trial on inflammation in diabetes-induced mice and rats]. 
 44 
 
Paredes-López O, Cervantes-Ceja M, Vigna-Pérez M, Hernández-Pérez T. (2010) Berries: Improving human 
health and healthy aging, and promoting quality life—A Review. Plant Foods for Human Nutrition 65: 299-
308. [A comprehensive report on the role of berries to improve human health]. 
Parry J, Su L, Luther M. (2005) Fatty acid composition and antioxidant properties of cold-pressed marionberry, 
boysenberry, red raspberry, and blueberry seed oils. Journal of Agricultural and Food Chemistry 53(3): 566-
573. [Used in Table 1 as a reference for boysenberry in vitro trial]. 
Passamonti S, Vanzo A, Vrhovsek U, Terdoslavich M, Cocolo A, Decorti G, Mattivi F. (2005) Hepatic uptake 
of grape anthocyanins and the role of bilitranslocase. Food Res Int 38:953-960.  
Patel SS, Goyal RK. (2011) Prevention of diabetes-induced myocardial dysfunction in rats using the juice of 
the Emblica officinalis fruit. Experimental and Clinical Cardiology 16(3):87-91. [Used in Table 3 as a 
reference for indian gooseberry juice trial in diabetes-induced rats].  
Polantov, EA, Shikov AN, Dorman HJD. (2009). Chemical and antioxidant evaluation of Indian gooseberry 
(Emblica officinalis Gaertn., syn. Phyllanthus emblica L.) supplements. Phytotherapy Research 23(9): 1309-
1315. [Used in Table 1 as a reference for Indian gooseberry total phenolics]. 
Samappito S, Butkhup L. (2010) Analysis of anthocyanin, flavonoids, and phenolic acid contents of ten fruits 
and antioxidant activity. International Journal of Fruit Science 10(3): 264-280. [Used in Table 1 as a reference 
for black currant, blueberry, raspberry, and mulberry total phenolics and total anthocyanins]. 
Scalzo J, Currie A. (2008) The anthocyanin composition of different Vaccinium, Ribes and Rubus genotypes. 
BioFactors 34: 13-21. [Used in Table 1 as a reference for elderberry in vitro]. 
Schreckinger M, Wang J, Yousef G, de Mejia E. (2010) Antioxidant capacity and in vitro inhibition of 
adipogenesis and inflammation by phenolic extracts of Vaccinium floribundum and Aristotelia chilensis. 
Journal of Agricultural and Food Chemistry 58(16): 8966-8976. [Used in Table 2 to indicate the role of Maqui 
berry phenolic extracts on cardiovascular disease risk factors in vitro]. 
Seeram NP. (2008) Berry Fruits: Compositional elements, biochemical activities, and the impact of their intake 
on human health, performance, and disease. J Agric Food Chem 56: 627-629. 
Strik B, Clar J, Finn C. (2008) Worldwide production of blackberries. ISHS Acta Hort 777: 209-218. [A 
grower-oriented article on the global production of berries]. 
Tarbart J, Franck T, Kevers C. (2011) Antioxidant and anti-inflammatory activities of Ribes nigrum extracts. 
Food Chemistry 131(4): 1116-1122. [Used in Table 1 as a reference for black currant total phenolics and 
antioxidant capacity]. 
Torri E, Lemos M, Caliari V. (2007) Anti-inflammatory and antinociceptive properties of blueberry extract 
(Vaccinium corymbosum). Journal of Pharmacy and Pharmacology 59(4):591-6. [Used in Table 2 to show 
blueberry extract anti-inflammatory and antiociceptive properties in vitro]. 
Tzanavari T, P. (2010) TNF-alpha and obesity. Current Directions in Autoimmunity 11: 45-56. [A standard as a 
reference that relates inflammation and diabetes]. 
Udani JK, Singh BB, Singh VJ, Barrett ML. (2011) Effects of Açai (Euterpe oleracea Mart.) berry preparation 
on metabolic parameters in a healthy overweight population: a pilot study. Nutrition Journal 12:45. [A standard 
reference that relates metabolic parameters in humans after berry intake, used in Table 4 as a reference for Açai 
pulp consumption clinical trial]. 
Valcheva-Kuzmanova S, Kuzmanov K, Tancheva S. (2007) Hypoglycemic and hypolipidemic effects of 
Aronia melanocarpa fruit juice in streptozotocin-induced diabetic rats. Methods and Findings in Experimental 
and Clinical Pharmacology 29(2):101-5. [Used in Table 3 as a reference for black chokeberry juice on 
glycemia and lipidemia in diabetes-induced rats]. 
Vasco C., Riihinen K, Ruales J, Kamal-Eldin A. (2009) Chemical composition and phenolic compound profile 
of mortino (Vaccinium floribundum Kunth). Journal of Agricultural and Food Chemistry 57 (18): 8274-81. 
[Used in Table 1 as a reference for Mortiño total anthocyanins]. 
 45 
 
Viskelis P, Rubinskiene M., Jasutiene I. (2009) Anthocyanins, antioxidative, and antimicrobial properties of 
American cranberry (Vaccinium macrocarpon ait.) and their press cakes. Journal of Food Science 74(2): C157-
C161. [Used in Table 1 as a reference for cranberry total phenolics and total anthocyanins]. 
Wang SL, Hecht SS, Carmella SG. (2009) Anthocyanins in black raspberries prevent esophageal tumors in rats. 
Cancer Prevention Research 2(1):84-93. [Used in Table 2 as a reference for blackberry anthocyanins on 
esophageal tumor growth in vitro]. 
Wilson T, Singh AP, Vorsa N, Goettl CD, Kittleson KM, Roe CM, Kastello GM, Ragsdale FR. (2010) Human 
glycemic response and phenolic content of unsweetened cranberry juice. Journal of Medicinal Food, 11(1):46-
54. [Used in Table 4 as a reference for cranberry juice clinical trial on postprandial glycemic response in 
healthy humans]. 
Wilson T, Meyers SL, Singh AP. (2008) Favorable glycemic response of type 2 diabetics to low-calorie 
cranberry juice. Journal of Food Science 73(9):H241-5. [Used in Table 4 as a reference for low-calorie 
cranberry juice clinical trial]. 
Wu X, Gu L. (2004) Characterization of anthocyanins and proanthocyanidins in some cultivars of Ribes, 
Aronia, and Sambucus and their antioxidant capacity. Journal of Agricultural and Food Chemistry 52: 7846-
7856. [Used in Table 1 as a reference for red currant total proanthocyanidins]. 
Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE, Prior RL. (2006) Concentrations of 
anthocyanins in common foods in the United States and estimates of normal consumption. J Agric Food Chem 
54: 4069-4075. 
Wu X, Liang L, Zou Y. (2011) Aqueous two-phase extraction, identification and antioxidant activity of 
anthocyanins from mulberry (Morus atropurpurea Roxb.). Food Chemistry 129(2): 443-453. [Used in Table 1 
as a reference for mulberry total phenolics and total anthocyanins]. 
Xie C, Kang J, Chen J, Lazarenko O. (2011) Lowbush blueberries inhibit scavenger receptors CD36 and SR-A 
expression and attenuate foam cell formation in ApoE-deficient mice. Food and Function 2:588-94. [Used in 
Table 3 as a reference for foam cell formation with 1% freeze-dried blueberry in diet of mice]. 
You Q, Chen F, Huang Z. (2011) Comparison of anthocyanins and phenolics in organically and conventionally 
grown blueberries in selected cultivars. Food Chemistry 125 (1): 201-208. [Used in Table 1 as a reference for 
blueberry total phenolics and total anthocyanins]. 
  
 46 
 
CHAPTER 3 
OBJECTIVES 
 
I. Aim 1: Evaluate commercially available blueberry and blackberry juices and wines 
produced in the state of Illinois. (Chapter 4).  
Hypothesis: Wines made from dark berry fruits contain 
phenolic compounds beneficial for health.  
Objectives: Evaluate blueberry and blackberry wines 
commercially available in Illinois for chemical and 
quality components relevant to consumers in order to 
study their potential health benefits.    
         Locations of wineries producing fruit wines  
                   made from blueberries and blackberries in Illinois. 
 
II. Aim 2: Determine the effect of fermentation on the chemical composition and quality of 
blueberry and blackberry fermented beverages. (Chapter 5).  
Hypothesis: The berry fruits of Highbush blueberry (Vaccinium corymbosum) contain bioactive 
compounds with potential to reduce glucose absorption that may be affected by fermentation 
temperature. 
Objectives: Compare fruits from fifteen blueberry cultivars and wines prepared from several of 
these blueberry cultivars throughout fermentation at room temperature and cold temperature 
fermentation for composition and quality parameters, and ability to inhibit starch-degrading 
enzymes. 
 
III. Aim 3: Assess the potential of combinations of blueberry-blackberry fermented beverages 
for antioxidant capacity, and to determine their ability to reduce activity of key enzymes related 
to diabetes, and modulation of inflammation using in vitro and computational studies.  
 
1. Specific Objective 3.1. Evaluate blends of blueberry-blackberry wines and their isolated 
phenolic compounds for total phenolics, total anthocyanins, and antioxidant capacity, in-
vitro inhibition of inflammatory markers, starch-degrading enzyme inhibition (α-amylase 
and α-glucosidase), and DPP-IV (dipeptidyl peptidase-4) inhibition. (Chapter 6).  
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Hypothesis: Berries and their fermented products are an excellent source of dietary flavonoids 
anthocyanins (ANCs) and proanthocyanidins which will have high antioxidant capacity and 
ability to inhibit starch-degrading enzymes and DPP-IV, with the ANC being more effective 
than the PAC.  
 
2. Specific Objective 3.2. Determine the inhibitory effect of berry phenolic compounds on 
DPP-IV (dipeptidyl peptidase-4) using a luminescence assay and computational modeling. 
(Chapter 7).  
Hypothesis: Anthocyanins (ANC) isolated from berry wine will be able to bind to the active 
sites of DPP-IV, thus inhibiting DPP-IV enzyme activity. 
 
3. Specific Objective 3.3. Evaluate combinations of blueberry-blackberry fermented 
beverages for their effect to decrease markers of inflammation and adipogenesis in a dual 
cellular system mimicking pathogenic interaction between adipocytes and macrophages. 
(Chapter 8). 
Hypothesis: Addition of antioxidant agents such as anthocyanins will lead to a reduction in the 
inflammatory cross-talk between macrophages and adipocytes and may improve insulin-
sensitivity as potential treatment to improve obesity-associated adverse consequences.  
 
IV. Aim 4: Evaluate the insulin secretory effect of phenolic compounds found in fermented 
berry beverages in vitro using a simulated absorption model of epithelial and physiologically-
relevant β-cells. (Chapter 9). 
Hypothesis: Anthocyanins (ANC) and proanthocyanidins (PAC) will be able to reduce DPP-IV 
activity to improve incretin function and therefore increase insulin secretion. 
 
V. Aim 5: Establish the role of anthocyanins in fermented berry beverages to reduce diet-
induced obesity and hyperglycemia in C57Bl/6j mice. (Chapter 10). 
Hypothesis: Consumption of fermented berry beverage and ANC and PAC phenolics will 
reduce hyperglycemia to aid, in a dose-dependent manner, in reducing diet-induced obesity 
and hyperglycemia in mice via improved insulin secretion and incretin function.   
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CHAPTER 4 
COMPARISON OF CHEMICAL COMPOSITION AND ANTIOXIDANT CAPACITY 
OF COMMERCIALLY AVAILABLE BLUEBERRY AND BLACKBERRY WINES IN 
ILLINOIS2 
 
Abstract 
Moderate wine consumption may reduce the incidence of certain age-related chronic 
diseases such as heart disease, hypertension, metabolic disease, and neurodegenerative disease. 
Blueberry and blackberry wines commercially available in Illinois were evaluated for chemical 
and quality components relevant to consumers in order to study their potential health benefits. 
Total polyphenolic content was measured by the Folin-Ciocalteu method, total anthocyanin 
content by the pH differential test, and in vitro antioxidant capacity by the oxygen radical 
absorbance capacity (ORAC) method. Color was measured using Hunter colorimetry and quality 
parameters including pH, °Brix, acid content, glucose-fructose and percent alcohol were 
measured using Fourier transform infrared (FTIR) spectroscopy. Blackberry wines (n=6) had an 
average total polyphenolic content of 2212.5 ± 1090.3 mg ellagic acid equivalents (EAE) /L, 
total anthocyanin content of 75.56 ± 70.44 mg/L, and antioxidant capacity of 26.39 ± 17.95 
mmol trolox equivalents (TE)/L. Blueberry wines (n=4) had an average total polyphenolic 
content of 1623.3 ± 645.5 mg EAE / L, total anthocyanin content of 20.82 ± 12.14 mg/L, and 
antioxidant capacity of 21.21 ± 7.71 mmol TE/L. Strong positive correlations were found 
between °Brix and glucose-fructose concentration (r = 0.90), total acid and malic acid (r = 0.90), 
and between total polyphenols and antioxidant capacity (r = 0.88). The results suggest that fruit 
                                                             
2 (Publication: Johnson MH, de Mejia EG. Comparison of Chemical Composition and 
Antioxidant Capacity of Commercially Available Blueberry and Blackberry Wines in Illinois. 
Journal of Food Science. 2012, 77(1): C141-8.)
 
This work has been previously published, with 
permission. ©2011 Institute of Food Technologists ®. doi: 10.1111/j.1750-3841.2011.02505.x. 
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wines made from blueberries and blackberries may have potential health applications and 
therefore could contribute to the economy of the wine industry.  
Practical Application: The majority of wines are produced from grapes, but wine can also be 
produced from other fruits including blueberries and blackberries, which contain phenolic 
compounds that may contribute to human health. A comparative evaluation was conducted on 
commercial non-grape fruit wines and parameters related to their health benefits. Fruit wines 
made from blueberries and blackberries may have potential health applications and therefore 
could contribute to the economy of the wine industry. 
Keywords: Wine, blueberry, blackberry, phenolics, antioxidants. 
Abbreviations used: AAPH: 2,2-azobis 2-amidinopropane dihydrochloride; EAE: ellagic acid 
equivalents; FTIR: Fourier transform infrared; GAE: gallic acid equivalents; TE: Trolox 
equivalents; TFA: trifluoroacetic acid; ORAC: oxygen radical absorbance capacity. 
Introduction 
There is accumulating literature indicating the benefits of drinking red wine and of 
consuming berries containing phenols and anthocyanins, supporting the concept that wines made 
from dark berry fruits can also be beneficial for health. Wine is a complex mixture of water, 
alcohol and other minor components such as polyphenolic compounds and it has been 
established as having positive effects on health with moderate consumption (USDA 2010). 
Clinical studies have established  a clear link between  moderate consumption of grape wines 
and cardiovascular disease through improvements in vascular function (Vauzour and others 
2010, Chaves and others 2009, Mellen and others 2010, Dohadwala and Vita 2009),  reduction of 
atherosclerosis (Badimon and others 2010), and potential reduction in total mortality   (Theobald 
and others 2000). Another study has shown an increase in plasma antioxidant capacity and 
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plasma total polyphenol concentration in humans after consumption of alcohol-free red wine 
(Serafini 1998), warranting further investigations into the polyphenolic compounds in red wines. 
  Beyond heart health, polyphenolic compounds in fruit beverages including flavonoids 
such as anthocyanins and proanthocyanidins have been found to have anticancer or 
antiproliferative effects (Cilla and others 2009, Mertens-Talcott and others 2008). Decreased 
lipidemia (Blade and others 2010) and favorable effects of wine consumption by those with 
metabolic diseases have been seen in previous studies (Burton-Freeman 2010), showing that 
wine may lead to decreased inflammatory-related disease risk when included as a part of a diet 
containing fruits and vegetables. Further connections have been proposed for compounds with 
longevity attributes in wines (Lekli and others 2010), protection against aging diseases such as 
Alzheimer’s (Singh and others 2008) and memory loss (Abraham and Johnson 2009), and overall 
brain health (Spencer 2009, Bastianetto 2000). All these potential impacts on health beyond 
cardiovascular disease call for further evaluation of wines as beneficial beverages.  
In addition to the health relevance, the wine industry has great importance to economy 
and agriculture. For instance, in Illinois there are over 110 wineries separated into six wine trails 
with most vineyards located in the southern part of the state. Wine must contain 75% Illinois 
grapes to be labeled Illinois wine therefore wine produced from local grape production 
contributes to the overall economy of the state. Of the 87 different grape varieties planted by 
Illinois wineries, thirteen grape varieties account for 85% of the 2006 grape harvest (Campbell 
and Shoemaker 2007). Further, of the 550,000 gallons of wine produced in Illinois in 2006, 
16.3% was non-grape wine (Campbell and Shoemaker 2007). Non-grape fruit wines can be 
produced from almost any fruit (Table 4.1 and Figure 4.1) and provides diversity to wines 
commercially available. 
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Table 4.1- Fruit Wines Produced in the State of Illinois Separated by Wine Trail. All cities 
listed in italics are in the state of Illinois. 
Northern Illinois Wine Trail Fruit Wine Brands Produced 
August Hill Winery 
Utica  
Augie’s Blackberry Port Style Dessert Wine 
Cooper's Hawk Winery  
Burr Ridge, Orland Park, South 
Barrington, Wheeling, Brookfield, 
Naperville 
Blueberry Fruit Wine, Cherry Fruit Wine, Cranberry Fruit Wine, Pomegranate 
Fruit Wine, Peach Fruit Wine, Plum Fruit Wine, Raspberry Fruit Wine, 
Rhubarb Fruit Wine 
Famous Fossil Vineyard & Winery 
Freeport 
Blackberry, Summer Rhubarb, Red Raspberry 
Fox Valley Winery  
Oswego 
Old Glory Red, Old Glory Blue, Sweet Blue (Blueberry and Blackberry) 
Galena Cellars Vineyard & Winery 
Galena  
Blackberry, Blueberry Wine, Cherry, Cranberry Wine, Peach Wine, Red 
Raspberry, Rhubarb 
Glunz Family Wine & Cellars 
Grayslake, Long Grove 
Raspberry, Black Currant 
Hailey's Winery & Vineyard  
Bryon 
Cranberry, Harvest Apple 
Illinois River Winery 
Utica 
2 Fruits Apple-Blueberry Fruit Wine, 2 Fruits Apple-Red Raspberry, 2 Fruits 
Blackberry-Blueberry, 2 Fruits Strawberry-Rhubarb, Blackberry, Chateau St. 
Nik (Apple), Cherry, Cranberry Snow, Cranberry-White Grape, Hallowine 
(Apple), Peach, Red Raspberry Ambrosia, Strawberry Wine 
Lavender Crest Winery  
Colona 
Jubilee (Cherry), Blossom (Peach), Out of the Blue (Blueberry), Cosmic Bog 
(Cranberry), Razmatazz (Raspberry)  
Lynfred Winery  
Roselle 
Apricot, Blackberry, Black Raspberry, Blueberry, Cherry, Cranberry, Kiwi 
Peach, Kiwi Rose, Mango, Peach, Pear, Plum, Pomegranate, Raspberry, 
Rhubarb, Strawberry, Strawberry Rhubarb 
Massbach Ridge Winery 
Elizabeth 
Berry Sweet Wine (Blackberry), Apple Wine, Cherry Rose 
Prairie State Winery  
Genoa  
Apple, Elderberry, Cranberry, Prairie Berry (Blueberry, Blackberry, 
Raspberry), Pomegranate, Pumpkin 
Silver Moon Winery 
Lanark 
Cranberry, Cherry, Peach 
The Village Vintner Winery  
Carpentersville 
Autumn Splash (Apple and Cranberry), Black Satin (Blackberry), Blue Moon 
(Blueberry), Cherish Noir (Black Cherry), Cran Chi (Cranberry), Melon 
Delight, Orchard Mist (Apple), Peachard (Peach), Pom-A-Berry 
(Pomegranate), Purple Passion (Acai & Raspberry), Razzmatazz (Raspberry), 
Rhubarb, Sweet Passion (Strawberry), Tropical Dream (Mango and 
Pineapple), White berry Bog (White Cranberry), Wine-A-Rita (Orange and 
Grapefruit) 
Waterman Winery and Vineyards  
Waterman 
Apple Wine (Apple and Cranberry), Cherrylicious (Cherry), Harvest 
Pumpkin, Perfect Pear, Wild Watermelon 
Wild Blossom Meadery & Winery 
Chicago  
Blueberry Mead, Cran-Nectar, Green Apple Riesling, Pom-Nectar, Raspberry 
Peach, Wild Berry Mead 
Illinois River Wine Trail Fruit Wine Brands Produced 
Hill Prairie Winery 
Oakford 
Cranberry Crush, Prairie Berry (Blueberry and Blackberry), Raz-Cherry(Red 
Raspberry and Cherry), Strawberry 
Willett's Winery and Cellar  
Manito 
Apple Splash, Blueberry Chill, Midnight Cherry, Strawberry Breeze, Black 
Raspberry Rush, Red Raspberry Thrill 
Wabash Valley Wine Trail Fruit Wine Brands Produced 
Fox Creek Vineyards 
Olney 
Framboise (Raspberry), Peach Wine, Pear Wine, Blackberry Cheer 
Lasata Wines 
Lawrenceville 
Blueberry Bliss  
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Table 4.1 (contd.)  
White Owl Winery 
Birds 
Chard-N-Apricot, Cherry Pie, Elderberry, Paw Paw, Persimmon Solera, Pink 
Grapefruit Sparkel, Spiced Pear, Old Blue Port (Blueberry), Watermelon 
Windy Knoll Winery 
Vincennes 
Cherry, Summer Strawberry, Royal Raspberry 
Heartland Rivers Wine Trail Fruit Wine Brands Produced 
Bretz Wildlife Lodge and Winery  
Carlyle 
Wild Life's Cherry, Strawberry Blonde, Bad Apple, Blackberry Blombshell, 
Peach 
Forsee Vineyards 
Coffeen 
Winter Blush,  Indian Summer (Blackberry and Blueberry) 
Mary Michelle Winery  
Carrollton 
Illinois Cellars Apple Wine 
Orchard View Winery 
Alma 
Blackberry, Apple Starboard, Front Porch (Apple), John James (Apple), 
French Kiss (Apple), Hay Loft (Apple with Strawberry), Mona Lisa (Peach), 
Strawberry, Nectarine 
Schorr Lake Vineyards  
Waterloo 
Apple Seasonal, Blackberry, Blackberry Port, Peach, Raspberry 
Vahlings Vineyards & Winery  
Stewardson 
Cherry Wine, Blackberry Wine, Blueberry Wine, Gnome Nectar (Blackberry), 
Honey Wine (Mead), Rhubarb Wine, Strawberry Wine 
Southern Illinois Wine Trail Fruit Wine Brands Produced 
Shawnee Winery  
Vienna 
Temptation (Apple), Black Pearl (Blackberry), Razzle Dazzle (Raspberry), 
Just Peachy 
Shawnee Hills Wine Trail  Fruit Wine Brands Produced 
Alto Vineyards  
Alto Pass 
Cherry, Cherry Berry (Cherry and Raspberry) 
Blue Sky Vineyard 
Makanda 
Framboise (Raspberry) 
Owl Creek Vineyard and Winery 
Cobden 
Framboise (Red Raspberry) 
Pomona Winery  
Pomona 
Jonathan (Apple), Jonathan Oak Aged Reserve (Apple), Golden (Apple), 
Golden Oak Aged Reserve (Apple), Kir (Black currants and Apple), Orchard 
Harvest (Apple), Orchard Spice (Apple), Once In A Blue Moon Blueberry 
Dessert Wine, Peach Dessert Wine, Strawberry Dessert Wine 
Von Jakob Vineyards 
Pomona, Alto Pass 
Honey Peach, Honey Raspberry, Honey Blackberry, Jonathan Apple, She’s A 
Peach 
Hidden Wine Trail Fruit Wine Brands Produced 
Black Diamond Vineyards 
Nashville 
Cherry Starboard 
Cameo Vineyards  
Greenup 
Cherry 
Collver Family Winery  
Barry 
Cherry, Barry Berry, Peach, Blueberry Razz, Raspberry Razz 
Grafton Winery & Brewhaus  
Grafton 
Apple Crisp, Blackberry, Raspberry Kiss, Winter Berry (Cranberry), Spring 
Berry (Blueberry and Blackberry), Summer Peach, Autumn Berry (Raspberry) 
LauNae Winery  
Red Bud 
Olde Tyme Apple, Blossom City Rose (Strawberry, Blackberry, Elderberry), 
Strawberry, Peach Honey, Elderberry, Blueberry Sparkling, Peach Sparkling, 
Strawberry Sparkling 
Pheasant Hollow Winery 
Whittington 
Midnight Medley (Strawberry, Raspberry, Black Cherry), Red & Blue (Cherry 
and Blueberry), Black & Blue (Blackberry and Blueberry), Cherry, Red Razz 
(Raspberry), Marionberry, Peach, Cracklin’ Cranberry 
Spirit Knob Winery 
Ursa 
Cerise (Cherry) 
Villa Marie Winery  
Maryville 
Sugar Loaf White (Peaches), Summerset Bliss (Strawberry) 
*This table was created using information available on the wineries’ websites.  
 53 
 
Figure 4.1- Numbers of Fruits Used in Non-Grape Wines Available in Illinois. 
 
Fruit wines may offer health benefits unique from wine produced from grapes because of 
different components present in the fruit initially and those formed during the fermentation 
process. Dark-colored fruit pigmentation results from the presence of a class of water-soluble 
flavonoids known as anthocyanins. Increased consumption of berries containing anthocyanins 
has been linked to decreased incidence of inflammatory related diseases in humans (Seeram and 
others 2008, Erlund and others 2008), as well as increased free radical scavenging capacity, 
especially from blackberries (Wang and Jiao 2000). Phenolic compounds including anthocyanins 
found in berries have many of the same potential health benefits as grape wine compounds 
regarding improvements of cardiovascular disease (Caton and others 2010, Leifert and 
Abeywardena 2008) and endothelial function and heart health (Mazza 2007).  
It is therefore important to look into the biological activity and potential health benefits of 
fruit wines available in Illinois and thus promote further production and information to the 
consumer. The objective of this study was to evaluate and compare fruit wines commercially 
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available in the state of Illinois made from blueberries and blackberries and describe their 
chemical composition and quality parameters in the context of the wine industry.  
Materials and Methods 
Chemicals  
Compounds used as standards and their purity were as follows: Trolox (≥ 97%), glucose 
(≥ 99.5%), gallic acid (≥ 98%) and ellagic acid (≥ 95%). All chemicals and reagents were 
purchased from Sigma (St. Louis, MO), unless otherwise specified.  
Commercial samples  
Wines were obtained from near Champaign, IL in February of 2011 and are summarized 
in Table 4.2 and Image 4.1. Blackberry wines purchased were produced by Door Peninsula 
Winery (Sturgeon Bay, WI), Galena Cellars Winery (Galena, IL), Lynfred Winery (Roselle, IL), 
St. James Winery (Saint James, MO), Vahling Vineyard (Stewardson, IL) and Von Jakob 
Vineyard (Pomona, IL). Blueberry wines purchased were produced by Galena Cellars Winery 
(Galena, IL), Pomona Winery (Pomona, IL), Tomasello Winery (Hammonton, NJ) and Wild 
Blossom Meadery (Chicago, IL). A blackberry and blueberry blend used for comparison of both 
groups was Pheasant Hollow Winery Black & Blue (Whittington, IL), and commercial blueberry 
juice was R.W. Knudsen Family® Just Blueberry™ Juice (Orrville, Ohio). Wines were tested for 
quality parameters immediately upon opening and stored at 4 °C until further testing.  
  
 Image 4.1. Wines used for commercial comparison. 
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Table 4.2- Commercial Information of Ten Blackberry and Blueberry Wines Available in Illinois. 
Winery name 
 
Location 
 
Bottle 
size 
(mL) 
Price 
($) 
 
Berry/juice source 
 
Claims 
 
 
Blackberry Wines 
     
Door Peninsula 
Winery  
Sturgeon Bay, WI 750 12.99 Fall berry from Door 
County, WI 
Semi-sweet blackberry 
wine 
Alcohol 11.5% by vol. 
Galena Cellars Galena, IL 750 13.99 Marion blackberry Dessert wine, serve 
chilled; Double Gold 
2010 Illinois State Fair 
Bronze; 2009 Indy 
Wine Competition; 
Alcohol 10% by vol. 
Lynfred Winery Roselle, IL 750 12.99 Produced from 100% 
Blackberries from 
Cascade Mountains 
in Washington  
Residual sugar 12%; 
Alcohol 11% by vol. 
St. James Winery Saint James, MO 750 8.99 Fresh picked 
blackberries 
Sweet wine; Serve 
chilled;  
“Award Winning”; 
Alcohol 10.5% by vol. 
Vahling Vineyard Stewardson, IL 750 9.99 Tame and wild 
blackberries 
Bronze Medal at the 
State Fair 
Von Jakob Vineyard Pomona, IL 750 13.99 75% honey wine 
(mead), 25% 
blackberry wine 
Enjoy with spicy foods 
or chocolate; Sweet 
blush table wine; 
Alcohol 12% by vol. 
 
Blueberry Wines 
     
Galena Cellars Galena, IL 750 13.99 Premium blueberries 
from Eastern 
Pennsylvania 
Serve chilled; 
Alcohol 10% by vol. 
Pomona Winery Pomona, IL 375 13.99 Port-style: neutral 
brandy added to 
blueberries from 
HallsBerry Farm in 
Lick Creek, Illinois  
Residual sugar 10%  
Alcohol 18% 
Silver 2010 Great 
Lakes; Silver 2010 
Illinois, Bronze 2010 
Indy International 
Tomasello Winery Hammonton, NJ 500 9.99 100% Highbush 
blueberries grown on 
Atlantic Blueberry 
Company farms 
Alcohol 11% by vol. 
Taster’s Guild Silver 
Medal winner 
Wild Blossom  
Meadery 
Chicago, IL 750 15.99 Local Chicagoland 
wildflower honey 
fermented with 20% 
blueberries from the 
Midwest aged 6-
months 
“Antioxidant content 
one of the highest for 
any beverage known 
on Earth”; 
Alcohol 12.5% by vol. 
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pH, °Brix, and color  
Samples were measured for pH using both an Accumet AR15 pH meter (Fisher 
Scientific, Pittsburg, PA) and with OenoFoss™ (FOSS, Hillerod, Denmark) machine and read 
using the Foss Integrator software. °Brix was measured using a portable refractometer. Color 
was determined with Hunter colorimetry and measured on a HunterLab Lab Scan XE color 
measurement instrument (Reston, VA) with Universal V3.71 software (Hunter Lab, Reston, Va., 
U.S.A.). 
Total phenolic content 
Total phenolic content (TP) was quantified using the Folin-Ciocalteu method described 
originally by Amerine and Ough (1974) adapted to a micro-assay. Briefly to a 96-well flat 
bottom plate, 50 μL of 1 N Folin-Ciocalteu’s phenol reagent and 50 μL of either sample diluted 
1:20, standard or blank were added; this mixture was allowed to stand for 5 min before the 
addition of 100 μL of 20% Na2CO3. The solution was allowed to stand for 10 min before reading 
at 690 nm using a Synergy 2 multi-well plate reader (Biotek, Winooski, VT). Ellagic acid was 
used to create a standard curve (40 to 200 mg/L), and results were expressed as mg ellagic acid 
equivalents (EAE) / L wine. 
Antioxidant capacity  
Antioxidant capacity (AC) was measured by the oxygen radical absorbance capacity 
(ORAC) assay as described previously (Prior 2003). A 20 µL trolox standard, sample, or blank 
of 75 mM phosphate buffer pH 7.4 were added in triplicate to a black walled 96-well plate. To 
each well, 120 µL of 116.9 nM fluorescein was added for a final concentration of 70 nM/well 
followed by 60 µL of 40 mM AAPH. The plate was read at 485 nm and 582 nm every 2 min at 
sensitivity 60 at 37 °C using a Synergy 2 multi-well plate reader (Biotek, Winooski, VT). Trolox 
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was used to create a standard curve (4 to 160 µM) and results were expressed as mmol Trolox 
equivalents (TE)/L wine. 
Total anthocyanin content 
Total anthocyanins were determined using the AOAC Official Method as described 
previously (Lee 2005). Samples were diluted to a factor of 1:10 using two different buffers (pH 
1.0, KCl buffer and pH 4.5, sodium acetate buffer). Diluted solutions at each pH were transferred 
to a 1 x 1 cm cuvette and the absorbance was read at 520 nm and 700 nm on a spectrophotometer 
(Beckman DU ® -64 Spectrophotometer, Fullerton, CA). The total anthocyanins were expressed 
as cyanidin-3-glucoside equivalents in mg/L using the equation below:  
𝑇𝑜𝑡𝑎𝑙 𝑚𝑜𝑛𝑜𝑚𝑒𝑟𝑖𝑐 𝑎𝑛𝑡ℎ𝑜𝑐𝑦𝑎𝑛𝑖𝑛𝑠 (
𝑚𝑔
𝐿
) =  
𝐴 𝑥 𝑀𝑊 𝑥 𝐷 𝑥 1000
𝜀 𝑥 𝑃𝐿
 
Where: A = (A520-A700) pH1.0 – (A520-A700) pH4.5, MW is 449.2 g/mol for cyanidin-3-glucoside, 
D = dilution factor determined experimentally with pH 1.0 buffer, PL is the constant at path-
length 1 cm, ε is 26900 L/mol cm, the molar extinction coefficient for cyanidin-3-glucoside, and 
1000 as the factor for conversion from g to mg. 
Wine quality 
Finished wine was measured for quality parameters using 600 μL of wine loaded onto the 
OenoFoss™ (FOSS, Denmark) machine and read using the Foss Integrator software. Glucose-
fructose, pH, total acid, malic acid, volatile acid, and percent ethanol were determined by Fourier 
transform infrared (FTIR) spectroscopy. Global calibrations provide accurate readings for ranges 
between 0-15 g/L for glucose-fructose, 2.6 - 4.5 for pH, 1.5 – 8.0 g/L for total acid, 0 - 7 g/L for 
malic acid, 0 - 1.5 g/L for volatile acid (as acetic acid), and between 8 – 18% ethanol. 
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Statistical analysis  
Data were expressed as means of at least three independent replicates and were presented 
as mean ± standard deviation. Statistical analysis was conducted using Tukey's Studentized 
Range Test groupings using the proc GLM function of SAS version 9.2 (SAS Inst. Inc., Cary, 
NC). Group means were considered to be significant at p < 0.05 based on minimum significant 
differences from one-way analysis of variance (ANOVA) with α = 0.05. Pearson’s correlation 
was used to determine correlation coefficients (r-values). 
Results and Discussion 
pH, Brix, and Color  
As seen in Table 4.3, commercial blackberry wine had an average pH of 3.4 and ranged 
from 3.1 to 3.7. The commercial blueberry wines had an average pH of 3.3 and ranged between 
2.8 to 3.7. These results for blueberry and blackberry commercial wines agreed with the typical 
pH range for red table wines between 2.9 to 4.2 (Zoecklein and others 1995). °Brix, a 
measurement of residual sugars, ranged from 14.6 to 18.0 with an average of 16.4° Brix for the 
blackberry wines while the commercial blueberry wines had °Brix measurements ranging from 
12.1 to 19.0 with an average of 15.3° Brix. Overall the blueberry wines had a slightly lower 
°Brix than the blackberry wines and a slight but not significantly lower pH. Typical °Brix values 
for wine produced from mature grapes are around 18° Brix (Zoecklein and others 1995), so the 
wines produced from blueberries and blackberries are similar to this value. Hunter colorimetric 
analysis provides a color scale that depicts the lightness, yellowness, and redness of a sample. 
Analysis of the wines showed an average Hunter L (lightness index) of 1.55 for the blackberry 
wines and 1.43 for the blueberry wines; the blueberry wines had slightly less lightness than the 
blackberry wines on average.  
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Table 4.3- Quality Parameters including pH and Brix of Blackberry and Blueberry Wines Available in Illinois. 
 
Commercial Sample 
 
pH 
 
°Brix 
 
Glucose-
Fructose 
(g/l) 
Total 
Acid (g/l) 
Malic 
Acid (g/l) 
Volatile 
Acid 
(Acetic 
acid) (g/l) 
%Ethanol 
 
 
Blackberry Wine        
Door Peninsula Blackberry 3.3 ± 0.1
abc
 15.6 ± 0.03
f
 100.3 ± 0.4
c
 5.7 ± 0.2
cd
 4.0 ± 2.2
c
 0.0 ± 0.0
c
 11.2 ± 0.1
c
 
Galena Cellars Blackberry 3.1 ± 0.4
bc
 14.6 ± 0.03
g
 86.3 ± 0.4
d
 8.1 ± 0.0
a
 6.6 ± 0.3
a
 0.1 ± 0.1
c
 11.7 ± 0.0
bc
 
Lynfred Blackberry 3.7 ± 0.2
a
 16.0 ± 0.03
e
 103.5 ± 2.1
bc
 5.9 ± 0.0
cd
 5.1 ± 0.4
b
 0.7 ± 0.1
a
 10.0 ± 0.1
e
 
St. James Blackberry 3.6 ± 0.4
ab
 18.0 ± 0.03
b
 124.8 ± 0.0
a 
4.2 ± 0.2
e
 2.2 ± 0.4
d
 0.1 ± 0.1
c
 9.6 ± 0.4
ef
 
Vahling Blackberry 3.3 ± 0.1
abc
 18.0 ± 0.07
b
 124.0 ± 0.7
a
 5.3 ± 0.2
d
 3.2 ± 0.5
cd
 0.2 ± 0.1
bc
 9.5 ± 0.3
ef
 
Von Jakob Honey Blackberry 3.6 ± 0.2
ab
 16.5 ± 0.07
d
 99.3 ± 0.4
c
 3.9 ± 0.4
e
 0.4 ± 0.3
e
 0.7 ± 0.1
a
 12.4 ± 0.1
b
 
 
Mean ± Std. Dev. 3.4 ± 0.2 16.4 ± 1.3 106.3 ± 15.2 5.5 ± 1.5 3.5 ± 2.2 0.3 ± 0.3 10.7 ± 1.2 
 
Blueberry Wine        
Galena Cellars Blueberry 3.7 ± 0.2
abc
 12.1 ± 0.07
i
 77.5 ± 0.0
e
 6.2 ± 0.1
c
 3.7 ± 0.4
c
 0.0 ± 0.1
c
 9.0 ± 0.0
f 
Pomona Once In A Blue Moon 3.0 ± 0.4
c
 19.0 ± 0.03
a
 107.5 ± 0.0
b
 5.7 ± 0.2
cd
 3.3 ± 0.6
c
 0.4 ± 0.3
ab
 15.2 ± 0.1
a
 
Tomasello Blueberry 2.8 ± 0.4
c
 17.4 ± 0.03
c
 121.6 ± 0.0
a 
7.1 ± 0.1
b
 3.7 ± 0.4
c
 0.1 ± 0.1
c
 10.9 ± 0.0
cd
 
Wild Blossom Blueberry Mead 3.6 ± 0.1
ab
 12.6 ± 0.03
h
 77.5 ± 0.7
e
 3.6 ± 0.4
e
 0.7 ± 0.3
e
 0.6 ± 0.1
a
 10.3 ± 0.0
de
 
 
Mean ± Std. Dev. 3.3 ± 0.4 15.3 ± 3.5 95.1 ± 23.8 5.6 ± 1.5 2.8 ± 1.5 0.3 ± 0.3 11.3 ± 2.7 
 
Pheasant Hollow Winery 
Black & Blue 3.4 ± 0.0 14.7 ± 0.16 93.1 ± 0.8 4.6 ± 0.0 2.5 ± 0.1 0.3 ± 0.0 11.6 ± 0.4 
 
Tukey's MSD 0.5459 0.1533 4.8152 0.7009 1.0071 0.2952 0.8629 
 
a-i
: Values within a column followed by different letters are significant at p < 0.05. Data is represented as the mean ± SD from at least a triplicate analysis.  
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Hunter b (yellowness index) values were 2.46 for the blackberry wines and 2.27 for the 
blueberry wines; blackberry wines were more yellow than blueberry. Hunter a (redness index) 
values were 1.36 for the blackberry wines and 1.19 for the blueberry wines on average; the 
blackberry wines had more redness than the blueberry wines. The blackberry wines had slightly 
more lightness, redness, and yellowness than the blueberry wines on average. There was a 
positive correlation between Hunter L and b values (r = 0.70) indicating the wines with more 
lightness also had more yellowness.  
Quality parameters  
Table 4.3 also lists the means and standard deviations of the glucose-fructose 
concentration, total acid, malic acid, and volatile acid as acetic acid, all in g/L, as well as the 
measured percent ethanol. Glucose-fructose concentration ranged from 77.5 g/L to 124.8 g/L. A 
strong positive correlation between high °Brix and high glucose-fructose was obtained (r = 0.90) 
as both are measures of the sugar content; wines with high residual sugars have high glucose-
fructose concentration while those with lower residual sugars contain less glucose-fructose. The 
blackberry wines had an average concentration of glucose-fructose of 106.3 g/L while blueberry 
wines had average glucose-fructose slightly lower at 95.1 g/L. Any wine with over 45 g/L may 
be labeled as ‘sweet’ (European Union 2002), so all the wines classify as a sweet wine, as was 
indicated on the labels of the products.  
Total acids present in wine are extracted from the fruit source during the wine making 
process and during fermentation. Total acids of all wines ranged from 3.6 g/L to 8.1 g/L. The 
average total acids for the blackberry wines (5.5 g/L) was not significantly lower than the 
average total acids of the blueberry wines (5.6 g/L). A typical range of total acid for wines is 
between 5-8 g/L (Zoecklein and others 1995). Most samples fall within this range, however 
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mead wines produced mainly from honey rather than grapes or berries would have lower acidity, 
the reason mead production often requires addition of acids.  There was a negative correlation (r 
= -0.60) between pH and total acid content, indicating that the pH is a fair representation of the 
total acid content of these fruit wines; as the total acid content increased, pH decreased, as 
expected.  
Fixed, or non-volatile, acids vary greatly depending on the amount of acid present in the 
fruit used to produce the wine and the yeast or bacteria used for fermentation as well as weather 
and fruit growing conditions. Expected values in red wines for the fixed acids are 1 to 4 g/L 
tartaric acid, 0-8 g/L malic acid, 0-0.5 g/L citric acid, and 0.5-2 g/L succinic acid (Zoecklein and 
others 1995). The commercial wines fell in the range of expected values for malic acid with a 
range between 0.7 to 6.6 g/L. Blackberry wines had an average of 3.5 g/L of malic acid, slightly 
higher than the average of the blueberry wines at 2.8 g/L. There was a very strong positive 
correlation (r = 0.90) between the total acidity and malic acid content, indicating that most of the 
total acid may be due to the malic acid present (Table 4.5). Along with malic acid, tartaric acid is 
another major acid found in wine present in the original fruit with trace amounts of citric acid, 
while lactic, acetic, and succinic acid are produced during the alcoholic fermentation process 
(Zoecklein and others 1995).  Volatile acid content, expressed as acetic acid, ranged from 0.0 g/L 
to 0.7 g/L. The average volatile acid content for all blackberry and blueberry wines was 0.3 g/L. 
Volatile acids are considered markers for spoilage with the legal limit in dessert wines set to 1.2 
g/L (Zoecklein and others 1995), therefore all wines tested fall safely below this level. Acidity of 
wine influences the stability and quality of wine; therefore it is important to measure it. Though 
the commercial samples are all sweet wines, they have similar amounts of acid present in grapes 
and wine.  
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Ethanol concentration is important for wine stability and many flavor properties. Alcohol 
measured as percent ethanol ranged from 9.0% to 15.2%. Average alcohol concentration for the 
blackberry wines was 10.7% ethanol and average alcohol for the blueberry wines was slightly 
higher at 11.3% ethanol. United States regulations define wine as having between 7 to 24% 
ethanol by volume, depending on the type of wine and the wine making process. There was a 
strong correlation (r = 0.83) between the reported alcohol concentration on the labels and the 
alcohol measured with the OenoFoss™ software, indicating that the values reported on 
commercial wine labels were accurate.  
Table 4.4- Total Polyphenols, Total Anthocyanins, and Antioxidant Capacity of Blackberry and 
Blueberry Wines Available in Illinois. 
 
Total 
Polyphenols (mg 
EAE/L) 
Total 
Anthocyanins  
(mg /L) 
Antioxidant 
Capacity (mmol 
TE/L) 
Blackberry Wine    
Door Peninsula Blackberry  1219.2 ± 92.7
efg
 16.61 ± 0.31
e
 14.65 ± 0.80
de
 
Galena Cellars Blackberry 3620.8 ± 165.8
b
 22.90 ± 2.65
de
 36.53 ± 7.86
c
 
Lynfred Blackberry 2805.0 ± 416.1
cd
 115.29 ± 6.48
b
 48.96 ± 3.16
b
 
St. James Blackberry  1494.2 ± 45.6
ef
 88.26 ± 9.40
c
 11.08 ± 0.29
de
 
Vahling Blackberry 3084.2 ± 294.1
c
 191.95 ± 6.16
a
 41.04 ± 11.21
bc
 
Von Jakob Honey Blackberry 1051.7 ± 53.6
fg
 18.35 ± 0.70
e
 6.10 ± 1.00
e
 
 
Mean ± Std. Dev. 2212.5 ± 1090.3 75.56 ± 70.44 26.39 ± 17.95 
 
Blueberry Wine    
Galena Cellars Blueberry 1460.0 ± 413.4
ef
 37.29 ± 2.34
d
 17.02 ± 3.31
de
 
Pomona Once In A Blue Moon 2510.8 ± 427.1
d
 10.71 ± 4.16
e
 32.76 ± 3.96
c
 
Tomasello Blueberry  966.7 ± 44.8
g
 12.72 ± 0.37
e
 17.44 ± 6.24
d
 
Wild Blossom Blueberry Mead 1555.8 ± 74.7
e
 22.56 ± 2.18
e
 17.62 ± 5.83
d
 
 
Mean ± Std. Dev. 1623.3 ± 645.5 20.82 ± 12.14 21.21 ± 7.71 
Pheasant Hollow Winery  
Black & Blue 2950.1± 168.3 95.12 ± 0.88
 
29.08 ± 2.2
 
Just Blueberry Juice™ 4160.8 ± 203.8a 192.12 ± 13.79a 70.94 ± 4.49a 
Tukey’s MSD 490.1200 14.5840 10.9360 
a-g
: Values within a column followed by different letters are significant at p < 0.05. Data is represented as the 
mean ± SD from at least two independent studies and at least a triplicate analysis.  
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Total polyphenols, total anthocyanins and antioxidant capacity  
Total polyphenols for the commercial samples ranged between 966.7 mg EAE/L to 
3620.8 mg EAE/L as seen in Table 4.4. The average total polyphenol content for commercial 
blackberry wines was 2212.5 mg EAE/L and for all blueberry wines was 1623.3 mg EAE/L. 
Total polyphenols can be expressed as either gallic acid equivalents or ellagic acid equivalents as 
both are phenolic acids. As many literature values are presented in gallic acid equivalents, a 
standard curve was also created using gallic acid showing the total polyphenols for the 
commercial blueberry and blackberry wines ranged from 188.1 ± 23.4 to 1115.3 ± 56.2 mg 
GAE/L, similar to values in typical table wines produced from grapes which range from 190-290 
mg GAE/L in aged white wines to between 955-1215 mg GAE/L in aged red wines (Zoecklein 
and others 1995). Most of these blueberry and blackberry wines fall near the higher end of the 
total polyphenols seen in red wines. Additionally, there was a strong negative correlation (r = -
0.76) seen between the Hunter L (lightness index) and total polyphenolic content; the more 
lightness of the wine, the lower total polyphenol content, suggesting the polyphenolic 
compounds contribute to the darkness of wines, as expected (Table 4.5). 
A recent study (Kontoudakis and others 2011) on grape phenolics and wine composition 
found that higher total phenolic index and anthocyanin and proanthocyanidin concentrations also 
had lower titratable acidity and bitterness, suggesting a higher wine quality. Also, a non-grape 
wine produced from kiwifruit found wines with higher total phenolics also had higher sensory 
quality (Towantakavanit and others 2011). Garcia-Ruiz and others (2008) provided evidence that 
supports the potential for phenolic compounds to be a natural antimicrobial agent during wine 
production, so wines containing higher total phenolics may also prevent microbial growth. 
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Table 4.5- Correlation Coefficients of Quality and Chemical Parameters, Color Measurements, 
TP, TA, and AC Parameters for the Blueberry and Blackberry Wines. 
*Presented r-values are Pearson’s correlation coefficients. TP is total polyphenols in (mg 
EAE/L). TA is total anthocyanins in mg cyanidin-3-glucoside equivalents/L. AC is antioxidant 
capacity as measured with ORAC in mmol TE/L. Bold values represent those with r > 0.45. 
 
Total anthocyanins measured as cyanidin-3-glucoside equivalents ranged from 10.71 
mg/L to 191.95 mg/L. Average total anthocyanins in blackberry wines was 75.56 mg/L and in 
blueberry wines was 20.82 mg/L. Most blackberry wine fell within a range of previous values 
seen for red grape wines of 67.0 to 101.54 mg/L (Granato and others 2011). There was a positive 
correlation (r = 0.47) between total polyphenols and total anthocyanins, indicating that the total 
phenolic content of wines increases with an increase in anthocyanin content. Because 
anthocyanins are the compounds that give berry fruits their red, blue, and purple pigmentation, 
wines with lighter visual color as measured with the Hunter L lightness index overall had lower 
Parameters 
 °Brix 
Glucose-
Fructose 
Total 
Acid 
Malic 
Acid 
Volatile 
(Acetic) 
acid Ethanol TP TA AC 
pH -0.47 -0.37 -0.60 -0.36 0.37 -0.52 -0.15  0.28 -0.15 
°Brix   0.90 -0.03 -0.02 0.03  0.43  0.12  0.30  0.17 
Glucose-
Fructose   -0.04 -0.03 -0.15  0.02 -0.01  0.49  0.10 
Total Acid     0.90 -0.51  0.08  0.44 -0.14  0.44 
Malic Acid     -0.43 -0.02  0.63  0.09  0.64 
Volatile 
(acetic) acid      0.26  0.05  0.04  0.17 
%Ethanol        0.10 -0.53  0.02 
Total 
Polyphenols         0.47  0.88 
Total 
Anthocyanins          0.55 
          
Hunter color 
index 
 
        
L (lightness)       -0.76 -0.44 -0.63 
a (red)        0.21  0.30  0.53 
b (yellow)       -0.45 -0.27 -0.25 
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anthocyanin content; indeed, there was a negative correlation between Hunter L value and total 
anthocyanins (r = -0.44). 
Other studies agree with the negative correlation seen between the lightness index and 
total anthocyanins for these commercial blueberry and blackberry wines. A study on elderberry 
wines found the hue value to be negatively correlated with total anthocyanins (Schmitzer and 
others 2010), and the effect of processing and storage on both blackberry (Hager and others 
2008) and blueberry products (Brownmiller and others 2008) found an increase in polymeric 
color but a decrease in total anthocyanins of juices stored over time. This also indicated that the 
colors in the wine may change during storage of the wines through conversion of monomeric 
anthocyanins to the polymerized form. A study done on various traditional berries used by 
Native Americans found the anthocyanins that provided most color associated with the berry 
were the 3-glucosides or the 3-galactosides of cyanidin and delphinidin (Kraft and others 2008). 
The profile of anthocyanins found in both blueberries and blackberries has been identified 
(Grace and others 2009, Cuevas-Rodriguez and others 2010), suggesting that the presence of 
these specific anthocyanins in wines produced from berries may provide more color to the 
finished wine product.  
Antioxidant capacity of wines ranged from 6.10 mmol TE/L to 48.96 mmol TE/L. The 
comparatively low antioxidant capacity for Von Jakob Honey Blackberry wine is consistent with 
other mead wines which range from 3.47 to 16.06 mmol TE/L (Gupta 2009). Average 
antioxidant capacity of blackberry wines was slightly but not significantly higher at 26.39 mmol 
TE/L than the average of the blueberry wines at 21.21 mmol TE/L (Table 4.4). There was a 
strong positive correlation (r = 0.88) between total phenolic content and antioxidant capacity as 
well as a positive correlation (r = 0.55) between total anthocyanin content and antioxidant 
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capacity indicating that the antioxidant potential of wines is likely due to phenolics and 
anthocyanins. Further, there was a negative correlation between the Hunter L values for lightness 
of the wines and antioxidant capacity (r = -0.63) and a positive correlation (r = 0.53) between the 
Hunter a values for redness of the wines; darker wines with more redness had a higher 
antioxidant capacity. Previous studies found average ORAC total antioxidant capacities of 25.7 
mmol TE /L for red wine and 20.6 mmol TE/L for blueberry juice (Seeram and others 2008), and 
between 13.87 to 35.11 mmol TE/L for South American red wines (Granato and others 2011). 
All of the quality parameters of the blueberry and blackberry wines are comparable to red grape 
wine as well as the antioxidant capacity, so blueberry and blackberry wines may have the 
potential health benefits that have been proven for red grape wine. Several foods and beverages 
are currently marketed based on their antioxidant capacity. From the results of these wines tested 
both blueberry and blackberry wines commercially available in Illinois have the potential to be 
marketed for their high antioxidant capacity. 
Comparing to Pheasant Hollow Winery Black & Blue, a commercial sample that is a 
blend of blueberries and blackberries, all values fell between the averages for the blueberry and 
the blackberry wines tested, as expected (Tables 4.3 and 4.4). Also seen in Table 4.4 are results 
from the Just Blueberries Juice™ as an example of concentrated blueberry juice. Because all of 
the commercial wines contained at least 9% alcohol by volume and were produced from fruit 
juices or fruit themselves rather than fruit concentrate, the non-alcoholic juice should be more 
concentrated in the phytochemical characteristics. The organic blueberry juice produced from 
concentrate showed the highest antioxidant capacity, highest (but not significantly higher than 
Vahling Blackberry) total polyphenolics, and the highest total anthocyanins; though these 
parameters were higher for the juice than the wines. Drinking fermented beverages is important 
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due to the conversion of the compounds present and increase anthocyanin and polymeric 
proanthocyanidins compounds and antioxidant capacity (Martin and Matar 2005), so though the 
total polyphenolic and total anthocyanin content was higher for the juice, it is not clear whether 
these compounds will have the same absorption and bioavailability as the compounds in the 
wines. 
 Previous studies on the health benefits of red wine have focused on the role of alcohol or 
in comparison to white wine rather than juices. For example, a study with alcohol-free red wine 
found an increase in plasma antioxidant capacity after consumption of 113 mL of red wine 
(Serafini and others 1998), which is the same as half the serving size indicated for the blueberry 
juice. Evaluation of Austrian red wines for anti-diabetic potential of whole wines and wine 
compounds found several compounds in red wines that would make them a beneficial natural 
alternative to drug therapy for diabetes and other metabolic diseases (Zoechling and others 
2011). Limited clinical trials with moderate red wine consumption have seen improved 
hypertensive side effects including higher high density lipoproteins (HDL) levels and lower 
triglyceride levels as reviewed by Opie and Lecour (2007) despite high sugar and ethanol content 
in wines. These and other previous studies and clinical trials on red wine are supportive of 
further research into the potential for non-grape wines to improve overall health and reduce 
metabolic diseases.  
Conclusions 
Wines produced from blueberries and blackberries have high total polyphenolics and 
total anthocyanin contents which correlate with their antioxidant capacity.  Comparing the 
commercial wines produced in Illinois from blueberries or blackberries to those from wineries in 
other states showed no significant differences overall. It should be noted that though these fruit 
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wines contain a higher °Brix than most red wines as they are sweet fruit wines, their antioxidant 
capacity is similar to red wine. Consumers should then take advantage of available blueberry and 
blackberry fruit wines. Evaluation of commercially available fruit wines produced from 
blueberry and blackberry found encouraging results to support further investigation into the 
mechanism and action of compounds present in fruit wines for potential health applications. The 
current wine industry would benefit from expanded production and marketing of high 
polyphenol and high antioxidant beverages such as non-grape wine produced from blueberries 
and blackberries.  
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CHAPTER 5 
CULTIVAR EVALUATION AND EFFECT OF FERMENTATION ON ANTIOXIDANT 
CAPACITY AND IN VITRO INHIBITION OF α-AMYLASE AND α-GLUCOSIDASE BY 
HIGHBUSH BLUEBERRY (Vaccinium corombosum)
3 
                                                                                                       
Abstract 
 
The berry fruits of Highbush blueberry (Vaccinium corymbosum) contain bioactive 
compounds with potential health benefits. The objective was to evaluate blueberries grown in 
southern Illinois as well as the effect of fermentation, at two different temperatures, on chemical 
and physical parameters. Fruits from fifteen blueberry cultivars were analyzed. Fruit diameter 
ranged from 12.8 mm to 18.7 mm, pH from 2.6 to 3.7, reducing sugars from 6.4 % to 15.2 %, 
total sugars from 13.9 % to 21.6 %, total polyphenols from 0.39   to 1.00 mg gallic acid 
equivalents (GAE)/ g blueberry and antioxidant capacity from 5.8 to 10.9 µM Trolox equivalents 
(TE) / g. In vitro α-amylase and α-glucosidase inhibitory capacity relative to the positive control 
acarbose, a known anti-diabetic drug, showed a range from 91.8 to 103.3 % for α-amylase and 
from 103.2 % to 190.8 % for α-glucosidase. Wines prepared from several of these blueberry 
cultivars were analyzed throughout fermentation and compared at room temperature and cold 
temperature fermentation for pH (3.5 to 6.3), °Brix (13.6 to 29.7), total polyphenols (375.4 to 
657.1 µg GAE / mL wine), and antioxidant capacity (4.5 to 25.1 mM TE). The wines were also 
tested for their in vitro capacity to inhibit α-amylase and α-glucosidase and maintained similar 
inhibitory action as the berries. Highbush blueberry cultivars and their fermented beverages are 
good natural sources of antioxidants and starch-degrading enzyme inhibitors important for type 2 
diabetes management.  
                                                             
3
 (Publication: Johnson MH, Meyer T, Lucius A, de Mejia EG. Cultivar evaluation and effect of 
fermentation on antioxidant capacity and in vitro inhibition of α-amylase and α-glucosidase by 
Highbush blueberry (Vaccinium corombosum). Journal of Agricultural and Food Chemistry. 
2011, 59 (16): 8923-8930.) This work has been previously published and reprinted (adapted), 
with permission ©2011 American Chemical Society; dx.doi.org/10.1021/jf201720z. 
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Abbreviations used: AAPH: 2,2-azobis 2-amidinopropane dihydrochloride; AC: antioxidant 
capacity; CAE: crude-amberlite extract; CT: Cold temperature (4 °C); EAE: ellagic acid 
equivalents; GAE: gallic acid equivalents; RT: Room temperature (20-22 °C); TE: Trolox 
equivalents; TFA: trifluoroacetic acid; TP: total polyphenol; ORAC: oxygen radical absorbance 
capacity. 
 
Introduction 
In the United States there are increasing numbers of teens and adults that have pre-
diabetes, and currently, 25.6 million people have diabetes [1]. This condition causes severe 
complications if blood glucose levels are not monitored properly, making diabetes prevention 
and management a very important health issue. There is a need to develop strategies for diabetes 
management in order to decrease its incidence and deaths from diabetes-related complications. 
One therapeutic approach for management of type 2 diabetes is to reduce glucose absorption by 
inhibiting α-amylase and α-glucosidase involved in starch degradation. Various berries have 
been investigated for their potential use in the management of diabetes by inhibiting starch-
degrading enzymes after the consumption of soft fruits [2], Brazilian native fruits [3], 
strawberries [4] and raspberries [5]. In clinical trials, consumption of whole blueberries and 
freeze-dried blueberry beverages have been found to exhibit anti-diabetic properties by reducing 
blood glucose concentration [6, 7] in both healthy subjects and those with metabolic syndrome. 
For those with diabetes, natural sources of inhibitors of α-amylase and α-glucosidase would be 
beneficial in order to avoid potential gastrointestinal side effects [8] caused by commercial α-
glucosidase inhibitors. 
Berries in general have been noted for having positive health effects due to their high 
amount of phenolic compounds and antioxidants [9, 10]. The phenolic profiles and composition 
of many fruits and vegetables have been investigated and blueberries have been found to be rich 
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sources of antioxidants. The high antioxidant activity of blueberries is well documented and it 
has been correlated to their anthocyanin [11] and total phenolic content [12, 13]. High 
concentrations of phenolic compounds, such as resveratrol and anthocyanins found in grapes, 
have shown potential for reducing hyperglycemia [14].  
Specific cultivars of blueberries and their composition have been studied [15], but not 
much research explains the compositional changes from processing, including fermentation. 
Studies have shown that during ripening of berries, especially blueberries, anthocyanins 
accumulate after harvest and even during storage [16]. Since the bioavailability of anthocyanins 
is relatively low compared to other flavonoids [17], and because fermentation is known to 
increase antioxidant capacity of blueberry juice [18], wine processing techniques that maximize 
the amount of skin contact are viable ways to increase the anthocyanin content and antioxidant 
capacity of berry juice products [18, 19]. In addition, ellagic acid, a major sedimentation product 
formed during fermentation, has been previously shown to have greater losses due to 
precipitation at higher temperatures of storage for wines produced from muscadine grapes [20]. 
One specific hypothesis of this study is that fermenting blueberries at colder temperatures will 
cause less ellagic acid precipitation, having important implication to wine quality.  
To our knowledge, no research has been conducted on the effect of berry fermentation 
temperature on the inhibition of starch-degrading enzymes. Therefore, there is a need to further 
investigate different genotypes of berries and the effects of fermentation for their potential use to 
decrease starch degradation. This research aimed to perform an evaluation of Highbush 
blueberries, V. corymbosum, grown at the Dixon Springs Agricultural Center (DSAC) in 
southern Illinois, including their physical descriptions, total polyphenols, antioxidant capacity, 
and in vitro enzymatic inhibition of α-amylase and α-glucosidase.  In addition, the effect of 
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fermentation of blueberries at two different temperatures on these parameters and the in vitro 
potential of the resulting wine for inhibiting starch breakdown were also assessed.  
Materials and Methods 
Chemicals. Compounds used as standards and their purity were as follows: Trolox (≥ 
97%), glucose (≥ 99.5%), gallic acid (≥ 98%), and ellagic acid (≥ 95%). All chemicals and 
reagents were purchased from Sigma (St. Louis, MO), unless otherwise specified.  
Blueberry cultivars. All berries were grown at the same location under the same 
environmental conditions and all of them were harvested when fully ripe, independently of their 
diameter, during June 2010 from the Dixon Springs Agricultural Center (DSAC) in Simpson, IL. 
They were immediately washed, dried, and stored in plastic bags at -4 °C. All blueberries grown 
at DSAC were of the species Vaccinium corymbosum. Cultivars studied were Berkley, Blue 
Chip, Blue Haven, Blue Jay, Bluecrop, Blueray, Bluetta, Collins, Coville, Darrow, Earliblue, 
North Country, Patriot, Spartan, and Stanley (Image 5.1). The results obtained from the 
blueberries grown at DSAC were compared to a fresh fully ripe commercial blueberry sample 
(Naturipe Farms, Naturipe Farms LLC, Martinez, GA).  
   
    Image 5.1. Blueberry cultivars evaluated. 
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Physical characterization.  One hundred blueberries were randomly picked from each 
cultivar. The cross-diameter of each berry was measured in duplicate immediately after 
harvesting using a pair of Vernier calipers (Bel-Art Products Scienceware, Pequannock, NJ 
07440-1992). Twenty grams of blueberries from each cultivar listed above were blended in 50 
mL double distilled (dd) water and filtered using Whatman #4 filter paper. The filtrates were 
stored at 4 °C in test tubes covered with Parafilm before analysis. The filtrates were taken out of 
refrigeration 10 min before the experiment to allow the samples to reach room temperature, 26.3 
°C. A pH meter (Mettler Toledo SevenEasy™, Columbus, OH) and pH probe (Mettler Toledo 
InLab® Expert 2m, Columbus, OH) were used to measure the pH of each blueberry extract. 
Reducing sugars were determined using a modified method originally described by Lindsay [21]. 
Briefly, 0.5 mL of each extract was transferred into a clean, dry test tube and 0.5 mL of 1.5 N 
H2SO4 were added, boiled in a water bath (100 °C) for 20 min with occasional mixing. Tubes 
were cooled down and 0.75 mL of 2 N sodium hydroxide added, then 1 mL of dinitrosalicylic 
acid reagent and 2 mL of dd water. The test tubes were heated again (100 °C) in a water bath for 
5 min and then cooled down, 16 mL of dd water were added and the absorbance read at 570 nm 
in a spectrophotometer (Beckman DU ® -64 Spectrophotometer, Fullerton, CA) using glucose as 
a standard. 
Extraction and removal of reducing sugars. Berry extraction and fractionation were 
performed based on procedures developed by Grace et al. [22]. Twenty grams of frozen berries 
were blended with 40 mL repeat washings of 100% methanol acidified with 0.3% trifluoroacetic 
acid (TFA) and filtered through Whatman # 4 filter paper until no further color was detected. 
The collected hydro-alcoholic extract was concentrated using a rotary evaporator (40 °C). Frozen 
berry extract or wine sample (5 mL) was loaded onto an amberlite XAD-7 column (30 × 3 cm) 
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preconditioned with acidified water, (0.3% TFA). The aqueous layer and resin was washed 
thoroughly with acidified water (0.3% TFA, ~600 mL) to remove free sugars, pectins, and 
phenolic acids. The polyphenolic mixture was then eluted with acidified methanol (0.3% TFA) 
and concentrated on a rotary evaporator (40 °C) to yield a crude-amberlite extract (CAE). 
Samples were then freeze-dried and stored at -80 °C.  
Fermentation of berry juice. Upon collection of the fruits from the various cultivars, the 
berries were stored frozen at -18 °C until use. Berry wines were prepared, as indicated in Figure 
5.1A, using about 90.7 kg of roughly even mixtures of cultivars Blue Chip, Bluecrop, Blue 
Haven, Blue Jay, Blueray, Bluetta, Collins, Coville, Darrow, Earliblue, Elliot, Jersey, Late Blue, 
and Spartan. After thawing frozen berries overnight at room temperature (20 – 22 °C), 180 mL 
SO2 solution (50 ppm), 3 g pectic enzyme solution (dissolved in water), 11.3 kg sucrose solution, 
and 180 g potassium bicarbonate in water were added. This mixture was then divided into four 
evenly divided lots, about 22.7 kg each. Dry wine yeast Lavin EC 1118 (Saccharomyces 
bayanus) was obtained from Presque Isle Wine Cellars (North East, PA). Yeast EC 1118 was 
rehydrated in potable water at 40 °C for 20 min with occasional gentle stirring to remove clumps 
prior to inoculation of the juice. Per manufacturer’s recommendations, yeast EC 1118 was 
inoculated at 40 mg dry yeast/100 mL and 35 mL yeast (23 °C) was added to each lot of fruit (22 
°C). Fifty g fermaid was dissolved in water and 15 mL of this nutrient was added to each lot. 
Lots 1 and 2 were held at room temperature (RT, 20 – 22 °C); lots 3 and 4 were held at cold 
temperature (CT, 4 °C) for two weeks until pressed (skin removed); RT ready to press 14 days 
after yeast was added, CT ready 5 days later. Juice from all treatments was tested each week for 
pH, °Brix (Figure 5.1B) and phenolics. Fermented wine has been stored at 0 °C. Results 
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presented are averages of the independent duplicates lots 1 and 2 as room temperature (RT) or 3 
and 4 as cold temperature (CT), unless otherwise specified.  
 A. 
 
B.   
Figure 5.1. A. Flow diagram of the fermentation of berry juice. B. Fermentation curves for each 
batch of wine throughout time. Batch 1 and 2 were fermented at room temperature (RT) while 3 
and 4 were fermented at cold temperature (CT). 
 
Collection of Highbush blueberries (V. corymbosum); 90.7 kg mixture of cultivars, 20-22 °C 
 
180 mL SO2 solution (50 ppm) 
3 g pectic enzyme solution (in water) 
11.3 kg sucrose solution 
180 g potassium bicarbonate (in water) 
 
Lot 1 Lot 2 Lot 3 Lot 4 
35 mL yeast Lavin EC 1118 (Saccharomyces bayanus), 23 °C; 15 mL fermaid yeast nutrient 
Room Temp: 20-22 °C Cold Temp: 4 °C 
Pressed (skin removed) 
Stored at 0 °C 
22.7 kg each, 22 °C 
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Total phenolic content. Total phenolic content (TP) was quantified using the Folin-
Ciocalteu method described originally by Amerine and Ough [23] adapted to a micro-assay. 
Briefly, to a 96-well flat bottom plate, 50 μL of 1 N Folin-Ciocalteu’s phenol reagent and 50 μL 
of either sample, standard or blank were added; this mixture was allowed to stand for 5 min 
before the addition of 100 μL of 20% Na2CO3. The solution was then allowed to stand for 10 min 
before reading at 690 nm using a Synergy 2 multi-well plate reader (Biotek, Winooski, VT). 
Results were expressed as µg gallic acid equivalents (GAE) / g blueberry or µg ellagic acid 
equivalents (EAE) / mL wine. 
Total anthocyanins. Total anthocyanins were determined using the AOAC Official 
Method as described previously by Lee [24]. Samples were diluted 1:10 using two different 
buffers (pH 1.0 KCl buffer and pH 4.5 sodium acetate buffer) and the absorbance was read at 
520 nm and 700 nm on a spectrophotometer (Beckman DU ® -64 Spectrophotometer, Fullerton, 
CA). The results were expressed as total monomeric anthocyanins as cyanidin-3-glucoside 
equivalents in mg/L using the equation below:  
 Total monomeric anthocyanins (mg/L) = (A x MW x D x 1000) / (ε x PL)  
Where: A = (A520-A700) pH1.0 – (A520-A700) pH4.5; MW is 449.2 g/moL for cyanidin 3-glucoside; 
D = dilution factor; PL is the constant at path-length1 cm; ε is 26900 L/moL cm, the molar 
extinction coefficient for cyanidin-3-glucoside; 1000 as the factor for conversion from g to mg. 
Antioxidant capacity. Antioxidant capacity (AC) was measured by the oxygen radical 
absorbance capacity (ORAC) assay as described by Prior et al. [25] using 20 µL trolox standard, 
samples, or blank (75 mM phosphate buffer pH 7.4), 120 µL of 116.9 nM fluorescein (final 
concentration 70 nm/well), and 60 µL of 40 mM AAPH per well. A black walled 96-well plate 
was read at 485 and 582 nm every 2 min at sensitivity 60 at 37 °C using a Synergy 2 multi-well 
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plate reader (Biotek, Winooski, VT). Results were expressed as mmoL Trolox equivalents (TE) 
or µmol TE/g blueberry. 
α-glucosidase and α-amylase inhibition. The methods for enzymatic inhibition assays 
were adapted from Apostolidis et al. [26]. Briefly for the α-glucosidase assay, to a 96-well plate 
50 μL of sample or positive control (1 mM acarbose) were added to 100 μL of a 1 U/mL α-
glucosidase solution (in 0.1 M sodium phosphate buffer pH 6.9) and incubated for 10 min. A 50 
μL aliquot  of a 5 mM p-nitrophenyl-α-D-glucopyranoside solution (in 0.1 M sodium phosphate 
buffer pH 6.9) were added briefly to each well and incubated at 25 °C for 5 min before reading 
the absorbance at 405 nm. For the α-amylase assay, 500 μL of sample or positive control (1 mM 
acarbose) were added to 500 μL of 13 U/mL α-amylase solution (Type VI-B from porcine 
pancreas in 0.02 M sodium phosphate buffer pH 6.9) and incubated in test tubes at 25 °C for 10 
min before 500 μL of 1% soluble starch solution (dissolved in sodium phosphate buffer and 
boiled for 10 - 15 min) was added to each tube and incubated for another 10 min. Finally, 1 mL 
of dinitrosalicylic acid color reagent was added and the tubes were placed in 100 °C water for 5 
min. The mixture was diluted with 10 mL of distilled water and absorbance was read at 520 nm. 
Results are presented as percent inhibition relative to the positive control acarbose having 100% 
inhibition.  
Wine quality. Finished wine was measured for quality parameters using 600 μL of wine 
loaded onto the OenoFoss™ (FOSS, Denmark) machine and read using the Foss Integrator 
software. Glucose/fructose, pH, total acid, malic acid, volatile acid, and percent ethanol were 
determined by Fourier transform infrared (FTIR) spectroscopy. Global calibrations provide 
accurate readings for ranges between 0-15 g/L for glucose/fructose, 2.6 - 4.5 for pH, 1.5 – 8.0 
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g/L for total acid, 0 - 7 g/L for malic acid, 0 - 1.5 g/L volatile acid (as acetic acid), and 8 – 18% 
ethanol. 
Statistical analysis. Data were expressed as means of at least three replications. 
Statistical analysis was conducted using Tukey's Studentized Range Test groupings using the 
proc GLM function of SAS version 9.2 (SAS Inst. Inc., Cary, NC). Group means were 
considered to be significant at p < 0.0001 based on minimum significant differences from one-
way analysis of variance (ANOVA) with alpha = 0.05. 
 
Results and discussion 
 Physical characterization of the blueberry cultivars. The physical and chemical 
characteristics of the different cultivars are presented in Table 5.1. 
Table 5.1. Physical and Chemical Characteristics of Blueberry Cultivars Grown in Southern 
Illinois, Dixon Springs Agricultural Center. 
a-f
 The data represents the mean ± SD from at least two independent studies and a least a triplicate 
analysis. Values within a column followed by different letters are significant at p < 0.05. Diameter 
minimum significant difference = 0.5003; % Total sugar minimum significant difference = 3.4178; % 
Reducing sugar minimum significant difference = 4.0038. 
V. corymbosum 
Cultivar 
pH of 
juice 
Average 
Diameter (mm) % Total sugar % Reducing sugar 
Berkley 2.8 16.57 ± 1.76
de 
16.9 ± 2.9
bc 
11.6 ± 0.2
abc 
Blue Chip 2.7 17.58 ± 2.74
b 
17.7 ± 0.3
b 
12.9 ± 0.5
abc 
Blue Haven 2.9 17.17 ± 1.36
bc 
17.4 ± 0.1
b 
13.6 ± 1.0
ab 
Blue Jay 2.9 16.63 ± 1.96
de 
15.3 ± 0.7
bc 
12.5 ± 1.5
abc 
Bluecrop 2.8 16.50 ± 1.14
de 
16.1 ± 0.3
bc 
13.7 ± 1.7
ab 
Blueray 3.0 16.84 ± 2.16
cd 
15.3 ± 0.1
bc 
10.8 ± 0.0
bcd 
Bluetta 3.0 15.20 ± 2.58
f 
16.7 ± 0.5
bc 
9.3 ± 0.1
cde 
Collins 2.8 16.44 ± 1.61
de 
16.3 ± 0.4
bc 
6.4 ± 0.1
de 
Coville 3.0 16.74 ± 2.13
cde 
15.6 ± 0.2
bc 
7.1 ± 0.0
de 
Darrow 3.0 18.49 ± 3.43
a 
16.7 ± 0.6
bc 
15.2 ± 2.2
a 
Earliblue 3.4 15.49 ± 2.46
f 
17.8 ± 1.0
b 
8.9 ± 0.1
cde 
North Country 3.0 12.80 ± 0.99
g 
21.6 ± 0.4
a 
14.6 ± 1.4
ab 
Patriot 2.6 17.46 ± 2.72
b 
15.6 ± 0.5
bc 
12.7 ± 1.4
abc 
Spartan 2.8 18.69 ± 1.84
a 
13.9 ± 0.1
c 
12.7 ± 0.8
abc 
Stanley 3.3 15.00 ± 1.38
f 
14.5 ± 0.2
bc 
12.0 ± 0.4
abc
 
Commercial Sample 3.7 16.28 ± 3.79
e 
14.4 ± 0.3
bc 
7.3 ± 0.3
de 
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Diameter. Darrow and Spartan cultivars were found to have the largest average diameters 
(18.49 ± 3.43 and 18.69 ± 1.84 mm, respectively). North Country, on the other hand had the 
smallest diameter (12.80 ± 0.99 mm). Eleven of the cultivars grown at DSAC were found to have 
higher average diameters than the commercial sample (16.28 ± 3.79 mm). The commercial 
sample showed the greatest variability in size. Despite variation in average diameters, all 
blueberries sampled were categorized as ‘large’ [27] since all of the average diameters fell above 
12 mm. It was found that diameter and total sugar had a strong negative correlation (r = - 0.568); 
as the diameter increased in these Highbush blueberry cultivars, the total sugar content 
decreased.  
pH. The commercial sample was found to have the highest pH (3.7), while Patriot 
showed the lowest (2.6). The pH among all cultivars ranged from 2.6 to 3.4 as seen in Table 5.1. 
This range is close to that found in the literature, from 2.85 to 3.49 [28].  
Reducing sugars. The range of reducing sugars across the blueberry cultivars was found 
to be as low as 6.4 ± 0.1% in Collins to 15.2 ± 2.2% in Darrow (Table 5.1). All other cultivars 
grown at DSAC were found to have higher reducing sugars than the commercial sample. The 
reducing sugars content of commercial blueberries was not significantly different from the value 
of 7.1% reported in the literature [28].  
Total sugars. Similarly, total sugar content varied across the blueberry cultivars from 
13.9 ± 0.1% in Spartan to 21.6 ± 0.4% in North Country, (Table 5.1). With the exception of 
Spartan, fourteen out of the fifteen cultivars grown at DSAC had comparable or higher content of 
total sugars than the commercial sample. The total sugar content in the commercial sample was 
approximately twice the value reported in the literature of 7.3% [29].  
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Total polyphenol content. Total polyphenols ranged from 0.39 ± 0.03 mg GAE /g berry 
in Collins to 1.00 ± 0.02 mg GAE /g blueberry in North Country (Table 5.2). The phenolic 
content could be affected by the diameter of the blueberry, as most polyphenolic compounds are 
located in the skins of the fruits; however no significant correlation was found (results not 
shown). Overall, most of the TP values for the blueberry cultivars were slightly below the 
reported average of 0.95 mg GAE/g blueberry [13] with exception of Collins. 
 
Table 5.2. Total Polyphenols, Antioxidant Capacity, Alpha-Amylase Inhibition and Alpha-
Glucosidase Inhibition of Blueberry Cultivars Grown in Southern Illinois, Dixon Springs 
Agricultural Center. 
V. corymbosum 
Cultivar 
Total 
Polyphenols 
(mg GAE / g 
berry) 
Antioxidant 
Capacity 
(µmol TE / g 
blueberry) 
CAE %  
α-amylase 
inhibition (%*) 
CAE %  
α-glucosidase 
inhibition (%*) 
Berkley 0.75 ± 0.03
b 
8.98 ± 0.31
b
 97.67 ± 0.28
cd 
147.07 ±0.04
bcd 
Blue Chip 0.48 ± 0.01
cd 
10.86 ± 0.22
a
 103.32 ± 0.34
a 
181.66 ±0.05
ab 
Blue Haven 0.55 ± 0.01
bcd 
5.81 ± 0.04
g
 96.59 ± 0.21
b 
157.62 ± 0.02
abc 
Blue Jay 0.47 ± 0.06
d 
7.50 ± 0.26
cd
 101.70 ± 0.62
g 
157.76 ± 0.02
cde 
Bluecrop 0.47 ± 0.04
d 
7.64 ± 0.33
c
 91.79 ± 0.82
de 
129.07 ± 0.39
abc 
Blueray 0.48 ± 0.03
cd 
6.14 ± 0.03
fg
 92.06 ± 0.34
g 
184.70 ± 0.01
ab 
Bluetta 0.54 ± 0.01
cd 
6.74 ± 0.12
ef
 95.78 ± 0.21
ef 
133.12 ± 0.07
cde 
Collins 0.39 ± 0.03
d 
7.02 ± 1.55
cde
 96.95 ± 0.00
cde 
193.61 ± 0.02
a 
Coville 0.54 ±  0.31
bcd 
10.76 ± 0.13
a
 97.08 ± 0.49
cde 
190.78 ± 0.01
a 
Darrow 0.69 ± 0.14
bc 
10.77 ± 0.45
a
 97.49 ± 0.49
cd 
155.24 ± 0.14
abc 
Earliblue 0.75 ± 0.04
b 
9.06 ± 0.32
b
 98.29 ± 0.84
c 
103.22 ± 0.15
f 
North Country 1.00 ± 0.02
a 
9.07 ± 0.04
b
 94.84 ± 0.43
f 
113.91 ± 0.09
def 
Patriot 0.65 ± 0.03
bcd 
6.77 ± 1.90
ef
 101.12 ± 0.40
b 
161.04 ± 0.07
abc 
Spartan 0.69 ± 0.01
bc 
6.86 ± 0.27
de 97.67 ± 0.68
cd 
184.03 ± 0.01
ab 
Stanley 0.66 ± 0.00
bc 
7.07 ± 0.71
cde
 101.39 ± 0.93
b 
161.99 ± 0.11
abc 
Commercial Sample 0.47 ± 0.03
d 
5.88 ± 0.26
g
 86.80 ± 0.39
h 
75.54 ± 0.19
f 
*Positive control acarbose was considered as 100% inhibition; CAE = crude amberlite extract; contains 
no reducing sugars that would interfere with assay 
a-h
 The data represents the mean ± SD from at least two 
independent studies and a least a triplicate analysis. Values within a column followed by different letters 
are significant at p < 0.05.  
 
Antioxidant capacity. AC varied from 10.86 ± 0.22 µmol TE / g blueberry in Blue Chip 
to 5.81 ± 0.04 µmol TE / g blueberry in Blue Haven (Table 5.2). Most blueberry cultivars grown 
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at DSAC showed higher AC values than the commercial sample (5.88 ± 0.26 µmol TE / g 
blueberry), except Blue Haven. Factors that have been known to impact antioxidant capacity 
include the total anthocyanin content, total phenolic content, fruit maturity, as well as growing 
and post-harvest storage conditions [30]. There was a strong positive correlation (r = 0.70) 
between total polyphenolics and antioxidant capacity, suggesting the antioxidant activity is due 
to phenolic compounds found in the berries.  
 
Blueberry cultivar and enzyme inhibitory capacity. 
α-amylase. The effectiveness of α-amylase inhibition of the blueberry fruits from the 
different cultivars was measured using acarbose, an anti-diabetic drug, as a positive control 
having 100% inhibition. In comparison to acarbose, all blueberry extracts showed similar α-
amylase inhibition capabilities, ranging from 91.79 ± 0.82% for Bluecrop to 103.32 ± 0.34% for 
Blue Chip, (Table 5.2). All blueberries grown at DSAC were found to have higher percent 
enzyme inhibition than the commercial sample (86.80 ± 0.39% inhibition). It is expected that the 
α-amylase inhibitory activity increases as the total polyphenolic content rise in a fruit as 
previously seen for small fruits [2]; there was a strong positive correlation between total 
polyphenolic content and α-amylase inhibitory activity (r = 0.85). Our preliminary studies with 
Vaccinium showed that a proanthocyanidin-enriched fraction had the lowest IC50 value (IC50   = 
31.4 µg/mL) for α-amylase, suggesting a higher enzyme inhibitory potential, in comparison to 
the anthocyanin-enriched fraction (IC50   >100 µg/mL).  
α-glucosidase. As seen in Table 5.2, all blueberry cultivar extracts were found to have 
higher α-glucosidase inhibitory capabilities than acarbose. Additionally, most blueberry cultivars 
grown at DSAC had significantly higher percent inhibition than the commercial sample (75.54 ± 
0.19%) with the highest inhibition seen by Collins (193.60 ± 0.02% inhibition) and Coville 
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(190.78 ± 0.01% inhibition). It is desirable for starch degrading inhibitory agents to have a high 
α-glucosidase inhibition and a moderate α-amylase inhibition to avoid gastrointestinal side 
effects [7]. This makes Highbush blueberry cultivars a good natural alternative for inhibiting 
starch degradation. There was a positive correlation (r = 0.47) between total polyphenolic 
content and α-glucosidase inhibition. Regarding α- glucosidase, our preliminary studies with 
Vaccinium showed that a proanthocyanidin-enriched fraction had the lowest IC50 value (IC50   = 
25.0 µg/mL), suggesting again a higher enzyme inhibitory potential, in comparison to the 
anthocyanin-enriched fraction (IC50   > 100 µg/mL).  
Combining all results from cultivar evaluation, after sugar elimination, blueberries grown 
at DSAC have hypoglycemic effects comparable to acarbose, a known anti-diabetic drug. 
Tannins normally present in fruits of red color such as red grapes, red wines, raspberries, and 
strawberries are not present in as high amounts in blueberries [2]. Because tannins contribute to 
the α-amylase inhibition, the effectiveness of the blueberry extracts to inhibit α-amylase is lower 
than the effectiveness to inhibit α-glucosidase. It was found that smaller V. corymbosum berries 
contained higher levels of total phenolics, anthocyanins, and flavonoids than larger  genotypes 
[31], although we found non-significant correlations.  
To summarize our findings on the blueberry cultivars, out of the fifteen studied, Blue 
Chip and Coville exhibited the most hypoglycemic potential having high antioxidant capacity, 
high total polyphenol content, high α -glucosidase inhibition, and moderate α -amylase 
inhibition. Overall, all cultivars had high antioxidant capacity measured as µmol trolox 
equivalents and high total polyphenol content measured as mg gallic acid equivalents. The 
commercial sample showed considerably lower antioxidant capacity, α-amylase inhibition and α-
glucosidase inhibition. A lower antioxidant capacity for the commercial sample could be due to 
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postharvest handling, storage, and transportation conditions which may have resulted in an 
oxidation of compounds having antioxidant activity. The phenolic profile of the blueberry 
cultivars needs to be further studied in order to attribute the enzyme inhibitory activity to a 
certain polyphenolic compound. 
Berry wine analysis: changes of berry juice due to fermentation 
Quality. Finished blueberry wine samples fermented at room temperature (RT) had a pH 
of 3.8 ± 0.13, total acid content of 6.2 ± 0.25 g/L, malic acid content of 4.5 ± 0.07 g/L, volatile 
acid content measured as acetic acid of 0.2 ± 0.11 g/L, and alcohol content of 11.2 ± 0.07 %. The 
blueberry wine samples that were fermented at cold temperature (CT) had a pH of 3.8 ± 0.14, 
total acid content of 5.3  ± 0.18 g/L, malic acid content of 4.2 ± 0.18 g/L, volatile acid content 
measured as acetic acid of 0.3 ± 0.12 g/L, and alcohol content of 9.5 ± 0.32 %. Comparing the 
temperature of fermentation, the RT samples had a slightly higher total acid content and higher 
alcohol content, indicating that CT fermentation of blueberries caused less acid and ethanol 
production than RT. Because the volatile acid content is actually lower for RT than CT and the 
malic acid contents varied only slightly, the larger acid content in the RT samples must be due to 
another acid present, most likely ellagic acid, a major sedimentation product formed during the 
production of berry wines. 
Brix. °Brix was measured daily during the fermentation process as a measure of total 
sugar content; the fruit was pressed following a rapid decrease in Brix. As seen in Table 5.3, 
Brix for RT decreased by 16.1 °Brix from week 0 to the fermented wine stage, and for CT it 
decreased by 6.3 °Brix, showing a greater decrease in Brix during RT fermentation than during 
CT fermentation. A similar decrease in Brix was previously seen for fermented lowbush 
blueberries [18], but the values of Brix for our Highbush blueberry wines were much higher than 
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the previously reported range. This difference could be due to higher initial sugar content in the 
blueberries used or an incomplete fermentation resulting in more sugar in our final fermented 
wine. 
pH. pH was also measured daily throughout the fermentation process. Because of the 
addition of potassium bicarbonate to the blueberry lot, the initial pH was much higher than 
expected for blueberry juice. As seen in Table 5.3, the pH for RT samples decreased by 2.5 from 
week 0 to the fermented wine stage, and for CT the pH decreased only 0.8.  
 
Table 5.3. Chemical Characteristics of Blueberries Throughout Fermentation 
 
 
 
 
 
 
Time points 
pH °Brix 
Total 
polyphenols 
(µg GAE/mL 
wine) 
α -amylase 
inhibition 
α-glucosidase 
inhibition 
% 
inhibition
* 
% / g 
GAE 
% 
inhibition
* 
% / g 
GAE 
RT 
Week 0 
Week1 
Pressed 
Fermented 
6.3
a
 
3.5
b
 
3.6
c
 
3.8
c
 
29.7
a
 
19.1
cde
 
15.5
e
 
13.6
de
 
362. 3 ± 6.9
c
 
563.3 ± 7.4
ab
 
657.1 ± 6.1
a
 
590.0 ± 26.7
ab
 
103.11 
- 
- 
92.21 
4.35
a
 
- 
- 
3.81
b
 
314.3 
- 
- 
308.4 
13.3
a
 
- 
- 
12.7
a
 
CT 
Week 0 
Week1 
Pressed 
Fermented 
4.5
c
 
3.5
c
 
3.6
c
 
3.8
c
 
26.3
abc
 
22.5
ab
 
20.6
cd
 
20.0
bc
 
357.4 ± 27.7
c
 
524.2 ± 13.4
c
 
378.5 ± 7.9
c
 
423.3 ± 35.0
c
 
102.89 
- 
- 
91.71 
4.19
a
 
- 
- 
3.74
b
 
319.4 
- 
- 
311.6 
13.0
a
 
- 
- 
12.7
a
 
*Positive control acarbose is 100% inhibition. 
Time points: Week 0 = day yeast was added: no fermentation occurred; Week 1 = 7 days after yeast 
added; Pressed (skin removed): RT ready to press (low Brix) 14 days after yeast, CT ready 5 days later; 
Fermented = stored in cold room at 0 °C. Values are averages of independent duplicates for each 
temperature treatment. RT= Room temperature (20-22 °C); CT= Cold temperature (4 °C).  
a-d
 The data represents the mean ± SD from at least two independent studies and a least a triplicate 
analysis. Values within a column followed by different letters are significant at p < 0.05. 
pH minimum significant difference = 0.2876; °Brix minimum significant difference = 6.0291; Total 
Polyphenols minimum significant difference = 100.52; α-amylase minimum significant difference = 
1.8067; α-glucosidase minimum significant difference = 19.755. 
 
Comparing the samples from the two fermentation temperatures, there was a greater 
decrease in pH for the RT samples than the CT samples, possibly due to a lower production of 
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acids such as ellagic acid during CT fermentation, although both fermentation temperatures 
resulted in the same final pH of 3.8. There was no difference in final pH due to temperature of 
fermentation. Overall, this trend of pH change due to fermentation is consistent with that seen 
previously [18] in that there was an initial decrease of pH and then a gradual increase throughout 
fermentation. 
Total polyphenol content. Figure 5.2A presents the TP content for the wines. TP 
increased from week 0 to the fermented wine by 228.0 µg GAE / mL (926.0 µg EAE / mL) for 
RT and increased by 65.9 µg GAE / mL (292.6 µg EAE / mL) for CT. The blueberry wine 
showed a significantly greater increase in TP from week 0 to fermented wine at RT than at CT 
fermentation (p < 0.0023) (Figure 5.3A). Since TP was measured in EAE, higher production of 
ellagic acid at RT could explain the higher total acid content measured in the finished wine for 
RT compared to CT. This indicated that the temperature of fermentation may affect the ellagic 
acid production in blueberry wine production. The TP results throughout time (Figure 5.2A) are 
consistent with those seen by Martin and Matar [19], in that there was a significant increase in 
the total phenolic content initially. Results from this previous study on red wines made from 
grapes indicated lower concentrations of ellagic acid at higher temperature fermentation (37 °C 
compared to 20 °C), but our results indicated lower total polyphenols measured as ellagic acid 
equivalents at the cold temperature of 4 °C compared to 20-22 °C. Figure 5.3B presents the total 
anthocyanin content for the blueberry fermented wine at RT (71.4 ± 10.4 mg cyanidin-3-
glucoside equivalents /L) and for the blueberry fermented wine at CT (57.7 ± 8.2 mg cyanidin-3-
glucoside equivalents /L); these values were not statistically different.    
Antioxidant capacity. The AC trend is seen in Figure 5.2B and the change from week 0 
to the fermented wine is seen in Figure 5.3C. AC for RT samples increased by 0.86 mM TE 
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from week 0 to the fermented wine stage, and for CT samples AC increased by 6.36 mM TE. RT 
fermentation showed a smaller increase in AC while CT fermentation showed a larger increase in 
AC for blueberry wine from the week 0 time point, although this was not significant between RT 
and CT (p = 0.172), as seen in Figure 5.3C. 
A.  
 B.    
Figure 5.2. A. Total polyphenol trend throughout fermentation: room temperature vs. 
cold temperature. Bars represent means ± standard deviation based on data from independent 
experiments. Different letters indicate significant differences (p < 0.05). B. Antioxidant capacity 
trend throughout fermentation: room temperature vs. cold temperature. Bars represent means ± 
standard deviation based on data from independent experiments. Different letters indicate 
significant differences (p < 0.05). Time points and treatments: Week 0 = day yeast was added: no 
fermentation occurred; Week 1 = 7 days after yeast added; Pressed (skin removed): RT ready to 
press 14 days after yeast, CT ready 5 days later; Fermented = stored in cold room at 0 °C: Values 
are averages of independent duplicates for each temperature treatment: RT= Room temperature 
(20-22 °C); CT= Cold temperature (4 °C). 
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Increases in antioxidant activities during the beginning of fermentation are associated 
with the production of phenolic compounds having antioxidant capacity. A decrease in AC 
throughout fermentation could be due to oxidation or degradation of compounds with antioxidant 
activity. A loss of antioxidant activity towards the end of fermentation has been attributed to the 
alteration of phenolic compounds but not a loss in total phenolics [18], which explains why we 
did not find a correlation between TP content and AC. The chemical profile of these wines will 
have to be further investigated in order to attribute the antioxidant activity to specific phenolic 
composition. 
A.   
 
Figure 5.3. A. Changes due to fermentation in total polyphenols as ellagic acid equivalents for 
room temperature vs. cold temperature. Bars represent means ± standard deviation based on 
data from independent experiments. Different letters indicate significant differences (p < 0.05). 
B. Total anthocyanins of fermented wines, room temperature (RT) vs. cold temperature (CT). 
Results are expressed as monomeric anthocyanins as cyanidin-3-glucoside equivalents. Bars 
represent means ± standard deviation based on data from independent experiments. Different 
letters indicate significant differences (p < 0.05). C. Change in antioxidant capacity due to 
fermentation of blueberry wine at room temperature vs. cold temperature. Bars represent means 
± standard deviation based on data from independent experiments. Different letters indicate 
significant differences (p < 0.05). Blueberry wine was produced by fermentation of Highbush 
blueberries (Vaccinium corymbosum, cultivars Blue Chip, Bluecrop, Blue Haven, Blue Jay, 
Blueray, Bluetta, Collins, Coville, Darrow, Earliblue, Elliot, Jersey, Late Blue, and Spartan) 
collected from Dixon Springs Agricultural Center in Simpson, IL Summer 2010 at RT= Room 
temperature (20-22 °C) or CT= Cold temperature (4 °C).   
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B.  
 
C.  
 
Figure 5.3 (contd.) 
 
 
Berry wine enzyme inhibitory capacity  
α-amylase. Due to the fact that reducing sugars interfere with the accuracy of this assay, 
the wine samples were run through an amberlite XAD-7 column to remove sugars along with 
pectins and phenolic acids. The crude amberlite extract (CAE) was then tested for enzyme 
inhibition. Results, expressed as a percentage of inhibition compared to the positive control of 
acarbose at 100% inhibition, are presented in Table 5.3 for both temperatures of the initial 
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samples and fermented wine samples. At week 0, the blueberry juice averaged between 
fermentation temperatures showed an α-amylase inhibition of 103%. Correcting for the TP 
content in the CAE used this was 4.27% inhibition/g GAE. The fermented wine, averaging RT 
with CT, showed 92% inhibition of α-amylase; correcting for the TP content in the CAE this was 
3.77% inhibition/g GAE. The blueberry wines at both stages of fermentation showed inhibitory 
capacities that were similar to the positive control acarbose; although there was a significant 
decrease in inhibition from week 0 to fermented wine (p < 0.0001), which was not correlated to 
any measured specific fermentation changes. 
α-glucosidase. The blueberry juice before fermentation showed 314.3% inhibition of α-
glucosidase compared to acarbose’s 100% inhibition, and the fermented blueberry wine had 
308.4% inhibition. Correcting for the TP content of the CAE used, this was 13.2%/g GAE and 
12.7%/g GAE for the blueberry juice and fermented wine, respectively. There was no significant 
difference in α-glucosidase inhibition at any time point or temperature of fermentation. This 
shows that fermentation maintains the α-glucosidase inhibitory capacity of blueberry juice. 
When considering natural sources for inhibition of starch degrading enzymes, it is desirable to 
have high α-glucosidase inhibition and moderate α-amylase inhibition to avoid unwanted side 
effects from undigested starch [8]. Our results show almost twice as high inhibition of α-
glucosidase than α-amylase for both unprocessed and fermented blueberry samples, indicating 
that both blueberry juice and fermented wines have desirable inhibition capacity for these two 
starch degrading enzymes. A previous study [31] found that wine had one of the highest α-
glucosidase inhibitory activities and this activity was linked to specific phenols including 
rosmarinic acid and resveratrol. Wines high in these compounds may also have a high α-
glucosidase inhibition relevant to diabetes management. 
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In summary, for the wine produced from blueberries at two different temperatures, we 
found that the cold temperature fermentation had significantly lower total polyphenolic content 
and no statistical difference in antioxidant capacity. It was found that fermentation retained the in 
vitro starch degrading enzyme inhibitory capacity of the blueberries. Exploring the phenolic 
profile of the blueberry wine would explain why different trends in activity were seen and is a 
goal for future studies. Blueberries and their fermented products are good natural sources of 
polyphenols, antioxidants, and in vitro inhibition of α-amylase and α-glucosidase. 
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CHAPTER 6 
ANTHOCYANINS AND PROANTHOCYANIDINS FROM BLUEBERRY-
BLACKBERRY FERMENTED BEVERAGES INHIBIT MARKERS OF 
INFLAMMATION IN MACROPHAGES AND CARBOHYDRATE-UTILIZING 
ENZYMES IN VITRO
4 
 
Abstract  
 
Berries are an excellent source of dietary flavonoids which have several health benefits. 
We evaluated well-characterized anthocyanins and proanthocyanidins from fermented blueberry-
blackberry beverages. Wines were produced from Highbush blueberries and blackberries grown 
in Illinois and blended to create ratios ranging from 100% blueberry to 100% blackberry. Total 
anthocyanins of the wine were strongly correlated to total phenolics (r = 0.99, p < 0.05) and to 
antioxidant capacity (r = 0.77, p < 0.05). Anthocyanin (ANC) and proanthocyanidin (PAC) 
enriched fractions were purified from each wine blend and a phenolic profile was generated. 
Anthocyanins increased with more blackberries from 1114 to 1550 mg cyanidin-3-glucoside 
(C3G) equivalents/L. Hydrolysable tannins were identified in the PAC enriched fraction. Both 
ANC and PAC enriched fractions inhibited starch-degrading enzyme α-glucosidase and 
dipeptidyl peptidase-IV activity. Computational docking demonstrated that delphinidin-3-
arabinoside effectively inactivated DPP-IV by binding with the lowest interaction energy (-3228 
kcal/mol). ANC and PAC (100 µM C3G and epicatechin equivalents, respectively) from 
blueberry-blackberry blends reduced LPS-induced inflammatory response in mouse 
                                                             
4 : (Publication: Johnson MH, de Mejia EG, Fan J, Lila MA, Yousef GG. Anthocyanins and 
proanthocyanidins from blueberry-blackberry fermented beverages inhibit markers of 
inflammation in RAW 264.7 macrophages and carbohydrate-utilizing enzymes in vitro. 
Molecular Nutrition and Food Research. 2013, 57: 1182-1197. doi: 10.1002/mnfr.201200678.) 
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim; made available with 
permission through Copyright Clearance Center's RightsLink service. John Wiley and Sons has 
partnered with RightsLink to license its content. The definitive published version can be found 
on Wiley Online Library: http://onlinelibrary.wiley.com/doi/10.1002/mnfr.201200678/abstract. 
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macrophages via the NFκB-mediated pathway.  Anthocyanin and proanthocyanidin (including 
hydrolysable tannins in blackberry) enriched fractions from blueberry and blackberry fermented 
beverages are beneficial sources of antioxidants, inhibitors of carbohydrate-utilizing enzymes, 
and potential inhibitors of inflammation. 
Abbreviations: DPP-IV, dipeptidyl peptidase-IV; EAE, ellagic acid equivalents; ORAC, oxygen 
radical absorbance capacity; TE, trolox equivalents; C3G, cyanidin-3-O-glucoside; LPS, 
lipopolysaccharide; DMEM, Dulbecco’s Modified Eagle Medium; MTS, 3-(4,5-dimethylthiazol-
2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium; PES, phenazine 
ethosulfate; p-p65 NFκB, phosphorylated p-65 subunit of nuclear factor kappa B; iNOS, 
inducible nitric oxide synthase; COX-2, cyclooxygenase-2; NO, nitric oxide; ANC, anthocyanin 
enriched fraction; PAC, proanthocyanidin enriched fraction 
 
Keywords: Anthocyanin/ Proanthocyanidin/ Berry/ Diabetes/ Inflammation/  
 
Introduction 
 
Blueberries and blackberries are a rich source of anthocyanins, the water-soluble 
pigments which give berries their red, blue, and purple coloring [1]. Berries also contain 
polymerized phenolic compounds including hydrolysable tannins such as ellagitannins and 
gallotannins and condensed tannins known as proanthocyanidins [2]. The consumption of 
anthocyanins is among the highest of all flavonoids due to their wide distribution in foods [3]. 
Positive health effects have been attributed to the high antioxidant capacity of these 
phytochemicals. Anthocyanins have been established as having a high antioxidant capacity by 
scavenging free radicals and reducing oxidative stress [4]. Proanthocyanidins may also reduce 
oxidative stress and inflammation [5]. Increased phenolic intake has been seen to correlate with 
health benefits and is linked with decreased incidence of several diseases, including metabolic 
syndrome [6] and diabetes [4].  
Fermentation is known to increase the phenolic content of berry juice products by 
increasing extraction from the skins, including anthocyanins [7], and therefore may increase the 
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antioxidant capacity [8] and potential for health benefits. Moderate wine consumption as part of 
a healthy diet may reduce the risk of certain chronic diseases linked to inflammatory processes 
[6, 9]. The health benefits and sensory properties attributed to fermented berry products may be 
due to the high amounts of polyphenolic compounds present [10-12]. 
Type 2 diabetes occurs when the body is unable to provide a proper insulin response to 
deal with glucose from the diet, leading to excessive blood glucose and insulin resistance. 
Several studies have been conducted to evaluate the reduction of absorption of glucose by berries 
and berry compounds to inhibit α-glucosidase and α-amylase [13-15]. One potential drug therapy 
for diabetics targets these carbohydrate-utilizing enzymes; natural sources of inhibitors of these 
enzymes would be beneficial to avoid undesirable side effects that occur with drug therapy [16]. 
Dipeptidyl peptidase-IV (DPP-IV) is another current pharmaceutical target for diabetes 
treatment. Inhibitors of this enzyme are emerging as anti-diabetes therapy and allow for 
stimulation of insulin secretion to consequently decrease blood glucose levels [17]. However, the 
inhibitory potential on DPP-IV by berry compounds needs to be further studied.  
Chronic inflammation due to abnormal circulating levels of pro-inflammatory cytokines 
is associated with the development of diabetes and other metabolic diseases. A stimulated 
inflammatory cascade may be mediated by nuclear-factor κB (NFκB) signaling pathway to 
upregulate pro-inflammatory enzymes such as inducible nitric oxide synthase (iNOS) and 
cyclooxygenase (COX-2). Dietary flavonoids have been linked to anti-inflammatory pathways 
[3], and many berries or berry compounds have been investigated for their anti-inflammatory 
properties and antioxidant capacity or radical scavenging activity [4, 18-21]. Fermented juices 
and wines from berries have been investigated [11, 22], and in several studies they were found to 
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inhibit inflammatory protein production or expression more than their unfermented counterparts 
[12, 23-25].  
 The objective of this study was to evaluate well-characterized anthocyanins enriched 
fraction (ANC) and proanthocyanidins enriched fraction (PAC) present in blueberry-blackberry 
fermented beverages for their effect on markers of inflammation in RAW 264.7 macrophages 
and carbohydrate utilization in vitro. We hypothesized that blends of ANCs and PACs present in 
blueberry-blackberry fermented beverages can enhance their antioxidant capacity, their ability to 
reduce carbohydrate-utilizing enzymes activity, and reduce inflammation. 
Materials and methods  
 
  
Scheme 6.1. Methodology. Anthocyanins (ANC) and proanthocyanidins (PAC) were extracted 
from blueberry-blackberry fermented beverages following this scheme. Freeze-dried ANC and 
PAC were used for Aim 3 and Aim 4 (in vitro); Freeze-dried PAE was used for Aim 5 (in vivo). 
Freeze dried 
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Materials 
 
Wines used were produced from Highbush blueberries (Vaccinium corymbosum) and 
blackberries (Rubus spp.) grown at Dixon Springs Agricultural Center in Simpson, IL. Blueberry 
wine was fermented as previously described [14]. Blueberry (Vaccinium corymbosum) cultivars 
Blue Chip, Bluecrop, Blue Haven, Blue Jay, Blueray, Bluetta, Collins, Coville, Darrow, 
Earliblue, Elliot, Jersey, Late Blue, and Spartan were collected from Dixon Springs Agricultural 
Center in Simpson, IL during the ripening season of 2010. Blueberry juice from crushed frozen 
blueberries were fermented with Saccharomyces bayanus at 23 °C until alcohol content reached 
5-6%; finished wine was filtered through cheesecloth. Blackberry wine was prepared at the same 
time using a similar procedure [14]. Blackberries (Rubus fruticosus) cultivars A-1937, A-2215, 
A-2241 Natchez, A-2315, APF 27, APF 40, APF 41, and Prime Jan were collected from Dixon 
Springs Agricultural Center in Simpson, IL during the ripening season of 2010. Upon collection, 
the berries were stored frozen at -18°C until use. Wine was prepared using 90.7 kg blackberries, 
with roughly even mixtures of all cultivars listed above. To the blackberry lot, 180 mL SO2 
solution (50 ppm), 3 g pectic enzyme solution (dissolved in water), and 10 kg sucrose solution 
were added. Dry wine yeast Lavin EC 1118 (Saccharomyces bayanus) obtained from Presque 
Isle Wine Cellars (North East, PA) was rehydrated at 40 °C for 20 min with occasional gentle 
stirring to remove clumps prior to inoculation of the juice. Per manufacturer’s recommendations, 
EC 1118 was inoculated at 40 or 50 mg dry yeast/100 mL, and held at 21 ± 1 °C during 
fermentation. Juice was sampled once each week to measure pH, Brix and phenolic composition. 
Blends ranging from 100% blueberry to 100% blackberry were made using room temperature 
fermented wines. Blends are presented as a ratio of %blueberry:%blackberry. The ratios were 
100:0, 70:30, 50:50, 30:70, and 0:100 of blueberry: blackberry wine blends, respectively. 
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All solvents used for phenolic extraction were HPLC-grade and were purchased from 
Fisher Scientific (Pittsburg, PA). Amberlite XAD-7 was purchased from Sigma-Aldrich (St. 
Louis, MO), Sephadex LH-20 was purchased from GE Life Sciences (Buckinghamshire, UK). 
Murine macrophage RAW 264.7 cell line and Dulbecco’s Modified Eagle Medium with L-
glutamine (DMEM) were purchased from American Type Culture Collection (ATCC) 
(Manassas, VA, USA). Fetal bovine serum was from Invitrogen (Grand Island, NY, USA). 
CellTiter 96® AQueous One Solution Proliferation assay kit (MTS/PES) was purchased from 
Promega Corporation (Madison, WI, USA). Mouse monoclonal antibodies (actin, iNOS, COX-2) 
and rabbit polyclonal antibody (p-p65 NFκB) were obtained from Santa Cruz Biotechnology 
(Santa Cruz, CA, USA) and antimouse and antirabbit IgG horseradish peroxidase conjugated 
secondary antibodies were from GE Healthcare (Buckinghamshire, UK).  Compounds used as 
standards and their purity were as follows: Trolox (≥ 97%), glucose (≥ 99.5%), gallic acid (≥ 
98%), ellagic acid (≥ 95%), (-)-epicatechin (≥ 99%), and cyanidin-3-O-glucoside (≥ 99%). All 
chemicals and reagents were purchased from Sigma (St. Louis, MO), unless otherwise specified. 
Total phenolic content  
Total phenolic content (TP) was quantified using the Folin-Ciocalteu method adapted to a 
micro-assay [26]. Briefly, to a 96-well flat bottom plate, 50 μL of 1 N Folin-Ciocalteu’s phenol 
reagent and 50 μL of either sample, standard or blank were added; this mixture was allowed to 
stand for 5 min before the addition of 100 μL of 20% Na2CO3. The solution was then allowed to 
stand for 10 min before reading at 690 nm using a Synergy 2 multi-well plate reader (Biotek, 
Winooski, VT). Results were expressed as µg ellagic acid equivalents (EAE) / mL wine. 
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Antioxidant capacity  
Antioxidant capacity was measured by the oxygen radical absorbance capacity (ORAC) 
assay as described by Prior et al. [27] using 20 µL trolox standard, samples, or blank (75 mM 
phosphate buffer pH 7.4), 120 µL of 116.9 nM fluorescein (final concentration 70 nm/well), 60 
µL of 40 mM AAPH per well. A black walled 96-well plate was read at 485 and 582 nm every 2 
min at sensitivity 60 at 37 °C using a Synergy 2 multi-well plate reader (Biotek, Winooski, VT). 
Results are expressed as mmol Trolox equivalents (TE) /L. 
Total anthocyanin content 
Total anthocyanins from wine blends were determined using the AOAC Official Method 
adapted from Lee [28] for micro-assay. Samples were diluted to a factor of 1:10 using two 
buffers (pH 1.0, KCl buffer and pH 4.5, sodium acetate buffer). Diluted solutions at each pH 
were transferred to a 96-well plate and the absorbance was read at 520 and 700 nm on a Synergy 
2 multiwell plate reader (Biotek, Winooski, VT). The total anthocyanins were expressed as 
cyanidin-3-O-glucoside (C3G) equivalents in milligram per liter using the equation below:  
𝑇𝑜𝑡𝑎𝑙 𝑚𝑜𝑛𝑜𝑚𝑒𝑟𝑖𝑐 𝑎𝑛𝑡ℎ𝑜𝑐𝑦𝑎𝑛𝑖𝑛𝑠 (
𝑚𝑔
𝐿
) =  
𝐴 ∗  𝑀𝑊 ∗  𝐷 ∗  1000
𝜀 ∗  𝑃𝐿
∗ 0.45, 
where: A = (A520-A700) pH1.0 – (A520-A700) pH4.5, MW = 449.2 g/mol for C3G, D = dilution 
factor determined experimentally with pH 1.0 buffer, PL is the constant at path-length 1 cm, ε is 
26900 L/mol cm, the molar extinction coefficient for C3G, and 1000 as the conversion factor 
from gram to milligram, and 0.45 as the conversion factor from the established method [27] to 
the plate reader method. The AOAC official method [28] has been standardized and validated 
and uses cyanidin-3-glucoside to express anthocyanin as equivalents as it is the most common 
anthocyanin pigment found in nature. Similarly, (-)-epicatechin was used to quantify 
proanthocyanidins due to common use as a standard. The pH differential method utilizes C3G to 
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calculate total monomeric anthocyanins and referred them as C3G equivalents, and therefore this 
was used as the quantification standard for the HPLC peaks. 
Phenolic extraction and preparation of enriched fractions  
Phenolic extraction was adapted from the method by Grace et al. [29]. To each blend, 
0.1% TFA was added to stabilize the anthocyanins during isolation. A rotary evaporator with 
temperature not exceeding 40 °C was used to remove the alcohol completely and most of the 
water from 600 mL of each blend. The dealcoholized and concentrated beverage blends were 
mixed with amberlite XAD-7 resin preconditioned with acidified water, (0.1% TFA), settled at 
room temperature for 20 min and water was decanted.  This process was repeated three more 
times until the supernatant became clear where sugars, pectins, phenolic acids, and other 
impurities were removed from samples. XAD-7 is a moderately polar resin and is used to remove 
relatively polar compounds from non-aqueous solvents, and to remove non-aromatic compounds 
from polar solvents. Acidified water was used to precondition the resin and was acidified to 
protect the anthocyanins from degradation. The sample was allowed to get into the resin pores 
for 20 min before the washing with acidified water removed any compounds that did not get into 
the resin pores, which included phenolic acids. The sample with resin was loaded onto a column 
(30 × 3 cm) and washed thoroughly with 1.5 L acidified methanol (0.1% TFA) to elute the 
polyphenolic mixture from resin. The polyphenolic mixture was concentrated to remove any 
methanol on a rotary evaporator (not exceeding 40 °C) to yield a crude extract which contained 
ANC and PAC phenolics present in wine. This was then partitioned with ethyl acetate to remove 
any non-polar compounds, and the polar eluate was then concentrated again on a rotary 
evaporator (not exceeding 40 °C). Samples were then stored at -80 °C and subsequently 
lyophilized on a Labconco freeze-dryer (Kansas City, MO). 
 105 
 
To generate enriched ANC and PAC enriched fractions, approximately 4 g of the freeze 
dried material dissolved in 10 mL of acidified water:methanol (80:20) (0.1% TFA) was loaded 
on a Sephadex LH-20 column (30 × 3 cm) preconditioned with water:methanol (80:20) (0.1% 
TFA). With an isocratic elution using the same solvent ratio, fractions were collected starting 
when colored material began to elute to generate ANC enriched fractions 1-4, and then 50% 
methanol was used to remove any remaining ANC as enriched fraction 5. Next, 70% acetone 
was used to elute the PAC, and enriched fractions were collected as PAC 1-4. The solvents were 
evaporated on a rotary evaporator (not exceeding 40 °C), and fractions were freeze dried, 
weighed, and stored at -80 °C until further use as indicated below:  
 
 Scheme 6.2. Phenolic extraction and fractionation procedure to prepare ANC and PAC enriched 
fractions, indicating the methods conducted. 
 
50% MeOH, 0.1% TFA 
  
70% Acetone 
Fractions 
PAC 1-4 
Sephadex-LH-20 
  
Fractions 
ANC 1-4 
Fraction 
ANC 5 
 
Total anthocyanin 
content 
Total phenolics 
Antioxidant capacity 
All enriched fractions were analyzed for: antioxidant capacity, enzymatic studies 
and evaluation of inflammatory markers in RAW 264.7 macrophages. 
Anthocyanin (ANC)-
enriched fraction  
Proanthocyanidin (PAC)-
enriched fraction  
Freeze-dried, 
stored at -80°C 
Wines were produced from Highbush blueberries and blackberries 
grown at Dixon Springs Agricultural Center in Simpson, IL. 
Blends were created: (% Blueberry: % Blackberry) 
100%:0, 70%:30%, 50%:50% 30%:70%, 0:100% 
Alcohol and sugars removed   
Post-amberlite extract 
Amberlite XAD-7 resin  
20% MeOH, 0.1% TFA 
  
20% MeOH, 0.1% TFA 
  
Phenolic analysis 
(HPLC-ESI-MS) 
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  ANC 1-5 and PAC 1-4 were collected from each blend; in this manuscript we will use 
ANC and PAC to indicate ANC enriched fraction and PAC enriched fraction, respectively. The 
following enriched fractions were used for further analysis because they had the highest ANC or 
PAC concentration based on HPLC analysis: ANC-3 for 100% blueberry and also for 50:50%; 
ANC-2, for 100% blackberry. PAC-1, for 100% blueberry; PAC-4 for 50:50%; PAC-2 for 100% 
blackberry. These fractions were enriched, so most phenolic acids should have been removed.  
The other fractions were not studied beyond HPLC analysis. 
Anthocyanin and proanthocyanidin analysis 
 
ANC analysis was conducted on a 1200 HPLC (Agilent Technologies, Santa Clara, CA) 
using a Supelcosil LC-18 RP column (250 × 4.6 mm, 5 µM) (Supelco, Bellefonte, PA). Samples 
were prepared by dissolving 2 mg of each fraction in 1 mL of methanol and filtering through 0.2 
µM PTFE syringe filters (Fisher Scientific, Pittsburg, PA) before injection. The mobile phase 
consisted of 5% formic acid in H2O (A) and 100% methanol (B). The flow rate was held constant 
during the HPLC analysis at 1 mL/min with a step gradient of 10%, 15%, 20%, 25%, 30%, 60%, 
and 10% of solvent B at 0, 5, 15, 20, 25, 45, and 60 min, respectively. For PAC analyses, the 
same instrumentation was used but with mobile phase consisting of 95% H2O: 5% acetonitrile 
with 0.1% formic acid (A) and of 95% acetonitrile: 5% H2O with 0.1% formic acid (B). The flow 
rate was held constant at 1 mL/min with a step gradient of 0%, 5%, 30%, 60%, 90%, and 0% of 
solvent B at 0, 5, 40, 45, 50, and 55 min, respectively. ANC were detected at 520 nm and PAC at 
280 nm using a diode array detector (DAD). Chemstation software (Agilent Technologies, Santa 
Cruz, CA) was used for both sample analysis protocol and data processing. A reference blueberry 
extract (post-amberlite extract, PAE 22%) was always run as an internal standard, during HPLC 
analysis, to account for any variation in the retention time among runs. For qualitative peak 
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identification of specific anthocyanins, we used pure standards that were already incorporated 
into our HPLC library, and then we did comparisons to references in the literature. MS was 
generated and identification of anthocyanins was performed; accurate determination was 
accomplished using our own reference library of peaks generated from the phenolic analysis of 
many blueberry cultivars on the same equipment and under exactly the same analytical 
conditions. ANC were identified based on comparison to standards as our previously published 
data indicated [20, 29]. 
Using the peak areas as measured by HPLC at 520 nm, total ANC were quantified from a 
standard curve generated from 0.125, 0.25, 0.5, and 1.0 mg/mL of cyanidin-3-O-glucoside and 
are presented as C3G equivalents. In the same way, total PAC was calculated as epicatechin 
equivalents from the peak areas measured at 280 nm. Fractions containing the highest total 
anthocyanins and proanthocyanidins were considered ANC and PAC, respectively. To further 
elucidate the composition of the PAC, samples were analyzed with HPLC-ESI-MS using the 
same protocol above except at a flow rate of 0.4 mL/min and Eclipse XDB-C18 RP column (250 
mm × 3 mm × 5 µm, Agilent Technology, Inc., Wilmington, DE). Liquid chromatography mass 
spectrometer (LC/MS) Accurate–Mass 6220 model (Agilent Technology, Inc., Wilmington, DE) 
was used for PAC analysis. Mass analyses conditions were: gas temperature at 350 °C, gas flow 
10 L/min, nebulizer 45 psi, ion source dual ESI, positive mode, and injection volume was 10 µL 
(2mg/ml sample). MassHunter Workstation Software for data acquisition version 2.B.00 and 
qualitative analysis version B.03.01 (Agilent Technology, Inc., Wilmington, DE) was used to run 
samples and analyze the total ion chromatogram (TIC) data at 150-3000 m/z range. 
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Enzymatic studies with α-glucosidase and α-amylase  
The methods for enzymatic inhibition assays were adapted from Kwon et al. [16]. For the 
α-glucosidase assay, to a 96-well plate, 50 μL of sample (0.1 mg freeze dried product/mL) or 
positive control (1 mM acarbose) were added to 100 μL of a 1 U/mL α-glucosidase solution (in 
0.1 M sodium phosphate buffer pH 6.9) and incubated for 10 min. Fifty μL of a 5 mM p-
nitrophenyl-α-D-glucopyranoside solution (in 0.1 M sodium phosphate buffer pH 6.9) were 
added briefly to each well and incubated at 25 °C for 5 min before reading the absorbance at 405 
nm. For the α-amylase assay, 500 μL of sample or positive control (1 mM acarbose) were added 
to 500 μL of 13 U/mL α-amylase solution (Type VI-B from porcine pancreas in 0.02 M sodium 
phosphate buffer pH 6.9) and incubated in test tubes at 25 °C for 10 min before 500 μL of 1% 
soluble starch solution (dissolved in sodium phosphate buffer and boiled for 10 - 15 min) was 
added to each tube and incubated for another 10 min. Finally, 1 mL of dinitrosalicylic acid color 
reagent was added and the tubes were placed in 100 °C water for 5 min. The mixture was diluted 
with 10 mL of distilled water and absorbance was read at 520 nm. Results were presented as 
percent inhibition relative to the current diabetes drug acarbose as the positive control, which 
was set at 100% inhibition.  
DPP-IV inhibition and computational docking study 
Measurements of the activity and potential inhibition of DPP-IV (EC 3.4.14.5), a type II 
membrane glycoprotein, were done using the DPP-IV Glo ™ Protease Assay (Promega, 
Madison, WI) following the manufacture’s protocol. Briefly, 50 µL of DPP-IV Glo ™ reagent 
was added to a black-walled 96-well plate containing 50 µL of blank, positive control, or 
treatment. The blank contained the vehicle control only while positive control contained the 
vehicle and purified DPP-IV enzyme at a final concentration of 1 ng/mL. Treatments used were 
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enriched ANC or known inhibitor, diprotin A, and the purified DPP-IV enzyme at a final 
concentration of 1 ng/mL. The content of the wells was gently mixed using a plate shaker at 400 
rpm for 30 s. DPP-IV cleavage of the provided substrate generated a luminescent signal by 
luciferase reaction with the amount of DPP-IV enzyme available to bind Gly-Pro-aminoluciferin 
proportional to relative light units (RLU) produced. This signal in RLU was measured after 30 
min in an Ultra Microplate Reader (Biotek Instruments, Winooski, USA) and was compared to 
the inhibitory action of diprotin A. Diprotin A linear standard curve (y = -50.41x + 86.35, R² = 
0.94) where y is the % maximum activity of the enzyme and x is the log10 of the concentration 
(µM) of known inhibitor diprotin A was used to calculate IC50 values. 
A computational docking study to predict the affinity of main ANC present in the blends 
as cyanidin-3-glucoside (PDB: 10099), malvidin-3-galactoside (PDB: 671499), malvidin-3-
arabinoside, delphinidin-3-glucoside (PDB: 13563) and delphinidin-3-arabinoside and diprotin A 
with DPP-IV enzyme (PDB: 1R9M) were conducted with the protein-ligand docking program 
SwissDock (http://swissdock.vital-it.ch/, accessed July 2012). The PDB format files of ANC and 
diprotin A were drawn by chemical drawing software Marvisketch (ver 5.10.3, ChemAxon). The 
OpenBabel GUI chemical expert system was used for converting chemical file format (PDB file) 
of ANC (malvidin-3-galactoside and delphinidin-3-arabinoside) and diprotin A to Mol2 files 
which can be read by the docking program. Docking results predicting binding modes were 
visualized with UCSF Chimera1.6.2, for displaying, animating and analyzing large biomolecular 
systems using 3-D graphics and built-in scripting. At the end, the best conformation was selected 
based on the lowest FullFitness [30]. The FullFitness is the sum of the total energy of the system 
and includes a solvation term:  = Eintra
ligand
+ Eintra
recept
+ Einter + ∆Gelec.solv + (σ ∗ SASA). 
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Where Eintra
ligand
 and Eintra
recept
 are the internal energy of anthocyanin and DPP-IV, respectively; 
Einter is the interaction energy between the anthocyanin and DPPI-IV, and is equal to the sum of 
the van der Waals and the electrostatic interaction energies; ∆Gelec.solv is electrostatic potential 
of solvent and calculated using the analytical Generalized Born Molecular Volume (GB-MV2) 
model implemented in CHARMM; SASA is the solvent accessible surface area; σ is 0.0072 
kcal/(mol Å
2
). 
Cell proliferation and treatment 
Murine macrophage cell line RAW 264.7 was cultured in DMEM supplemented with 1% 
penicillin/streptomycin, 1% sodium pyruvate, and 10% fetal bovine serum at 37 °C in 5% 
CO2/95% air using a CO2 Jacketed Incubator (NuAIRE DH Autoflow, Plymouth, MN, USA). 
The cell proliferation assay was conducted using the CellTiter 96® AQueous One Solution 
Proliferation assay kit containing a tetrazolium compound, 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS), and an electron coupling 
reagent, phenazine ethosulfate (PES) (Promega, Madison, WI). Briefly, 1×104 cells were seeded 
in a 96-well plate and the total volume was adjusted to 200 L with growth medium. After 24 h 
incubation, the cells were treated with 5, 50, or 100 µM C3G (for ANC) or epicatechin (for 
PAC) equivalents, and incubated for an additional 24 h. After this time, the growth medium was 
replaced with 100 L fresh growth medium and 20 L MTS/PES were added to each well. The 
plate was incubated for 2 h at 37 ºC in 5% CO2/95% air and the absorbance was read at 515 nm 
in an Ultra Microplate Reader (Biotek Instruments, Winooski, USA). The percentage of viable 
cells was calculated with respect to untreated cells in complete media.  
For treatments, RAW 264.7 macrophages were seeded at 2x10
5
 in a six-well plate, and 
the total volume was adjusted to 2 mL with growth medium and incubated for 48 h at 37 °C in 
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5% CO2/95% air. After 48 h incubation, the cells were treated with 25, 50, or 100 µM C3G (for 
ANC) or epicatechin (for PAC) equivalents, stimulated with 1µg/mL lipopolysaccharide (LPS) 
and incubated for an additional 24 h. After 24 h, spent medium was collected for nitric oxide 
production measurement and whole cell lysates were collected for western blot analysis of 
inflammatory markers, as follows.  
Nitric oxide (NO) measurement in supernatant of RAW 264.7 cell culture 
Nitrite measurement was performed using Griess reaction. Briefly, 100 L of the growth 
medium diluted 1:5 were plated in 96-well plate and an equal amount of Griess reagent (1% 
sulfanilamide and 0.1% N-1-(naphthyl)ethylenediamine-diHCl in 2.5% H3PO4) was added. The 
plate was incubated for 5 min at room temperature and the absorbance was measured at 550 nm 
in an Ultra Microplate Reader (Biotek Instruments, Winooski, USA). The amount of NO was 
calculated using sodium nitrite standard curve (y = 0.14x + 0.05, R² = 0.997) 
Western blot analysis  
Treated cells were washed twice with ice cold DMEM and twice with ice cold PBS and 
the cells were lysed with 200 L of Laemmli buffer (BioRad, Hercules, CA) containing 5% -
mercaptoethanol. The cell lysates were sonicated for 30 s and then boiled for 5 min. Protein was 
quantified using the RCDC Assay (BioRad, Hercules, CA), and 30 g protein was loaded in 4–
20% Tris–HCl gels (BioRad) for protein separation. The resolved proteins were transferred to a 
PVDF membrane (Millipore, Billerica, MA) and blocked with 3% milk in 0.1% TBST for 1 h at 
room temperature. After blocking, the membrane was washed with 0.1% TBST (5 times, 5 min 
each) and incubated with primary antibody (1:500) at 4°C overnight. The membrane was washed 
again and incubated with anti-mouse or anti-rabbit IgG horseradish peroxidase conjugate 
secondary antibody (1:2500) for 1 h at room temperature. After incubation and repeated 
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washing, the expression of proteins was visualized using chemiluminescent reagent (GE 
Healthcare, Pittsburgh, PA) following manufacturer’s instructions. The membrane picture was 
taken with a GL 4000 Pro Imaging system (Carestream Health Inc., Rochester NY). 
Statistical analyses 
Data were expressed as means of independent duplicates with at least three replications. 
Statistical analysis was conducted using the proc GLM procedures of SAS version 9.3 (SAS Inst. 
Inc., Cary, NC). Group mean comparisons were conducted using LSD means and were 
considered to be significant at p < 0.05 based on minimum significant differences from one-way 
analysis of variance (ANOVA) with alpha = 0.05. Correlations were done using Pearson’s 
correlation values with p < 0.05. 
Results 
Blackberry increased total anthocyanins, total phenolics and antioxidant capacity of wine 
blends. 
Blueberry-blackberry wine blends had total anthocyanins ranging from 76.8 (100% 
blueberry) to 137.2 mg C3G equivalents/L (100% blackberry); total polyphenols ranging from 
2196.7 (100% blueberry) to 4029.0 mg EAE/L wine (100% blackberry); and antioxidant capacity 
from 24.5 (70:30 blend) to 37.4 mmol TE/L (100% blackberry), as can be seen in Table 6.1. 
Both total polyphenols and total anthocyanins increased consistently with a higher percent of 
blackberry in the blend, with the highest values for the 100% blackberry wines. Antioxidant 
capacity increased with 70% blackberry in the blend, with the highest antioxidant capacity seen 
again for the 100% blackberry blend. Table 6.1 also shows that based on our previous study 
[14], and for comparative purposes, blueberry juice decreased 16.1 brix, pH decreased by 2.5 and 
total polyphenols increased by 625.4 µg/ml EAE from week 0 to fermented wine at room 
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temperature. Blackberry juice decreased 17.5 brix, pH increased only slightly (by 0.3) and total 
polyphenols increased 643.8 µg/ml EAE from week 0 to fermented wine at room temperature. 
Table 6.1. Total anthocyanins (TA) and total phenolics (TP) of wine blends and antioxidant 
capacity (AC) of wine and ANC and PAC.
1 
 
Blend ratio 
(%Blueberry : 
%Blackberry) 
Total 
anthocyanins 
(mg C3G-
equivalents/L 
wine) 
Total phenolics 
(mg EAE
2
/L 
wine) 
Antioxidant capacity (mmol Trolox Eq. /L) 
 
Wine 
ANC
3
 PAC
3
 
100:0 76.8 ± 2.6
d 
2196.7 ± 42.7
e
 25.3 ± 2.2
b 
407.3 ± 48.8
bc
 657.0 ± 63.7
a 
70:30 94.3 ± 6.2
cd 
2611.2 ± 76.6
d
 24.5 ± 0.82
b 
667.6 ± 58.2
ab
 540.5 ± 74.1
a 
50:50 105.8 ± 6.3
bc 
2932.3 ± 28.5
c
 25.3 ± 1.0
b 
758.8 ± 58.2
a
 646.6 ± 50.0
a 
30:70 121.7 ± 8.7
ab 
3403.4 ± 50.5
b 
26.5 ± 0.1
b 
545.0 ± 63.5
abc
 604.7 ± 38.6
a 
0:100 137.2 ± 9.6
a 
4029.0 ± 68.4
a 
37.4 ± 1.4
a 
757.2 ± 45.9
a
 579.2 ± 52.3
a 
C
o
rr
el
at
io
n
s5
 
TA_wine 1.00 0.99 0.77 0.61 -0.35 
TP_wine  1.00 0.84 0.59 -0.34 
AC_wine   1.00 0.44 -0.26 
AC_ANC    1.00 -0.41 
AC_PAC     1.00 
Total ANC
4
 0.93 0.93 0.70 0.55 0.00 
Total PAC
4
 0.78 0.72 0.31 0.82 0.52 
1
Values are means ± SEM. Means with different letters in each column are significantly different across 
columns (p < 0.05). 2EAE: Ellagic acid equivalents. 3ANC and PAC at 0.1mg freeze dried product/mL. 4Total 
ANC and PAC are based on HPLC data presented in Table 6.2. 
5Correlation values are Pearson’s r-
values (p < 0.05). Note based on our previous results [14]: For blueberries: Wk0 (Unfermented): Total 
polyphenols (µg/mL EAE), 993.8 ± 6.9. For blackberries: Wk0 (Unfermented): Total polyphenols (µg/mL 
EAE), 2141.3 ± 101.1. Week 0 = no fermentation occurred; Values are averages of independent duplicates. 
 
Main anthocyanins and proanthocyanidins in the blueberry and blackberry enriched 
fractions. 
ANC identified for each blend are presented in Table 6.2.  Chromatographic analysis 
revealed up to seventeen anthocyanins present in blueberry and blackberry blend fermented 
beverages. Malvidin-3-galactoside was the main anthocyanin present in 100% blueberry, while 
delphinidin-3-arabinoside was the predominant anthocyanin in the blends containing blackberry. 
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Total ANC, using total peak areas at 520 nm as quantified with HPLC in comparison with the 
commercial standard cyanidin-3-O-glucoside, increased with more blackberry in the blend and 
ranged from 1112.3 (70:30 blend) to 1550.4 mg C3G equivalents /L (100% blackberry), 
confirming the increase in total ANC seen by the wines before phenolic separation. The 
identification of anthocyanins and proanthocyanidins were based on their mass charges (m/z), 
UV absorption (520 nm for ANC, and 280 nm for PAC), and our previously published data on 
blueberry and blackberry species [19, 20, 29]. Total PAC were quantified using peak areas at 280 
nm and ranged from 560.3 (100% blueberry) to 1249.0 mg (-)-epicatechin equivalents/L (100% 
blackberry) (Table 6.2).  
Table 6.2. Anthocyanin identification and quantification by HPLC, and total 
proanthocyanidins determined at maximum absorption of 520 and 280 nm, respectively. 
Anthocyanins (mg C3G equivalents/L) per blend  
(%Blueberry : %Blackberry)  
RT (min) Anthocyanin ID 100:0 70:30 50:50 30:70 0:100 
24.44 Delphinidin-3-galactoside 10.8 11.2 9.1 6.9 nd 
25.98 Delphinidin-3-glucoside 26.8 51.0 34.7 12.3 8.8 
27.33 Cyanidin-3-galactoside 6.5 6.3 nd 17.7 23.8 
28.86 Delphinidin-3-arabinoside 11.9 nd 993.3 1079.3 1244.7 
29.69 Cyanidin-3-glucoside  23.4 564.1 12.1 10.2 10.1 
30.82 Cyanidin-3-arabinoside 140.2 16.7 8.0 nd 116.8 
31.62 Petunidin-3-glucoside 7.3 79.6 45.7 100.9 9.6 
32.69 Peonidin-3-glucoside 39.8 6.7 6.7 8.4 10.1 
33.95 Petunidin-3-arabinoside 178.5 34.5 23.7 14.3 9.7 
34.39 Malvidin-3-galactoside 292.1 32.7 11.9 38.4 6.7 
35.19 Malvidin-3-glucoside 11.1 69.3 22.6 49.6 6.4 
37.14 Malvidin-3-arabinoside 278.9 127.2 111.5 44.7 7.5 
39.03 Delphinidin-6-acetyl-3-glucoside 7.3 12.6 10.3 nd nd 
40.55 Cyanidin-6-acetyl-3-glucoside 7.8 nd 6.1 6.1 43.9 
41.70 Malvidin-6-acetyl-galactoside 26.7 13.6 8.0 7.7 nd 
42.25 Petunidin-6-acetyl-3-glycoside nd 11.9 10.9 nd nd 
44.40 Malvidin-6-acetyl-3-glucoside 10.8 19.4 14.6 nd nd 
 
Total ANC 
 
1113.7 1112.3 1403.1 1448.2 1550.4 
PAC total  
[mg (-)-Epicatechin equivalents/L] 560.3 1166.7 1244.7 1240.5 1249.0 
Bold values indicate the concentration of the predominant ANC in 100% blueberry and 100% blackberry. 
 nd = Peak not detected.  
 115 
 
Further HPLC-ESI-MS analyses for PAC revealed complex tannin composition with 
highly polymerized compounds. In the fraction mostly composed of blueberry matrix (100:0, 
70:30, 50:50; blueberry: blackberry), in addition to monomers, proanthocyanidin oligomers and 
polymers were the predominant compounds ranging from 2- to 14-units of catechin/epicatechin. 
This was consistent with published data on complex PAC in blueberry and cacao extracts [31-
34]. Fractions derived mostly from blackberry matrix/blend (0:100, 30:70, 50:50; blueberry: 
blackberry) contained in addition to PAC, a complex chemical composition of hydrolysable 
tannins (HTs). Basic structures for anthocyanins, proanthocyanidins, and HTs are presented in 
Figure 6.1. Figure 6.2 shows the composition of a mixture of blueberry: blackberry, with a 
blend of 50% each.  Based on the relative abundance of the ESI chromatogram, HTs are the 
predominant polymerized compounds in the matrix obtained from mostly blackberry wine. 
Proanthocyanidins (condensed tannins) were polymeric forms of catechin and/or epicatechin 
molecules (m/z 291.0234 each, [M+H]+), while HTs were more complex, diverse, and with 
larger molecular size [20].  Based on LC-MS data across all PAC, blueberry contributed 
proanthocyanidins while blackberry contributed mostly HTs (Figure 6.2).  
The HTs in blackberry included gallic acid (m/z : 170.2129) and ellagic acid  (m/z : 
303.0307) which form gallotannins and ellagitannins, respectively, in diversified polymers 
ranging from 465.269 to 2486.2511 m/z [M+H]+  present as shown in Figure 6.2.  More than 
1000 HTs have been identified from simple glucogallin to pentameric ellagitannins with 
molecular weight ranging from 332 to 5000 [35].  LC-MS/MS fragmentation of HTs in 
blackberry samples led to the identification of several major compounds based on their m/z,  UV 
absorption at 280 nm, and published data such as ellagic acid pentoside (m/z: 435.2345), ellagic 
acid glucose (m/z: 465.0272), galloyl-HHP glucose (m/z: 633.0259),  sanguiim H-6 (m/z: 
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1871.2658) , nobotanin A/ malabathrin B (m/z: 1736.1203), and lambertianin isomers A, C, and 
D (m/z: 1871.1403.5335, and 1870.9546, respectively).  These identifications were in agreement 
with previous publications [20, 36-40].  A comprehensive structural elucidation of HTs in 
blackberry and other plant species was recently reviewed [41]. 
 
Figure 6.1. Basic chemical structures for bioactive phytochemicals found in blueberry and 
blackberry: anthocyanins (cyanidin, peonidin, delphinidin, petunidin), proanthocyanidin 
(catechin, epicatechin), and hyrolyzable tannins (gallic acid, ellagic acid). 
 
R
1
=OCH
3
, R
2
=OCH
3 
  Malvidin 
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Additions of glycoside(s) from different sugar types to anthocyanidins results in formation of anthocyanins listed in Table 6.2.  
Addition of glucoside(s) and/or polymerization of gallic/ellagic acids results in the formation of hydrolysable tannins shown in Figure 
6.2. Proanthocyanin polymers are multi-units of catechins and/or epicatechins.  
 
 
Figure 6.2. HPLC-ESI-MS chromatograph for PAC from 50:50 blend of blueberry: blackberry. The large bold numbers refer to 
average degree of polymerization for proanthocyanidins, consisting of dimers (2 units of catechin/epicatechin) to 14-mers, with peaks 
contained two bold numbers indicated the presence of a doubly charged ion and the presence of both degrees of polymerization (i.e. 
7/14 heptamer and 14-mers).  Mass ions tagged with HT refer to polymerized hydrolysable tannins contributed only by blackberry. 
Hydrolysable tannins included gallic acid  (m/z : 170.2129) and ellagic acid  (m/z : 303.007) that formed gallotannins and ellagitannins 
in diversified polymers shown in LC-MS spectrum ranging from of 465.268 to 2486.2511 m/z [M+H]+. 
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The HTs in blackberry included gallic acid (m/z : 170.2129) and ellagic acid  (m/z : 
303.0307) which form gallotannins and ellagitannins, respectively, in diversified polymers 
ranging from 465.269 to 2486.2511 m/z [M+H]+  present as shown in Figure 6.2.  More than 
1000 HTs have been identified from simple glucogallin to pentameric ellagitannins with 
molecular weight ranging from 332 to 5000 [35].  LC-MS/MS fragmentation of HTs in 
blackberry samples led to the identification of several major compounds based on their m/z,  UV 
absorption at 280 nm, and published data such as ellagic acid pentoside (m/z: 435.2345), ellagic 
acid glucose (m/z: 465.0272), galloyl-HHP glucose (m/z: 633.0259),  sanguiim H-6 (m/z: 
1871.2658) , nobotanin A/ malabathrin B (m/z: 1736.1203), and lambertianin isomers A, C, and 
D (m/z: 1871.1403.5335, and 1870.9546, respectively).  These identifications were in agreement 
with previous publications [20, 36-40].  A comprehensive structural elucidation of HTs in 
blackberry and other plant species was recently reviewed [41]. 
Freeze-dried ANC had an antioxidant capacity ranging from 407.3 (100% blueberry) to 
758.8 mmol TE/L (50:50 blend), with an increase in all blends containing blackberry compared 
to 100% blueberry (Table 6.1), however there was no difference in the antioxidant capacity of 
PAC, having an average antioxidant capacity of 605.6 mmol TE/L. Correlations between 
components of the wines and enriched-fractions are shown in Table 6.1. 
Anthocyanins significantly inhibited activity of α-glucosidase and DPP-IV. 
While α-amylase was not inhibited by either the ANC or the PAC (data not shown), α-
glucosidase was significantly inhibited (Table 6.3). The ANC concentration needed to inhibit α-
glucosidase by 50% (IC50) in C3G equivalents ranged from 27.6 µM for 100% blackberry to 36.2 
µM for 100% blueberry, with the 50:50 blend having an IC50 value in between the 100% blends. 
When compared to the IC50 values for PAC, which ranged from 54.3 µM in epicatechin 
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equivalents for 100% blackberry to 115.1 µM for 100% blueberry, it can be seen that less ANC 
was needed to reduce α-glucosidase than PAC. Correlations between IC50 values needed to 
inhibit the enzyme are shown in Table 6.3. There was a strong negative correlation (r = -0.97, p 
< 0.05) between the amount of ANC required to inhibit α-glucosidase by 50% (IC50) and the total 
ANC present as determined by HPLC. Similarly, there was a strong negative correlation (r = -
0.93, p < 0.05) between PAC needed to inhibit α-glucosidase by 50% (IC50) and the total PAC 
present as determined by HPLC. 
 
Table 6.3. Determination of IC50 values (mean ± standard error) of ANC and PAC needed to 
inhibit enzymes involved in diabetes management.
1
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ANC- 36.2 ± 13.2
b 
33.7 ± 9.8
b 
27.6 ± 9.7
b 
1.00 0.90 0.98 -0.86 
PAC- 115.1 ± 28.5
a 
71.3 ± 28.9
ab 
54.3 ± 30.8
ab  1.00 -0.99 -1.00 
D
P
P
-I
V
 
IC
5
0
 v
al
u
es
 
(µ
M
) ANC- 15.9 ± 0.7
a 
4.2 ± 1.5
b 
5.5 ± 0.4
b   1.00 -0.95 
PAC- 16.6 ± 1.1
a 
19.3 ± 1.1
a 
18.2 ± 3.2
a    1.00 
1
IC50 values were determined from at least two independent duplicates done in triplicate. Values are means ± 
SEM. Means with different letters in each column are significantly different for each enzyme (p < 0.05).  
2
Positive control of inhibition for α-glucosidase was acarbose having an IC50 value of 500 µM.  
4
The positive control of inhibition for DPP-IV was diprotin A (Ile-Pro-Ile) at 0.1 mg/mL, and had an IC50 
value of 4.3 ± 1.6 mg/mL. 
5
Correlation values are Pearson’s r-values (p < 0.05). 
 
Compared to a standard curve of diprotin A, a known inhibitor of DPP-IV containing an 
Ile-Pro-Ile sequence, ANC and PAC all had the ability to inhibit DPP-IV activity at 
concentrations of 20 and 40 µM in C3G and epicatechin equivalents, respectively. ANC were 
more effective at inhibiting DPP-IV activity than the PAC, as seen by IC50 values in Table 6.3.  
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Overall, the 50:50 blend was the most effective at reducing the activity of DPP-IV with 
an IC50 value of 4.0 µM C3G, comparable to the known inhibitor’s IC50 value of 4.3 ± 1.6 
mg/mL. Correlations between IC50 values needed to inhibit the enzyme are shown in Table 6.3, 
as well as between IC50 values to inhibit both DPP-IV and α-glucosidase. A strong negative 
correlation between amount of ANC (r = -0.90, p < 0.05) and IC50 values to inhibit DPP-IV 
indicated that less of the compound was needed to inhibit the activity of the enzyme. Conversely, 
there was a strong positive correlation between PAC and the IC50 value to inhibit DPP-IV, 
indicating that higher PAC was required in the sample to inhibit the enzyme activity. Results 
from the computational docking study showed that the FullFitness of the anthocyanins with the 
DPP-IV had no obvious differences (from -3228 to -3052 kcal/mol) (Table 6.4
5
). Moreover, they 
were as low as those of diprotin A (-3208 kcal/mol), which is a potent DPP-IV inhibitor. These 
results suggest that anthocyanins contained in blueberry and blackberry have strong DPP-IV 
inhibiting effect. Among the four chains in DPP-IV, chain C bound each anthocyanin with the 
lowest interaction energy. Malvidin-3-galactoside in blueberry and delphinidin-3-arabinoside in 
blackberry, present in the highest concentrations, were presumed to be the major active 
components of blueberry and blackberry. The interactions of chain C with the two anthocyanins 
are shown in Figure 6.3. These results indicate that delphinidin-3-arabinoside and malvidin-3-
galactoside could effectively inhibit the activity of the enzyme.  
Markers of inflammation were inhibited in the NFκB-mediated pathway 
Proliferation assays showed that none of the ANC or PAC from 100% blueberry, 50% 
blueberry: 50% blackberry, or 100% blackberry were cytotoxic to RAW 264.7 mouse 
macrophages at concentrations up to 100 µM in C3G or epicatechin equivalents, respectively.  
                                                             
5
 The work shown in Table 6.4 and Figure 6.3 were completed by Dr. Junfeng Fan.  
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Table 6.4. Interactions of chains of DPP-IV and anthocyanins
6
.  
 Chain of 
DPP-IV 
FullFitness   
(kcal/mol) 
SimpleFitness* 
(kcal/mol) 
H Bond Position Distance of 
H Bond (Å) 
       ⊿G 
     (kcal) 
Cyanidin-3-
glucoside  
a -3096.22 83.08 - - -7.34 
b -3076.18 84.01 PHE95 HN-C3G O8 2.135 -7.68 
c -3118.97 85.40 TRP62 NH- C3G O1 2.563 -7.26 
d -3051.96 78.58 TRP62 O- C3G H7 2.032 -7.83 
Malvidin-3-
galactoside 
 
a -3079.03 124.70 - - -7.23 
b -3063.75 115.45 ASN74 O-M3GA H11 2.622 -7.79 
c -3106.89 115.08 PHE461 HN- M3GA 
O10 
2.275 -7.87 
   ILE107 O- M3GA H 2.691  
d -3033.99 116.42 TRP305 NH- M3GA O4 2.145 -7.59 
Malvidin-3-
arabinoside 
 
a -3094.00 116.12 GLY99 HN-M3A O7 2.151 -7.63 
b -3075.47 110.77 - - -7.88 
c -3118.97 113.62 ARG669 O- M3A H4 2.836 -7.73 
d -3046.40 113.68 - - -7.45 
Delphinidin-
3-glucoside  
a -3102.27 78.94 - - -7.59 
b -3081.15 80.25 - - -7.47 
c -3125.95 82.11 HIS533 HN-D3G O9 2.168 -7.64 
   ASN506 O- D3G H 2.114  
   LYS41 HN- D3G O 2.385  
d -3052.84 79.68 - - -7.48 
Delphinidin-
3-arabinoside  
a -3202.45 35.04 ASN74 O- D3A H8 2.043 -7.64 
   ILE102 HN- D3A O4 2.467  
   ASN92 O- D3A H14 2.150  
b -3183.53 30.69 ASN74 O- D3A H8 1.763 -8.38 
   ILE102 HN- D3A O9 2.194  
c -3227.73 36.22 ILE107 HN- D3A O10 2.223 -7.62 
   TRP62 O- D3A H14 1.990  
   ILE63 O- D3A H9 2.338  
d -3155.24 39.17 - - -7.03 
Diprotin A a -3183.60 -7.07 LYS71 HZ3-DA O4 2.618 -7.62 
b -3161.06 -8.22 LEU90 O-DA H12 
PHE95 O-DA H22 
HIS100 O-DA H23 
ILE102 HN-DA O4 
2.582 
2.643 
2.428 
1.874 
-8.25 
c -3208.29 -9.23 LYS122 O-DA H22 2.678 -7.72 
   GLU191 OE2-DA H12 1.875  
d -3135.71 -11.14 - - -7.17 
C3G, M3GA, M3A, D3G, D3A and DA represent cyanidin-3-glucoside, malvidin-3-galactoside, malvidin-3-arabinoside, 
delphinidin-3-glucoside, delphinidin-3-arabinoside and diprotin A, respectively. Other abbreviations indicate the three-letter 
amino acid code in the binding site. *The SimpleFitness is equal to the total energy of the system calculated with the 
CHARMM22 molecular mechanics force field, and neglects the effect of solvent known to have an important contribution to the 
binding free energy. 
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 This work was conducted by Dr. Junfeng Fan. 
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Figure 6.3.  Computational visualization of the most optimal docking conformation of (A) 
delphinidin-3-arabinoside, (B) malvidin-3-galactoside, and (C) diprotin A, with chain C of the 
DPP-IV enzyme. This work was conducted by Dr. Junfeng Fan. 
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None of the ANC or PAC (100 µM C3G or epicatechin equivalents) increased production 
of any of the inflammatory proteins tested when not stimulated with LPS. All three (100:0, 
50:50, and 0:100) blueberry-blackberry blend ANC at 100 µM were able to lower total p-p65 
NFκB subunit following LPS-stimulation by 68.9, 88.6, and 80.8%, respectively (Figure 6.4A). 
ANC from the blends containing 50% or 100% blackberry were able to significantly inhibit the 
activation of the p-p65 NFκB subunit at 50 µM by 88.6 and 72.0%, respectively. PAC from the 
100% blueberry and the 50:50 blends were also able to significantly decrease the p-p65 NFκB 
subunit at 100 µM epicatechin equivalents by 55.7 and 40.0%, respectively; however PAC from 
the 100% blackberry blend did not significantly decrease this inflammatory protein (Figure 
6.4A). This can be attributed to the fact that, unlike blueberry with more polymeric 
proanthocyanidins or condensed tannins, blackberry contains HTs.  
COX-2 expression was decreased by all ANC at 100 µM C3G equivalents; 52.4% for 
100:0, 67.8% for 50:50, and 72.2% for 0:100 (Figure 6.4B). PAC from 100% blackberry and 
the 50:50 blends were also able to decrease COX-2 expression significantly by 64.3 and 65.2%, 
respectively. PAC at 100 µM epicatechin equivalents from the 100% blueberry blend decreased 
COX-2 expression by 36.8%, however this decrease was not significant. iNOS expression was 
decreased by ANC with the 100% blueberry and 50:50 blends at 100 µM C3G equivalents, with 
ANC from the 100% blueberry the most effective with 75.7% inhibition compared to 40.2% for 
50:50 (Figure 6.5A). PAC from all blends were able to decrease iNOS expression in mouse 
macrophages following LPS-stimulation at 100 µM epicatechin equivalents, with the 50:50 
blend the most effective to decrease iNOS expression by 57.4% compared to 53.0% inhibition by 
100:0 and 42.3% by 0:100. iNOS protein produces the inflammatory marker nitric oxide (NO) 
when active, so NO production was also measured.  
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Figure 6.4.  Effect of ANC (cyanidin-3-O-glucoside equivalents) and PAC (epicatechin 
equivalents) at 50 and 100 M on NFκB (A), and COX-2 expression (B). Western blots are 
shown above with p-p65 subunit of NFκB detected at 65 kDa, COX-2 at 70-72 kDa, and actin at 
43 kDa from whole cell lysates. Values are relative expression of protein of interest over actin; 
means ± SEM with different letters are significantly different (n = 4, p < 0.05).  
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 As seen in Figure 6.5B, ANC at 100 µM were able to decrease NO production with 
blackberry in the blend by 37.9% for 50:50 and 48.1% for 0:100; however the 100% blueberry 
ANC was unable to show a significant decrease in NO production. PAC from 100:0, 50:50, and 
0:100 at 100 µM epicatechin equivalents also decreased NO production by 16.4, 4.8, and 14.7%, 
respectively; however, these decreases were not significant (p > 0.05).  
 
Figure 6.5. Effect of ANC (cyanidin-3-O-glucoside equivalents) and PAC (epicatechin equivalents) at 
50 and 100 µM on (A) iNOS expression. Western blots are shown above with iNOS detected at 130 kDa 
and actin at 43 kDa from whole cell lysates. Values are relative expression of protein of interest over 
actin. (B) NO assay presents data from treatments at 100 µM cyanidin-3-O-glucoside (C3G) equivalents 
(ANC) or epicatechin equivalents (PAC) and was measured from spent medium. Means ± SEM with 
different letters are significantly different (n = 4, p < 0.05). 
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Discussion  
Fermented berry beverages have been established as having an increased phenolic 
content and higher antioxidant capacity than their non-fermented counterparts [7-9, 23]. 
Beneficial effects of berries in the diet have been attributed to their high phenolic content, 
especially their anthocyanin content [40]. Wines were tested for their total polyphenols, total 
anthocyanin content, and antioxidant capacity, and these levels increased with more blackberry 
in the blend associated with higher ANC concentration. To our knowledge, this is the first 
reported analysis of anthocyanins from fermented blueberry-blackberry blends; however, the 
results from blueberry and blackberry wines were comparable to previously reported values [24]. 
In this study, we show that the anthocyanin profile from fermented berry beverages may be 
altered from profiles previously generated for blackberry fruits [20] or even phenolic-rich 
blueberry extracts [29]. Malvidin contains two methoxy side chains on its B ring, while 
delphinidin has two hydroxyl groups, which may contribute to the higher antioxidant capacity 
seen for the blackberry blends. Delphinidin (45.0 - 74.9 mg/100 g FW) and malvidin (37.1 - 62.2 
mg/100 g FW) were the predominant anthocyanins in the varieties tested in Highbush and 
lowbush blueberries [42], similar to the findings from the fermented products.  
During wine processing from berries, phenolic compounds may be effectively extracted 
into the wines; delphinidin-3-glucoside has been identified as a major component in red wine and 
had the most variation among all anthocyanins [43]. Although cyanidin 3-glucoside has been 
identified as the major anthocyanin in different blackberry species, cyanidin 3-rutinoside was the 
major component in the wines from Andean blackberry (Rubus glaucus Benth.) [44]. These 
results contrast with the major anthocyanin identified in our study as delphinidin-3-arabinoside, 
though many unknown compounds in their study were only tentatively identified. Authors agree 
that fermentation causes an absolute and relative change in anthocyanin content, allowing for 
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new pigments to be generated or formed during the fermentation process or during wine 
maturation. While the process of anthocyanin transformation is not clear, it is supported by the 
changes seen in wines during aging as native blackberry anthocyanins are transformed during 
and after alcoholic fermentation. 
Our results showed inhibition of -glucosidase activity; other studies on red and black 
currants and red and green gooseberries have shown strong inhibition of intestinal glucose 
absorption by inhibiting α-glucosidase activity [13]. Anthocyanins present in blueberry fruits and 
their fermented products appear to be more potent at inhibiting α-glucosidase than the 
proanthocyanidins. While a previous study in our laboratory evaluated blueberry wines and 
found strong inhibition of α-amylase in vitro [14]. During the phenolic extraction process 
phenolic acids were removed indicating these may be the bioactive compounds with ability to 
inhibit α-amylase activity rather than the ANC or PAC. Grussu et al. [45] demonstrated that it is 
not the anthocyanins that are required to inhibit α-amylase because both red and yellow 
raspberries showed similar inhibitory capacity. 
  A study of rowanberry proanthocyanidin-rich fraction had a low level of inhibition 
compared to the whole extract [46], suggesting that tannin and ellagitannin components are not 
influential or are poor inhibitors of α-glucosidase. Our results indicate that there was some 
inhibition of the enzyme by the PAC-enriched fraction, but the ANC-enriched fraction was more 
potent. The efficacy of the anthocyanins to inhibit DPP-IV enzyme activity at a rate comparable 
to a known inhibitor (diprotin A) indicated that anthocyanins may be able to act as naturally-
occurring DPP-IV inhibitors of DPP-IV. If DPP-IV is inactivated by drugs or natural 
compounds, the degradation of glucagon-like peptide-1 (GLP-1) and glucose-dependent 
insulinotropic polypeptide (GIP) is prevented, and these hormones are able to inhibit glucagon 
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release and stimulate insulin release, respectively, thereby lowering blood glucose levels [17]. 
All of the anthocyanins tested showed similar FullFitness energies from the computational 
modeling study; therefore, they have no major difference in anti-DPP-IV activity. Due to the 
higher amounts of malvidin-3-galactoside in blueberry and delphinidin-3-arabinoside in 
blackberry, these ANC are likely the major active components. To confirm these results, the 
SwissDock computational docking study demonstrated that delphinidin-3-arabinoside and 
malvidin-3-galactoside were able to interact with DPP-IV through ligand interaction, and 
therefore potentially inactivate the activity of the enzyme. The most optimal conformation 
happened in chain C of DPP-IV indicated by the lowest interaction energies of -3228 kcal/mol 
(for delphinidin-3-arabinoside) and -3107 kcal/mol (for malvidin-3-galactoside), which are 
comparable to the interaction energy of the known inhibitor diprotin A with the enzyme of -3208 
kcal/mol. Due to the lowest interaction energy of chain C, we concluded that the chain C was the 
major binding site of these anthocyanins. 
Our results agree with previous studies that reported the ability of berries to reduce 
inflammation through decreased expression of enzymes iNOS and COX-2 [19-20]. The upstream 
mediator in the NFκB-mediated pathway, the p-p65 subunit of NFκB that lead to the induction of 
these inflammatory markers was inhibited by ANC 50:50% blend and 100% blackberry. The 
strong anti-inflammatory effect was considered to be exerted by a combination of various 
polyphenol compounds rather than any single compound.  
 Berry extracts can inhibit α-glucosidase at concentrations less than 50 µg GAE/mL, an 
amount that can be easily reached in the gastrointestinal tract after consumption of berries or 
juices [47]. Additionally, a previous study reports that a moderate drink of 140 mL of wine made 
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from Highbush blueberry would correspond to an intake of 2.42 mmol of TE of ORACPE/day 
[43]. 
 
Concluding remarks 
ANC and PAC at 100 µM C3G/ epicatechin equivalents obtained from blueberry-
blackberry blends affected LPS-induced inflammatory response in RAW 264.7 mouse 
macrophages. These ANC and PAC reduced the phosphorylation of the p65-subunit NFκB, 
decreased iNOS and COX-2 expression, and decreased NO production. Along with the high 
antioxidant capacity and phenolic content and ability to decrease enzyme activity related to 
improved glucose utilization, bioactive ANC and PAC compounds present in fermented berry 
beverages may act synergistically to reduce risk factors for chronic inflammatory diseases, 
especially type 2 diabetes. 
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CHAPTER 7 
BERRY AND CITRUS PHENOLIC COMPOUNDS INHIBIT DIPEPTIDYL PEPTIDASE 
IV: IMPLICATIONS IN DIABETES MANAGEMENT
7 
 
 
Abstract 
Beneficial health effects of fruits and vegetables in the diet have been attributed to their 
high flavonoid content. Dipeptidyl peptidase IV (DPP-IV) is a serine aminopeptidase that is a 
novel target for type 2 diabetes therapy due to its incretin hormone regulatory effects. In this 
study, well-characterized anthocyanins (ANC) isolated from berry wine blends and twenty-seven 
other phenolic compounds commonly present in citrus, berry, grape, and soybean, were 
individually investigated for their inhibitory effects on DPP-IV by using a luminescence assay 
and computational modeling. ANC from blueberry-blackberry wine blends strongly inhibited 
DPP-IV activity (IC50, 0.07 ± 0.02 to >300 μM). Of the twenty-seven phenolics tested, the most 
potent DPP-IV inhibitors were resveratrol (IC50, 0.6 ± 0.4 nM), luteolin (0.12 ± 0.01 μM), 
apigenin (0.14 ± 0.02 μM), and flavone (0.17 ± 0.01 μM), with IC50 values lower than diprotin A 
(4.21 ± 2.01 μM), a reference standard inhibitory compound. Analyses of computational 
modeling showed that resveratrol and flavone were competitive inhibitors which could dock 
directly into all three active sites of DPP-IV, while luteolin and apigenin docked in a 
noncompetitive manner. Hydrogen bonding was the main binding mode of all tested phenolic 
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compounds with DPP-IV. These results indicate that flavonoids, particularly luteolin, apigenin, 
and flavone, and the stilbenoid resveratrol can act as naturally occurring DPP-IV inhibitors. 
Abbreviations used: 
ANC: Anthocyanins 
C3G: Cyanidin-3-glucoside 
DPP-IV: Dipeptidyl peptidase IV 
GLP-1: Glucagon-like peptide-1 
GIP: Glucose-dependent insulinotropic polypeptide 
IC50: Concentration to inhibit 50% enzyme activity 
Ki: Enzyme inhibitor constant. 
 
Introduction 
Type 2 diabetes is characterized by excessive blood glucose and insulin resistance due to 
an improper insulin response of the body to manage glucose from the diet [1]. Dipeptidyl 
peptidase IV (DPP-IV, EC 3.4.14.5), a serine peptidase, is one of the newest pharmaceutical 
targets for type 2 diabetes treatment [1]. On the other hand, incretin-based therapy has several 
potential sites of action for the treatment of type 2 diabetes ranging from increasing insulin 
secretion, reducing glucagon secretion, and regulating glucose control [2]. It is well known that 
glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are 
major human incretin hormones that stimulate insulin release in a glucose-dependent manner in 
healthy individuals [3, 4]. However, DPP-IV rapidly transforms these two gut incretin hormones 
after secretion by cleavage of the penultimate proline or alanine at N-terminus, and thus forms 
their inactive metabolites [5–7]. Both hormones have very short half-lives (approximately 2 min) 
due to the rapid degradation by DPP-IV [8]. Among the several peptide substrates of DPP-IV, 
GLP-1 is one of the well-characterized physiological and pharmacological substrates of the 
enzyme. GLP-1, which is secreted in a nutrient-dependent manner, stimulates glucose-dependent 
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insulin secretion and regulates glycemia. However, the actions of GLP-1 do not last long due to 
degradation by DPP-IV. For this reason, DPP-IV inhibition is expected to result in elevated 
plasma insulin levels by inhibiting the degradation of active GLP-1 after oral glucose intake. 
This in turn leads to the suppression of blood glucose elevation. Therefore, development of DPP-
IV inhibitors is being actively conducted worldwide, and control of blood glucose levels by 
enhancement of GLP-1 action is a new option for the treatment of diabetes. 
In recent years, protein-ligand docking has become a powerful tool for drug development, 
and is also a method to be able to identify binding modes with high accuracy. For DPP-IV, 
computational docking analyses have been commonly used for designing inhibitors [9], 
screening of potential inhibitors [10], and explaining the differences in activity of drugs with 
different structures [11]. However, most of the previously investigated inhibitors of DPP-IV have 
been synthetically derived. As for naturally occurring flavonoids, the binding modes with DPP-
IV are still not yet established. 
Phenolic compounds, such as flavonoids, widely abundant in fruits and vegetables, have 
been suggested as important compounds for diabetes reduction [9, 10]. However, so far only a 
few phenolic compounds have been investigated to inhibit DPP-IV activity. These include 
procyanidin from grape seeds [12] and naringin from orange peel [13]. Therefore, it is necessary 
to further elucidate the modulating effect on DPP-IV activity of phenolic compounds from other 
natural sources. 
In epidemiological studies, berries were the most important contributors to lowering risk 
for type 2 diabetes [14]. Additionally, an inverse relationship between intake of flavonoids, 
specifically those from berries, and risk of type 2 diabetes was found [15]. However, there is lack 
of evidence for the role of specific phenolics in clinical trials, and there is not yet sufficient data 
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to confirm that anthocyanins have a protective effect against the risk of type 2 diabetes [16]. 
Additionally, anthocyanins found in berries have been found to have a beneficial effect on 
glucose metabolism; however, stronger scientific evidence is needed. 
Anthocyanins (ANC) from blueberry-blackberry wine blends have been evaluated for 
DPP-IV and carbohydrate-utilizing enzymes inhibitor studies in our laboratory, and they have 
exhibited potent DPP-IV and α-glucosidase inhibitory activities [17]. Thus, the aim of the 
present study was to further characterize the ANC-rich fractions from blueberry-blackberry wine 
blends by HPLC and analyze their DPP-IV inhibitory effect in vitro. Furthermore, a variety of 
other phenolic compounds commonly present in berries, citrus, and other plant foods were 
studied for their DPP-IV inhibitory activity. We hypothesized that berry and citrus phenolics 
could bind to the active sites of DPP-IV, thus inhibiting DPP-IV enzyme activity. For the most 
potent compounds, kinetic and computational docking analyses were used to elucidate the 
binding modes with the DPP-IV enzyme. 
 
Materials and Methods 
Materials 
Wines were produced from Highbush blueberry (Vaccinium corymbosum) cultivars Blue 
Chip, Bluecrop, Blue Haven, Blue Jay, Blueray, Bluetta, Collins, Coville, Darrow, Earliblue, 
Elliot, Jersey, Late Blue, and Spartan and blackberry (Rubus fruticosus) cultivars A-1937, A-
2215, A-2241 Natchez, A-2315, APF 27, APF 40, APF 41, and Prime Jan, collected from Dixon 
Springs Agricultural Center in Simpson, IL, USA during the ripening season of 2010. Blueberry 
wine and blackberry wine were separately fermented using Saccharomyces bayanus as 
previously described [17]. After the fermentation, blends ranging from 100% blueberry to 100% 
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blackberry were made using room temperature fermented wines. Blends were prepared with 
different ratios of % blueberry : % blackberry. The ratios were 100 : 0, 75 : 25, 25 : 75, and 
0 : 100 of blueberry: blackberry wine blends, respectively. 
All solvents used for phenolic extraction were HPLC-grade and were purchased from 
Fisher Scientific (Pittsburg, PA). Amberlite XAD-7 was purchased from Sigma-Aldrich (St. 
Louis, MO). Sephadex LH-20 was purchased from GE Life Sciences (Buckinghamshire, UK). 
Porcine kidney DPP-IV enzyme (88% sequence homology with human; both are homodimers 
with a subunit molecular mass of ~30 kDa) and diprotin A were purchased from Sigma-Aldrich. 
DPP-IV Glo
TM
 Protease Assay kits were purchased from Promega (Madison, WI). Flavonoids 
with high purities that were purchased from Sigma-Aldrich included luteolin (>98%), apigenin 
(>95%), quercetin (>98%), kaempferol (>97%), rutin hydrate (>94%), naringenin (>95%), 
neohesperidin (>90%), flavone (>97%), naringin (>90%), hesperidin (>80%), cyanidin-3-
glucoside (>95%), cyanidin (>95%), malvidin (>95%), resveratrol (>99%), protocatechuic acid 
(>97%), catechin (>98%), epicatechin (>90%), epigallocatechin gallate (EGCG, >95%), gallic 
acid (>97.5%), caffeic acid (>98%), and chlorogenic acid (>95%). Hesperetin (>95%) was 
purchased from Sigma-Aldrich (Wicklow, Ireland) and limonin (>90%) from MP BioMedicals 
(Solon, OH). Narirutin (>93.9%) and eriocitrin (>97.4%) were purchased from Chromadex 
(Irvine, CA). Genistein (>90%) and genistin (>90%) were kindly donated by Dr. Mark Berhow, 
USDA. All other reagents were of analytical grade. 
Phenolic extraction and preparation of ANC fractions 
Phenolic extraction and preparation of ANC fractions were conducted as previously 
described [17]. Briefly, each wine was firstly acidified, dealcoholized, and then mixed with 
amberlite XAD-7 resin to remove sugars and phenolic acids. After nonpolar compounds were 
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further removed from the crude polyphenolics, the polar eluate was loaded onto a Sephadex LH-
20 column to generate ANC-enriched fractions. With an isocratic elution using water : methanol 
(80 : 20, containing 0.1% TFA) and then 50% methanol, five anthocyanin-rich fractions (ANC 
1–5) were obtained. ANC 2–5 from each blend of blueberry and blackberry were analyzed by 
HPLC to determine their ANC composition. 
Anthocyanin analysis 
ANC analyses were conducted as previously published [17] using a 1200 HPLC (Agilent 
Technologies, Santa Clara, CA) with a Supelcosil LC-18 RP column (250 × 4.6 mm, 5 μM) 
(Supelco, Bellefonte, PA). ANC were detected at 520 nm using a diode array detector (DAD). 
Specific anthocyanins were identified based on comparison to our previously published data [18, 
19]. A previously well-characterized blueberry extract [19] was included with each sample run to 
verify compound separation and identification. Using the peak areas as measured by HPLC at 
520 nm, total ANC were quantified from a standard curve generated from 0.125, 0.25, 0.5, and 
1.0 mg/mL of cyanidin-3-glucoside (C3G) and ANC amounts are presented as C3G equivalents. 
DPP-IV inhibition 
Measurement of the activity and potential inhibition of DPP-IV, a type II membrane 
glycoprotein, was done using the DPP-IV Glo
TM
 Protease Assay following the manufacture’s 
protocol (Promega, Madison, WI). Briefly, 50 μL of DPP-IV GloTM reagent was added to a 
white-walled 96-well plate containing 50 μL of blank, positive control, or treatment. The blank 
contained the vehicle only while positive control contained the vehicle and purified DPP-IV 
enzyme (at a final concentration of 1 ng/mL). Treatments used were enriched ANC fractions 
(0.5, 5, 20, and 40 μg/mL), phenolic compounds (0.5, 5, 20 and 40 μg/mL) or known inhibitor, 
diprotin A (1, 2, 12, 24, 125, and 250 μM), and the purified DPP-IV enzyme at a final 
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concentration of 1 ng/mL. The content of the wells was gently mixed using an Ultra Microplate 
Reader (Biotek Instruments, Winooski, VT) at medium intensity for 4 s. DPP-IV cleavage of the 
provided Gly-Pro-amino methyl coumarin (AMC) substrate generated a luminescent signal by 
luciferase reaction, with the amount of DPP-IV enzyme available to bind Gly-Pro-AMC 
proportional to relative light units (RLU) produced. This signal in RLU was measured after 
30 min in the Ultra Microplate Reader and then compared to the blank. Diprotin A linear 
standard curve (y = 41.936x + 27.294, R
2
 = 0.91), where y was the % inhibitory activity of 
diprotin A and was the log10 of the concentration (μM) of known inhibitor diprotin A, was used 
to calculate IC50 value: the concentration needed to decrease the activity of the enzyme by 50% 
of its original activity. IC50 values were calculated based on the molecular mass of each 
compound or C3G as the equivalent for ANC-enriched fractions. 
Inhibitory kinetics study 
Porcine kidney DPP-IV activity was measured at various concentrations of three 
flavonoids (5 and 10 mg/mL for luteolin, apigenin, and flavone; and 0.25 and 0.5 mg/mL for 
resveratrol). Each concentration was evaluated in the presence of various concentrations of Gly-
Pro-AMC (0–60 μM). DPP-IV activity was measured using the DPP-IV Glo Protease Assay as 
mentioned above. The inhibition pattern was evaluated utilizing the Lineweaver-Burk plot. 
Enzyme-inhibition constant Ki was determined by plotting the reciprocal of the initial 
luminescence versus the reciprocal of the initial substrate concentration. 
Molecular modeling and computational docking study
8
 
The DPP-IV enzyme exists as a dimer in the crystal form, and each monomer consists of 
726 amino acids [20]. The docking studies were conducted with the monomeric unit of the 
enzyme, as the active site of the enzyme resides deep within each monomer of the receptor 
                                                             
8
 Dr. Junfeng Fan conducted all the molecular modeling and computational modeling performed in this chapter.  
 142 
 
protein and not on the enzyme surface [21]. The molecular docking analysis of flavonoids was 
carried out using AUTODOCK 4.2 (CCDC, UK; http://www.ccdc.cam.ac.uk/products/csd/) [22]. 
The crystal structure of the DPP-IV enzyme (Protein Data Bank (PDB) ID: 2I03) was obtained 
from the protein data bank (http://www.rcsb.org/pdb), and the protein structure was prepared 
using Accelrys Discovery Studio 3.5 program (Accelrys Software Inc., San Diego, CA). For the 
computational docking study, the energies of diprotin A and flavonoids were minimized by 
applying a CHARM22 force field, using the Accelrys Discovery Studio 3.5 program. After 
removing water molecules and adding all the hydrogen atoms, Gasteiger-Hückle charges were 
assigned to the enzyme. The ligand conformers were treated as flexible and protein structures 
were treated as rigid during the docking process. The docking was carried for 100 genetic 
algorithm runs, which was optimum to validate the crystal structure of the ligand. Most of the 
other genetic algorithm parameters such as the population size were maintained at their default 
values. The best docking results were considered to be the conformation having the lowest 
binding energy (⊿G) using the equation: 
⊿G = ⊿G (intermolecular) + ⊿G (internal) +⊿G (tor) - ⊿G (Unbound extended) 
Where ⊿G (intermolecular) denotes the sum (kcal/mol) of Van der Waals energy, hydrogen bond 
energy, electrostatic energy and desolvation energy; ⊿G (internal) is final total internal energy 
(kcal/mol); ⊿G (tor) denotes torsional free energy (kcal/mol); and ⊿G (Unbound extended) is the 
unbound system’s energy (kcal/mol). In the context of Autodocking, inhibition constant (Ki) is 
directly related to the binding energy: Ki = e 
[⊿G/(RT )] 
Where e is the base number of natural logarithm (approximately equals to 2.72), R is gas 
constant (kcal/mol), and T is the absolute temperature. Smaller Ki and more negative ⊿G mean 
tighter binding. 
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Statistical analyses 
Data were expressed as means of independent duplicates with at least three replicates. 
The dose-response analysis of each compound on DPP-IV activity was performed using 
nonlinear or linear regression (curve fit) using EXCEL Microsoft (e.g., see Supplementary 
Information available online at http://dx.doi.org/10.1155/2013/479505). Statistical analysis was 
conducted using the proc GLM procedures of SAS version 9.3 (SAS Inst. Inc., Cary, NC, 2009). 
Group mean comparisons were conducted using Duncan means and were considered to be 
significant at  P < 0.05 based on the least significant differences (LSD) from one-way analysis of 
variance (ANOVA) with alpha = 0.05. Correlations were made using Pearson’s correlation 
values with P < 0.05. 
Results 
Blackberry wine presented high concentrations of delphinidin-3-arabinoside 
Relative distribution of ANC in the extracts of blueberry-blackberry wine blends are shown 
in Table 7.1.  Chromatographic analyses revealed up to seventeen ANC present in blueberry-
blackberry blends. Malvidin-3-galactoside and cyanidin-3-glucoside were the main ANC present 
in the blueberry wine, while delphinidin-3-arabinoside was the predominant ANC present in the 
blackberry wine. Total ANC ranged from 1653.8 mg C3G equivalents/L for blueberry wine to 
3267.8 mg C3G equivalents/L for blackberry wine. It was also observed that there was an 
obvious difference between ANC amounts of different fractions generated as ANC 2–5. 
Anthocyanins from blackberry wine potently inhibited DPP-IV 
 
ANC-enriched fractions (ANC 1–5) isolated from blueberry-blackberry wine blends were 
analyzed for their DPP-IV inhibitory effect. Table 7.2 shows the IC50 values of ANC from 
blueberry-blackberry wine blends needed to inhibit DPP-IV enzyme.  
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Table 7.1. Anthocyanin (ANC) identification and quantification by HPLC at maximum absorption of 520 nm. 
 
RT 
(min) 
ANC ID 
 Anthocyanins (mg C3G equivalents/L) per blend (%Blueberry : %Blackberry)  
100:0 75:25 25:75 0:100 
ANC2 ANC3 ANC4 ANC5 ANC2 ANC3 ANC4 ANC5 ANC2 ANC3 ANC4 ANC5 ANC2 ANC3 ANC4 ANC5 
24.44 
Delphinidin-3-
galactoside 
6.3 10.8 10.0 nd 6.6 11.2 nd nd 6.9 7.0 nd nd nd nd nd nd 
25.98 
Delphinidin-3-
glucoside 
nd 26.8 45.5 nd 9.0 51.0 7.7 nd 12.3 17.7 nd nd 8.8 nd nd nd 
27.33 
Cyanidin-3-
galactoside 
6.1 6.5 nd nd nd 6.3 nd nd 17.7 nd nd 6.5 23.8 nd 6.9 7.0 
28.86 
Delphinidin-3-
arabinoside 
nd 11.9 30.9 nd nd nd nd nd 1079.3 716.1 30.1 16.8 1244.7 794.1 35.8 17.8 
29.69 
Cyanidin-3-
glucoside 
6.4 23.4 nd nd 60.6 564.1 29.7 9.3 10.2 12.2 nd nd 10.1 6.5 6.1 nd 
30.82 
Cyanidin-3-
arabinoside 
nd 140.2 7.4 nd 11.0 16.7 8.0 7.2 nd 20.2 10.0 nd 116.8 nd 10.8 7.0 
31.62 
Petunidin-3-
glucoside 
9.7 7.3 24.9 10.5 56.1 79.6 13.3 6.7 100.9 nd 12.2 6.6 9.6 nd 12.2 7.2 
32.69 
Peonidin-3-
glucoside 
6.0 39.8 nd nd 8.3 6.7 nd 8.0 8.4 nd 13.9 7.0 10.1 7.1 18.8 8.0 
33.95 
Petunidin-3-
arabinoside 
5.9 178.5 22.5 nd nd 34.5 9.1 nd 14.3 8.3 10.4 6.5 9.7 nd 9.7 9.9 
34.39 
Malvidin-3-
galactoside 
74.8
＊
 292.1 13.2 6.2 266.1 32.7 14.5 6.4 38.4 nd 15.5 nd 6.7 6.3 15.9 nd 
35.19 
Malvidin-3-
glucoside 
63.1 11.1 19.0 6.1 266.3 69.3 18.3 7.4 49.6 11.8 11.2 6.4 6.4 11.7 10.7 10.4 
37.14 
Malvidin-3-
arabinoside 
5.9 278.9 19.7 8.3 91.5 127.2 24.5 9.2 44.7 150.2 30.6 6.5 7.5 nd 37.1 7.0 
39.03 
Delphinidin-6-
acetyl-3-glucoside 
nd 7.3 17.9 6.7 6.3 12.6 11.4 6.4 nd nd nd 6.8 nd 7.2 nd 6.2 
40.55 
Cyanidin-6-acetyl-
3-glucoside 
nd 7.8 6.7 nd 8.9 nd 6.6 nd 6.1 nd 7.3 6.9 43.9 nd nd 7.1 
41.70 
Malvidin-6-acetyl-
galactoside 
nd 26.7 7.1 nd nd 13.6 nd nd 7.7 nd 6.3 nd nd nd 7.2 6.6 
42.25 
Petunidin-6-
acetyl-3-glycoside 
nd nd 12.9 6.0 nd 11.9 nd nd nd nd nd nd nd nd 6.9 nd 
44.40 
Malvidin-6-acetyl-
3-glucoside 
nd 10.8 10.5 nd 11.5 19.4 8.4 nd nd 8.9 8.1 6.4 nd 14.2 9.3 5.9 
 
Sub-total ANC 
 
190.5 1113.7 275.6 74.0 864.0 1112.3 183.8 81.6 1448.2 1073.3 239.2 146.8 1550.4 1204.8 302.8 229.8 
Total ANC 1653.8 2241.7 2907.5 3267.8 
＊
Bold numbers indicate the dominant flavonoids in that particular ANC fraction. 
nd = Peak not detected.
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Compared to a standard curve of diprotin A (IC50, 4.21 ± 2.01 μM), a known DPP-IV inhibitor 
with an Ile-Pro-Ile sequence, ANC 2–5 tested at concentrations of 0.5, 5, 20, and 40 μM in C3G 
equivalents obtained from each blend had IC50 values ranging from 2.64 ± 1.40 μM in ANC 2 
from blueberry wine to 0.07 ± 0.02 μM in ANC 3 from blackberry wine (Table 7.2). Table 7.2 
also shows that ANC from blackberry wine were the most effective of the blends at reducing the 
activity of DPP-IV (with IC50 values of no more than 0.22 μM C3G). 
 
Table 7.2: Anthocyanin (ANC) concentration (μM) from blueberry-blackberry wine blends 
needed to inhibit DPP-IV enzyme activity by 50%
1,2
.  
Blend ratio 
(%blueberry:%blackberry) 
Fractions IC50 (μM) 
100% Blueberry ANC-1 >300 
 ANC-2 2.64±1.40a 
 ANC-3 0.64±0.33bc 
 ANC-4 1.37±0.58abc 
 ANC-5 0.72±0.25bc 
25%:75% ANC-1 NA 3 
 ANC-2 2.02±0.56ab 
 ANC-3 0.41±0.11c 
 ANC-4 0.22±0.05c 
 ANC-5 0.36±0.16c 
75%:25% ANC-1 NA 
 ANC-2 0.34±0.10c 
 ANC-3 0.33±0.08c 
 ANC-4 0.52±0.18c 
 ANC-5 0.20±0.10c 
100% Blackberry ANC-1 NA 
 ANC-2 0.22±0.03c 
 ANC-3 0.07±0.02c 
 ANC-4 0.18±0.07c 
 ANC-5 0.20±0.09c 
1 
IC50 values were determined from at least two independent duplicates done in triplicate and 
calculated in C3G equivalents. Values are means ± SEM. Means with different letters in the IC50 
column are significantly different (p < 0.05). 
2 
The positive control of inhibition for DPP-IV was 
diprotin A (Ile-Pro-Ile) at 0.1 mg/mL, and had an IC50 value of 4.21±2.01 μM. 
3 
NA: No activity 
detected at > 300 μM. 
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Resveratrol, a stilbenoid, luteolin, apigenin, and flavone, flavonoids commonly present in 
fruits, have strong DPP-IV inhibitory activity 
Twenty-seven phenolic compounds commonly present in citrus, berries, grape, soybeans, 
and other plants were tested for DPP-IV inhibitory effect (Table 7.3). Sixteen phenolic 
compounds demonstrated DPP-IV inhibitory activity with IC50 values ranging from 0.6 ± 0.4 nM 
(resveratrol) to 10.36 ± 0.09 μM (eriocitrin). Eleven compounds did not have DPP-IV inhibitory 
activity including rutin, narirutin, naringin, hesperidin, limonin, neohesperidin, genistin, 
catechin, epicatechin, chlorogenic acid, and protocatechuic acid (data not shown). 
Table 7.3: DPP-IV inhibition
1
 by flavonoids (IC50), their number of hydroxyl groups (OH), 
binding energy, inhibition constant (Ki)
2, H bonds involved, and π interactions. 9 
 
Flavonoids IC50 (μM) 
Number 
of OH 
groups 
Binding 
energy 
(kcal/mol) 
Ki
 
 
(μM) H Bonds 3 π interactions 
Positive 
control 
Diprotin A 
 
 
4.21 ± 2.01 bc 
 
 
0 
 
 
-7.31 
 
 
4.42 
TYR547:HH-UNK:O22 
UNK:H28-TYR666:OH 
UNK:H11-GLU206:OE1 
UNK:H11-GLU206:OE2 
UNK:H12-GLU205:OE2 
π-cation 
TYR666-UNK:N13 
Berry 
flavonoids 
Cyanidin 
 
 
1.31 ± 0.34 e 
 
 
5 
 
 
-5.95 
 
 
43.43 
TRP563:HN-UNK:O15 
ALA564:HN-UNK:O18 
UNK:H7-TYR48:OH 
UNK:H11-GLY741:O 
π-π 
UNK-B:TRP629 
UNK-B:TRP629 
UNK-B:TRP629 
UNK-B:TRP629 
Cyanidin-
3-glucoside 
0.42 ± 0.09 ef 8 -6.35 22.33 PHE357:HN-UNK:O20 
ARG358:HH22-
UNK:O17 
ARG358:HE-UNK:O27 
GLU361:HN-UNK:O9 
ARG669:HH21-
UNK:O31 
UNK:H1-PHE208:O 
UNK:H6-GLU361:OE1 
UNK:H20-GLU206:OE1 
UNK:H20-UNK:O26 
π-cation 
UNK-HIS126:NE2 
UNK-
ARG358:NH1 
UNK-
ARG358:NH2 
UNK:ARG358:NH
1 
 
Malvidin 0.74 ± 0.16 
ef
 3 -6.36 21.64 ARG356:HH11-
UNK:O13 
ARG356:HH11-
UNK:O17 
ARG358:HE-UNK:O11 
ARG585:HH-UNK:O14 
UNK:H6-ILE405:O 
UNK:H14-GLU206:O 
π-π 
UNK-PHE357 
UNK-PHE357 
π-Cation 
UNK-
ARG669:NH2 
UNK-
ARG669:NH1 
UNK-
ARG669:NH2 
                                                             
9
 All computational work was conducted by Dr. Junfeng Fan. 
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Table 7.3 (contd.)      
Citrus 
flavnoids 
Luteolin 
 
 
0.12 ± 0.01 f 
 
 
4 
 
 
-6.26 
 
 
25.83 
ARG358:HE-UNK:O10 
GLU361:NH-UNK:O1 
UNK:H1-GLU361:OE1 
UNK:H6-GLU205:O 
UNK:H7-SER209:OG 
UNK:H9-UNK:O7 
π-cation 
UNK-
ARG669:NH2 
π-Sigma 
UNK-PHE357:CB 
Apigenin 0.14 ± 0.02 
f
 3 -6.14 31.77 ARG356:HH11-
UNK:O10 
ARG358:HE-UNK:O5 
GLU361:HN-UNK:O14 
UNK:H4-UNK:O8 
UNK:H5-GLU205:O 
UNK:H10-GLU205:O 
UNK:H10-SER209:OG 
π-cation 
UNK-
ARG669:NH2 
 
Quercetin 2.92 ± 0.68 
d
 5 -6.33 23.03 ARG356:HN-UNK:O5 
ARG356:HN-UNK:O3 
UNK:H2-UNK:O4 
UNK:H3-ARG358:O 
UNK:H4-GLU206:O 
UNK:H5-SER209:OG 
π-cation 
unk-ARG358:NH2 
UNK-
ARG358:NH2 
UNK-
ARG669:NH1 
UNK-
ARG669:NH2 
Kaempferol 0.49 ± 0.02
ef
 4 -6.62 13.99 SER209:HG-UNK:O21 
ARG356:HN-UNK:O8 
PHE357:HN-UNK:O13 
ARG358:HN-UNK:O13 
UNK:H3-UNK:O8 
UNK:H4-ARG358:O 
UNK:H5-GLU361:OE2 
UNK:H10-SER209:OG 
π-cation 
UNK-
ARG356:NH1 
UNK-
ARG358:NH1 
UNK-
ARG358:NH2 
 
Flavone 0.17 ± 0.01 
f
 0 -6.64 13.57 No hydrogen bonds No π interactions 
Hesperetin 0.28 ± 0.07
ef
  -6.85 9.57 ARG358:HH22-UNK:O2 
ARG669:HH21-UNK:O5 
UNK:H2-GLU206:OE1 
UNK:H1-UNK:O2 
UNK:H3-ARG358:O 
π-cation 
UNK-
ARG358:NH1 
 
Naringenin 0.24 ± 0.03
ef
 3 -6.83 9.9 ARG356:HH11-
UNK:O20 
ARG358:HE-UNK:O10 
GLU361:HN-UNK:O19 
UNK:H11-GLU361:OE1 
UNK:H12-UNK:O11 
UNK:H10-SER209:OG 
π-cation 
UNK-arg358:NH1 
UNK-
ARG358:NH2 
 
 
Eriocitrin 10.36 ± 
0.09a 
9 -9.07 225.9
6 
ARG356:HH11-UNK:O8 
PHE357:HN-UNK:O10 
ARG358:HN-UNK:O10 
ARG358:HE-UNK:O14 
ARG429:HH22-
UNK:O23 
ARG669:HH21-
UNK:O30 
UNK:H5-ARG358:O 
UNK:H12-TYR585:OH 
UNK:H28-TYR585:OH 
UNK:H32-CYS551:O 
UNK:H20-GLU206:O 
UNK:H15-GLU206:O 
π-cation 
UNK-
ARG356:NH1 
Soy isoflavone 
Genistein 
 
 
0.25 ± 0.06ef 
 
3 
 
-6.5 
 
17.31 
ARG356:HN-UNK:O12 
PHE357:HN-UNK:O10 
ARG358:HN-UNK:O10 
π-π 
PHE357-UNK 
π-cation 
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Genistein  
 contd. 
UNK:H4-ARG358:O 
UNK:H4-UNK:O10 
UNK:H5-GLU36:OE1 
UNK:H10-GLU206:O 
UNK-
ARG356:NH1 
UNK-
ARG358:NH1 
UNK-
ARG358:NH1 
UNK-
ARG669:NH1 
Grape 
flavonoid 
Resveratrol 
 
0.0006 ± 
0.0004 g 
 
3 
 
-6.54 
 
 
 
15.96 
ARG669:HH21-UNK:O7 
UNK:H12-SER630:OG 
UNK:H5-SER209:OG 
UNK:H4-GLU206:O 
 
 
Other 
flavonoids 
EGCG  
 
10.21 ± 
0.75a 
 
8 
 
-4.39 
 
604.9
1 
GLN553:HN-UNK:O32 
UNK:H8-GLU206:OE1 
UNK:H11-TYR666:OH 
UNK:H15-TYR662:OH 
UNK:H15-TYR585:OH 
π-π 
PHE357-UNK 
PHE357-UNK 
π-cation 
UNK-HIS740:NE2 
Gallic acid 
 
 
 
 
 
 
Caffeic acid 
4.65 ± 0.99 b 
 
 
 
 
 
 
3.37 ± 0.14cd 
3 
 
 
 
 
 
 
3 
-3.96 
 
 
 
 
 
 
-5.23 
1.25 
 
 
 
 
 
 
147.6
6 
ARG356:HH11-
UNK:O11 
PHE357:HN-UNK:O7 
ARG358:HN-UNK:O7 
TRY585:HH-UNK:O10 
UNK:H3-ARG358:O 
UNK:H5-ILE405:O 
UNK:H6- ILE405:O 
ARG358:HE-UNK:O13 
ARG358:HH22-
UNK:O12 
ARG669:HH21-UNK:O9 
UNK1:H6-GLU206:OE1 
UNK:H7-GLU206:OE1 
π-cation 
UNK-
ARG356:NH2 
 
 
 
 
 
π-π 
PHE357-UNK 
 
Table 7.3 (contd.)          
 1 IC50 values were determined from at least two independent duplicates done in triplicate for each of 
the concentrations tested. Concentrations (μM) were calculated based on the molecular mass of each pure 
compound. Values are means ± SEM. Means with different letters in each column are significantly different 
for DPP-IV (p < 0.05). 
2 
Ki values were obtained from computational docking as indicated in Materials and 
Methods section. 
3 
UNK refers to phenolic compound or diprotin A. 
 
Of the sixteen effective phenolic compounds, three had IC50 values higher than diprotin A 
(4.21 ± 2.01 μM) including eriocitrin (IC50 value of 10.36 ± 0.09 μM), EGCG (10.21 ± 0.75 μM), 
and gallic acid (4.65 ± 0.1 μM). However, IC50 values of the other thirteen compounds were 
lower than that of diprotin A, indicating that less of these compounds was needed to inhibit DPP-
IV. These thirteen phenolics could be divided into three categories according to the results of 
statistical differences on their DPP-IV inhibitory effect: less active with high IC50 values (1.31–
3.37 μM), intermediate activity with IC50 values of 0.24–0.74 μM, and very high activity with 
low IC50 values (0.0006–0.17 μM). The phenolic compounds with high IC50 values were 
 149 
 
cyanidin, quercetin, and caffeic acid; the ones with intermediate activity were naringenin, 
hesperetin, cyanidin-3-glucoside, kaempferol, and malvidin. The four phenolics with very high 
activity included resveratrol, luteolin, apigenin, and flavone. IC50 value of resveratrol had the 
highest DPP-IV inhibitory activity among all of the compounds tested (P < 0.05). 
Resveratrol and flavone inhibited DPP-IV activity in a competitive manner, while luteolin and 
apigenin inhibited noncompetitively 
To examine whether the most potent phenolic compounds, resveratrol, luteolin, apigenin 
and flavone, inhibited DPP-IV through interaction with the active site of the enzyme, we tested 
the enzyme kinetics. The inhibitory manner of the flavonoids was determined through generating 
a Lineweaver-Burk plot (Figure 7.1). As noted in Figures 7.1(a) and 7.1(d), both the slope and 
the x-intercept were changed by the addition of inhibitors, but there was no effect on the y-
intercept. This is the definition of linear competitive inhibition. Therefore, resveratrol (Figure 
7.1(a)) and flavone (Figure 7.1(d)) inhibited DPP-IV activity in a competitive manner. The 
values were calculated to be 0.2 ± 0.01 μM for resveratrol and 18.6 ± 0.3 μM for flavone. As for 
luteolin and apigenin (Figures 7.1(b) and 7.1(c)), both the slope and the y-intercept were 
changed by the added inhibitors, but there was no effect on the x-intercept. Therefore, luteolin 
and apigenin noncompetitively inhibited the enzyme, with Ki values at 4.9 ± 0.2 μM and 7.9 ± 
1.4 μM, respectively. 
Diprotin A and natural phenolic compounds inhibit DPP-IV activity by binding tightly into the 
active site of the enzyme 
Binding pose of diprotin A, resveratrol and flavone in the DPP-IV active site is indicated 
in Figures 7.2 and 7.3, showing that these three compounds interact closely with key residues of 
sites S1, S2 and S3 within the active pocket.   
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Figure 7.1: Inhibition kinetics of porcine dipeptidyl peptidase-IV (DPP-IV) by resveratrol (a), 
luteolin (b), apigenin (c), and flavone (d). Different concentrations of the flavonoids (0, 5, and 
10 μg/mL for luteolin, apigenin, and flavone and 0, 0.25, and 0.5 μg/mL for resveratrol) were 
incubated in the presence of various concentrations of Gly-Pro-AMC (0–60 μM) as substrate. Initial 
rates of the reaction were measured, and the results are expressed as a Lineweaver-Burk plot. Data 
are expressed as the mean of four independent experiments. 
 
Figure 7.2: Key interactions of diprotin A (A1, A2) with active sites of DPP-IV enzyme. Binding 
of diprotin A (A1, grey) in the DPP-IV active site is indicated (surface view: blue), wherein it interacts 
closely with key residues of active sites S1, S2, and S3. Residues with pink circles indicate hydrogen 
bond, or ionic or polar interactions; residues with green circles indicate Van der Waals interactions. The 
arrows indicate hydrogen bonds to side chain residues in blue and backbone residues in green. 
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Figure 7.3: Key interactions of resveratrol (A1, A2), flavone (A1, A3), luteolin (B1, B2), apigenin 
(B1, B3), quercetin (C1, C2), and genistein (C1, C3) with active sites of DPP-IV enzyme. Binding 
pose of resveratrol (A1, green) and flavone (A2, yellow) in the DPP-IV active site is indicated (surface 
view: blue), wherein two compounds interact closely with key residues of active sites S1, S2, and S3. 
Binding pose of luteolin (B1, green), apigenin (B1, yellow), quercetin (C1, green) and genistein (C1, 
yellow) in the DPP-IV binding site is indicated, wherein these flavonoids interact closely with the key 
residues of sites S2, and S3. Residues with pink circles indicate hydrogen-bond, or ionic or polar 
interactions, residues with green circles indicate Van der Waals interactions. The arrows indicate 
hydrogen bonds to side chain residues in blue and backbone residues in green. 
 
Diprotin A is a potent DPP-IV inhibitor with Ile-Pro-Ile sequence commonly used as a 
reference compound. Figure 7.2 shows the binding mode of diprotin A with DPP-IV. The 
binding site of diprotin A is located at the S1, S2 and S3 sites (Figure 7.2(A1)). In the S2 site 
(Figure 7.2(A2)), the N-terminal amino group of diprotin A is hydrogen-bonded to the carboxyl 
oxygens of two Glu residues (Glu205 and Glu206). Furthermore, the N-terminal amino group 
forms a π interaction to the Tyr666. The carbonyl oxygen of Ile-1 of diprotin A forms an 
electrostatic interaction with Tyr662, Arg125, and Asn710 residues. Pro-2 of diprotin A is 
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located in the S1 site and forms a hydrophobic interaction with the phenol rings of Tyr666, and 
Tyr547. The carbonyl oxygen of Ile-3 of diprotin A also forms double hydrogen bonds to Tyr547 
and Tyr666. In the S3 site, Van der Waals interactions are also seen between diprotin A and 
Ser209 and Phe357 residues of DPP-IV. These observations agree with the reported results 
obtained from X-ray crystal structure complex of DPP-IV and diprotin A [20]. 
The overlay of binding poses of resveratrol (green) and flavone (yellow) in the DPP-IV 
active site is shown in Figure 7.3(A). As observed in Figure 7.3(A1), resveratrol and flavone 
dock very well into all three active sites S1, S2, and S3 of DPP-IV. Resveratrol showed 
hydrogen bonding of 4′-OH-, 3′-OH-, and 5′-OH-group with hydroxyl of side chain of Ser630 
(S1 pocket) and Ser209 (S3 pocket). Hydrogen bonds were also seen between 5′-OH of 
resveratrol, NH2-group of side chain of Arg 669 residues, and C=O groups of side chains of 
Glu206 (S2 pocket) (Figure 7.3(B2)). At the same time, electrostatic interactions were also 
observed between resveratrol and S1 pocket (His740, Tyr631, Ser630, His125), S2 pocket 
(Glu205, Glu206), S3 pocket (Ser209), and Arg669 of DPP-IV. 
No hydrogen bonds were seen between flavone and amino acids in the pockets of DPP-
IV (Figure 7.3(A3)). However, electrostatic interactions between flavone and amino acid 
residues in S1 pocket (Tyr547, Ser630, Asn710, and His740), S2 pocket (Arg125, Glu205), and 
Van der Waals interactions between flavone and amino acid residues in S1 pocket (Tyr631, 
Val656, Tyr666, Val711), S2 pocket (Glu206) and S3 pocket (Phe357), allowed flavone to 
anchor in the active sites of DPP-IV. 
The overlay of binding poses of luteolin (green) and apigenin (yellow) in the DPP-IV 
active site is also shown in Figure 7.3(B). As shown in Figure 7.3(B1), luteolin and apigenin had 
almost identical binding modes with the active sites of DPP-IV with each having ring B and C 
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docked into sites S2 and S3. Three common features of binding with DPP-IV exist between both 
flavonoids (Figures 7.3(B2) and 7.3(B3)). Firstly, hydrogen bonds and π-interactions played 
important roles in docking both the flavonoids into the active pockets S2 and S3 of DPP-IV 
enzyme. In the S2 pocket, the B ring 5′-hydroxyl of luteolin formed a hydrogen bond with 
hydroxyl group of side chain of Ser209 (S3 pocket), while the 4′-hydroxyl group on B ring of 
apigenin forms a similar hydrogen bond within the S3 pocket. Luteolin also showed H-bonding 
by B ring 4′-hydroxyl with C=O groups of side chains of Glu205 (S2 pocket). Secondly, in the 
S3 pocket, both compounds formed a hydrogen bond of the C ring 1′-oxygen with the NH of 
Arg358’s guanidine side chain. H-bonding of the A ring 8′-hydroxyl with C=O groups of side 
chains of Glu361 favors strong binding of both flavonoids to the DPP-IV active site. A third 
common feature of both flavonoids was shown by π-cation interactions of ring B and the NH2 of 
Arg669. Additional features of each flavonoid added to their unique docking within the active 
site of DPP-IV. A hydrogen bond between the A ring 5′-hydroxyl of apigenin and the NH of 
Arg361’s guanidine side chain also enhanced the docking of apigenin and DPP-IV. For luteolin, 
a π-sigma interaction was also seen between the side chain of Phe357 and C ring of luteolin (S3 
pocket). 
Quercetin and genistein had a comparable binding position to luteolin and apigenin 
(Figure 7.3(c)). Hydroxyl groups in A and B rings were also important for quercetin and 
genistein to bind into the S2 and S3 sites (Figures 7.3(C2) and 7.3(C3)). At the same time, π-
interactions between these flavonoids and Arg358 and Arg669 also contributed to the tethering 
of the two flavonoids to the active sites. All hydrogen bonds formed between phenolic 
compounds and DPP-IV are indicated in Table 7.3. 
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The binding energies obtained by computational docking analyses were compared among 
the compounds tested (Table 7.3). Gallic acid had the highest binding energy (−3.96 kcal/mol), 
while diprotin A had the lowest binding energy (−7.31 kcal/mol). IC50 values of the phenolic 
compounds that were found to inhibit DPP-IV activity correlated with their binding energies (𝑟 = 
0.67, p < 0.05). Both a lower IC50 value and lower binding energy indicate stronger inhibitory 
potency. The inhibition constant (Ki) obtained by computational docking analyses is also shown 
in Table 7.3. The Ki values of these phenolic compounds varied from 1.25 μM for gallic acid to 
604.91 μM for EGCG. A highly significant correlation existed between Ki values and IC50 values 
(r = 0.82, p = 0.0002). Significant correlations were also found between Ki values and binding 
energies (r = 0.56, p < 0.05), and between Ki values and number of hydroxyl group (r = 0.56, p < 
0.05). 
 
Discussion and conclusions 
This study showed that ANC from berry wine and a variety of other phenolic compounds 
commonly present in fruits and vegetables had strong DPP-IV inhibitory effect in vitro and in 
silico. Computational docking analyses also showed for the first time that these natural phenolics 
could inhibit DPP-IV activity by binding tightly into the active sites of the enzyme. The 
biological activities, stability, and bioavailability of anthocyanins depend on their chemical 
structures. Blends were created to generate a mixture of potentially bioactive compounds 
commonly present in both blueberries and blackberries after fermentation, which can be 
optimized based on the characterization and potential benefit. 
Previous studies on wine compounds and biological activity indicated that it is not the 
presence of a single compound that is responsible for beneficial effects such as antioxidant 
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capacity or ability to reduce inflammation, but rather involves several phenolic compounds. 
Major contributions are from compounds such as transresveratrol as well as minor contributions 
from cinnamic and hydroxycinnamic acids, cyanidin, and some phenolic acids [23]. The 
combination of these phenolic compounds within the blends produced from fermented blueberry 
and blackberry provided a unique potential for inhibition of DPP-IV. Therefore, while the 
inhibitory effects demonstrated by the anthocyanin-enriched blends are primarily due to the 
major anthocyanin components, the presence of other compounds also influenced the 
demonstrated potency. 
In general, anthocyanins may protect beta-cells, increase the secretion of insulin, reduce 
the digestion of sugars in the small intestine, and thereby have multiple and simultaneous 
antidiabetic effects. Inhibitors of DPP-IV have been found to prevent pancreatic beta cell 
destruction in mice [24]. Extracts enriched in flavonoids have been seen to inhibit plasma DPP-
IV [25]. 
The primary anthocyanin in the blackberry blends was delphinidin, which has previously 
shown potency to inhibit enzymatic activity of a glyoxalase I, which is being investigated as a 
target for prevention of cancer. Compared to other anthocyanins found in berries, (cyanidin and 
pelargonidin), delphinidin had the most potent DPP-IV inhibitory effect, suggesting the 
importance of interactions of the hydroxyl groups on the B ring of anthocyanins. Further, binding 
modes indicated that the hydroxyl groups located at the R1 position greatly contribute to 
inhibitory potency and specificity to the binding site [26]. This previous study, along with the 
results from our research, indicated that the anthocyanin delphinidin can form several hydrogen 
bonds to several amino acids due to its hydroxyl groups at R1 position. 
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Our previous study also showed that the blueberry-blackberry wine contained high 
amounts of total anthocyanin [17]. However, correlation was not seen between DPP-IV 
inhibitory effect and anthocyanin concentration in ANC fractions (P > 0.05) from berry wines. 
For example, ANC3, ANC4, and ANC5 from blackberry wine were of similar IC50 values to 
inhibit DPP-IV, while the anthocyanin concentration was almost 4 times higher in ANC3 than in 
ANC4 and ANC5. Additionally, ANC4 and ANC5 had the same IC50 values and ANC 
concentration, but their anthocyanin compositions differed. These results indicate that 
delphinidin-3-arabinoside, as the major anthocyanin identified in blackberry blends, could 
contribute to the DPPIV inhibition, however, other ANC may also play an important role in 
DPP-IV inhibition. Therefore, DPP-IV inhibitory effect of ANC could depend on not only the 
concentration but the composition and structures of flavonoids present. More research should be 
conducted to clarify the relationship between DPP-IV inhibitory effect and anthocyanin structure 
of ANC from berries. 
Phenolic compounds are widely recognized for their ability to improve diabetic 
conditions by decreasing blood glucose levels [27]. It is interesting that most of the ANC 
fractions showed potent DPP-IV inhibitory activity, with the lowest IC50 value from blackberry 
wine. Grape seed-derived procyanidins (GSPE) were also able to inhibit recombinant human 
DPP-IV activity, achieving around 70% inhibition at 200 mg/L of GSPE [12]. In order to 
compare with the GSPE, the percentage inhibition was given in this study as IC50 values. The 
concentrations of all ANC from blackberry wine for achieving the same inhibitory effect on 
DPP-IV were less than 200 mg/L. Especially for ANC3 from blackberry wine, the concentration 
of 41.9 mg/L could lead to around 70% inhibition of DPP-IV activity. These results suggest that 
ANC from blueberry and blackberry wine have strong DPP-IV inhibitory activity. The efficacy 
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of the ANC to inhibit DPP-IV enzyme activity at a rate comparable to diprotin A and GSPE 
indicated that ANC may be able to act as naturally occurring DPP-IV inhibitors. 
Many kinds of natural flavonoids exist in plants but only a few have been reported for 
DPP-IV inhibitory effect [12, 13]. In the present study of twenty-seven phenolic compounds 
commonly present in berries, citrus, soybeans, and other plant commodities, most flavonoids 
were determined to have DPP-IV inhibitory effect. It is interesting that most of the flavonoids 
tested in the present study showed lower IC50 values and therefore were more potent than the 
reference inhibitor standard diprotin A. Resveratrol, luteolin, apigenin and flavone showed the 
most potent DPP-IV inhibitory activity due to their lowest IC50 values. In particular, this study 
demonstrated that resveratrol was the most potent DPP-IV inhibitor with IC50 value at 0.6 nM 
exhibiting even lower values than sitagliptin (18 nM) and vildagliptin (3.5 nM) [10], two current 
pharmacologic drug inhibitors of DPP-IV. A summary of current foods and food components in 
the prevention of diabetes by Thomas and Pfeiffer [16] has indicated that the potential evidence 
for phenolic compounds is not conclusive; however, resveratrol was found to have a beneficial 
effect on protecting beta cells, which may be due to its ability to modulate the activity of DPP-
IV. 
DPP-IV has three binding pockets/active sites (S1, S2 and S3). The specificity pocket S1 
is composed of the side chains of catalytic triad (Ser630, Asn710, and His740), which are 
involved in strong hydrophobic interactions [10]. The cavity near Glu205, Glu206 and Tyr662 
residues is referred to as the S2 pocket. The S3 pocket of DPP-IV consists of Ser209, Arg358, 
and Phe357 [21]. The outside position of the S3 pocket in DPP-IV allows larger groups access to 
the site; on the other hand, the inside position of the S3 pocket favors smaller groups [28]. The 
four most potent compounds, resveratrol, luteolin, apigenin and flavone, had low Ki values to 
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inhibit DPP-IV, which indicated that they had high affinity to the active sites of DPP-IV. The 
kinetic analysis showed that resveratrol and flavone inhibited DPP-IV activity in a competitive 
manner, while luteolin and apigenin were in a noncompetitive manner. Further computational 
docking analyses are consistent with the tested inhibitory manner of the phenolic compounds. 
Docking analysis showed that resveratrol and flavone bound well into all the three sites S1, S2 
and S3 of DPP-IV, while luteolin and apigenin could only bind into S2 and S3 pockets. Although 
luteolin and apigenin could dock into S2 and S3 pockets, the kinetic analysis showed that they 
inhibited DPP-IV in a noncompetitive manner. We presume that the binding of luteolin and 
apigenin into S2 and S3 may lead to DPP-IV conformational changes, or changes in the side 
chain of amino acid residues of DPP-IV, and the catalytic activity will be decreased when the 
substrate is also bound. 
We found that apigenin had a similar effect as resveratrol to directly inhibit DPP-IV 
activity, and genistein also exhibited a potent DPP-IV inhibitory effect. In the present study, 
most of the glycosylated flavonoids with two sugar groups, including naringin, rutin, narirutin, 
hesperidin, and neohesperidin, had no DPP-IV inhibitory effect. One explanation is that 
conjugation of bulky sugar groups to the flavonoid core structure could sterically hinder binding 
to the active sites within DPP-IV, thus resulting in no inhibitory capacity of the tested 
flavonoids. The computational docking analyses further supported this phenomenon. However, 
cyanidin-3-glucoside, which has been identified as the major ANC in different blackberry 
species [29], showed no statistical difference (P > 0.05) on DPP-IV inhibitory activity (IC50, 
 μM) than cyanidin (IC50, ) and malvidin (IC50, ). Considering ANC-enriched fractions from 
blueberry and blackberry wines contain a mixture of flavonoids with only one sugar group, 
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flavonoids with monosaccharide groups may have better DPP-IV inhibitory effects than 
flavonoids with more sugar groups due to less steric hindrance. 
Flavone, luteolin, and apigenin have the same flavone core structure. However, flavone 
could dock into all three active sites of DPP-IV, while luteolin and apigenin could dock into only 
two of them. Computational docking showed comparably strong binding of luteolin and apigenin 
due to hydrogen bonds of ring B hydroxyls with residue Ser209 in the S3 pocket, for ring C 1′-
oxygens with the NH of guanidine side chain of Arg358 in the S3 pocket, and for ring A 8′-
hydroxyls with C=O groups of side chains of Glu361. These features also exist in the binding of 
other citrus flavonoids (including kaempferol, quercetin, hesperetin, and naringenin) to DPP-IV, 
which have the same flavone core structure. Even the binding of genistein, a soy isoflavone, to 
DPP-IV also had these features. Therefore, hydroxyls in these flavonoids are important to dock 
into active sites of DPP-IV with the same binding modes. Furthermore, the formation of π-
interaction between A or B ring of citrus flavonoids and Arg669 or Arg358 also favors the 
binding of citrus flavonoids into S2 and S3 sites. Flavone has no hydroxyl residues capable of 
hydrogen bonding with residues in S2 and S3 pockets with the same binding modes as 
flavonoids like luteolin. Therefore, although it could dock into all the three pockets of DPP-IV, 
flavone had a higher Ki value due to absence of hydroxyl groups. 
Significant correlations were seen between IC50 values of these flavonoids and their 
binding energies and values determined computationally in the present study. In the docking 
studies, if a compound shows lower binding energy compared to the standard, it proves that the 
compound has higher activity [30]. These results indicated that more negative binding energy 
and smaller Ki result in tighter binding, and then more potent inhibitory effect. Meanwhile, a 
significant correlation also exists between the Ki values determined in silico and the number of 
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hydroxyl groups of flavonoids (r = 0.56, p < 0.05), which indicated that more hydroxyl groups of 
flavonoids can result in higher inhibition constant and therefore higher IC50 value, indicating less 
affinity to bind the active site. This could explain why quercetin with five hydroxyls has a higher 
IC50 value (less potent) than the other citrus compounds, despite sharing the same flavone core 
structure. IC50 values of citrus compounds were also found to be significantly correlated with 
their numbers of hydroxyls. 
We obtained Ki values using the computational analyses as well as experimentally. Ki 
values determined with the computational analyses were calculated from the binding energy. 
However, the binding energy is designed to score and rank conformations of ligand and protein 
and not designed to give accurate binding energy. Therefore, Ki values generated from Autodock 
correlated with free binding energies significantly (r = 0.56, p < 0.05) but differed from the 
experimental Ki values. 
In conclusion, our study demonstrated that ANC isolated from blueberry-blackberry wine 
blends and a variety of other phenolic compounds commonly present in citrus, berry, soy, and 
other plants could strongly inhibit DPP-IV activity. Resveratrol and flavone were competitive 
inhibitors which could dock into all the three active sites, while luteolin and apigenin bound to 
DPP-IV in a noncompetitive manner. Results obtained from this study further support the 
efficacy of flavonoids as naturally occurring DPP-IV inhibitors. 
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CHAPTER 8 
ANTHOCYANINS FROM FERMENTED BERRY BEVERAGES INHIBIT 
INFLAMMATION-RELATED ADIPOSITY RESPONSE IN VITRO
10 
 
Abstract 
Increased adiposity has been associated with macrophage infiltration into the adipose tissue, 
which in turn leads to obesity co-morbidities, including type 2 diabetes. The objective of this 
study was to evaluate the effect of anthocyanin (ANC)-enriched fractions from blackberry: 
blueberry beverages on inflammation and adipogenesis in an in vitro model of inflammation 
mimicking the pathologic interaction between adipocytes and macrophages. Blends ANCs 
inhibited secretion of nitric oxide (17.5%), TNF-α (89.4%) and phosphorylated p65 NFB 
(52.1%) in lipopolysaccharide-induced RAW 264.7 macrophages after 24 h. Blends reduced 
intracellular fat accumulation (28.2%) when applied during 3T3-L1 adipocyte differentiation, 
and inhibited isoproterenol-induced lipolysis (18.6%) of mature 3T3-L1 cells. In addition, Blend 
ANCs restored adiponectin-blunted gene expression induced by TNF-α treatment (18.2%), and 
reduced the glycerol release (15.9%) induced by LPS-induced macrophage conditioned media 
(CM) in adipocytes. Furthermore, blends slightly restored the insulin-induced glucose uptake of 
adipocytes, blunted by the CM treatment. In conclusion, anthocyanins from blueberry and 
blackberry dealcoholized fermented beverages are potential inhibitors of inflammation-related 
adiposity response and sensitizers of insulin signaling in adipocytes. 
Keywords: adiposity, anti-inflammatory, anthocyanins, diabetes, fermentation. 
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 (Publication: Garcia-Diaz D, Johnson MH, de Mejia EG. (2015) Anthocyanins from blueberry-
blackberry fermented blends inhibit the pathogenic interaction between adipocytes and 
macrophages. Journal of Medicinal Foods 18(4):489-96. doi:10.1089/jmf.2014.0039.)
 
Reprinted 
with permission from Mary Ann Liebert, Inc. My roles were to prepare and provide the anthocyanin 
blends for cell culture, to conduct the detection of secreted inflammatory proteins with Western blot and 
ELISA, assist with the analysis and interpretation, and help to prepare and revisise the manuscript. 
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Introduction 
Obesity is an important health issue negatively affecting our society [1]. Excessive body 
fat accumulation initiates several associated clinical manifestations, such as type 2 diabetes 
(T2D) and cardiovascular disease, among others [2].  
Obesity is often accompanied by a low-grade inflammation in the adipose tissue [3]. 
Adipokines, cytokines, and other factors produced by this tissue during adipose hyperplasia 
could be responsible for the presence and prevalence of inflammation [4]. Several inflammatory 
proteins derived from adipose tissue, such as tumor necrosis factor-alpha (TNF-α), interleukin-6 
(IL-6), monocyte chemoattractant protein-1 (MCP-1), and nitric oxide (NO) correlates with 
increased body adiposity [5]. This may lead to inflammatory macrophage infiltration into the 
adipose tissue. Since the crosstalk between macrophages and adipocytes may negatively 
influence cellular insulin sensitivity [6], this consequently aggravates the obesity state [7]. 
Therefore, a reduction in inflammatory status by anti-inflammatory agents could constitute a 
potential approach to reduce adverse obesity-associated consequences. 
Dietary flavonoids have been linked to anti-inflammatory pathways [8], and several 
berries or berry compounds have been investigated for their anti-inflammatory properties [9-11]. 
Blueberries (Vaccinium corymbosum) and blackberries (Rubus spp.) are important sources of 
anthocyanins; water-soluble pigments responsible for the colors of fruits and vegetables [12]. It 
has been reported that the consumption of these phytochemicals exerts several positive health 
effects, particularly due to their high antioxidant capacity [8,13]. Research has shown that 
fermented juices and wines from berries inhibit inflammatory protein production or expression 
more than their unfermented counterparts [14-17]. The role of phenolic compounds, such as 
anthocyanins, in the interaction between the adipose and inflammatory state is not yet fully 
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understood. Therefore, it is important to identify and evaluate specific bioactive phenolic 
compounds from fermented berry beverages on obesity-related inflammation. 
The aim of the present study was to evaluate the effect of anthocyanins extracts, from 
combinations of blueberry-blackberry dealcoholized fermented beverages, on the levels of 
markers of inflammation and adipogenesis in a dual cellular system, mimicking the pathogenic 
interaction between adipocytes and macrophages. The hypothesis was that the addition of 
antioxidant agents such as anthocyanins would lead to a reduction in the inflammatory crosstalk 
between macrophages and adipocytes and thus improve insulin-sensitivity as a potential 
approach to improve obesity-associated adverse consequences.  
Materials and methods 
Materials 
Enriched ANC fractions stored from previous work of our group were utilized for all 
experiments [18]. The rationale for using fermented blends ANCs was that fermentation has been 
seen to increase the phenolic content of fruit juices and their anti-inflammatory effects [14-17]. 
These fractions were obtained from the following blends of blackberry (Bck) and blueberry 
(Blue) wines: 100%Bck:0%Blue, 70%Bck:30%Blue, and 30%Bck:70%Blue. These blend ANCs 
were selected based on their high antioxidant and anti-inflammatory properties and 
chromatographic results at both 520 nm and 280 nm to determine composition of both 
anthocyanins and other phenolic compounds [18]. The blends were made from wines produced 
from Highbush blueberries (Vaccinium corymbosum) and blackberries (Rubus spp.) grown at 
Dixon Springs Agricultural Center in Simpson (Illinois), and fermented with Saccharomyces 
bayanus, as previously described [18,19]. One hundred µM cyanidin-3-glucoside (C3G) 
equivalents were used for cell culture.  
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Murine macrophage RAW 264.7 and pre-adipocyte 3T3-L1 cell lines and Dulbecco’s 
Modified Eagle Medium with L-glutamine (DMEM) were purchased from American Type 
Culture Collection (ATCC) (Manassas, VA, USA). Fetal bovine serum and bovine serum were 
from Invitrogen (Grand Island, NY, USA). 
Rabbit polyclonal antibody (p-p65 NFκB) and mouse monoclonal antibody (actin) and 
their control lysates were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). 
Anti-rabbit and anti-mouse IgG horseradish peroxidase conjugated secondary antibodies were 
from GE Healthcare (Buckinghamshire, UK). 
Cell culture
11
 
Mouse pre-adipocytes 3T3-L1 and RAW264.7 mouse macrophages (ATCC, Rockville, 
USA) cell lines were maintained at 37 ºC in a humidified atmosphere containing 5% CO2. 
Experiments were conducted as follows:  
I. RAW264.7 mouse macrophages were seeded in 6-well plates at 70,000 cells/cm
2
 density, pre-
treated with each blend ANC (100 µM C3G) for 1 h, and then stimulated with 
lipopolysaccharides (LPS; 1 µg/mL) for 24 h. Cells were collected and processed 
immediately according to western blot sample preparation. Supernatants were collected and 
stored at -80ºC for their use as conditioned media (CM) or until secretion analyses were 
performed.  
II. Pre-adipocytes 3T3-L1 cells were cultured in 6-well plates in DMEM containing 4.5 g/L 
glucose and 10% calf serum. Two days after full confluence, cells were differentiated by 
incubation with 0.5 mM isobutylmethylxanthine, 1 μM dexamethasone, and 10 μg/mL 
insulin in 4.5 g/L mM glucose DMEM supplemented with 10% fetal bovine serum, using a 
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 For this publication, Dr. Diego Garcia was responsible for the initial design of the co-culture experiment, cell 
culture maintenance and conducted all of the experiments involving the adipocytes.  
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previously described protocol [20]. To determine the impact on adipogenesis, blend ANCs 
were added at each media re-feed until adipocytes reached 8-10 days of differentiation. Fully 
differentiated adipocytes were fixed and stained for triglyceride determination as described 
below, or were incubated for 24 h in the presence or absence of 10 nM isoproterenol (IP) and 
each blend ANC for lipolysis assays. IP was used as a model of catecholamine-induced 
lipolysis. Cells were collected for gene expression assays and supernatants were collected 
and stored at -80ºC for glycerol determination.  
III. Fully differentiated adipocytes were incubated for 24 h in presence or absence of 
macrophage CM (obtained as described in I) for 24 h or 4 ng/mL TNF-α (Sigma-Aldrich 
Company, St. Louis, USA). Cells were pre-treated for 1 h with each blend ANCs and then 
incubated with TNF-α. Cells and supernatants were collected and stored at -80ºC until further 
analysis for glycerol release, gene expression and secretion of MCP-1 and adiponectin.  
IV. Fully differentiated adipocytes were incubated for 96 h (replacing media every 24 h) with 
CM (obtained as described in I) for evaluating modulation of insulin-sensitivity (by 
incubating with 100 nM insulin). Supernatants were collected and stored at -80ºC for 
determination of glucose uptake. 
Cell viability assay 
Cell viability was measured with the lactate dehydrogenase (LDH) Cytotoxicity Assay at 
24 h according to manufacturer`s instructions (Cayman Chemical Company, Ann Arbor, USA). 
Western blot 
Western blotting was performed by loading 20 µg protein from cell lysates in 4–20% 
Tris–HCl gels (BioRad, Hercules, USA) for SDS-PAGE as described previously [18]. Proteins 
were transferred to a PVDF Hybond-P membrane (GE Healthcare, Buckinhamshire, UK), 
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blocked, washed, and subsequently incubated with either p-Akt or p-p65 NFκB primary antibody 
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Membranes were washed again and incubated 
with anti-mouse (for p-Akt) or anti-rabbit (for p-p65 NFκB) IgG horseradish peroxidase 
conjugate secondary antibody. The expression of proteins was visualized using 
chemiluminescent reagent (GE Healthcare, Pittsburgh, PA) following manufacturer’s 
instructions using a GL 4000 Pro Imaging system (Carestream Health Inc., Rochester NY). 
Adipogenesis assay 
Adipogenesis was determined by measuring triglyceride accumulation through Oil-Red-
O staining, according to a modified protocol [21]. Briefly, the staining solution was prepared by 
dissolving Oil-Red-O (Sigma-Aldrich, St. Louis, USA) in isopropanol (0.5% w/v), then filtered 
and diluted 40% with distilled water. Adipocyte layers were washed with PBS, fixed with 2.7% 
formaldehyde, washed with 60% isopropanol, allowed to dry, and then stained for 30 min with 
Oil-Red-O solution. Wells were washed 4 times with distilled water before quantifying the 
accumulated lipid by eluting the stain from cells with 100% isopropanol and reading the 
absorbance at 540 nm. 
Glycerol release 
Glycerol production, as a measure of adipocyte lipolysis, was calculated as the increase 
of glycerol in the medium from adipocytes after 24 h using a glycerol assay (RANDOX 
Laboratories, Crumlin, United Kingdom) according to manufacturer indications.  
Nitric oxide release measurement 
The amount of nitrite in supernatant was measured using Griess reagent according to 
manufacturer`s protocol (range of standards = 0.43-65 µM Nitrite) (Sigma-Aldrich Company, St. 
Louis, USA). 
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Gene expression assays
12
 
All procedures were as previously described with modifications [20]. Briefly, total RNA 
was isolated from samples using the RNeasy Mini Kit according to manufacturer instructions 
(QIAGEN, Valencia, USA). First strand cDNA was then obtained using a High-Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems, California, USA). The resultant cDNA was 
amplified with specific probes for mouse MCP-1 and adiponectin (ADIPOQ) in a total volume of 
10 μL. Real-time PCR was performed in an ABI PRISM 7000 HT Sequence Detection System 
following manufacturer's recommendations: 50 ºC for 2 min, 95 ºC for 10 min, and 40 cycles of 
95 ºC for 15 s, and 60 ºC for 1 min. RT-PCR products were analyzed with the SDS 2.3 and the 
RQ Manager 1.2 software (Applied Biosystems). Expression levels of target genes studied (FAS, 
HSL, MCP-1, ADIPOQ) were normalized with the expression of cyclophilin as the selected 
internal control (probe supplied by Applied Biosystems). Fold change between groups was 
calculated using the 2
−ΔΔCt
 method. 
MCP-1, adiponectin and TNF-α secretion analyses 
MCP-1 secretion into culture media was measured following manufacturer’s instructions 
using the MCP-1 Mouse ELISA Kit (Invitrogen, Grand Island, NY, USA), adiponectin using the 
Adiponectin Mouse ELISA Kit (Invitrogen) and TNF-α using the TNF alpha Murine ELISA Kit 
(Abcam Inc., Cambridge, USA). 
Glucose uptake
13
 
Glucose utilization by cells was assessed by measuring the concentration of glucose in 
the medium with the Autokit Glucose from Wako Chemicals (Richmond, USA). After 100 nM 
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 Dr. Diego Garcia conducted the RNA extraction and gene expression assays. 
13
 Dr. Diego Garcia conducted the glucose uptake assays. 
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insulin treatment for 24 h, the amount of glucose in the medium was then subtracted from the 
initial concentration of glucose with previously reported calculations [22]. 
Statistical analyses 
Results are expressed as mean ± standard deviation (SD). All data were evaluated using 
one-way ANOVA, followed by Tukey’s post-hoc test. Association analyses were performed 
using the Pearson correlation coefficient. Significance was determined at p < 0.05. Statistical 
analyses were performed using the GraphPad Prism Software 6.0 (GraphPad Software Inc., San 
Diego, USA). 
 
Results 
Inhibition of macrophage activation 
The 100% Bck and 30%Bck:70%Blue blend ANCs treatment effectively reduced LPS-
induced macrophage activation as measured by NO release (Figure 8.1A). Likewise, LPS-
induced TNF-α release was also significantly inhibited compared to the LPS-stimulated control 
in these same treatment groups (Figure 8.1B), with the greatest reduction by the 
30%Bck:70%Blue treatment (90%)). NO and TNF-α release were highly correlated (r = 0.897, p 
< 0.001). Moreover, the expression of the p-p65 subunit of nuclear factor kappa-B (NFκB) was 
decreased due to treatments with all blend ANCs in comparison to the non-treated LPS-
stimulated control (53.4  25.6%, 47.9  19.5%, 56.8  33.2% for 100%Bck, 70%Bck:30%Blue 
and 30%Bck:70%Blue, respectively, vs 100% LPS control group) (Figure 8.1C). The analysis of 
the relative expression of p-Ser
473
-Akt is presented in Figure 8.1D; no statistical differences 
were observed between LPS-control and blend ANCs treated groups.  
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Figure 8.1. LPS-stimulated macrophage response. The level of macrophage activation by LPS (1 µg/mL) treatment was determined 
by NO release (A), TNF-a secretion (B), relative p-p65 expression (C), and relative p-Akt expression (D) after 24 h, in the presence or 
absence of each blend ANCs (100 µM C3G equivalents). Data (n = 3–6) are expressed as mean – SD. One-way ANOVA followed by 
Tukey’s post hoc test was performed to identify statistical differences. Different letters represent statistical differences of at least p < 
0.05. ANC, anthocyanin; Bck, blackberry; Blue, blueberry; C3G, cyanidin-3-O-glucoside; C, Control; LPS, lipopolysaccharide; NO, 
nitric oxide; phosphorylated-p65, p-p65; SD, standard deviation; TNF-a, tumor necrosis factor-α. 
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Modulation of fat accumulation in adipocytes 
The blend ANCs were tested for modulation of triglyceride accumulation in adipocytes 
during the differentiation period (Figure 8.2A). Cells that were treated with 30%Bck:70%Blue 
blends ANCs had higher lipid accumulation after 14 days than the differentiated control group 
(128.2  12.9% vs. 100  2.5%). Blend ANCs were then analyzed for their effect on IP-induced 
lipolysis of adipocytes as measured by amount of glycerol released (Figure 8.2B). As expected, 
IP treatment caused higher glycerol release. Blend ANCs treatment following IP treatment 
caused a protective effect, with significant reduction of glycerol release by 100%Bck and 
30%Bck:70%Blue (85.3  4.3% and 81.4  6.3%, respectively, vs 100.0  3.2% IP group). No 
significant differences were observed among groups regarding IP-induced FAS mRNA 
expression (Figure 8.2C). In addition, treatment with the 30%Bck:70%Blue blend showed 
highest HSL gene expression in IP-induced adipocytes (124.9  13.2% vs. 100.0  0.9% IP 
group) (Figure 8.2D). 
 
Figure 8.2. Modulation of adipocyte fat accumulation. (A) The level of lipid accumulation was 
determined at the final stage of differentiation (8-10 days) of adipocytes that had previously been 
treated daily with each blend ANC (100 µM C3G equivalents) since day 1. Glycerol release (B), 
and FAS (C), and HSL gene expression (D), were determined in fully differentiated adipocytes 
after a 24 h treatment with isoproterenol (IP) (10 nM), in presence or absence of each blend 
ANC. Data (n=3-6) are expressed as mean ± SD. One-way ANOVA followed by Tukey’s post-
hoc test were performed to identify statistical differences. Different letters represent statistical 
differences of at least p < 0.05. C, Control; D, Differentiated; IP, isoproterenol; Bck, Blackberry; 
Blue, Blueberry. 
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Figure 8.2 (contd.) 
Figure 8.3 shows modulation of lipolysis in adipocytes treated with TNF-α for 24 h, 
measured as glycerol release. A slight but not statistically significant trend toward inhibition of 
TNF-α induced lipolysis was observed by treatment with 30%Bck:70%Blue blend ANCs (90.7  
4.5% vs. 100.0  6.6% TNF-α group), (Figure 8.3A). Adipocytes were also treated for 24 h with 
CM from macrophages that were previously treated with LPS and/or each blend ANCs. 
Treatment with 100%Bck and 70%Bck:30%Blue blends significantly reduced the LPS-induced 
glycerol release (86.1  1.2% and 84.1 
 3.7%, respectively, vs. 100.0  2.7% 
CM-LPS group) (Figure 8.3B).  
Figure 8.3. Modulation of lipolysis by 
inflammatory inducers and fermented 
blend ANCs of fully differentiated 
adipocytes. The lipolysis modulation, 
measured by glycerol release, was 
determined after 24 h treatment in fully 
differentiated adipocytes by 4 ng/ml 
TNF-α (A) and activated macrophage 
conditioned media (CM-LPS)  (B), in 
presence or absence of each blend ANC 
(100 µM C3G equivalents). Data (n=3-
6) are expressed as mean ± SD. One-
way ANOVA followed by Tukey’s 
post-hoc test were performed to 
identify statistical differences. Different 
letters represent statistical differences 
of at least p < 0.05.  
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Inhibition of inflammatory processes involved in obesity 
Figure 8.4 presents the effects of TNF-α and blend ANCs treatments on MCP-1 and 
adiponectin mRNA expression and protein secretion by adipocytes. Regarding MCP-1 gene 
expression, surprisingly 70%Bck:30%Blue group presented significant higher mRNA expression 
(p < 0.05), compared to control (108.8  5.8% vs. 100.0  3.4% TNF-α group) (Figure 8.4A). 
Both gene expression and secretion of MCP-1 were highly correlated (r = 0.919; p < 0.001); 
however, there was no significant difference detected for MCP-1 secretion (Figure 8.4B). 
Treatment with the 30%Bck:70%Blue blend ANCs induced higher ADIPOQ gene expression 
than TNF-α treated cells (118.2  9.7% vs. 100.0  8.3% TNF-α group) (Figure 8.4C). Although 
an important significant correlation was observed between the gene expression and secretion of 
this adipokine (r = 0.722, p < 0.001); however, when adiponectin secretion was evaluated, no 
differences were observed among TNF-α treated groups (Figure 8.4D). The same analysis was 
performed utilizing CM from macrophages previously treated with LPS and/or each berry blend; 
no differences were observed among groups (data not shown). 
Effects on insulin sensitivity of adipocytes  
Glucose uptake of adipocytes after a chronic treatment of macrophage CM-LPS is 
presented in Figure 8.5. As expected, insulin (INS) induced higher glucose uptake. LPS 
treatment reduced the capability of INS to induce glucose uptake in adipocytes. While blend 
ANCs did not have an insulin-sensitizing effect (p > 0.05), from either INS or LPS groups; 
however, when independent t-test was performed among specific groups, significant differences 
were observed between INS control group (100.0  9.5%) vs. INS-CM-LPS (56.0  23.1%) (p < 
0.05), vs. INS-CM-LPS 70%Bck:30%Blue (67.9  10.6%) (p < 0.05), and vs. INS-CM-LPS 
30%Bck:70%Blue (64.0  7.7%) (p < 0.01).  
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Figure 8.4. Gene expression and secretion of inflammatory markers after the blend ANCs treatment. mRNA expression (A) and 
secretion (B) of MCP-1, and mRNA expression (C) and secretion (D) of adiponectin were measured in adipocytes after 24 h of 
treatment with 4 ng/ml TNF-α and/or each fermented blend (100 µM C3G equivalents). Data (n=3-6) are expressed as mean ± SD. 
One-way ANOVA followed by Tukey’s post-hoc test were performed to identify statistical differences. Different letters represent 
statistical differences of at least p < 0.05. C, Control; Bck, Blackberry; Blue, Blueberry. MCP, monocyte chemoattractant protein-1. 
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Figure 8.5. Insulin sensitivity as determined by glucose uptake of adipocytes. Fully 
differentiated adipocytes were treated with activated macrophage conditioned media (CM-LPS) 
and/or each blend ANC (100 µM C3G equivalents) for 4 days. After this period, the glucose 
uptake for 24 h was determined by measuring the concentration of glucose in the medium as 
induced by 100 nM insulin, and then subtracting it from the initial concentration of glucose. Data 
(n=3-6) are expressed as mean ± SD. One-way ANOVA followed by Tukey’s post-hoc test were 
performed to identify statistical differences. Different letters represent statistical differences of at 
least p < 0.05. C, Control; INS, insulin; CM, conditioned media; LPS, lipopolysaccharides; Bck, 
Blackberry; Blue, Blueberry. 
 
Discussion 
In the current study, ANCs from dealcoholized fermented blueberry-blackberry beverage 
blends were applied to macrophages and adipocytes in order to determine their potential to 
counteract the interaction between these two cells in order to reduce the self-perpetuating cycle 
of inflammation and obesity. 
Our results show inhibition of NO and TNF-α secretion from macrophages following 
treatment with 30%Bck:70%Blue ANC, which consists of C3G as its major anthocyanin [18]. 
NO and TNF-α secretion were highly correlated, consistent with LPS-activation of macrophages. 
The fact that the 70%Bck:30%Blue and 100%Bck treatments did not reduce TNF-α secretion 
may be due to their anthocyanin composition; these blends contain mainly delphindin-3-
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arabinoside, with minor amounts of C3G [18]. Previous studies show that C3G is related with 
down-regulation of pro-inflammatory cascades [23]. A decrease in the phosphorylation of p65 
NFκB in macrophages was also observed. In this regard, polyphenols such as resveratrol have 
been able to reduce the phosphorylation of p65 NFκB in adipocytes [24]. Moreover, C3G has 
been reported to have the capability to inhibit LPS-induced expression of inflammatory 
mediators through decreasing I-kappa-B-alpha phosphorylation in human macrophages [23].  No 
differences were observed regarding the relative expression of p-Ser
473
-Akt among LPS-treated 
groups, suggesting that the inflammatory mechanism of activation is most probably not driven 
through the PI3K pathway. These previous reports, along with the results of the present work, 
indicate that phenolic compounds from berry fruits have the ability to reduce the low grade 
inflammatory state associated with obesity due to inhibition of the NFκB-mediated pathway in 
both macrophages and adipocytes. 
A previous study using phenolic-enriched extracts from berries showed their ability to 
inhibit adipogenesis, and that the highest inhibition of lipid accumulation was observed in 
adipocytes treated with proanthocyanidin-enriched fraction from Vaccinium floribundium [21]. 
Another study indicated that fermented blueberry juice decreased triglyceride accumulation to 
levels comparable to the control; however, the non-fermented juice did not affect adipogenesis 
[17]. On the other hand, the higher triglyceride content induced by the 30%Bck:70%Blue ANC 
treatment in our study could be related to an upregulation of PPAR-γ activity, since it is a key 
molecule involved in adipogenesis [25] and inhibitor of NFκB signaling [26]. 
In obese subjects, visceral adipose tissue lipolysis is known to be upregulated [27]. The 
increase in free fatty acids (FFA) levels has been directly correlated with the establishment of 
insulin-resistance. Even though the present study was in vitro, some blend ANCs were able to 
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modulate the fat accumulation in the adipocytes by exerting a protective effect on glycerol 
release. This fact is remarkable regarding adipose tissue inflammation; less FFA release has 
potential to cause a reduction in the insulin-resistant environment. C3G has been previously 
related with anti-lipolytic effect in 3T3-L1 cells via decreased expression of adipose triglyceride 
lipase [28]. Furthermore, it has been described that anthocyanin extracts (68.3% cyanidin-3-O-
glucoside, 25.2% delphinidin-3-O-glucoside, and 6.5% petunidin-3-O-glucoside) from black 
soybean inhibit basal lipolysis [29]. As expected, no effects of IP treatment regarding FAS and 
HSL expression were observed, since both proteins are post-transcriptionally activated by 
catecholamines [30]. Our experiment found that only IP and 30%Bck:70%Blue ANC increased 
HSL expression. This apparently contradicts the obtained lipolysis results, however, this 
contradiction is explained by post-transcriptional modifications of HSL following stimuli. 
Finally, the fact that only delphinidin-enriched ANCs inhibited CM-LPS induction of glycerol 
release indicated prevention of lipolysis by a specific ANC in a more physiological model of 
obesity-related inflammation. 
It has been reported that adiponectin production is reduced in subjects with visceral fat 
accumulation [31]. Hypoadiponectinemia induced by visceral fat accumulation has also been 
closely associated with T2D, lipid disorders, hypertension and certain inflammatory diseases 
[31]. ANC from dealcoholized fermented beverages did not inhibit MCP-1 induction in TNF-α-
induced or LPS-induced-CM adipocytes. However, TNF-α-induced ADIPOQ gene expression 
inhibition was significantly reduced by 30%Bck:70%Blue ANC treatment. This result correlated 
significantly with the TNF-α-induced glycerol release. To our knowledge, this is the first time 
that a C3G-enriched berry blend from a fermented and dealcoholized beverage has been related 
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to the reduction of the blunted effect of adiponectin gene expression caused by an inflammatory 
inducer. 
Our results indicate that glucose uptake was stimulated following insulin treatment. INS-
CM-LPS effectively reduced glucose uptake, thus adipocytes were significantly insulin-resistant. 
The fact that no significant difference was observed between INS and INS-CM-LPS 100%Bck, 
indicate that this treatment induced some insulin-sensitizing improvement. In a previous study it 
was observed that amelioration of glucose uptake in the presence of insulin by blueberry juices 
was highest at 6 h following LPS-stimulation [17]. In this regard, ANC interventions have 
potential to induce reduction of T2D incidence through modulation of insulin sensitivity and 
glucose utilization [32].  
In conclusion, anthocyanin enriched fractions from blueberry-blackberry dealcoholized 
fermented beverages presented a significant positive effect on an in vitro adipose tissue 
inflammatory model, in relation to several markers of adipogenesis and inflammation. 
Accordingly, more research is needed in order to unveil the promising features of these 
fermented beverages and their bioactive compounds in vivo on inflammatory-related insulin-
sensitivity. 
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CHAPTER 9 
ANTHOCYANINS FROM FERMENTED BERRY BEVERAGES INCREASED INSULIN 
SECRETION FROM PANCREATIC Β-CELLS IN VITRO BEYOND THEIR ABILITY 
TO REDUCE DIPEPTIDYL PEPTIDASE IV
14 
 
Abstract 
Berries are a rich source of phenolic compounds that can inhibit the enzyme dipeptidyl 
peptidase IV (DPP-IV), a target for type-2 diabetes therapy. The objectives were to determine the 
role of berry phenolic compounds to modulate incretin-cleaving hormone DPP-IV and its 
substrate GLP-1 in order to increase insulin secretion from pancreatic β-cells, and to investigate 
the modulation of genes and proteins involved in insulin signaling pathway. iNS-1E pancreatic 
β-cells were used to elucidate the role of phenolic compounds to act as insulin secretagogues 
both directly and following simulated absorption in a dual-cell system with Caco-2 cells. 
Anthocyanins (ANC) from 50%blueberry- 50%blackberry (Blu-Bla) and 100% blackberry (Bla) 
fermented beverages at 50 µM cyanidin-3-glucoside equivalents were able to increase glucose-
stimulated insulin secretion directly and after Caco-2 transport. ANCs increased the protein 
expression of IGF-II, IGFBP-2 and 3, and VEGF in iNS-1E cells. ANC50%Blu-Bla and 
ANC100%Bla up-regulated incretin hormone gene for GLP-1 and genes in the insulin secretory 
pathway including iGF1R. PTP1B gene expression was down-regulated by ANC100%Bla, a 
type-2 diabetes therapeutic target. In conclusion, anthocyanins from fermented berry beverages 
have the potential to increase insulin secretion due to reduced DPP-IV expression and up-
regulated expression of mRNA of insulin-receptor associated proteins. 
 
                                                             
14
 Publication: Johnson MH, de Mejia EG. Anthocyanins from fermented berry beverages 
increased insulin secretion from pancreatic beta cells in vitro beyond their ability to reduce 
dipeptidyl peptidase IV. Food and Function. [Submitted for publication, manuscript ID: F0-
ART-04-2015-000350, April 2015]. This work has not yet been published as of the completion of this 
dissertation. 
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Abbreviations: ANC, anthocyanin; 100%Bla, 100% blackberry fermented beverage; 50%Blu-
Bla, 50%blueberry-blackberry fermented beverage; DPP-IV, dipeptidyl peptidase IV; EMEM 
Eagle’s Minimum Essential Medium; GLP-1, glucagon-like peptide-1; GSIS, glucose stimulated 
insulin secretion; KRBH, Krebs-Ringer-bicarbonate-HEPES buffer; PAC, proanthocyanidins; 
RLU, relative light units, Res, resveratrol; Sitag, sitagliptin; TEER, transepithelial electrical 
resistance; VB, VitaBlue® 
Keywords: anthocyanin, diabetes, DPP-IV, insulin, pancreatic β-cell 
 
Introduction 
Type-2 diabetes is a serious metabolic disease that affects over 9.3% of the United States 
(U.S.) population, with 1.7 million new cases diagnosed in 2012 [1]. The inability to control 
blood glucose increases the risk of serious complications such as heart disease, stroke, blindness, 
kidney failure, and lower limb amputations. As a result, diabetes was the 7
th
 leading cause of 
death in the U.S. in 2010. The economic burden of diabetes in the U.S. is staggering with $176 
billion for direct medical costs and $69 billion due to reduced productivity in 2012 [1]. One 
strategy to manage type-2 diabetes is to increase insulin secretion. The incretin hormone 
glucagon-like peptide-1 (GLP-1) is able to stimulate insulin release from pancreatic β-cells; 
however, it is rapidly degraded to inactive metabolites by dipeptidyl peptidase-IV (DPP-IV) [2]. 
DPP-IV is a serine aminopeptidase, a current target for type-2 diabetes therapy since its 
inactivation by drugs or natural compounds prevents the degradation of GLP-1 [3]. Our previous 
results using computational and enzymatic studies indicated that anthocyanins (ANC) are strong 
inhibitors of purified DPP-IV [4]. However, there is lack of information on the efficacy of ANC 
from fermented berries to inhibit DPP-IV in β-cell function. 
In addition to fiber, minerals, and vitamins, blueberries and blackberries are rich sources 
of polyphenolic ANC as well as proanthocyanidins (PAC), the polymerized forms of ANC and 
other phenolic compounds like epicatechin [5-7]. Berry fermentation increases contact with berry 
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skins rich in phenolic compounds thus becoming a viable way to increase the phenolic content of 
berry juice products, and consequently increasing the potential for health benefits [8]. Clinical 
studies have shown the potential of bioactives from blueberries to improve insulin sensitivity or 
insulin resistance [9, 10]. Furthermore, an increased consumption of ANC and ANC-containing 
foods results in decreased risk for type-2 diabetes [11]. Nevertheless, the role of berry phenolics 
to increase insulin secretion is not fully understood.  
Current cell-based assays used to investigate β-cell function lack mechanistic data needed 
to translate and promote new interventions to improve insulin secretion.  Human-derived Caco-2 
cells are a well-studied model of epithelial transport and are commonly used for permeability, 
transport, or absorption studies, and in addition they express DPP-IV [12-14]. Rat insulinoma 
iNS-1E β-cells are a clone of the commonly used iNS-1 cell line that better mimic human 
responses to glucose and insulin secretion at physiological levels [15, 16]. Further, these cells are 
able to be cultured over long periods of time without losing their response to glucose [17]. Caco-
2 and iNS-1E cells have been previously cultured using transwell inserts to study the transport of 
plant extracts [18]. Transport of materials across the insert membrane allows only absorbed 
phenolic compounds and metabolites to impact the insulin secretion of pancreatic β-cells 
growing on the plates below them, thus simulating their gastrointestinal absorption.  
This study applied current cellular absorption and more physiologically-relevant β-cell 
models to investigate the role of phenolic compounds following simulated absorption to improve 
insulin secretion. The objectives were to demonstrate the role of ANC and PAC, from fermented 
blueberry and blackberry, to modulate incretin-cleaving hormone DPP-IV and its substrate GLP-
1 in order to increase insulin secretion from pancreatic β-cells, and in addition, to investigate the 
corresponding modulation of potential genes and proteins involved in the insulin signaling 
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pathway. Using a simulated absorption model and a physiologically-relevant β-cell line allows 
for an assessment of the role of phenolic compounds to act as insulin secretagogues. The 
hypothesis was that ANC and PAC from fermented berry beverages will improve glucose-
stimulated insulin secretion in vitro using Caco-2 epithelial and iNS-1E pancreatic β-cells 
through reduction of DPP-IV activity and expression, and modulation of genes and proteins 
involved in insulin secretion and signaling. 
 
Materials and methods 
Materials 
Eagle’s Minimum Essential Medium (EMEM), RPMI-1640, and 0.25% (w/v) trypsin-
0.53 mM EDTA were purchased from American Type Culture Collection (ATCC) (Manassas, 
VA, USA). Penicillin-streptomycin was purchased from Corning Inc. (Corning, NY, USA), fetal 
bovine serum (FBS) from Hyclone (Thermo Scientific Hyclone, Logan, UT, USA). Primary 
mouse monoclonal antibodies GADPH (sc-47724), DPP-IV (sc-9153), and GLP-1R (sc-66911) 
were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). All other chemicals 
were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise stated.  
Controls used were the commercial DPP-IV inhibitor Sitagliptin (Sitag) at 0.5 and 5 M 
based on the IC50 value to inhibit DPP-IV, and purified phenolic compound resveratrol (Res) at 5 
μM as a control of a purified stilbenoid. VitaBlue® (VB) 20% anthocyanin blueberry extract 
(N208.2) was provided by FutureCeuticals, Inc. (Momence, IL, USA) and used as a commercial 
semi purified ANC-enriched extract from whole blueberry (ethanol-water extraction 70-30) at 50 
μM considering 20% anthocyanins by weight. Phenolic extracts were previously characterized 
[15]; ANC- and PAC- enriched fractions extracted from a 50%blueberry-blackberry fermented 
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beverage (50%Blu-Bla) and from a 100% blackberry fermented beverage (100%Bla), were also 
used at 50 μM.  
Caco-2 and iNS-1E cell proliferation  
Caco-2 cells (HTB-37 from ATCC, Manassas, VA) were subcultured using EMEM 
media supplemented with 20% FBS, 1% penicillin-streptomycin, and 1% sodium pyruvate. iNS-
1E cells were kindly provided by Dr. Maechler [17] and were maintained in RPMI-1640 media 
containing 10 mM HEPES, 2 mM L-glutamine, 1mM sodium pyruvate, 50 µM 2-
mercaptoethanol, and 4500 mg/L glucose, supplemented with 10% FBS, and 1% Amphotericin 
B. Cells were maintained at 37°C in 5% CO2/95% air using a CO2 Jacketed Incubator (NuAIRE 
DH Autoflow, Plymouth, MN). Cells were grown at 5000 cells/well in a 96-well plate for 24 h 
(Caco-2) or 5,000 cells/well in a 96-well plate for 3 d (iNS-1E) and proliferation was measured 
using a CellTiter 96® AQueous One Solution Proliferation assay kit (Promega, Madison, WI); 
viability of neither cell line was significantly affected compared to the media-only treated cells 
(p > 0.05) by treatments of sitagliptin at 0.5 μM, resveratrol at 5 μM, or by VB, ANC 50%Blu-
Bla, ANC 100%Bla, PAC 50%Blu-Bla, and PAC 100%Bla at 50 μM in cyanidin-3-glucoside or 
epicatechin equivalents, respectively. The concentration of 50 µM was chosen based on efficacy 
in previous studies [4, 21]. While much higher concentrations than what could be achieved in 
plasma for these compounds were used, the proposed cell culture system is a simulated 
absorption and the in vitro concentration of 50 µM of ANC in C3G equivalents translates to 
consumption of 3 mg of ANC by a human, assuming their intestinal fluid volume is 150 mL [18] 
and that 1% of this would reach their β-cells. 
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Dual-layered simulated absorption  
Phenolic compounds were applied to the apical side of human epithelial Caco-2 cells 
grown in a monolayer inserts above iNS-1E pancreatic β-cells to determine the effect of 
transported ANC or PAC compounds or their metabolites on insulin secretion (Figure 9.1).  
 
 
Figure 9.1 Diagram of the dual-cell simulated absorption system. Caco-2 cells were seeded on 
the apical side of 24-well cell culture inserts at a density of 5*10
4
 cells /cm
2
 alone, with volume 
of culture media at 0.4 mL. Only those cells that successfully formed a monolayer, as determined 
by TEER measurement to insure the integrity of the monolayer were used for the experiment. On 
day 18, pancreatic iNS-1E cells were seeded onto 24-well plates at a density of 1*10
5
 cells /cm
2
, 
with 1 mL of culture medium. After 20 days, Caco-2 cells reached confluence and treatments 
(sitagliptin, VB, ANC 50%Blu-Bla and 100%Bla, or PAC 50%Blu-Bla and 100%Bla) were 
added to the apical side for 24 h before cells were layered by transferring the inserts into the 24-
well plates containing the iNS-1E cells. Diagram adapted from [16]. 
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This dual-cell system is a combination of both human and rat cells as there is currently no 
appropriate human β-cell line that is physiologically relevant [15]; however, they are not 
growing as a co-culture adjacent to each other which should avoid any cross-species concerns. 
Hanging cell culture inserts contained a polystyrene membrane with a 0.4 µM pore that allows 
transport of phenolic compounds [19].  Caco-2 cells were seeded on the apical side of 24-well 
cell culture inserts at a density of 5*10
4
 cells /cm
2
 alone, with volume of culture media at 0.4 
mL. Only those cells that successfully formed a monolayer, as determined by Transepithelial 
Electrical Resistance (TEER) measurement to insure the integrity of the monolayer were used for 
the experiment. TEER measurement with Millicel-ERS volt-ohm-meter (Millipore, Billerica, 
MA) was taken daily and before and after the experiment to insure the integrity of the monolayer 
in each well. On day 18, pancreatic iNS-1E cells were seeded onto 24-well plates at a density of 
1*10
5
 cells /cm
2
, with 1 mL of culture medium. After 20 days, Caco-2 cells reached confluence 
(average TEER for all wells was 300.9 ± 4.8 Ω*cm2); only compounds that passed through the 
Caco-2 cells would be able to affect the pancreatic β-cells growing on the inserts below. 
Treatments (sitagliptin, VB, ANC 50%Blu-Bla and 100%Bla, or PAC 50%Blu-Bla and 
100%Bla) were added to the apical side for 24 h, and cells were layered by transferring the 
inserts into the 24-well plates containing the iNS-1E cells. After 24 h, the media from both the 
apical and basolateral side and both cell lysates were collected, centrifuged at 4°C for 10 min at 
1000 g to remove cell debris, and stored for analysis of insulin as described previously or for 
GLP-1 as follows. While this model will not address the metabolism of the extracts before they 
reach the part of the gut that is represented by the Caco-2 cells nor the effect that gut bacterial 
may have on the metabolism of the extracts, it is an attempt to go a step beyond direct treatment 
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of the extracts to the cell line that is a limiting factor to translation of in vitro results to in vivo 
effects.  
Glucose stimulated insulin secretion (GSIS) 
Measurement of insulin release from INS-1E cells was performed according to Asfari et al. 
[20], with modifications. INS-1E cells were plated 8 x 10
4
 cells/well in 24-well plates and 
incubated for 3 days at 37 ºC.  On the day of the experiment, the media was replaced by RPMI 
1640 without glucose supplemented with 10% fetal bovine serum, 1% penicillin-streptomycin, 
1% HEPES, 1% sodium pyruvate, and 50 μM β-mercaptoethanol and incubated for 2 h as 
starvation. The cells were then gently washed 3 times with modified Krebs-Ringer-bicarbonate-
HEPES buffer (KRBH), containing 135 mM NaCl, 3.6 mM KCl, 0.5 mM NaH2PO4, 0.5 mM 
MgCl2, 10 mM HEPES, 2 mM NaHCO3, and 1.5 mM CaCl2. Cells were incubated in 0-glucose 
modified KRBH or treatments dissolved in the 0-glucose modified KRBH buffer, and incubated 
for 30 min. The KRBH was replaced by KRBH with 0.1% bovine serum albumin (BSA) 
containing 0, 2.5, or 20 mM glucose for glucose stimulation, and incubated for another 30 min. 
The 0-glucose KRBH treated wells were used as the negative control. 
For the dual-cell system, INS-1E cells were plated (8 x 10
4
 cells/well in 24-well plates) 
on day 18 and incubated for 3 days at 37 ºC, in a humidified 95% air, 5% CO2 atmosphere. 
Following the 24 h layered-cell treatment, INS-1E media was changed to 0-glucose RPMI media 
for 2 h before experiment (as starvation) before stimulation with 0 or 20 mM glucose modified-
KRBH.  
In both direct and dual-layered experiments, the medium was collected and cleared by 
centrifugation at 15,000 g for 1 min, and stored at -20 ºC until assayed by Insulin ELISA 
(Abcam, Cambridge, MA). To determine insulin content, each standard (recombinant human 
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insulin, 0-300 µIU/mL) or sample was loaded into the supplied wells and allowed to adhere 
overnight at 4°C with gentle shaking. After, the solution was discarded and the wells were 
washed of non-adherent material. Then, a biotinylated insulin detection antibody was added to 
each well and incubated for 1 h at room temperature with gentle shaking, followed by additional 
washing. Next, HRP-Streptavidin solution was added to each well, incubated for 45 min at room 
temp, and wells washed again. Finally, the provided substrate reagent was added to each well, 
incubated for 30 min at room temperature in the dark with gentle shaking until the stop solution 
was added and the absorbance was read at 450 nm on an ELx808™ Microplate Reader (Biotek 
Instruments, Winooski, VT). Insulin content was calculated using the standard curve y = 0.0014x 
- 0.0068, R² = 0.986. 
Dipeptidyl peptidase-IV inhibition 
Activity of DPP-IV was measured using DPP-IV Glo ™ Protease Assay (Promega, 
Madison, WI) following manufacturer’s instructions. Cell lysates collected from Caco-2 cells, 
plated at 2*10
5
 cells/well in 6-well plates following direct treatment with samples for 4, 8, 24, 
and 48 h were collected, normalized for protein content, and diluted to a final concentration of  
10 ng of protein per well. The provided Glo-substrate was added, and the content of the wells 
was gently mixed using an Synergy2 multi-well plate reader (Biotek, Winooski, VT) at medium 
intensity for 4 s. DPP-IV cleavage of the provided Gly-Pro-amino methyl coumarin (AMC) 
substrate generates a luminescent signal by luciferase reaction, with the amount of DPP-IV 
enzyme available to bind Gly-Pro-AMC proportional to relative light units (RLU) produced. 
This signal in RLU was measured after 30 min, and treatments were compared to wells 
containing cell lysates treated with media only as control of no DPP-IV enzyme inhibition. 
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Adipokine array 
The effect on adipokine expression were carried out on non-glucose stimulated INS-1E 
cells without using the dual cell system in order to determine the direct action of the compounds 
tested. Pancreatic iNS-1E cells plated at 2*10
5
 cells/well in 6-well plates were treated with 50 
µM ANC 50%Blu-Bla or  ANC 100%Bla, sitagliptin (0.5 µM), or media only for 24 h. Cells 
were washed twice with DPBS before collecting cell lysates using a lysis buffer containing 1% 
Igepal CA-630, 20 mM Tris-HCl (pH 8.0), 137 mM NaCl, 1% SDS, 2 mM EDTA, 10 μg/mL 
Aprotinin, 10 μg/mL Leupeptin, and 10 μg/mL Pepstatin. Cell lysates were diluted to 200 µg 
protein, mixed with a cocktail of biotinylated detection antibodies, and incubated overnight with 
the Proteome Profiler Rat Adipokine Array nitrocellulose membranes (R&D Systems, 
Minneapolis, MN) containing capture and control antibodies spotted in duplicate. The membrane 
was then washed to remove unbound material before application of streptavidin-HRP and 
chemiluminescent detection reagents. The chemiluminescent signal produced was captured using 
a GelLogic 4000 Pro Imaging System (Carestream Health, Inc., Rochester, NY) and analyzed for 
pixel intensity. 
Gene expression 
Gene expression analyses were carried out on non-glucose stimulated INS-1E cells 
without using the dual cell system in order to determine the direct action of the compounds 
tested. iNS-1E cells growing at 1*10
5
 cells/well in a 6-well plate were treated with 50 µM 
ANC50%Blu-Bla and ANC100%Bla to determine modulation of genes involved in insulin 
signaling based on the potential of these two treatments to have the greatest effect in the insulin 
secretion analysis. After treatment for 24 h, RNA was collected using an RNAeasy® Kit 
(Qiagen, Germantown, MD), quantified, and checked for quality. cDNA was synthesized using a 
 195 
 
Qiagen RT
2
 First Strand synthesis kit. Quantitative RT-PCR was performed using an 7900HT 
Fast Real-Time PCR System Cycler (Applied Biosystems, Foster City, CA) and a targeted array 
(PARN-030ZA RT
2
 Profiler PCR Array, Qiagen, Germantown, MD) that profiles the expression 
of 84 insulin-responsive genes. Thermocycling conditions were: 1 cycle at 95°C for 10 min and 
then 40 cycles at 95°C for 15 s followed by 60°C for 1 min before a dissociation stage. The 
relative mRNA expression levels of each gene were calculated using the 2
-∆∆Ct
 method in 
reference to β2 microglobulin, present in all nucleated cells.   
Active glucagon-like peptide 1 measurement 
The active form of GLP-1 was quantified from both the apical and basolateral media 
using an ELISA (EGLP-35K, EMD Millipore, Billerica, MA). Per manufacturer’s instructions, 
the active GLP-1 present in media was captured in a 96-well plate by a monoclonal antibody that 
binds the N-terminal region of the active GLP-1 molecule. The wells were washed to remove 
unbound materials, and anti-GLP-1 alkaline phosphatase detection conjugate was added to bind 
the immobilized GLP-1. Next, the unbound conjugate was washed, and bound detection 
conjugate was quantified by addition of methyl umbelliferyl phosphate, which forms a 
fluorescent signal proportional to the concentration of active GLP-1 in the unknown sample. 
Fluorescence was read using a FL600 Microplate Fluorescence Reader (Bio-Tek, Winooski, VT) 
with excitation/emission wavelength of 360/460 nm and quantified using GLP-1 standards 
ranging from 2-100 pM with equation of  y = 0.44x - 2.52, R² = 0.95.  
Western blot analysis 
To measure the effect of phenolic compounds on DPP-IV inhibition and resulting active 
GLP-1, equal amounts of Caco-2 or iNS-1E cell lysate protein (20 µg) were loaded in each well 
of 4-20% gradient SDS-polyacrylamide gels. After electrophoresis, proteins were transferred to 
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polyvinylidene difluoride membranes and blocked with 3% non-fat dry milk in 0.1% TBST for 1 
h at 4°C. After blocking, the membranes were washed with 0.1% TBST (5 times, 5 min each) 
and incubated with primary antibodies (1:500) overnight at 4°C. The membranes were washed 
again and incubated with anti- IgG horseradish peroxidase conjugate secondary antibodies 
(1:2500) for 2 h at room temperature. After incubation and repeated washing, the membranes 
were prepared for detection using a 1:1 mixture of chemiluminescent reagents A (luminol 
solution) and B (peroxide solution) (GE Healthcare Biosciences, Pittsburgh, PA). The membrane 
pictures were taken on a GelLogic 4000 Pro Imaging System (Carestream Health, Inc., 
Rochester, NY).  Relative expression of DPP-IV and GLP-1R were normalized to GAPDH. 
Statistical analysis 
Means of at least three replicates of independent duplicates were generated and adjusted 
with Tukey’s post hoc comparisons using Statistical Analysis System Software, version 9.3 
(Cary, NC).  Significant differences were reported at p-values < 0.05. 
 
Results and discussion 
Glucose-stimulated insulin secretion was increased by anthocyanin treatments when   
directly applied to iNS-1E cells 
Direct treatment of the phenolic compounds tested did not affect the proliferation of iNS-
1E pancreatic β-cells. Cell viability was 104.2 ± 5.8%, 104.1 ± 7.7%, 108.8 ± 5.5%, 87.8 ± 3.6%, 
100.4 ± 8.8%, 100.0 ± 14.0%, and 100.4 ± 1.7% for sitagliptin, resveratrol, VB, ANC50%Blu-
Bla, PAC50%Blu-Bla, ANC100%Bla and PAC100%Bla, respectively (p < 0.05). Insulin 
secretory response of iNS-1E cells following glucose stimulation and pre-treatment by 
sitagliptin, VB, or ANC and PAC from 50%Blu-Bla or 100%Bla was measured to determine 
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their ability to act as insulin secretagogues in cell culture. When iNS-1E cells were not 
stimulated with glucose (0 mM), there was an increase of insulin secretion seen by all treatments 
(Figure 9.2); this increase was significantly higher than media-only treated cells (106.9 ± 4.3 
µIU/mL) for sitagliptin (289.3 ± 18.9 µIU/mL), VB (254.6 ± 41.4 µIU/mL), ANC50%Blu-Bla 
(232.7 ± 30.0 µIU/mL), and PAC100%Bla (272.7 ± 36.7 µIU/mL). Sitagliptin was able to 
enhance the secretion of insulin even without any glucose or GLP-1 present. The fact that the 
ANC and PAC treatments are able to stimulate insulin secretion even without the presence of 
glucose can be attributed to the glycosidic side chains of these compounds allowing them to act 
as glucose mimetics [21]. Previous studies have indicated that procyanidins, part of the 
proanthocyanidin class of flavonoids, may play a role to modify insulin synthesis and secretion  
leading to decreased insulin production [22], while proanthocyanidins in this study were seen to 
increase insulin secretion without glucose stimulation. This difference could be due to the degree 
of polymerization of these compounds from grapes in the previous study rather than those 
present in blackberries used in this study. Glucose-stimulation at 2.5 mM did not alter insulin 
secretion from iNS-1E cells among treatments (Figure 9.2A). As expected [17,19], stimulating 
the β-cells with 20 mM glucose induced insulin secretion in media-only treated cells (301.0 ± 
33.3 µIU/mL). Within treatment, the ability to increase insulin secretion in response to glucose 
was most increased by the ANC 50%Blu-Bla (452.7 ± 105.1µIU/mL) and ANC 100%Bla (376.0 
± 29.6 µIU/mL). The glucose-stimulated insulin secretion from iNS-1E cells was only increased 
when stimulated with 20 mM glucose compared to media-only treated cells following 30 min 
pretreatment by ANC 50%Blu-Bla. The fact that the increase in insulin secretion by treatments, 
compared to media-only, seen without glucose stimulation was lost when stimulated with 20 mM 
glucose is an interesting finding, and suggests the mechanism may not be directly through 
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improved glucose-stimulation. Previously, anthocyanins present in fruits were shown to increase 
the insulin secretion following 4 and 10 mM glucose in pancreatic β-cells in vitro, with the most 
effect seen by cyanidin-3-glucoside and cyanidin-3-galactoside [21]. The primary anthocyanin 
present in the ANC100%Bla was delphidin-3-arabinoside, which has two hydroxyl groups in its 
B-ring, while the ANC50%Blu-Bla contained higher amounts of cyanidin derivatives [4]. The 
difference in ability of these anthocyanins to act as insulin secretagogues may be attributed to the 
difference in the concentration of different anthocyanins present and their structure [23]. 
Dipeptidyl peptidase-IV expression and activity in Caco-2 cells treated with blueberry         
extracts for 24 h were reduced 
Due to limited bioavailability, the ability of anthocyanins to affect glucose homeostasis in 
the body may be mediated by the effects of the compounds within the gastrointestinal tract. As 
such, Caco-2 cells were treated with media only, sitagliptin, resveratrol, a commercial berry 
extract (VB), and anthocyanin and proanthocyanidin extracts from a fermented berry beverage, 
and the activity and amount of DPP-IV protein expression was measured. The greatest reduction 
of DPP-IV activity was seen in Caco-2 cells after treatment for 24 h by 23.6% ± 2.6 for Res and 
10.7% ± 1.5 for VB, respectively. Following dual-layering with treatments for 24 h, DPP-IV 
protein expression was reduced by VB (69.5%), ANC 50%Blu-Bla (48.7%) and PAC 50%Blu-
Bla (54.0%) in Caco-2 cells (Figure 9.2B). There was no reduction seen by the DPP-IV inhibitor 
sitagliptin on expression of DPP-IV as the mechanism of inhibition is competitive binding within 
the active site rather than an inhibition of the enzyme’s expression; the IC50 of DPP-IV for 
sitagliptin was reported as 0.06 ± 0.03 μM [24]. Resveratrol was evaluated as a control of a 
purified stilbenoid, which may be present in the PAC fractions and was previously seen to be the 
most potent inhibitor of DPP-IV activity using computational modeling [25]. In this study we 
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found no reduction in the expression of DPP-IV by resveratrol indicating that the inhibition is 
purely through competitive inhibition rather than reduction in protein expression. As VB (extract 
standardized to 20% anthocyanins) is an ANC-enriched extract from blueberry that contains both 
ANC and PAC, and since no reduction was seen by the 100%Bla extracts, this effect to reduce 
DPP-IV activity and expression appears to be due to compounds present only in blueberries.  
  
Figure 9.2 A) Glucose-stimulated insulin secretion from iNS-1E cells following 30 min pretreatment by 
anthocyanin (ANC) or proanthocyanidins (PAC) from a 50% blueberry-50% blackberry blend or from 
100% blackberry (50%Blu-Bla or 100%Bla, respectively, sitagliptin (Sitag), or VitaBlue® (VB). Values 
are means ± SEM, n=4-8. Lowercase letters indicate significant differences (p < 0.05) between 0 mM 
treatments, uppercase letters between 20 mM treatments; 2.5 mM treatments did not differ among groups 
(p > 0.05); * indicates significant difference within treatments. B) Relative DPP-IV expression in Caco-2 
cells following treatments for 24 h. Values are means ± SEM. Means with different letters are 
significantly different (p < 0.05).  
A. 
B. 
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Our previous studies have indicated that phenolic compounds, especially anthocyanins, 
are strong inhibitors of the enzyme DPP-IV [25]. Grape seed procyanidins have been found 
previously to inhibit Caco-2 expressed DPP-IV activity by about 20%, with longer treatment 
leading to inhibition not seen by higher concentrations for 24 h [26], which agrees with the 
results seen in our study. While a reduction in the protein expression would lead to a reduction in 
the cleavage of GLP-1, inhibition through competitive binding of the active site rather than a 
reduction of protein expression would allow the Caco-2 cells expressing DPP-IV to maintain 
their normal function, however there is limited data regarding intestinal DPP-IV activity.  
Proteins of iNS-1E cells related to insulin growth factor binding were increased with         
anthocyanins from 50% blueberry-50% blackberry treatment 
Following treatment with anthocyanins from 50%Blu-Bla or anthocyanins from 
100%Bla, the relative expression of adipokines in iNS-1E proteins was measured to determine 
the impact of anthocyanins on proteins in pancreatic β-cells (Figure 9.3 and Figure 9.4). It is 
well established that cytokines secreted from adipose have an effect on the function of the 
pancreas to secrete insulin, and that their secretion from adipocytes may be modulated by 
anthocyanin treatment [27]; and it is also known that the pancreas itself can secrete these 
compounds [28]. The proteins with the highest pixel intensity that were significantly increased 
by treatment with ANC 50%Blu-Bla in comparison to the control were insulin-like growth factor 
binding proteins 3 (IGFBP-3, fold-change 1.58 ± 0.01), insulin-like growth factor 2 (IGF-II, 
fold-change 1.40 ± 0.19), vascular endothelial growth factor (VEGF, fold-change 1.53 ± 0.06), 
and insulin-like growth factor binding proteins 2 (IGFBP-2, fold-change 1.26 ± 0.01) (Figure 
9.3A). IGFBP-2 binds to IGF-I and IGF-II, and these proteins are involved in insulin-signaling 
pathway and in the cellular response to various stimuli. Since ANC 50%Blu-Bla increased the 
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pixel intensity of these proteins more than ANC 100%Bla, anthocyanins from blueberries may 
contribute more than those from blackberries to the increased expression of these proteins. An 
increase of VEGF by anthocyanins is supported by previous research that purified C3G protected 
against endothelial dysfunction in mice [28]. The role of VEGF in inhibiting apoptosis indicates 
a potential mechanism by which anthocyanins may protect β-cells from loss of mass of the 
pancreas.  
 
Figure 9.3  Rat adipokine array of thirty proteins detected in iNS-1E after 24 h treatment by 
anthocyanins from a 50% blueberry-50% blackberry blend or from 100% blackberry (ANC 
50%Blu-Bla or ANC 100%Bla, respectively. A) The pixel intensity of the most expressed 
proteins indicated in membranes and B) pixel intensity of proteins less highly expressed sorted 
by largest to smallest pixel intensity based on the ANC 50%Blu-Bla treatment. Different letters 
in A) indicate significant differences for each protein (p < 0.05); while in B) * indicates 
significant difference from the media-only control and # indicates significant differences 
between ANC treatment and the control.  
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Other adipokine proteins that were less highly expressed were also modulated by treatment with 
anthocyanins (Figure 9.2B), with the trend being an increase in protein expression by ANC 
50%Blu-Bla and a slight decrease by ANC 100%Bla treatment relative to the control.  
 
 
Figure 9.4. Blots that were generated using the Rat Adipokine 
Array and the location of the thirty proteins detected. The 
array was conducted using iNS-1E cells after 24 h treatment 
by anthocyanins from a 50% blueberry-50% blackberry blend 
or from 100% blackberry (ANC 50%Blu-Bla or ANC 
100%Bla, respectively. 
 
Adipokines that were affected differentially between ANC from either 50%Blu-Bla or 
100%Bla control include leukemia inhibitory factor (LIF), IGFBP-5 and -6, fibroblast growth 
factor 21 (FGF-21), monocyte chemoattractant protein-1 (MCP-1), and Lipocalin-2. LIF is a 
secreted cytokine with growth factor activity, related to the role of IGFBP-5, which plays a key 
     Media control       ANC50%Blu-Bla (50 μM)   ANC100%Bla (50 μM)   
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role in growth factor binding as well as signal transduction and cellular response to cAMP [37]. 
IGFBP-6 also is involved in cell growth and has a higher affinity for IGF-II than IGF-I, which 
also agrees with the observed increased expression of IGF-II over IGF-I. Another adipokine that 
is a member of the growth factor family, FGF-21, is involved in regulation of glucose import 
beyond its activities related to cell and tissue growth and may lead to increases in proliferation or 
mass of β-cells as well as increases in insulin transcription [29]. Lipocalin-2 is involved in 
apoptosis and inflammatory response, indicating that the reduced expression of this adipokine by 
the ANC from 100%Bla would be more protective against inflammatory-mediated cell death 
than ANC from 50%Blu-Bla. Finally, MCP-1 is involved in cellular calcium ion homeostasis, 
response to ATP, and VEFG signaling, indicating the compounds present in ANC50%Blu-Bla 
may be more responsive to intracellular signaling than ANC100%Bla. 
Circulating adipokine proteins DPP-IV, TNFα, IL-6, and IGFBP-1 were not affected by 
either anthocyanin treatment compared to the control (data not shown). As these are secreted 
proteins, any effect may not have been detected due to screening of the whole cell lysate rather 
than secreted proteins. It is important to note that the adipokines that have been reported to have 
the most significant deleterious effects on the function and proliferation and eventual failure of 
β-cells, including TNFα and DPP-IV, were not increased in our study [29]. These results from 
the array also agree with our results from the western blot in that there was no change by the 
ANC treatments to affect the expression of DPP-IV. Overall, an increase in these cytokines 
produced by the β-cell may have a protective role in defense against infection and eventual loss 
of pancreatic function; however, the physiological relevance of these results may be impacted by 
the presence of circulating adipokines from adipose, and should be considered as only direct 
effects on protein expression within the pancreatic β-cell.  
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Genes affected in specific pathways related to insulin signaling were up-regulated following 
anthocyanin treatment  
Beyond the ability of ANC from 50%Blu-Bla or 100%Bla, with no glucose stimulation, 
to act as insulin secretagogues, the effect on gene expression of genes involved in insulin 
signaling was compared to media-only treated iNS-1E cells. Genes linked to insulin signaling 
that were most up-regulated by either anthocyanin treatment are shown in Table 9.1, while 
Table 9.2 indicates the genes that were most down-regulated. Overall, ANC from 50%Blu-Bla 
were able to up-regulate 28 genes in the array (fold-change >1.5), while ANC from 100%Bla up-
regulated 14 genes. Of genes most up-regulated, there was an effect on insulin, insulin receptors 
and insulin binding including Ins1 and Ins2, as well as Dok3, Igfbp1, and Igf1r. Dok3 (docking 
protein 3) plays a key role in insulin binding and Ras protein signal transduction, and was 
upregulated by 8.5 and 6.5-fold for ANC 50%Blu-Bla and 100%Bla, respectively. Glucagon 
(Gcg) induces glucose production, regulates carbohydrate and protein metabolism, and also 
induces transcription of GLP-1, an important inducer of insulin secretion following food intake. 
There was an increase of Gcg by 3.0 and 2.0-fold compared to the control for ANC 50%Blu-Bla 
and 100%Bla, respectively. This increase in the gene that induces GLP-1 may be the reason 
these anthocyanins were able to increase insulin secretion following glucose stimulation. Igf1r 
(insulin-like growth factor 1 receptor) is the receptor for Igf-1 which is involved in the induction 
of cell cycle progression and survival, and therefore the induction of this gene by 2.3 ± 0.6  for 
ANC 50%Blu-Bla and 1.6 ± 0.3 by ANC 100%Bla may allow for an increase in survival of 
pancreatic β-cells in response to excess glucose. Igfbp1 (insulin-like growth factor binding 
protein 1) is a modulator of insulin growth factor (IGF) bioavailability and was also up-regulated 
by both ANC treatments.  
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Table 9.1 Fold-change of the genes most up-regulated in iNS-1E cells following anthocyanin 
treatment. 
Gene 
Symbol 
(ID) 
Official Full Name Cell action ANC 
50%Blu-
Bla 
ANC 
100%Bla 
Dok3 
(306760) 
docking protein 3  
Insulin binding and Ras protein signal 
transduction 
8.58 ± 0.34 6.52 ± 4.31 
Gcg/GLP-1 
(24952) 
glucagon  
Glucose production; regulates 
carbohydrate and protein metabolism 
3.03 ± 1.45 2.00 ± 0.31 
Rras/p23 
(361568) 
related RAS viral 
(r-ras) oncogene 
homolog 
GDP, GTP, and protein binding 
involved in catabolic processes and Ras 
protein signal transduction 
2.66 ± 0.79 2.03 ± 0.60 
Igf1r 
(25718) 
insulin-like growth 
factor 1 receptor 
Involved in the induction of cell cycle 
progression and survival, ATP and 
insulin binding 
2.30 ± 0.63 1.61 ± 0.26 
Akt2 
(25233) 
v-akt murine 
thymoma viral 
oncogene homolog 
2 
Involved in phosphatidylinositol 3-
kinase (PI3-K) mediated signaling and 
ATP binding 
2.10 ± 0.47 1.71 ± 0.73 
Ins2 
(24506) 
insulin 2 
Encodes pre-pro-insulin, involved in 
hormone activity 
2.17 ± 0.47 -1.05 ± 0.17 
Irs2 
(29376) 
insulin receptor 
substrate 2 
Insulin receptor binding, involved in 
insulin-stimulated fetal liver growth and 
PI3-K binding 
2.13 ± 0.61 1.09 ± 0.37 
Fos 
(314322) 
FBJ osteosarcoma 
oncogene 
Encodes a nuclear protein involved in 
signal transduction, involved in DNA 
binding and cellular response to calcium 
ion 
1.87 ± 0.30 2.20 ± 0.52 
Ldlr 
(300438) 
low density 
lipoprotein receptor 
Calcium ion binding and LDL particle 
binding 
1.80 ± 0.20 1.05 ± 0.15 
Insr 
(24954) 
insulin receptor 
Receptor for insulin, involved in 
intracellular signaling and ATP binding 
1.74 ± 0.61 -1.41 ± 0.04 
Igfbp1 
(25685) 
insulin-like growth 
factor binding 
protein 1 
Modulator of insulin growth factor 
bioavailability and insulin receptor 
signaling, and positive regulation of cell 
growth 
1.53 ± 0.81 1.95 ± 0.08 
iNS-1E cells were treated for 24 h with anthocyanins at 50 µM from either 50% blueberry-50% 
blackberry (ANC 50%Blu-Bla) or 100%blackberry (ANC 100%Bla). Fold-change was 
calculated using the 2
–ΔΔCT
 method. Data are expressed as the mean + SEM compared to media-
only treated cells. Cell actions from [37].  
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Table 9.2 Fold-change of the genes most down-regulated in iNS-1E cells following 
anthocyanin treatment. 
Gene 
Symbol 
(ID) 
Official Full Name Cell action ANC 
50%Blu-
Bla 
ANC 
100%Bla 
Gpd1 
(60666) 
glycerol-3-phosphate                         
dehydrogenase 1 
(soluble) 
Mitochondrial G3P dehydrogenase, 
functions in NADH oxidation and 
gluconeogenesis 
1.42 ± 0.60 -2.40 ± 0.06 
Ins1 
(24505) 
insulin 1 
Involved in glucose metabolism 
chaperone binding and hormone 
activity 
-2.11 ± 0.14 1.48 ± 0.55 
Insl3 
(114215) 
insulin-like 3 
Ligand for the LGR8 relaxin receptor, 
functions in G-protein coupled 
receptor binding 
-1.44 ± 0.02 -1.95 ± 0.08 
Pklr 
(24651) 
pyruvate kinase, liver 
and RBC 
L-isozyme of pyruvate kinase that 
catalyzes the conversion of ATP and 
pyruvate to ADP and 
phosphoenolpyruvate in glycolysis 
-1.36 ± 0.15 -1.92 ± 0.28 
Shc1 
(85385) 
SHC (Src homology 2 
domain containing) 
transforming protein 1 
Involved in Ras-dependent 
transformation and differentiation, 
interacts with growth factor and 
insulin receptor binding 
-1.41 ± 0.42 -1.92 ± 0.05 
Ptpn1 
(24697) 
protein tyrosine 
phosphatase,  non-
receptor type 1 
Negative regulator of insulin 
signaling, involved in the ER unfolded 
protein response 
-1.35 ± 0.33 -1.92 ± 0.08 
Fbp1 
(24362) 
fructose-1,6-
bisphosphatase 1 
Catalyzes the hydrolysis of fructose 
1,6-bisphosphate to fructose 6-
phosphate and inorganic phosphate in 
gluconeogenesis 
1.01 ± 0.34 -1.91 ± 0.07 
Jun 
(24516) 
jun proto-oncogene 
Transcription factor that acts as a 
proto-oncogene and may be involved 
in activated TLR4 signaling and DNA 
binding 
-1.01 ± 0.02 -1.88 ± 0.03 
Slc2a1 
(24778) 
solute carrier family 2  
(facilitated glucose 
transporter), member 1 
Transporter for glucose and other 
hexoses, may be involved in response 
to stress 
 
-1.34 ± 0.20 -1.76 ± 0.04 
Pparg 
(25664) 
peroxisome proliferator-
activated receptor 
gamma 
Ligand-activated transcription factor, 
mediates expression of genes involved 
in lipid metabolism 
-1.77 ± 0.13 1.84 ± 0.04 
G6pc 
(25634) 
glucose-6-phosphatase,                       
catalytic subunit 
Catalyzes the conversion of D-glucose 
6-phosphate and water to D-glucose 
and phosphate, involved in calcium 
ion binding and cation channel 
activity 
-1.75 ± 0.22 -1.66 ± 0.09 
iNS-1E cells were treated for 24 h with anthocyanins at 50 µM from either 50% blueberry-50% 
blackberry (ANC 50%Blu-Bla) or 100%blackberry (ANC 100%Bla). Fold-change was 
calculated using the 2
–ΔΔCT
 method. Data are expressed as the mean + SEM compared to media-
only treated cells. Cell actions from [37]. 
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Other genes that were up-regulated by both ANC treatments included Rras (related RAS 
viral, r-ras, oncogene homolog), Akt2 (v-akt murine thymoma viral oncogene homolog 2) that is 
related to phosphatidylinositol 3-kinase (PI3-K) mediated signaling, Hras (Harvey rat sarcoma 
virus oncogene), and Frs2 (fibroblast growth factor receptor substrate 2).  
Ins2 and Irs2 were only up-regulated by ANC 50%Blu-Bla, indicating that the presence 
of malvidin or cyanidin structures in the blueberry may be able to affect these genes, rather than 
delphinidin from blackberry. Ins2 (insulin 2) gene encodes pre-pro-insulin, which is processed to 
form the insulin hormone involved in glucose and lipid metabolism while Irs2 encodes the 
insulin receptor substrate necessary for insulin signaling to occur.  
Table 9.2 indicates the genes that were most down-regulated by either anthocyanin 
treatment. Overall, ANC from 50%Blu-Bla were able to down-regulate with fold-change < -1.5 
only 7 genes, while ANC from 100%Bla down-regulated the expression of 16 genes in the array. 
G6pc (glucose-6-phosphatase, catalytic subunit) was down-regulated by both anthocyanin 
treatments by -1.7 for both ANC 50%Blu-Bla and ANC 100%Bla. This enzyme plays a role in 
gluconeogenesis through catalyzing the conversion of D-glucose 6-phosphate and water to D-
glucose and phosphate. Pparg (peroxisome proliferator-activated receptor gamma) and Ins1 
(insulin 1) were down-regulated only by ANC50%Blu-Bla (-2.11 ± 0.14 and -1.77 ± 0.13, 
respectively). PPARγ is a ligand-activated transcription factor that mediates expression of genes 
involved in lipid metabolism. Other studies have indicated that cyanidin is an agonistic ligand of 
PPARα [30], and therefore the binding by cyanidin present in the 50%Blu-Bla blend that was not 
seen by ANC 100%Bla could be due to this similarity in binding ligand properties of cyanidin. 
Other studies have found that cyanidin-3-glucoside up-regulated PPARɣ activity and mRNA 
levels in adipocytes [31, 32]; however, in this study we found a down regulation of the gene for 
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this protein. This difference could be due to diverse roles or regulation of PPARɣ by various cell 
types in response to anthocyanins. The ANC 50%Blu-Bla treatment did not strongly down-
regulate many genes, though down-regulation of several genes involved in insulin signaling was 
seen following treatment by ANC 100%Bla. This could be due to the ability of the primary 
anthocyanin present, delphinidin-3-arabinoside, to down-regulate genes more than other cyanidin 
or malvidin derivatives contributed by ANC from fermented blueberries [4]. Genes most 
strongly down-regulated by the ANC 100%Bla treatment were Gpd1, Insl3, Pklr, Shc1, Ptpn1, 
and Fbp1.  Gpd1 (glycerol-3-phosphate dehydrogenase 1, soluble) is involved in carbohydrate 
and lipid metabolism and the glycerol-phosphate shuttle. Insl3 (insulin-like 3) is a ligand for the 
LGR8 relaxin receptor that leads to stimulation of adenylate cyclase and increase of cAMP. Pklr 
(pyruvate kinase, liver and RBC) catalyzes the conversion of ATP and pyruvate to ADP and 
phosphoenolpyruvate in glycolysis. These three down-regulated genes are all involved in energy 
metabolism, and increasing ATP through downregulation of Pklr, for example, would allow for 
the glucose-stimulated increase of insulin secretion resulting from the increased ATP to ADP 
ratio to occur. Ptpn1 (protein tyrosine phosphatase, non-receptor type 1) has phosphotyrosine 
phosphatase activity and is a negative regulator of insulin-signaling, and is therefore a current 
target of type-2 diabetes therapy. Other flavonoids from licorice or botanical roots have been 
identified as natural inhibitors of PTPN1 [33, 34], however there is a need for studies with 
flavonoids from fermented berries. Slc2a1, a transporter for glucose and other hexoses that may 
be involved in response to osmotic and metabolic stress, and Jun, a transcription factor that acts 
as a proto-oncogene and may be involved in activated TLR4 signaling, were down-regulated, 
indicating that ANC from blackberry may affect sensing of pancreatic β-cells to the extracellular 
state of the body. Figure 9.5 illustrates the primary predicted downstream pathways affected 
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including glucose metabolism by ANC from 50%Blu-Bla (A) or from 100%Bla (C) and cell 
viability 50%Blu-Bla (B) or from 100%Bla (D). 
  
 
Figure 9.5 Gene expression results as interpreted using Ingenuity® 
Pathway Analysis at FDR <0.3. Genes differentially expressed are 
listed surrounding the predicted affected pathway. A) illustrates the up 
or down-regulation of genes surrounding pathways related to glucose 
metabolism affected by the 50%Blu-Bla ANC while B) illustrates the 
genes that lead to a predicted decrease of cell death and apoptosis 
with a predicted increase in cell viability by 50%Blu-Bla ANC; C) 
illustrates the downstream predicted effect on glucose metabolism by 
100%Bla ANC, and D) illustrates the downstream prediction for 
100%Bla ANC to increase cell viability while decreasing apoptosis.  
A. 
B. 
C. 
D. 
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This analysis utilizing the IPA software takes into consideration all of the genes that were 
affected in the array indicating that both ANC treatments would lead to an improvement of 
glucose metabolism and cell vitality indicating the primary ways that ANC may act upon 
pancreatic β-cells to lead to an improvement in insulin secretion. 
Glucose-stimulated insulin secretion following treatment in the simulated absorption        
model of Caco-2 cells on inserts over iNS-1E cells was attenuated by treatment with        
anthocyanins from 100% blackberry 
To simulate absorption, Caco-2 cells that had formed a confluent monolayer on cell 
culture inserts were treated with compounds that could cross into the basolateral side only if 
transported through the epithelial cells. After treatment for 24 h, iNS-1E cells on the wells below 
were evaluated for response to glucose stimulation. As seen with the direct treatment, all groups 
were able to increase the amount of insulin secreted without any glucose stimulation, compared 
to the media-only, except ANC 100%Bla (Figure 9.6).  
 
Figure 9.6 Insulin secretion from iNS-1E cells at 0 or 20 mM glucose stimulation after dual-
layering Caco-2 cells with treatments for 24 h. Values are means ± SEM. Lowercase letters 
indicate significant differences (p < 0.05) between 0 mM glucose, uppercase letters between 20 
mM glucose; * indicates significant differences within treatments. 
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When cells were stimulated with 20 mM glucose, insulin secretion was increased by VB 
(291.1 ± 7.6 µIU/mL), ANC 50%Blu-Bla (274.4 ± 37.9 µIU/mL) and ANC 100%Bla (300.8 ± 
5.1 µIU/mL) compared to media-only treated cells. In the simulated absorption model, the 
polymerized compounds were no longer able to act as insulin secretagogues, or may have been 
cleaved into their smaller components such as procyanidins that have previously been shown to 
decrease insulin secretion [22]. 
GLP-1 and GLP-1R were increased following proanthocyanidins treatment from 100% 
blackberry, but this increase did not correlate directly with insulin secretory results 
To measure the effect of inhibiting DPP-IV in order to increase biologically active GLP-1 
in the media that is able to stimulate insulin release from pancreatic β-cells, GLP-1 was 
measured in both the apical and basolateral sides of the dual-layered system. Total GLP-1 was 
not measured as this takes into account the inactive metabolites of GLP-1 after cleavage by DPP-
IV, and thus these other forms of GLP-1 would not lead to stimulation of insulin secretion. Total 
active GLP-1 in the supernatant of Caco-2 (apical side) and of iNS-1E cells (basolateral side) 
was increased for only the PAC 100%Bla treatment (Figure 9.7A). Active GLP-1 of the apical 
side only was increased from media-only treated cells following treatment with sitagliptin (39.1 
± 13.3 pM) that was mirrored by VB (53.1 ± 13.1 pM), PAC 50%Blu-Bla (51.4 ± 12.9 pM), and 
PAC 100%Bla (50.8 ± 8.7 pM), suggesting these compounds were acting through a DPP-IV 
inhibitory mechanism to increase GLP-1. Further, because VB contains a mixture of ANC and 
PAC, and acted similarly to the PAC-only treatments rather than the ANC treatments, it seems as 
if the more complex polyphenolic compounds were needed to have an effect to increase GLP-1 
on the apical side.  
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A.  
B.   
 
Figure 9.7 A) Total active GLP-1 in the supernatant of dual-layered Caco-2 and iNS-1E cells 
and B) Expression of GLP-1R in iNS-1E cells with treatments for 24 h. Means ± SEM with 
different uppercase letters indicate indicates significant (p < 0.05) differences for total active 
GLP-1,  * indicates significant differences between apical side compared to control of media-
only. Different lowercase letters are significantly different (p < 0.05) for the relative intensity of 
GLP-1R protein expression. 
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Previous studies have indicated the importance of the GLP-1 receptor to regulate 
endogenous glucose production [35] and to enhance insulin secretion [36], therefore the relative 
amount of the GLP-1R protein in the pancreatic β-cells following the dual-cell experiment was 
measured. There was an increased expression of GLP-1R in iNS-1E cells following the treatment 
for 24 h by PAC100%Bla (relative intensity of 3.0 ± 1.9); however, other treatments did not 
differ from the media-only treated cells (Figure 9.7B). This increase in the GLP-1R for PAC 
100%Bla correlates with the increase seen in the total active GLP-1 in the media of the dual-cell 
system, however, these results do not correlate with the modulation of insulin secretion seen. 
Therefore, we concluded that ANC and PAC from fermented berry beverages may be acting 
through a mechanism beyond DPP-IV inhibition to increase incretin-mediated insulin secretion 
in pancreatic β-cells. Based on all of these results, a proposed mechanism of action is presented 
in Figure 9.8.  
 
Conclusions 
We demonstrated the role of phenolic compounds (such as ANC and PAC) from 
fermented berry beverages to modulate incretin-cleaving hormone DPP-IV and its substrate 
GLP-1 for increasing insulin secretion from pancreatic β-cells.  Bioactive compounds (ANC and 
PAC) from fermented berry beverages reduced incretin-cleaving hormone DPP-IV protein 
activity and protein expression in Caco-2 cells, increased insulin secretion of iNS-1E pancreatic 
β-cells both directly and following a dual-cell layered model of simulated absorption. Of the 
genes that were affected by both anthocyanin treatments, Dok3 was the most up-regulated 
(average of 7.5 fold change for both ANCs). Additionally, the ANC treatments up-regulated 
genes of insulin-receptor associated proteins and GLP-1, and down-regulated PTP1B in iNS-1E 
cells. 
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Figure 9.8 Proposed mechanism of action by which phenolic compounds from berries will affect genes (blue boxes, green outline 
indicates up-regulation while red outline indicates down-regulation) and proteins (light green boxes) due to GLP-1 mediated or 
glucose stimulated insulin secretion with the pancreatic β-cell.
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Our results indicated that the ability of ANC to act as insulin secretagogues in cell culture 
beyond their DPP-IV inhibitory action is possibly linked to enhanced insulin receptor signaling 
and up-regulation of proteins IGFBP-2 and -3, IGF-II, and VEGF. These effects, however, 
should be further evaluated in vivo, in a more complete physiological model system.  
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CHAPTER 10 
ALCOHOL-FREE FERMENTED BLUEBERRY-BLACKBERRY BEVERAGE 
PHENOLICS REDUCE DIET-INDUCED OBESITY AND BLOOD GLUCOSE IN 
C57BL/6J MICE
15 
 
Abstract 
 
 The purpose of this research was to determine the potential of phenolic compounds from a 
fermented 70:30% blackberry-blueberry beverage to reduce obesity and hyperglycemia in three 
week old male diet-induced obese C57BL/6j mice. Mice were randomized into six groups (n= 
12/group) to drink (ad libitum) an alcohol-free fermented beverage (AFFB), three doses of a 
phenolic extract (PAE) generated from AFFB to consume 0.1X, 1X and 2X where X contains the 
amount of anthocyanins (ANC) in the AFFB (65.1 ± 1.6 mg cyanidin-3-glucoside (C3G) 
equivalents/L); sitagliptin as positive control of DPP-IV inhibition (30 mg/kg body weight 
(BW)/day, or d); water as the negative control. After a week of treatments, mice started on a 60% 
high fat diet (HFD) to induce obesity and hyperglycemia. The diet-induced obesity and fat mass 
gain was attenuated by mice receiving the highest doses of the phenolic extract (11.7 and 10.3 g 
BW gained for 1X and 2X, respectively, compared to water control 16.7  1.1, p < 0.05). There 
was also a reduction (p < 0.05) in the percent fat mass, epididymal fat pad weights, adipocyte 
diameters, and plasma triglycerides and cholesterol by the PAE treatments. All groups became 
hyperglycemic due to the HFD, but by the end of the study (week 12), fasting blood glucose for 
mice receiving 9 (1X) or 19 (2X) mg ANC/kg BW/d was significantly lower (167.5 and 183.7 
mg/dL, respectively) than the water (221.8 mg/dL) and the sitagliptin group (216.9 mg/dL, p < 
                                                             
15 Publication: Johnson MH, Wallig M, Luna Vital DA, de Mejia EG. Alcohol-free fermented 
blueberry-blackberry beverage phenolics reduce diet-induced obesity and blood glucose in 
C57BL/6J mice. Journal of Nutritional Biochemistry. [In preparation]. This work has yet to be 
submitted for publication. 
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0.05). Follow-up histochemical analysis observed an unexpected adverse event of enlarged livers 
and lipid deposition in the livers of mice fed ANC at the levels of 1X or 2X that was associated 
with increased plasma alanine aminotransferase and alkaline phosphatase levels, increased 
hepatocyte proliferation, but not increased oxidation, indicating that there was potential toxicity 
at these doses. The PAE also induced the most gene expression changes, including down-
regulation of the lipoprotein lipase gene and up-regulation of zinc-a2-glycoprotein 1(AZGP1) 
gene. This indicated a highly significant predicted downstream effect to reduce D-glucose 
concentrations for all three doses of the PAE with significant z-scores of -2.71, -2.12 and -2.12 
for 0.1X, 1X, and 2X respectively. Overall, phenolic compounds from a fermented blueberry-
blackberry beverage reduced HFD-induced BW gain, fat mass accumulation, plasma 
triglycerides and fasting blood glucose in C57BL/6j mice. However, the dose of the phenolic 
extract should not exceed 9 mg/kg BW/d to avoid adverse effects on the liver. 
 
Abbreviations: AFFB, alcohol-free fermented beverage; BW, body weight; C3G, cyanidin-3-
glucoside; DIO, diet-induced obesity; EGCG, epigallocatechin-3-gallate; FBG, fasting blood 
glucose; HFD, high-fat diet; PAE, post-amberlite extract. 
Keywords: Anthocyanins, phenolics, berries, diet-induced obesity, hyperglycemia, C57Bl/6j 
mice 
 
Introduction 
 
 Type-2 diabetes is a serious metabolic disease that currently affects over 9.3% of the U.S. 
population, with 1.7 million new cases diagnosed in 2012 [1]. Current obesity trends and modern 
sedentary lifestyle along with diets low in fruit and vegetable intake lead to postprandial 
oxidative stress and inflammation in the body that contribute to insulin resistance and 
development of diabetes [2]. Diets rich in whole grains, fruits, vegetables, legumes, nuts, and 
moderate alcohol have been linked to a reduced risk of type-2 diabetes [3,4]. Specific fruits such 
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as blueberries, grapes, apples [5], as well as specific compounds present in these fruits such as 
anthocyanins [6], flavones, and flavan-3-ols [7] have been attributed to these effects. Blueberries 
and blackberries contain high amounts of water-soluble phenolic anthocyanin (ANC) pigments 
[8] in addition to other phenolic compounds such as catechins and gallic or ellagic acid that can 
polymerize to form proanthocyanidins (PAC) [9]. Data from mechanistic studies supports the 
role of flavonoids such as anthocyanins to be beneficial on insulin sensitivity, to decrease blood 
glucose levels, and to improve insulin secretion. 
 Previous studies have shown that dietary blueberries may have a role in reducing 
hyperglycemia in high-fat fed C57BL/6 mice, a model that mimics pathological development of 
obesity-induced hyperglycemia [10-14], compared to other chemically-induced or genetically 
altered models of diabetes. However, the mechanisms by which berry phenolics reduce the risk 
of type-2 diabetes are not yet clear. There is then need to identify and evaluate the effects and 
mechanism of action of fermented berry phenolics to reduce obesity and hyperglycemia. 
Previous studies conducted in C57BL/6j mice evaluating the role of anthocyanins on diet 
induced obesity at doses of 0.2 and 0.6 mg ANC/d [15] showed an improvement of β-cell 
function with purified ANC at levels of 0.2 mg/mL [16]. Also, fasting blood glucose and glucose 
tolerance improved at 12.5 mg ANC/mouse/d [17] without any adverse effects indicating that 
there may be a specific dose at which purified ANC might be most effective. There are several 
studies on purified ANC to reduce obesity outcomes in C57BL/6 mice fed a HFD [18-20]; 
however, information is needed on the effect of a fermented berry beverage to reduce obesity or 
hyperglycemia. 
 We found in vitro that ANC and PAC from fermented blueberries and blackberries were 
able to inhibit enzymes related to glucose absorption and incretin cleavage [21], reduce 
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inflammatory response in macrophages [22], and improve insulin secretion in pancreatic β-cells. 
Fermentation increases the phenolic content of berry juice products through increased extraction 
from the skins and creates a more stable environment for ANC pigments and converts naturally 
present sugars into ethanol. An alcohol-free fermented beverage thus has increased potential for 
health benefits [23-27]. Our hypothesis was that consumption of a fermented blueberry-
blackberry beverage and its phenolic compounds will reduce obesity and hyperglycemia, in diet-
induced obese mice.  
 The objective of this research was to understand the effect of phenolic compounds from 
fermented berry beverages, using mice fed a high fat diet, on hyperglycemia and obesity in vivo. 
To explain any observed changes in obesity and hyperglycemia induced by a high-fat diet due to 
the phenolic compounds treatments, we also evaluated body composition, histomorphological 
changes and genes affected.  
 
Materials and Methods 
 Preparation of fermented beverage and phenolic extracts. Fermented berry beverages 
made from blueberries (Vaccinium corymbosum) and blackberries (Rubus spp.) grown at the 
Dixon Springs Agricultural Research Station in Illinois [21, 22] were used. The alcohol was 
removed from these fermented beverages through rotoevaporation and the removed volume was 
replaced with water to yield the resulting alcohol-free fermented beverage (AFFB) that was 70% 
blackberry-30% blueberry and contained 65.1 ± 1.6 mg cyanidin-3-glucoside (C3G) 
equivalents/L. This AFFB was eluted through Amberlite XAD-7HP to remove the sugars and 
phenolic acids in order to generate the post-amberlite extract (PAE). The PAE was then 
concentrated, freeze dried (Labconco) and adjusted to 6.4 (0.1X), 59.6 (1X) and 192.4 (2X) mg 
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C3G eq./L dissolved in water. Total anthocyanins of the AFFB and PAE groups were determined 
using the AOAC official method [28]  and total polyphenols using the Folin-Ciocalteu method 
adapted for micro-assay as previously performed [21, 22].  
 Identification of anthocyanins using HPLC-MS/MS. Analysis of phenolic compounds 
was conducted by high-performance liquid chromatography/electrospray ionization tandem mass 
spectrometry (HPLC-ESI-MS) using a Q-tof Ultima mass spectrometer (Waters Corporation, 
Milford, USA), equipped with an Alliance 2795 HPLC system. Samples were prepared by 
dissolving freeze-dried AFFB and PAE from both blueberry and blackberry and the 
70%blackberry-30%blueberry mixture in 2% formic acid-H2O at 10 mg dry weight/mL. The 
separation of the components was performed using a mobile phase of solvent A, 2% formic acid 
in H2O and solvent B (100% Methanol) at a constant flow rate of 0.5 mL/min. The elution was in 
a linear step of 100%, 75%, 50%, 100% and 100% of solvent A at 0, 15, 40, 41, and 60 min, 
respectively. ANC were detected at 520 nm, PAC and hydroxycinnamic acids at 280 nm, and 
flavanols or flavonoids at 320 and 360 nm, respectively. To further elucidate the composition of 
the phenolic compounds present, a Q-tof Ultima mass spectrometer equipped with a Z-spray ion 
source with a positive ion electrospray mode (+ESI) was used. The Q-tof was operated at 
capillary voltage of 3.5 kV and a cone voltage of 35V. MassLynx 4.1V software (Waters, 
Milford, USA) was used to control the instruments and to process the data. 
Animal care and diet 
 Animal husbandry and care. Animal use was conducted in accordance with Institutional 
Animal Care and Use Committee approved protocols (#14060) at the University of Illinois at 
Urbana-Champaign. Male C57BL/6J mice 3 weeks old were purchased from Jackson Laboratory 
(Bar Harbor, Maine), housed in standardized conditions with a reversed 12 h light/dark cycle, 
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Figure 1.  
 
 
Figure 1.  
 
 
kept in a room maintained at 23°C in individual caging systems (singly) in order to accurately 
determine feed and water intake, and acclimated for one week upon arrival. Power analysis 
indicated that a sample size of 12 animals/group would provide at least 95% power to detect a 1-
standard deviation effect of blood glucose levels at P = 0.05, α =0.05.  
 Diet and treatments. The experimental design can be seen in Figure 10.1. All treatment 
groups received a standard 22/4 rodent diet (TD.8640) for weeks 1 and 2 before switching to a 
high-fat diet (TD.06414: 60% fat, 21% carbohydrate, 18% protein, Harlan Laboratories, 
Madison, WI) at week 3. The composition of the HFD was (in g/Kg): casein, 265.0; L-cystine, 
4.0; maltodextrin, 160.0; sucrose, 90.0; lard, 310.0; soybean oil, 30.0; cellulose, 65.5; mineral 
m x, AIN-93G-MX (94046), 48.0; calcium phosphate, dibasic, 3.4; vitamin mix, AIN-93-VX 
(94047), 21.0; choline bitartrate, 3.0; blue food color, 0.1.  
 
 
Figure 10.1. Experimental Design. Three week old male diet-induced obese C57BL/6j mice (n= 
12/group) were randomized into six groups to drink: an alcohol-free fermented beverage (AFFB) 
containing 65.1 ± 1.6 mg cyanidin-3-glucoside (C3G) equivalents/L; three doses of a phenolic extract 
where AFFB was eluted through Amberlite XAD-7HP and adjusted to 6.4 (0.1X), 59.6 (1X) and 192.4 
(considered as 2X based on consumption) mg C3G eq./L; sitagliptin (30 mg/kg BW/d) as positive control 
of DPP-IV inhibition, or water as negative control. After a week of baseline measures, mice were 
randomized into one of these six treatment groups. After an additional week of measurements to 
determine the effect of the treatment, all mice were started on a 60% fat diet (HFD). After about three 
weeks of the HFD, the mice began to develop the obesity and hyperglycemia phenotype.  
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 Food and treatment intake. Food was provided ad libitum and intake was recorded bi-
weekly. After 1 week of baseline blood glucose measures, the mice were randomized to receive 
one of 6 treatments in place of water (ad libitum), including an alcohol-free fermented beverage 
(AFFB), three doses of phenolic compounds from AFFB (PAE), and a commercial DPP-IV 
inhibitor as an admix also provided in the water, as follows: (n = 12/group): (a) AFFB 
(70%blackberry-30% blueberry); (b) dose 0.1X PAE; (c) dose 1X PAE; (d) dose 2X PAE; where 
x is the equivalent dose of ANC found in fermented beverage group (AFFB); (e) water only as 
the negative control; or (f) the group receiving sitagliptin phosphate at 150 mg/L  in water as the 
positive control. All treatments were replenished daily and were covered in foil to reduce 
degradation or loss of the phenolic compounds due to heat or light, and adjusted for sucrose 
content based on intake so that all mice were consuming the same amount of sucrose as naturally 
present in the AFFB (10% w/v). After starting on the HFD, mice received treatments for 9 more 
weeks based on the time of phenolic compounds to reduce hyperglycemia in previous studies 
[20, 29]. 
 Body weight. Body weight was evaluated at least bi-weekly by transfer to a clean empty 
weighing cage using a calibrated scale. 
 Body composition analysis. Echo-MRI scans for body composition were conducted on 
weeks 1, 4, 7, 10, and 12 to determine lean mass versus fat mass using the EchoMRI 700 system 
from Echo Medical Systems. The EchoMRI-700 Body Composition Analyzer for animals takes 
direct measurements of total body fat, lean mass, free water, and total body water without 
anesthesia, sedation, or restraint; animals were allowed free movement within the limited space 
of the scanning tube. 
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 Blood glucose. Blood was collected under red-light during metabolically-active hours for 
the mice from the tail vein of conscious animals [30] that had been morning fasted for 4-6 h, 
during which time their treatments were replaced with plain water containing no sucrose. Briefly, 
the tail was lanced with a sterile scalpel blade and blood was measured directly onto glucose 
testing strips with a handheld glucometer (FreeStyle Freedom, Abbott Laboratories, Abbott Park, 
IL) [31].  
Plasma analysis  
 Plasma collection. At the end of the study, animals were deeply anesthetized with 
isoflurane and a larger volume of blood was collected into a cryovial by cardiac puncture. Blood 
was processed by centrifugation for 10 min at 2500xg and 4°C, and plasma was then isolated 
from whole blood, aliquoted, and frozen at -80°C before the following analyses. 
 Insulin content and HOMA-IR calculation. Serum insulin was measured using a 
sandwich ELISA assay (Abcam). HOMA-IR was calculated from these measurements as a 
degree of insulin resistance using the following equation: 
𝑏𝑙𝑜𝑜𝑑 𝑔𝑙𝑢𝑐𝑜𝑠𝑒 (
𝑚𝑚𝑜𝑙
𝐿
)∗𝑠𝑒𝑟𝑢𝑚 𝑖𝑛𝑠𝑢𝑙𝑖𝑛 (
𝑚𝑈
𝐿
)
22.5
 
and HOMA-β calculated as a degree of the percent beta-cell function with the following 
equation: 
20∗𝑠𝑒𝑟𝑢𝑚 𝑖𝑛𝑠𝑢𝑙𝑖𝑛 (
𝑚𝑈
𝐿
)
𝑏𝑙𝑜𝑜𝑑 𝑔𝑙𝑢𝑐𝑜𝑠𝑒 (
𝑚𝑚𝑜𝑙
𝐿
)−3.5
% as previously reported [32].  
 Plasma triglycerides. Triglyceride content of plasma was quantified using a commercial 
colorimetric kit following the manufacturer’s instructions (Abcam). 
 Plasma DPP-IV activity. Dipeptidyl peptidase IV (DPP-IV) activity in 5uL plasma was 
measured using a commercial DPP-IV Glo® kit (Promega, Madison, WI) after 30 min and a 
standard curve (y = 115.81x + 727.15, R² = 0.9985) was produced using human DPP-IV enzyme 
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(Sigma-Aldrich) as previously reported [33]. Percent of the maximal activity of DPP-IV was 
calculated considering the water mice as 100% activity. 
 Plasma analysis of liver function. To determine liver function, plasma was screened for 
enzymes alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyl 
transpeptidase (GGT), alkaline phosphatase (ALP), and total bilirubin using a Beckman Coulter 
AU 680 Chemistry System (Beckman Coulter, Inc., Brea, CA) [34].  
 Tissue analyses. Immediately following euthanasia, tissues were collected and weighed 
including pancreas, liver, and adipose (both epididymal and retroperitoneal fat pads), and a 
portion of each tissue was fixed with 10% formalin.  A separate portion of the pancreas and liver 
were preserved in RNAlater® (Life Technologies, Carlsbad, CA) for genetic analysis. 
 Immunohistochemical analysis. Formalin-fixed unprocessed tissue of pancreas, liver, and 
adipose tissue (n=12/group) was used for hematoxylin and eosin (H&E) staining to determine 
histomorphological features. In liver, a standard non-alcoholic fatty liver disease (NAFLD) lipid 
scoring tool was used to determine the size and distribution of lipid vacuoles. In adipose, the 
macrophage infiltration was determined as the number of macrophages per total cell and 
adipocyte diameter was measured using ImageJ to measure the diameter of 50 adipocytes per 
animal (total 500 adipocytes/group) [35]. Histomorphologic features of the pancreas such as 
presence or absence of inflammation, apoptosis, necrosis, and fibrosis were evaluated. Pancreatic 
islet diameters were measured using ImageJ (n > 24/group). Prior to immunohistochemical 
(IHC) analyses, paraffin-embedded tissues (n=12/group) were cut at 5 µm thickness and 
transferred to a slide. Liver and pancreas were stained with rabbit polyclonal antibodies for 
proliferating cell nuclear antigen (PCNA) (ab2426, Abcam) as a marker of cell proliferation and 
malondialdehyde (MDA) (ab6463, Abcam) as a marker of oxidation to assess free radical 
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damage. For assessment of islet cell function, IHC analyses for insulin and glucagon were 
performed. The total number of cells in each islet was counted, then just the number of insulin-
positive (beta) cells to obtain the proportion of β-cells in each islet. Glucagon-positive (alpha) 
cells were counted and related to the total cell population in the same manner. Insulin (and 
glucagon) content was semi-quantified on a scale from 0-4 as follows: 0- no positive staining for 
insulin; 1- weak diffuse staining; 2- sparse granular staining; 3- strong granular staining in most 
cells; 4- intense granular staining in most or all cells. The mean scores were analyzed using non-
parametric statistics. Analyses were performed at the Veterinary Diagnostic Laboratory at the 
University of Illinois under the supervision and training of Mathew Wallig DVM, PhD. Stained 
slides were visualized using Nanozoomer Digital Pathology (Olympus Hamamatsu, Bridgewater, 
NJ).  
 Gene expression analysis. RNA was extracted from RNAlater®-stabilized frozen 
pancreatic tissue using a RNeasy Mini Kit (Qiagen, MD, USA) following manufacturer’s  
protocol to measure changes in expression of all mouse genes and was analyzed using an 
Illumina MouseWG-6 v2.0 Expression BeadChip. Microarray data pre-processing and statistical 
analyses were done in R [36] (v 3.0.1) using the limma package [37] (v 3.16.7). Pairwise 
comparisons between treatments and control were pulled as contrasts from the model; along with 
the equivalent of a one-way ANOVA test for the treatments. Raw p-values were adjusted 
separately for each comparison using the False Discovery Rate method [38]. Gene annotation for 
each probe, including Gene Ontology terms and KEGG pathways, were taken from the package 
maintained by Bioconductor [39]. The cut-off used for reporting significant changed in gene 
expression was FDR p-value <0.3 for pancreatic tissue. Similarities and differences on the genes 
affected by the treatments were analyzed by GeneVenn [40]. Genes were annotated and 
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biological processes were analyzed using the DAVID v 6.7 [41, 42].  As an alternative approach 
to identify biological processes and functions that are modulated after exposure to the treatments, 
exploratory functional analysis was performed using Ingenuity® Pathway Analysis (IPA) v 9.0 
(Ingenuity® Systems)
16
. A Downstream Effect Analysis was performed using IPA, which 
identifies biological functions that are expected to be increased (z > 0) or decreased (z < 0) given 
the observed gene expression changed in a data-set uploaded to the software. The z-score 
statistic is a calculated quantity to reflect the overall predicted activation state of a biological 
function.  A particular function has more increased than decreased predictions if z ≥ 0 or vice 
more decreased than increased predictions if z ≤ 0. If an absolute z-score is large enough it will 
fall into the tail of the Gaussian distribution of the possible calculated z-score statistic, thus, it 
would be unlikely to obtain that value of z by chance. In practice, z-scores less than -2 or greater 
than 2 can be considered significant in order to reduce the chance that random data will generate 
significant predictions. Therefore, z-scores ≤ -2 indicate a significant decrease while z-scores ≥ 2 
indicate a significant increase of that biological function.  
 Statistical analysis. Group mean comparisons were conducted using one-way analysis of 
variance (ANOVA) and LSD post-hoc comparison using the proc GLM procedures and non-
parametric Mann-Whitney test of SAS version 9.3 (SAS Inst. Inc., Cary, NC). Significance was 
considered at p < 0.05, and data are presented as means ± SEM, n=12 mice/group unless stated. 
 
Results 
 Identification of anthocyanins using HPLC-MS/MS. The main peaks of the 
70%blackberry-30%blueberry AFFB or PAE were detected at maximal absorbance at 280, 320, 
360, and 520 nm (Figures 10.2 and 10.3). The primary peak present in both AFFB and PAE was 
                                                             
16
 Gene expression analysis using IPA was conducted by Diego Luna Vital. 
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seen at retention times of 38.9 min. This peak was maximally absorbed at 280 nm, indicating that 
it was a phenolic acid or hydrolysable tannin that was tentatively identified as ellagic acid with 
MS/MS analysis. After passing the AFFB through Amberlite resin to generate the PAE, the 
concentration of phenolic acids and anthocyanins was increased, while the flavonols and 
hydroxycinnamic acids were filtered out (Figure 10.3). The relative proportion of the peak at 
38.9 min was reduced in the PAE relative to the AFFB due to the increase of peaks at 22.9 and 
27 min. The peak at 27 min was identified as a derivative of the anthocyanin cyanidin, while the 
peak at 22.9 was identified as the flavonol gallic acid 3-O-gallate. Total polyphenolic content in 
the PAE groups was determined to be 65.1, 631.6, and 2033.6 mg gallic acid equivalents (GAE) 
per mL leading to a consumption of phenolic compounds at 0.41, 2.64, and 6.38 mg 
GAE/mouse/d for 0.1X, 1X, and 2X, respectively. 
 Diet and treatments. The consumption of anthocyanins for the AFFB group (8.35 mg/kg 
BW/d), was almost the same and not statistically different (p > 0.05) as the amount consumed by 
the 1X group (9.04 mg/kg BW/d.). The 0.1X group consumed 1.11 mg/kg BW/d, which was 
12% of the ANC content present in the AFFB and 1X PAE group. The highest PAE group 
consumed twice as much (18.9 mg/kg BW/d), therefore is referred to as 2X. This is equivalent to 
0.23, 0.032, 0.24, and 0.47 mg C3G/mouse/d for AFFB, 0.1X, 1X, and 2X, respectively. 
Consumption of sucrose was not significantly different between groups (p > 0.05) (Table 10.1). 
While food intake was lower for the 2X group compared to the water control (p > 0.05), the 
metabolic efficiency was not. The metabolic efficiency was determined as the ratio of BW 
gained compared to the amount of diet consumed. This only differed between the 1X PAE and 
sitagliptin mice compared to the 0.1X PAE and water-only mice (p < 0.05).  
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Figure 10.2. HPLC chromatogram of AFFB with RT (retention time, in min) indicating the peaks present at maximum absorbance of 360 nm 
(flavonols), 320 nm (hydroxycinnamic acids), 280 nm (phenolic acids and hydrolysable tannins), and 520 nm (anthocyanins) and the full diode 
array. AFW.BB: Alcohol-free fermented beverage. 
Retention time (min) 
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Figure 10.3. HPLC chromatogram of the phenolic extract PAE with RT (retention time, in min) indicating the peaks present at maximum 
absorbance of 360 nm (flavonols), 320 nm (hydroxycinnamic acids), 280 nm (phenolic acids and hydrolysable tannins), and 520 nm 
(anthocyanins) and the full diode array. PAE.BB: Post-amberlite extract; both are 70% blackberry – 30% blueberry. 
Retention time (min) 
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Table 10.1. Averages of food intake, sucrose consumption, body weight gain, fat and lean mass, and fasting blood glucose, 
throughout the entire study or changes in parameters from baseline to week 12 of the experiment. 
 
        Value  
 
Group 
Avg. total 
Food Intake 
(g) 
Ratio (g BW/ 
g HFD 
consumed) 
Avg. sucrose 
consumption 
(g/day) 
Weight gain 
(g) 
Week 12 % BW 
Fat, (Fat Mass 
Gain  in g) 
Lean 
Mass Gain 
(g) 
Week 12 FBG and 
(change due to 
HFD^) (mg/dL) 
Water 187.8  5.0a 0.10  0.006b 0.30  0.02a 16.7  1.1a 31.1  1.2  
(19.3  1.2)a 
4.9  0.5ab 221.9  7.7a 
(109.2  18.4ab) 
Sitagliptin 188.0  6.0ab 0.11  0.005a 0.30  0.02a 14.9  1.4ab 27.4  2.1  
(15.9  2.0)ab 
4.7  0.4ab 216.9  10.5a 
(119.8  15.2a) 
AFB 181.4  4.2abc 0.10  0.006ab 0.35  0.02a 12.6  0.8bc 23.8  1.5  
(12.2  1.4)bc 
4.5  0.3ab 228.6  6.6a 
 
(107.9  17.9ab) 
0.1X 180.9  4.9ab 0.09  0.003b 0.31  0.01a 14.7  0.9ab 25.6  1.5  
(13.4  1.6)b 
5.4  0.5a 185.0  9.8b 
(49.9  18.7c) 
1X 179.0  3.3bc 0.11  0.007a 0.32  0.02a 11.7  0.4c 21.3  1.6 
 (9.2  1.5)cd 
4.0  0.4b 167.5  9.4b 
(66.3  19.7bc) 
2X 171.7  2.4c 0.10  0.005ab 0.34  0.02a 10.3  0.3c 18.1  0.8  
(6.8  0.9) d 
4.5  0.2ab 183.7  7.3b 
(40.3  17.8c) 
 
HFD, high-fat diet; BW, body weight; FBG, fasting blood glucose. All values are mean  standard error of the mean over the 
course of the experiment. “Gain” indicates a change from week 0. Different letters in each column indicate significant 
differences between groups for that column (p < 0.05). ^Change is from week 3 when the HFD began until the end of the 
study.  
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 Body weight. The body weight of all groups did not differ at baseline (p > 0.05) nor at the 
first week when mice were randomized into treatment groups. After groups were started on the 
high-fat diet for about three weeks they started to gain weight (Figure 10.4A). At the end of the 
experiment, the water group had gained the most weight (16.7 g), though this was not 
significantly different than the weight gained by the mice in the sitagliptin group or the mice 
receiving the lowest ANC concentration (0.1X PAE) (Figure 10.4B). There was, however, a 
marked difference (p < 0.05) in the body weights of the mice receiving the 1X and 2X PAE (11.7 
and 10.3 g BW gained, respectively) compared to the other groups. This attenuation of diet-
induced obesity could also be observed phenotypically comparing mice receiving only water 
(Figure 10.4C) to those receiving the highest dose of PAE (Figure 10.4D).  It was found that 
mice in the group consuming the most anthocyanins (9 or 19 mg C3G/kg BW/d) had the lowest 
body weight gain. 
 A.  
 
Figure 10.4. Body weight in grams throughout time (A), and body weight gain from baseline 
(B). (C) indicates a representative mouse from the water group, and (D) a representative mouse 
from the 2X PAE group at week 12. n=12/group. Different letters indicate significant differences 
(p < 0.05). 
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B. 
 
C.         D.  
 
 
 
 
 
 
Figure 10.4 (contd.)  
 
 
 Body composition analysis. Free and total body water did not differ between the groups 
throughout the study (p > 0.05). The percent body weight for free water decreased for all mice 
throughout the study from 0.62 ± 0.10% at baseline to 0.55± 0.15% at week 12, while total body 
water decreased from 63.8 ± 1.1% at baseline to 51.2 ± 1.3% at week 12. Percent fat mass for all 
groups increased over the course of the study (Figure 10.5A) with clear differences due to 
treatments observed at week 10 and week 12 of treatments, with an inverse association observed 
for percent lean mass (Figure 10.5C). The percent of fat mass for all groups at week 10 was 
lower compared to the water group (p < 0.05). Fat mass gain in absolute terms was also 
significantly (p < 0.05) lower in mice drinking AFFB and all three doses of PAE compared to 
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water (Figure 10.5B). At week 12, the lowest percent fat mass was seen for the 2X PAE group, 
followed by the 1X PAE mice, the AFFB group, the 0.1X, and finally the sitagliptin group which 
did not differ from the water group (p > 0.05). The absolute fat mass followed the same trend as 
the percent fat mass; mice in the 2X group gained the least amount of fat (6.75 g) compared to 
the water group (19.33 g). This trend was mirrored for the percent lean mass in that the percent 
lean mass was highest for the mice receiving the 2X PAE, and mice consuming water had the 
lowest percent lean mass. The percent lean mass was significantly higher for all groups 
compared to the water control mice at week 12 (Figure 10.5C). However, there was no 
difference in the gain in lean mass over time between the groups, except for the mice in the 1X 
group who gained slightly less lean mass than the other groups (Figure 10.5D); the differences 
seen between groups for percent lean mass over time is due to gained fat mass, rather than a 
change in absolute lean mass. Overall, mice in both groups consuming the most anthocyanins 
attenuated the HFD-induced weight gain seen by the water control mice, and also had the lowest 
gain in fat mass (18.0 ± 0.8 % BW).  
 Blood glucose. There was no difference in baseline fasted (4-6 h) blood glucose (FBG) 
due to the treatments for one week before beginning the HFD (Figure 10.6A). After being on the 
HFD for three weeks the mice began to develop the hyperglycemic phenotype, and at week 6, all 
groups had FBG above 120 mg/dL. There was no difference among the groups until week 11, 
when the FBG for both, the 1X and the 2X PAE mice, had a lower FBG than the water group. At 
week 12, all three PAE groups had a lower FBG (p < 0.05) than the water group (221.8 mg/dL) 
at 184.9, 167.4, and 183.4 mg/dL for 0.1X, 1X and 2X, respectively.  
 
 238 
 
A. 
 
B. 
 
 
 
C.  
 
D. 
 
 
bc 
bc 
bc 
ab, ab 
b b 
c cd 
cd 
c d 
d 
b ab 
a 
a 
a 
0
5
10
15
20
25
30
35
1 3 5 7 9 11 13
%
Fa
t 
m
as
s 
Week 
bc 
b 
cd 
d 
ab 
a 
0
5
10
15
20
25
H2O Sitag AFB 0.1x 1x 2x
G
ai
n
 in
 F
at
 m
as
s 
(g
) 
a 
bc 
bc 
cd 
cd 
ab ab b 
a 
a 
a 
bc, bc 
de 
d 
c 
e 
e 
55
60
65
70
75
80
85
90
1 3 5 7 9 11 13
%
Le
an
 m
as
s 
Week 
AFB 0.1X 1X
3X SITAG H2O
ab 
a 
b 
ab ab ab 
0
1
2
3
4
5
6
7
H2O Sitag AFB 0.1x 1x 2x
G
ai
n
 in
 L
ea
n
 m
as
s 
(g
) 
2X 
Figure 10.5. Fat mass as a percent by week (A), and as an absolute change (B) was significantly lower in mice drinking AFFB and 
all three doses of PAE compared to water. Percent lean mass was significantly higher for all groups compared to the water control 
mice at week 12 (C), but there were no significant differences in terms of absolute lean mass (D). Different letters indicate significant 
differences (p < 0.05) for that week (A and C) and in (B and D) different letters indicate significant differences for absolute mass gain 
(p < 0.05). Mice were scanned with an EchoMRI-700 Body Composition Analyzer. n=12/group. 
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 Considering the change in blood glucose that was induced by consumption of the HFD, all 
three doses of the phenolic extract attenuated the HF-driven hyperglycemia with the 0.1X and 
the 2X mice the most effective (Figure 10.6B). FBG for 1X and 2X groups was also 
significantly lower than the sitagliptin group (216.9 mg/dL, p < 0.05). The increase in FBG due 
to the HFD for the group receiving 1X PAE was also not different from either the AFB or the 
sitagliptin group. Further, AFFB and sitagliptin were not able to attenuate the induction of 
hyperglycemia due to the consumption of the HFD compared to water.  
A.  
B.  
 Figure 10.6. Fasting blood glucose induced by the HFD was attenuated by the PAE. Mice 
(n=12/group) were morning fasted 4-6 h and treatments were replaced with plain water until tail 
blood was measured for glucose using an Alpha-Trak2 handheld glucometer. *Indicates 
significant (p < 0.05) difference from water group for that week. Different letters for gains 
indicate significant (p < 0.05) differences between groups (change from week 3 to week 12).   
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 Insulin content and HOMA-IR calculation. Fasting plasma insulin did not differ due to 
treatments; all mice became hyperinsulinemic (Table 10.2), as expected for this strain of mice. 
At the end of the study (week 12), the range of insulin was from 2.43 to 2.95 ng/mL. When 
considering the glucose along with the plasma insulin all three PAE groups had a calculated 
HOMA-IR lower than the water group, while the HOMA-β for the PAE groups were all higher 
than the water group (Table 10.2). HOMA-IR is a calculated value that provides the degree of 
insulin resistance, while HOMA-β is a calculated value indicating the percent beta cell function. 
This takes into account both the plasma glucose and insulin that was confirmed with 
immunohistochemical detection of insulin and glucagon content in pancreatic islets (results 
shown in the histochemical assessment of the pancreas section below).  
 Plasma triglycerides. Plasma triglycerides were highest for the mice receiving water, 
sitagliptin, or the AFFB that was attenuated by the mice receiving the highest amount of phenolic 
compounds (1X and 2X) (Table 10.2). There was no difference (p > 0.05) between the 1X and 
2X mice, similar to the results seen for the reduction in fat mass.  
 Plasma DPP-IV activity. Plasma DPP-IV was evaluated to determine the effect on 
prolonging incretin action by reducing the activity of this incretin-cleaving hormone. As 
expected, sitagliptin, used as the control of DPP-IV inhibition, was able to decrease the maximal 
activity of DPP-IV seen in the water group by 36.6% activity. There were also decreases of 16.7 
and 11.5 % for AFFB and 0.1X PAE, respectively. There was a trend to decrease, but was not 
significant, the DPP-IV activity in the mice receiving the higher doses of the phenolic extract. 
 Tissue analysis.  Table 10.3 indicates the weights of the tissues collected at the end of the 
study. There was no effect on the weights of the spleens or the weight of the pancreas (when 
corrected for BW) and no major differences in the weights of the lungs.  
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Table 10.2. Absolute weight and relative to body weights of spleen, pancreas, liver, kidney, lungs, heart, pericardial fat, 
and visceral adipose in g (% of BW) collected at the end of the study.  
 
Group Spleen Pancreas  Liver  Kidney  Lungs Heart Pericardial 
adipose 
Total 
Visceral 
Adipose^ 
Water 0.072 ± 0.002 
(0.22 ± 0.01) 
 
0.227 ± 0.013
a 
(0.71 ± 0.03) 
1.081 ± 0.035
c 
(3.37 ± 0.09
D
) 
0.342 ± 0.008
ab
 
(1.06 ± 0.02
C
) 
0.132 ± 0.005
b
 
(0.41 ± 0.01
D
) 
0.113 ± 0.015
a
 
(0.35 ± 0.04
CD
) 
0.026 ± 0.006
ab
 
(0.06 ± 0.02
AB
) 
2.431 ± 0.158
a 
(7.52 ± 0.37
A
) 
Sitag 0.074 ± 0.006 
(0.24 ± 0.02) 
0.224 ± 0.017
a 
(0.72 ± 0.03) 
1.026 ± 0.035
c 
(3.34 ± 0.08
D
) 
0.332 ± 0.013
ab
 
(0.98 ± 0.09
C
) 
0.132 ± 0.008
b
 
(0.44 ± 0.04
CD
) 
0.127 ± 0.005
ab
 
(0.41 ± 0.01
D
) 
0.030 ± 0.010
a
 
(0.09 ± 0.02
A
) 
2.088 ± 0.282
ab 
(6.46 ± 0.56
AB
) 
AFB 0.073 ± 0.012 
(0.27 ± 0.04) 
0.175 ± 0.018
bc 
(0.65 ± 0.07) 
1.071 ± 0.093
c 
(3.99 ± 0.35
CD
) 
0.332 ± 0.020
ab
 
(1.24 ± 0.08
AB
) 
0.130 ± 0.004
b
 
(0.48 ± 0.02
BC
) 
0.121 ± 0.003
b
 
(0.45 ± 0.01
BC
) 
0.015 ± 0.002
ab
 
(0.04 ± 0.01
BC
) 
1.438 ± 0.191
cd 
(5.12 ± 0.54
CD
) 
0.1X 0.067 ± 0.002 
(0.23 ± 0.01) 
0.209 ± 0.013
ab 
(0.72 ± 0.05) 
1.326 ± 0.046
b 
(4.52 ± 0.14
C
) 
0.326 ± 0.007
b
 
(1.11 ± 0.03
BC
) 
0.135 ± 0.004
b
 
(0.46 ± 0.02
CD
) 
0.124 ± 0.003
ab
 
(0.42 ± 0.01
CD
) 
0.024 ± 0.005
ab
 
(0.06 ± 0.01
ABC
) 
1.773 ± 0.188
bc 
(5.88 ± 0.43
BC
) 
1X 0.070 ± 0.004 
(0.26 ± 0.01) 
 
0.191 ± 0.007
ab 
(0.72 ± 0.02) 
1.871 ± 0.140
a 
(7.02 ± 0.52
B
) 
0.356 ± 0.009
a
 
(1.33 ± 0.02
A
) 
0.149 ± 0.003
a
 
(0.56 ± 0.01
A
) 
0.109 ± 0.013
ab
 
(0.41 ± 0.05
AB
) 
0.016 ± 0.003
ab
 
(0.05 ± 0.01
BC
) 
1.125 ± 0.065
de 
(4.19 ± 0.19
DE
) 
2X 0.065 ± 0.002 
(0.27 ± 0.01) 
 
0.165 ± 0.005
c 
(0.67 ± 0.03) 
2.004 ± 0.056
a 
(8.17 ± 0.13
A
) 
0.340 ± 0.007
ab
 
(1.39 ± 0.04
A
) 
0.132 ± 0.005
b
 
(0.54 ± 0.02
AB
) 
0.110 ± 0.007
b
 
(0.45 ± 0.03
A
) 
0.009 ± 0.001
b
 
(0.02 ± 0.01
C
) 
0.820 ± 0.073
e 
(3.30 ± 0.24
E
) 
 
^Total visceral adipose includes both the epididymal and retroperitoneal fat pads. Data are mean ± standard error of the mean, n = 
9-12. Different lowercase letters indicate significant differences for that organ by weight and different uppercase letters by % of 
BW; no letters indicate there were no differences (p > 0.05). BW, body weight.
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 Mice in the 2X group had the smallest hearts in terms of absolute mass that were largest as 
a percent of BW. There was a significant reduction in the percent weight of pericardial fat by the 
AFFB, 1X and 2X PAE compared to the water as well as a dramatic reduction in total visceral 
adipose in both absolute weight and when corrected for BW. There was an unexpected increase 
in the weights of the livers by both the 1X and 2X PAE, which prompted further 
histomorphological investigation. 
 Histomorphologic features of the pancreas. Staining with Hematoxylin and Eosin (H&E) 
indicated no presence of apoptosis, inflammation, necrosis or fibrosis in any of the groups 
(Figure 10.7A1-A6). The islet diameter for all groups fell within the functional range; they were 
the largest for the sitagliptin treated mice (151 ± 23 µm), with no difference from the 1X and 2X 
PAE groups (p > 0.05), while mice in the AFFB group had the smallest islet diameters (111 ± 17 
µm). The relative insulin and glucagon content indicated that most islets stain strongly for 
glucagon on the periphery of the islets (α-cells) while the staining for insulin occurs in the 
majority of the islet, indicating β-cells (Figure 7B). Results of insulin and glucagon content of 
the pancreatic islets in consideration with the total number of islet cells determine any difference 
in the functionality of the pancreatic β-cells. As most of the mice were hyperinsulinemic, many 
of the β-cells stained only lightly for insulin as much of the insulin had been secreted already, 
however there was stronger staining present for glucagon. The amount of proliferating cells in 
pancreatic islets was also determined by staining with PCNA; the more cells that are 
proliferating in the pancreatic islets may indicate apoptosis of the currently existing β-cells. 
There was a trend to increase the number of proliferating cells per islet in the sitagliptin group 
(1.8 ± 0.2 cells/islet) that was only significantly different (p < 0.05) than the 2X mice that had 
the fewest proliferating cells per islet (1.1 ± 0.2 cells/islet).  
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Table 10.3. Insulin, calculated insulin resistance and -cell function, triglycerides, DPP-IV, and liver functional enzymes 
analyzed in fasting plasma. 
 
       Value  
 
Group 
Insulin 
(ng/mL) 
HOMA-IR HOMA-β 
(%) 
Triglycerides 
(nmol/μL) 
[DPP-IV]  
(% of water) 
ALT (U/L) AST (U/L) AST:ALT 
ratio 
ALP 
(U/L) 
Water 2.95  0.28a 3.75  0.4a 15.8  1.5b 1.23  0.39a 100.0  5.4a 69  25b 324  138a 3.8  0.6ab 53  2c 
Sitagliptin 2.50  0.19a 3.30  0.4ab 14.5  1.1bc 1.13  0.34a 63.4  4.1c 35  5b 194  36a 5.0  0.6a 54  2c 
AFB 2.57  0.19a 3.37  0.3ab 13.0  1.0c 1.20  0.10a 83.3  2.7b 91  36ab 250  48a 4.2  0.7ab 63  2bc 
0.1X 2.55  0.17a 2.69  0.2bc 18.7  2.1ab 1.03  0.08ab 88.5  6.9b  71  19b 259  72a 3.8  0.3ab 77  4b 
1X 2.43  0.21a 2.29  0.2c 21.6  2.9a 0.65  0.07c 90.8  3.4ab  52  7b 171  23a 3.4  0.3bc 219  7a 
2X 2.57  0.30a 2.67  0.3bc 18.5  2.8ab 0.76  0.10bc 93.5  1.7ab 146  34a 257  46a 2.1  0.2c 234  9a 
HOMA, homeostatic model assessment; HOMA, homeostatic model assessment; IR, insulin resistance as [blood glucose 
(mmol/L)*serum insulin (mU/L))/22.5]; %β, percent beta cell function as [20* serum insulin (mU/L))/blood glucose (mmol/L) – 
3.5]*100%]; DPP-IV, dipeptidyl peptidase IV; ALT, alanine transaminase; AST, aspartate transaminase; ALP, alkaline phosphatase. 
GGT, gamma-glutamyl transferase, was not detected in any of the groups (except 0.1X, 0.1 ± 0.1 U/L) and total bilirubin was not 
different between the groups (p > 0.05) and ranged from 0.1   0.01 mg/dL for 2X to 0.2  0.03 mg/dL for all other groups. All values 
are mean  standard error of the mean. Different letters in each column indicate significant differences between groups for each 
column (p < 0.05).  
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Figure 10.7. Representative images hematoxylin and eosin stained tissue indicating average 
diameter (µm) of A) pancreatic islets (40x zoom), and B) islets stained for glucagon (-a) and  
insulin (-b) as an example of staining in order to do calculations of β-cell functionality (40x 
zoom); and C) diameter of adipocytes in epididymal fat pads (10x zoom); where numbered 
subscripts indicate treatment group: 1 - water, 2 - Sitagliptin, 3 - AFFB, 4 - 0.1X PAE, 5 - 1X PAE, 
6 - 2X PAE. Different letters indicate significant differences (p < 0.05) for that tissue. 
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 Histomorphologic features of adipose. The macrophage infiltration in the adipose was not 
markedly different between treatments (Figure 10.7 C1-C6), however the adipocyte size 
(diameter) was significantly smaller for both the 1X and 2X mice compared to the water group 
that had the largest adipocyte diameters (94.8 ± 2.6 µm). There was no difference seen by the 
sitagliptin nor the 0.1X dose of PAE compared to water; but the AFFB was also able to reduce 
the adipocyte diameter compared to water (p < 0.05). The results for the adipocyte diameter 
mimic the results for the total visceral adipose weight (Table 10.2).  
 Histomorphologic features of the liver. The weights of the livers in the mice receiving the 
PAE were significantly higher than all the other groups of mice (Table 10.3); therefore, the 
livers were analyzed by histopathological assessments. The livers in these groups appeared pink 
and smooth during necropsy, with no obvious indications of fat accumulation or damage. 
Staining of livers with H&E indicated no clear inflammation, necrosis or apoptosis (Figure 10.8 
A1-A6); however, we detected an unexpected lipidosis present in the PAE groups (Figure 10.8 
A5 and 10.8 A6). These lipids were both macro- as well as microvesicular and located focally 
only in the periportal region compared to the lipids in the HFD-fed water mice that were located 
in zone 2 (Figure 10.8 A1). Using a standard NAFLD scoring tool to assess the degree of 
lipidosis from 1-5 where 5 indicates the most severe lipidosis present throughout the whole liver, 
there were lipids present in the HFD-water control mice that was at a similar level to those 
present in the sitagliptin group (p > 0.05). There was no lipidosis present in any of the AFFB 
mice, however the PAE extract exhibited an increasing amount of lipids and distribution with the 
higher doses indicated in Figure 10.8A. The liver lipids in the 1X and 2X groups indicated an 
adverse effect due to dose, rather than a response to the high-fat feeding as the lipid distribution 
and intensity differs from the HFD-induced lipids in the water control mice.  
 246 
 
A) 
  
 
 
 
 
 
 
B)  
   
 
 
 
 
 
 
 
 
 
 
 
        
 C1.  C2. 
Figure 10.8. Representative images of livers stained for A) Hematoxylin and eosin (20x zoom) 
with the subjective NAFLD score; B) malondialdehyde to determine lipid peroxidation present 
with percentage of livers that stained moderately, as represented, or strongly  in that group (20x 
zoom). Subscripts for A) and B) indicate group: 1 - water, 2 - Sitagliptin, 3 - AFFB, 4 - 0.1X PAE, 
5 - 1X PAE, 6 - 2X PAE; and C) proliferating cell nuclear antigen to determine cell proliferation 
between the water  mice (C1) and 2X (C2) at 20x zoom. B) and C) have a background stain of 
Hematoxylin. Different letters indicate significant differences (p < 0.05) for that tissue.  
A1 A2 A3
A4 A5 A6
0.7 ± 0.2c 
0.8 ± 0.2c 
0.6 ± 0.2cd 
1.7 ± 0.2b 
0.1 ± 0.1d 
2.4 ± 0.1a 
B1 B2 B3
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75% 
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 To further assess the changes observed in the liver due to PAE, malondialdehyde (MDA) 
staining was obtained to determine the degree of fatty acid peroxidation, as well as proliferating 
cell nuclear antigen (PCNA) to determine the effect on proliferation. Figure 10.8B illustrates the 
representative oxidation seen by malondialdehyde present in the livers; while most groups 
indicated MDA staining that was moderate or strong, there was no increase in the proportion in 
the 1X or the 2X group compared to the water-control group; the toxicity by these high doses 
was apparently not due to lipid peroxidation. There was a difference seen in the amount of 
proliferating hepatocytes present in the livers of the 1X and 2X PAE fed mice and water mice; 
there were many more proliferating hepatocytes focally distributed in the 2X mice (Figure 
10.8C). Plasma was analyzed for liver function by screening for ALT, AST, GGT, ALP and total 
bilirubin (Table 10.3). There was no difference in aspartate transaminase (AST) but there was a 
2.1-fold increase in the alanine transaminase (ALT) levels seen by the mice receiving the highest 
dose of the PAE. An increase in ALT but not AST can be due to excess alanine amino-group 
transfer to form glutamate and pyruvate. The AST to ALT ratio is also helpful in differentiating 
causes of liver damage; in this study the ratios for all groups were above 2, and were actually 
lowest for the 2X group. Alkaline phosphatase (ALP) was the only liver enzyme with a 
significant increase for both the 1X and 2X PAE groups. Total bilirubin was not increased (p > 
0.05) in any of the groups (average of 0.16 ± 0.01 mg/dL for all mice). 
 Gene expression analysis. To determine what mechanisms may have contributed to the 
lowering of HFD-driven hyperglycemia in the mice receiving PAE, gene expression changes in 
the pancreas were evaluated. Figure 10.9 shows the heat map generated for the Illumina array; 
there was a trend to shift the expression profile with the water and sitagliptin groups having a 
similar pattern, but different from both the AFFB and 0.1X, and the 1X and 2X. 
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10.9. Heat map illustrating the trend of up-regulated (red) or down-regulated (blue) genes in pancreatic RNA of the mice extracted 
from RNAlater-stabilized frozen pancreatic tissue (n = 4/group) and gene expression analyzed using an Illumina MouseWG-6 v2.0 
Expression BeadChip. 
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 Within the full list of the represented genes in the microarray compared to the control of 
the water group, 1, 29, 202 and 123 were found to be differentially expressed for AFFB, 0.1X, 
1X and 2X respectively (Figure 10.10).  No genes were significantly modified compared to 
water for the sitagliptin group. With FDR < 0.3 (30% chance of false discovery rate, based on the 
fact that the most highly expressed genes within the pancreas will be secretory or enzyme-related 
due to the highly specialize pancreas function), 1X and 2X treatments shared 66 differentially 
expressed genes (DEGs). Interestingly, 0.1 X, 1X and 2X treatments shared 7 DEGs and only 
one Kdsr (3-ketodihydrosphingosine reductase), which encodes proteins involved in the 
biosynthesis of sphingolipids, was shared by the four treatments including AFFB. 
     
10.10. Venn diagram of shared differentially expressed genes (DEGs) between the treatments, 
false discovery rate < 0.3. 
 
 Analysis of this set of genes using DAVID showed that using functional annotation 
clustering, 8, 52 and 26 were generated for 0.1X, 1X and 2X respectively. However, only 6 and 1 
2X 
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clusters had an enrichment score > 1.3 (-log p-value) equivalent to p=0.05) for 1X and 2X 
respectively (Tables 10.4 and 10.5). The highly-enriched clusters were associated mainly to 
cellular localization of the molecules, as there were no associations found with canonical 
pathways. The main clusters affected by 1X were related to ribosomal function, Ubl conjugation, 
oxidation reduction, mitochondrial structure, NAD(P) binding, and antioxidant activity. There 
was only one cluster with significant enrichment scores for the 2X treatment that was related to 
ribosomal structure and function.  
Table 10.4. Functional annotation clustering with significant enrichment scores for 1X PAE 
treatment. 
Annotation cluster 1 
Enrichment Score: 4.93 Count P-Value 
Ribosome 11 2.3E-8 
Translation 16 4.7E-7 
Structural constituent of ribosome  12 4.7E-7 
Intracellular non-membrane-bounded organelle 29 3.7E-2 
Annotation cluster 2 
Enrichment Score: 2.19 Count P-Value 
Ubl conjugation 14 1.6E-3 
Cross-link:Glycyl lysine isopeptide (Lys-Gly) 
(interchain with G-Cter in ubiquitin) 
7 9.3E-3 
Isopeptide bond 8 1.8E-2 
Annotation cluster 3 
Enrichment Score: 2.07 Count P-Value 
Oxidation reduction 15 5.7E-3 
Annotation cluster 4 
Enrichment Score: 1.51 Count P-Value 
Mitochondrion 25 4.6E-3 
Respiratory chain 5 4.6E-3 
Mitochondrial matrix 4 2.4E-1 
Mitochondrial lumen  4 2.4E-1 
Annotation cluster 5 
Enrichment Score: 1.42 Count P-Value 
Nucleotide phosphate-binding region:NADP 4 2.7E-2 
NAD(P)-binding domain  4 1.7E-1 
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Annotation cluster 6 
Enrichment Score: 1.38 Count P-Value 
Peroxidase activity 3 3.4E-2 
Oxidoreductase activity, acting on peroxide as 
acceptor 
3 3.4E-2 
Antioxidant activity 3 6.5E-2 
 
Genes were analyzed using DAVID functional annotation clustering; 52 total clusters were 
generated for 1X PAE. Enrichment scores are considered significant if > 1.3 [-log(p-value) 
equivalent to p=0.05]. 
 
Table 10.5. Significant enrichment scores generated by functional annotation clustering for 2X 
PAE treatment 
Annotation cluster 1 
Enrichment Score: 1.71 Count P-Value 
Translation 9 6.1E-4 
Ribosome  5 1.2E-3 
Structural constituent of ribosome  6 2.5E-3 
Intracellular non-membrane-bounded organelle 10 8.7E-1 
Non-membrane-bounded organelle 10 8.7E-1 
 
Genes were analyzed using DAVID functional annotation clustering; 26 total clusters were 
generated for 2X PAE. Enrichment scores are considered significant if > 1.3 [-log(p-value) 
equivalent to p=0.05]. 
 
 An alternative approach used to identify biological processes affected by the treatments 
was Ingenuity® Pathway Analysis (IPA). Further enrichment analysis on canonical pathways of 
IPA Knowledge Base provided significant overlaid pathways through the list of DEGs, finding 
potential activation of amino acid metabolism pathways by the treatments (Table 10.6). Highly 
correlated gene network among DEGs in pancreatic tissue was highest for cell cycle and cellular 
development (S=41), carbohydrate metabolism, molecular transport and small molecule 
biochemistry (S=38), and metabolic disease, lipid metabolism and molecular transport (S=25) for 
0.1X, 1X and 2X treatments respectively.  
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Table 10.6. Comparison analysis among PAE treatments of differentially expressed genes by top 
canonical pathway, predicted downstream function and network. 
           Samples 
Comparison 
0.1X 1X 2X 
Top canonical 
pathways 
Glycine biosynthesis 1       
(p=0.00209, ratio=1/2) 
Methionine degradation I 
(p-value = 0.00356, 
ratio= 2/17) 
Methionine degradation I 
(p-value=0.00153, 
ratio=2/17) 
dTMP de novo 
biosynthesis (p-
value=0.00522, 
ratio=1/5) 
Cysteine biosynthesis III 
(p-value = 0.00445, 
ratio= 2/17) 
Cysteine biosynthesis III 
(p-value=0.00191, 
ratio=2/19) 
Folate 
polyglutamylation (p-
value=0.00522, 
ratio=1/5) 
Alanine degradation III 
(p-value = 0.0105, ratio= 
1/2) 
Superpathway of 
methionine degradation 
(p-value=0.00539, 
ratio=2/32) 
Top biological 
functions 
Cell cycle (p-
value=0.036, M=4) 
Carbohydrate metabolism 
(p-value = 0.000142, 
M=15) 
Amino acid metabolism 
(p-value=0.0238, M=6) 
Cellular development 
(p-value=0.047, M=8) 
Molecular transport (p-
value = 0.000142, M= 
16) 
Molecular transport (p-
value=0.0271, M=12) 
Lipid metabolism (p-
value=0.049, M=6) 
Small molecule 
biochemistry (p-value = 
0.000142, M=24) 
Small molecule 
biochemistry (p-
value=0.0371, M=17) 
Top 
toxicological 
functions 
Increased levels of 
bilirubin (p-value= 
0.00626, M=1) 
Pulmonary hypertension 
(p-value=0.000410, M=4 
Liver cholestasis (p-
value=0.00686, M=1) 
Cardiac arrhythmia (p-
value=0.00209, M=1) 
Glutathione depletion in 
liver (p-value = 0.00528, 
M=2) 
Liver steatosis (p-
value=0.00754, M=4) 
Liver cholestasis (p-
value=0.0417, M=1) 
Glomerular injury (p-
value = 0.00528, M=2) 
Cardiac fibrosis (p-
value=0.0103, M=1) 
Top networks 
Cell cycle, cellular 
development (S=41) 
Carbohydrate 
metabolism, molecular 
transport and small 
molecule biochemistry 
(S=38) 
Metabolic disease, lipid 
metabolism and 
molecular transport 
(S=25) 
Cardiovascular 
disease, hematological 
disease, hereditary 
disorder (S=3) 
Cell cycle, cellular 
development and cellular 
growth and proliferation 
(S=24) 
Protein synthesis, cellular 
assembly and 
organization, cellular 
compromise (S=25) 
Embryonic 
development, 
infectious disease 
(S=2) 
Connective tissue 
disorders, dermatological 
diseases (S=24) 
DNA replication, 
recombination, cell cycle 
(S=23) 
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Table 10.6 (contd.) 
 
T
o
p
 m
o
le
cu
le
s 
Fold 
change 
up-
regulated 
Acot1 ↑7.42 REEP ↑3.84 REEP ↑3.88 
ANGPTL4 ↑3.94 GDF15 ↑2.46 SLAMF9 ↑2.43 
NR1H4 ↑2.57 SLAMF9 ↑2.05 NDRG2 ↑2.09 
SHMT2 ↑1.81 AZGP1 ↑1.98 SLC7A3 ↑2.08 
RANGFR ↑1.74 SLC7A3 ↑1.86 MAT1A ↑2.05 
Fold 
change 
down-
regulated 
GPER ↓-1.90 GCNT1 ↓-2.69 RPRM ↓-2.53 
FOXO1 ↓-1.63 RPRM ↓-2.45 GCNT1 ↓-2.34 
TOP1 ↓-1.58 COBL ↓-2.06 LPL ↓-2.07 
ME2 ↓-1.54 OXCT1 ↓-2.00 COBL ↓-2.05 
PAF1 ↓-1.46 ADH1C ↓-1.92 GDE ↓-1.99 
Results were interpreted using Ingenuity® Pathway Analysis at FDR <0.3, significance indicates 
the probability of association of molecules from the dataset with the canonical pathway by 
random chance alone. M: number of molecules; S: Score = -log(Fisher's Exact test result) = 6. 
  
 Additionally, a Downstream Effect Analysis was performed using IPA, which identified 
biological functions that were expected to be increased or decreased given the observed gene 
expression changed in a data-set uploaded to the software. The differential gene expression of 
the treatments resulted in a high (absolute z-score of ≥ 2) predicted decrease of concentration of 
glucose for 0.1X (z-score = -2.12), 1X (z-score = -2.12) and 2X (z-score = -2.71) (Figure 10.11).  
A.  
  Figure 10.11. Predicted downstream function to inhibit D-glucose concentration by all 
three PAE treatments 0.1X (A), 1X (B) and 2X (C). RNA extracted from RNAlater-stabilized 
frozen pancreatic tissue (n = 4/group) and gene expression analyzed using an Illumina 
MouseWG-6 v2.0 Expression BeadChip. Results were interpreted using Ingenuity® Pathway 
Analysis at FDR <0.3. 
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B.  
C.  
 
Figure 10.11 (contd.)  
 
 
Discussion 
 We found that C57BL/6j mice in the groups consuming the most anthocyanins had the 
lowest body weight gain due to an attenuated gain in fat mass induced by the HFD, while 
absolute lean mass did not differ. Mice in the 2X group did consume less of the HFD than the 
mice getting only water, but it is not clear whether the reduction of diet intake was the cause or 
effect of reduction in body weight. The fact that a dose-response was not found between the two 
highest doses of the PAE agree with previous work showing that lower (1 mg/mL) doses of ANC 
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may be effective to reduce obesity markers but higher doses may not [15]. Another study 
indicated a dose of 2 mg ANC/mouse/d may be close to the upper limit that is effective for ANC 
as they tested 1.8 mg ANC/mouse/day and it was not effective, while the upper limit of purified 
ANC effectiveness was determined to be 6 mg/mouse/day [20]. Additionally, the fact that our 
study utilized a combination of ANC with other phenolic compounds may affect the results in 
comparison with purified ANC in these previous studies. It has been previously seen that 
purified ANC from blueberries and strawberries can prevent HFD-induced dyslipidemia and 
obesity in mice, but whole blueberries do not, and that the sugars and lipid components may be 
masking the benefits of the ANC and other polyphenols [15, 19, 43]. Prevention of diet-induced 
obesity of C57BL/6 mice with ANC in the diet has been done at 50, 100, or 200 mg/kg food 
[18], which is equivalent  to 0.2 and 0.6 mg ANC/day; this is the level of ANC in the AFFB and 
1X groups and the 2X groups, respectively. More studies are needed to determine which 
compound present in the mixture of phenolic compounds extracted from the alcohol-free 
fermented blueberry-blackberry beverage was most effective to blunt the diet-induced obesity. 
 After 3 weeks of treatment, all groups were hyperglycemic, however, at the end of the 
study mice consuming 1X and 2X groups had significantly lower fasting blood glucose than the 
water and the sitagliptin group. The values of fasted insulin were in range of that seen by other 
studies of HFD in C57BL/6J mice as it is expected for this strain of mice to become 
hyperinsulinemic, and supports no differences seen among the groups [15-20, 29]. Improved 
fasting blood glucose and glucose tolerance was seen previously at 12.5 mg ANC/mouse/d [43] 
however these were extracted ANC that were added to the diets at a dose much higher than those 
used in this study. An intervention trial in humans with the addition of blueberry powder 
equivalent to about 2 cups of fresh whole blueberries (668 mg of anthocyanins, or 6.7 mg 
 
 
256 
 
ANC/kg BW/d) reported that these compounds in blueberries improved insulin sensitivity in 
obese, insulin-resistant men and women [10]. Translating to an effective dose in mice, this is 
equivalent to an intervention of 0.16 mg ANC per mouse per day. So, this does fall between the 
dose for the AFFB or 1X PAE and the 2X PAE and indicates the levels of ANC used in our 
study can be consumed by humans and would lead to a positive effect on insulin sensitivity.  
 As no significant reduction in DPP-IV activity by the mice receiving the highest doses of the 
phenolic compounds was observed, the reduction of hyperglycemia by these two groups cannot 
be attributed to an action on DPP-IV. The reduction seen by AFFB but not the 1X and 2X PAE 
suggests there may have been another compound present in the extract which could have 
interfered with the inhibition of DPP-IV. We have previously established ANC, as well as other 
berry phenolic compounds, as effective DPP-IV inhibitors using enzymatic and computational 
modeling, so likely these are the compounds present in AFFB that are effective at reducing the 
activity of DPP-IV in the plasma of the mice, but may also be due to the metabolites produced 
from these compounds [22, 33].  
 The effect on plasma, tissue morphological changes, and gene expression were evaluated 
to understand the reduction in fat mass and fasting blood glucose in the mice consuming AFFB 
or the three doses of PAE. All of the groups were in the range of islet sizes known to have a 
proper insulin secretory response (100-150 µm) [44]. Previous studies have found that there was 
improved -cell function with purified ANC, primarily malvidin-3-glucoside and –galactoside as 
well as delphinidin-3-glucoside, provided in the water at levels of 0.2 mg/mL [15]; which is 
equivalent to 0.49 mg/mouse/d. In our study the 2X mice were consuming ANC close to this 
dose (0.47 mg C3G/mouse/d) indicating that there may have been an effect on the improvement 
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of -cell function to secrete insulin in response to glucose. The results we found for adipocyte 
diameter agrees with the literature in that less obese mice have smaller adipocytes [45].  
 The beneficial results seen by the highest doses need to be taken into consideration with 
the adverse effects seen for increased liver weights. The unexpected periportal liver lipids 
observed in the highest doses of the PAE that were not seen in mice receiving the AFFB  
indicated that there are some compounds in the extract that may have potential toxic effects at 
the provided doses. It was found that the AFFB protected against the HFD-induced lipid 
deposition which may suggest there is a compound in the AFFB blunting the negative effects of 
the extract, or during the extraction process some compounds were increased beyond their 
beneficial effect. As the anthocyanin content was not different between the AFFB and the 1X 
group, these adverse effects seem to be independent of the anthocyanin concentration. Further, 
previous studies conducted using C57BL/6j mice fed blueberries or purified anthocyanins were 
found to have no adverse effects or an improvement in hepatic steatosis caused by high-fat 
feeding [16, 46-49]. Previous studies that found polyphenolic compounds from berry fruit 
prevented inflammation in diet-induced obese mice were an equivalent dose of 120 mg per day 
in humans [46]; this dose is just above that seen for the 0.1X PAE group. Additionally, higher 
levels than those used in this study in db/db mice (equivalent to consuming 160-300 mg C3G per 
kg BW per day of ANC) have been reported to attenuate obesity-associated hepatic steatosis 
without any noticeable detrimental effects on behavior or appetite, and the mice tolerated the 
high doses well [48]. This previous study indicated the kidneys, liver, and heart all showed 
improved or unchanged histopathology as indicated by less heavy livers than the HFD control, 
reduced microvesicular steatosis, and significant reductions in ALT levels. PACs have also been 
previously reported to reduce HFD-induced steatosis at a dose of 100 mg/kg BW/d [50]. The 
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effect of polyphenols from blueberry to inhibit hepatic steatosis in HepG2 cells in vitro was 
previously seen to be primarily due to the phenolic acids, specifically the caffeic acid present 
[51]. These phenolic acids would have been remove during the phenolic extraction process with 
the Amberlite, therefore the PAE may have been less effective than the AFFB, which still 
contained phenolic acids, to inhibit the high-fat diet-induced hepatic lipids.   
 Of the liver functional panel enzymes tested in plasma, ALP was the only enzyme with a 
significant increase for both the highest PAE doses, and increases in this enzyme can occur due 
to peroxisome proliferation or glycogen accumulation rather than lipidosis [52]. Additionally, the 
detected bilirubin levels for all mice falls towards the low end of the reference range (between 
0.1 -1.0 mg/dL) indicating that there was no severe liver failure or hepatitis present in any of the 
groups [53]. Considering the transaminases ALT and AST are markers of liver damage resulting 
in more permeability of hepatocytes, most liver cell injuries result in ASL levels that are lower 
than ALT levels, however this is not what was observed. As GGT was not detected in any of the 
mice, the potential for cholestatic damage or alcoholic liver disease can be eliminated. It is well 
established that rodents are not a good model for studying cholesterol metabolism; as we saw a 
dramatic increase in ALP, it is possible there could have been an alteration on the cholesterol 
metabolism in the livers of the mice causing the lipids to become accumulated rather than 
directed toward circulation and eventual storage in adipose. The histological characterization of 
the increase in ALP and microvesicular steatosis resembles Reye’s syndrome, but additional 
studies will be needed to evaluate any mitochondrial toxicity in the liver. Similar results to 
reduce HFD-induced obesity were seen with purified ANC from mulberry at up to 0.68 mg C3G 
per day, which is higher than the 2X dose of ANC, without any reported toxicity and an 
attenuation of the HFD-induced increases in ALT and AST [16]. A polyphenol-rich extract from 
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lotus has also been used at a dose of 166 mg/kg/d to reduce the ASL, ALT, and ALP levels in 
ethanol-fed mice [54]. The increases in liver enzymes appear to not be due to the dose of the 
ANC but other phenolic compounds present in the PAE. 
 Gene expression changes, while measured in the pancreatic tissue, indicated that an up-
regulation of methionine degradation and cysteine biosynthesis which could have affected the 
liver cholesterol concentrations as methionine is known to induce hypercholesterolemia through 
increased expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase levels [55]. Also, 
highly expressed changes in the cysteine biosynthetic pathway were observed, which occurs due 
to the alternative pathway of methionine breakdown via the reverse-transulfurylation pathway. 
LPL was significantly reduced by both the 1X and 2X groups, indicating these groups may not 
have been able to hydrolyze the triglycerides in lipoproteins such as VLDL. This could also 
explain the focal lipid deposition in the periportal region indicating triglycerides coming from 
the intestine in chylomicrons may not have been hydrolyzed. Taken together, it appears that 
pathways in the liver to maintain normal plasma cholesterol and triglycerides were affected by 
the highest doses of the PAE resulting in lipid accumulation in the periportal region of livers in 
mice consuming 1X and 2X.  
 In the present study, gene-expression profiling in the pancreatic tissue revealed that the 
treatments had effects on amino acid metabolism in addition to its effect on genes that are 
directly involved in concentration of glucose. Although the underlying mechanisms are not well 
understood, glucagon is known to play an important role in amino acid metabolism [56, 57]. 
Hypoaminoacidemia, weight loss, and muscle wasting are key features of glucagonoma [58]; 
conversely, lean body mass and circulating amino acids are increased in mice with targeted 
deletion of the glucagon receptors [59]. Interestingly, the profile of differential gene expression 
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did not overlap with specific canonical pathways; however, the predicted downstream effect for 
the three treatments 0.1X, 1X and 2X pointed to a decrease of glucose concentration. As part of 
these set of genes that predicted a downstream decrease of glucose, the three treatments up-
regulated zinc-a2-glycoprotein 1(AZGP1) gene. In a previous study done by Wargent et al. [60], 
the authors reported that AZGP1 reduced body fat content and improved glucose homeostasis 
and the plasma lipid profile in obese mice, and was suggested that this might be mediated via 
physiological agonism of β3- and possibly β2-adrenoceptors. Moreover, 1X and 2X treatments 
down-regulated LPL. It has been reported that islet LPL contributes to glucose homeostasis by 
acting as an insulin secretion regulator [61], and furthermore, stimulation of LPL activity 
suggests that it may contribute to increasing delivery of lipids to the islets. Acute exposure of 
islets to fatty acids potentiates glucose-stimulated insulin secretion [62], but chronic exposure 
causes impaired insulin responses and beta cell death [63]. On the other hand, an important 
marker down-regulated by 0.1X treatment was FOXO1. Although FOXO1 expression is 
considered as a double-edged sword in the pancreas [64], it has been reported that its inhibition 
protects pancreatic islet β-cells against fatty acid and endoplasmic reticulum stress–induced 
apoptosis [65]. Similarly high doses of ANC from purple corn (10 mg/kg body weight/d) have 
been seen to be protective against pancreatic beta-cell death in db/db mice, with no reported 
adverse effects [66].  From the microarray evaluation of pancreatic tissue of mice, it can be 
inferred that the treatments 0.1X, 1X and 2X, caused differential gene expression of networks 
related to cell proliferation, carbohydrate and protein metabolism. Additionally, the treatments 
exerted their contributing-hypoglycemic effect in pancreas mainly through the modulation of 
genes that have been strongly related to phenotypic changes for improving glucose homeostasis. 
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 While not necessarily an indication of severe liver damage, the unexpected adverse effects 
to increase liver weight and some of the liver enzymes indicated that there is a potentially 
beneficial dose that must be optimized. The amount of blueberry polyphenolics seen previously 
to have a benefit in reducing hyperglycemia, weight gain, and cholesterol in mice was 13.9 mg/d, 
which is half as much as the total polyphenolic concentration of the 2X dose (6.4 mg gallic acid 
equivalents/mouse/d) [19]. Toxicological evaluation of a procyanidin-rich extract from red grape 
skins and seeds determined an LD50 of 5000 mg/kg [67]. The 2X dose was 250 mg phenolics/kg 
BW/d, and because the adverse effects seen have not been reported for ANC, it is important to 
identify which other non-anthocyanin phenolic compound may have been increased to cause the 
adverse effects seen. Compounds that contain a gallic acid moiety or a propyl gallate appear to 
be more cytotoxic to hepatocytes through collapsing the mitochondrial membrane potential and 
forming reactive oxygen species to deplete glutathione levels [68]. It will also be important to 
consider the formation of compounds that may form similar cytotoxic structures during 
absorption and metabolism. 
 Most studies that have reported adverse effects on liver function are due to extremely high 
doses of phenolics at levels that could usually only be consumed in supplement form. For 
example, the toxic dose for epigallocatechin-3-gallate (EGCG) appears to be between daily 
intakes of 500-700 mg/kg for mice, which translates to 30-90 mg/kg for a human, or between 10-
32 cups of green tea [69]. One recent review on the role of isoquercetin is an example of what 
needs to be done to establish a recommended dose of phenolic compounds and that likely there 
may be a U-shaped curve of effect; there are protective or benefits at a middle dose below which 
no benefit is seen, but above which may exhibit adverse events [70]. At higher doses, the very 
same mechanisms that allow the antioxidant and anti-carcinogenic response may cause 
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flavonoids to act as mutagens, pro-oxidants, and inhibitors of key enzymes involved in hormone 
metabolism [71-73]. More studies and controlled treatment trials are needed to add to the 
literature on incidence of adverse effects of polyphenolic compounds at higher doses, especially 
when consumed as a whole extract.  
 In summary, it was found that fasting blood glucose for diet-induced obese mice 
consuming either 9 or 19 mg C3G/kg BW/d was significantly lower than both the water and the 
sitagliptin groups, indicating there were effects beyond DPP-IV inhibition. Additionally, mice in 
the group consuming the most anthocyanins had the lowest body weight gain through reduced fat 
mass that was correlated with visceral fat and plasma triglycerides, while absolute lean mass was 
not affected. There was an unexpected finding of enlarged livers by the two highest doses 
indicating some of the adverse effects that can be seen due to excess consumption of compounds 
that are beneficially effective at lower doses, which requires additional studies to optimize 
benefits with no adverse effects. Overall, phenolic compounds extracted and concentrated from 
the fermented blueberry-blackberry beverage reduced weight gain, fat mass accumulation, 
plasma triglycerides, and fasting blood glucose in diet-induced obese mice. Considering the 
efficacy and the unexpected enlarged livers, the dose at which the combination of compounds 
present in the PAE will be most beneficial is between 1.1 mg C3G/kg/d and 9 mg C3G/kg/d. 
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CHAPTER 11 
CONCLUSIONS 
 
 Wines produced from blueberries and blackberries have high total polyphenolics and total 
anthocyanin contents which correlate with their antioxidant capacity. 
 Blueberries and their fermented products are good natural sources of polyphenols, antioxidants, 
and in vitro inhibition of α-amylase and α-glucosidase; fermentation retained the in vitro starch 
degrading enzyme inhibitory capacity of Highbush blueberries (Vaccinium corombosum). 
 ANC and PAC at 100 µM C3G or epicatechin equivalents obtained from blueberry-blackberry 
blends reduced the phosphorylation of the p65-subunit NFκB, decreased iNOS and COX-2 
expression, and decreased NO production in RAW 264.7 mouse macrophages. Along with the 
high antioxidant capacity and phenolic content and ability to decrease enzyme activity related 
to improved glucose utilization, bioactive ANC and PAC compounds present in fermented 
berry beverages may act synergistically to reduce risk factors for chronic inflammatory 
diseases. 
 ANC isolated from blueberry-blackberry wine blends and a variety of other phenolic 
compounds commonly present in citrus, berry, soy, and other plants could strongly inhibit 
DPP-IV activity, supporting the role of flavonoids to act as naturally occurring DPP-IV 
inhibitors. 
 Blueberry-Blackberry blend ANCs are potential inhibitors of inflammation-related adiposity 
response and sensitizers of insulin signaling in adipocytes through their action to blunt 
adiponectin gene expression induced by TNF-α treatment (18.2%) and reduce glycerol release 
in adipocytes. (15.9%) induced by LPS-induced macrophage conditioned media.   
 Bioactive ANC and PAC from fermented berry beverages reduced incretin-cleaving hormone 
DPP-IV protein activity and protein expression in Caco-2 cells, increased insulin secretion of 
iNS-1E pancreatic β-cells both directly and following a dual-cell layered model of simulated 
absorption, up-regulated genes of insulin-receptor associated proteins and GLP-1, and down-
regulated PTP1B in iNS-1E cells, and enhanced insulin receptor signaling and up-regulation of 
proteins IGFBP-2 and -3, IGF-II, and VEGF. 
 Diet-induced obese mice consuming either 9 mg C3G/kg BW/d had significantly lowered 
fasting blood glucose, the lowest body weight gain via reduced fat mass gain, and reduced 
visceral fat and plasma triglycerides. 
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INTEGRATION AND FUTURE WORK 
 
There are increasing numbers of teens and adults that have pre-diabetes in the United 
States and worldwide, the number of people with diabetes is projected to increase from over 360 
million in 2014 to over 550 million by 2030. Diabetes causes severe complications if glucose is 
not monitored and is a major contributing factor of rising health costs. In general, diets that are 
high in fruit and vegetable intake have been linked to a decreased risk of chronic diseases; 
specifically, increased berry consumption has been linked to improved cognitive function and 
decreased incidence of inflammatory diseases such as cardiovascular disease and cancer. There 
is a need to develop strategies for diabetes management in order to decrease the incidence and 
deaths from diabetes-related complications. It is important to first understand the chemistry and 
investigate inflammatory pathways leading to increased chronic diseases in order to suggest 
ways to prevent or manage them.  
My research presented in this dissertation was designed to investigate the overall 
understanding of berry fruit compounds as they relate to inflammatory diseases focusing on type-
2 diabetes. This work focused on the evaluation of blueberry (Vaccinium corymbosum) and 
blackberry (Rubus spp.) fermented beverages and their bioactive components to reduce 
progression and onset of type-2 diabetes. Blueberries and blackberries are a rich source of 
anthocyanins (ANC), water-soluble pigments that give berries their red, blue, and purple color. 
Increased consumption of ANC and ANC-containing foods results in decreased risk for type-2 
diabetes. Berries also contain proanthocyanidins (PAC), polymerized forms of ANC. Berry 
fermentation increases extraction from fruit skins and is a viable way to increase the phenolic 
content of berry juice products, thus increasing the potential for health benefits. Current incretin-
based therapies have potential for treatment of type-2 diabetes as the incretin hormone glucagon-
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like peptide-1 (GLP-1) is able to stimulate insulin release; however, it is rapidly degraded to 
inactive metabolites by the enzyme dipeptidyl peptidase-IV (DPP-IV). Our results using 
computational and enzymatic studies indicated that ANC are strong inhibitors of DPP-IV.  We 
have also shown that fermented blueberry-blackberry beverages have a high antioxidant 
capacity, total phenolics, and have identified these compounds using HPLC-MS/MS analysis of 
anthocyanin and proanthocyanidin extracts. We showed in vitro inhibition of markers of 
inflammation and the enzyme DPP-IV as well as the ability of these compounds to increase 
insulin secretion from pancreatic β-cells in vitro. Finally, we showed the efficacy of these 
compounds animal study investigating their potential to reduce obesity and hyperglycemia in 
C57BL/6j mice fed a high-fat diet.The primary findings from each of the five aims presented in 
this dissertation are included below, with a brief discussion of their relevance.  
Aim 1 Conclusions: Blackberry 
wines (n = 6) had an average total 
phenolic content of 2212.5 ± 1090.3 mg 
ellagic acid equivalents (EAE) per liter, 
total anthocyanin content of  75.56 ± 
70.44 mg/L, and antioxidant capacity 
(AC) of 26.39 ± 17.95 mmol trolox 
equivalents (TEs) per liter. Blueberry 
wines (n = 4) had an average total 
phenolic content of 1623.3 ± 645.5 mg EAE per liter, total anthocyanin content of 20.82 ± 12.14 
mg/L, and AC of 21.21 ± 7.71 mmol TE per liter. Strong positive correlations were found 
between total phenolic compounds and AC (r = 0.88). Fruit wines made from blueberries and 
blackberries may have potential health applications and therefore could contribute to the 
economy of the wine industry, especially in the state of Illinois. The fermentation process may 
create more stable polymers of the beneficial pigment compounds as well as new compounds 
that may also have health benefits. 
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Figure 11.1: Increase in total polyphenols as ellagic 
acid equivalents due to fermentation comparing 
room temperature (RT, 20°C) and cold temperature 
(CT, 4°C). 
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Aim 2 Conclusions: The wines maintained similar action to inhibit α-amylase and α-
glucosidase as the berries, relative to the positive control acarbose, a known anti-diabetic drug 
(from 91.8 to 103.3% for α-amylase and from 103.2% to 190.8% for α-glucosidase). Cold 
temperature fermentation had a larger increase in antioxidant capacity of blueberry wine than 
room temperature fermentation.  
The overall impact of these initial studies provides valuable information that blueberries 
grown in southern Illinois are a good source of polyphenols and antioxidant capacity, and a 
natural source of starch degrading enzyme inhibition in vitro. Wine made from blueberries and 
blackberries, especially when fermented at cold temperatures, have increased antioxidant 
capacity. The commercial availability of wines containing high amounts of beneficial 
anthocyanins and antioxidants provides grounds to optimize high quality characteristics with 
potential health beneficial effects. These results suggest that fruit wines made from blueberries 
and blackberries may have potential health applications based on their high polyphenolic 
concentration.  
Specific Objective 3.1 Conclusions: Total ANCs of the wine were strongly correlated to 
total phenolics (r = 0.99, p < 0.05) and to antioxidant capacity (r = 0.77, p < 0.05). Both ANC- 
and PAC-enriched fractions inhibited starch-degrading enzyme α-glucosidase and dipeptidyl 
peptidase-IV activity. ANC and PAC (100 µM C3G and epicatechin equivalents, respectively) 
from blueberry–blackberry blends reduced in vitro LPS-induced inflammatory response in 
mouse macrophages via the nuclear factor kappa B-mediated pathway through decreased iNOS 
and COX-2 expression, and decreased NO production. Computational modeling interaction 
energy of D3A when bound to DPP-IV was -3227.7 kcal / mol, similar to known inhibitor 
diprotin A of -3208.3 kcal / mol. Bioactive ANC and PAC compounds present in fermented 
berry beverages may act synergistically to reduce risk factors for chronic inflammatory diseases.  
 
Figure 11.2: Effect of anthocyanin (ANC) and 
proanthocyanidin (PAC) on NFκB expression. Values are 
means ± SEM with significantly different letters (n=4, p < 
0.05). 
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Figure 11.3: Surface representation of 
delphindin-3-arabinoside, the 
predominant anthocyanin present in 
blackberry, bound to DPP-IV, thus 
inhibiting its action to degrade GLP-1. 
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Specific Objective 3.2 Conclusions: Computational docking analyses showed for the first 
time that natural phenolics could inhibit DPP-IV activity by binding tightly into the active sites 
of the enzyme. DPP-IV has three binding pockets/active sites (S1, S2 and S3). ANC from 
blueberry-blackberry wine blends strongly inhibited DPP-IV activity (IC50, 0.07 ± 0.02 to > 300 
μM) by binding to the catalytic site. Compared to other anthocyanins found in berries, (cyanidin 
and pelargonidin), delphinidin had the most potent DPP-IV inhibitory effect, suggesting the 
importance of interactions of the hydroxyl groups on the B ring of anthocyanins.  
Specific Objective 3.3 Conclusions: 
Anthocyanin blends affected lipolysis by 
preventing LPS-induced glycerol release into 
culture media, inducing intracellular fat 
accumulation (28.2% max.) when applied 
during differentiation, and inhibiting 
isoproterenol-induced lipolysis (18.6% max.) 
of mature 3T3-L1 cells. ANC treatment 
slightly restored the insulin-induced glucose 
uptake of adipocytes that was blunted by 
conditioned medium treatment. Anthocyanins 
from blueberry and blackberry fermented beverages are potential inhibitors of inflammation and 
sensitizers of insulin-signaling, possibly through inhibition of lipolysis in adipocytes.  
The overall impact of the findings from aim 3 is that the chemical composition of 
blended blueberry and blackberry fermented beverages provide valuable information as to which 
compounds are able to have potential for improving the management of diabetes. Studying the 
bioactive compounds using in vitro models allows the mechanism of action to be better 
understood in preventing chronic inflammatory diseases. This is important in order to promote 
future studies in vivo in order to fully understand the bioactivity and potential mechanism of 
action of these compounds to reduce inflammatory diseases. Overall, these results suggest that 
due to the presence of phenolic compounds, specifically anthocyanins, blueberry and blackberry 
fermented beverages are good natural sources of antioxidants, are starch-degrading enzyme 
inhibitors, can bind strongly to the active site of DPP-IV to inhibit its activity, and are able to 
reduce markers of adipogenesis. These findings give light to specific roles of these compounds to 
Figure 11.4: Modulation of lipolysis measured by 
glycerol release from fully differentiated adipocytes 
activated by macrophage conditioned media (CM-
LPS) in presence or absence of each blend ANC (100 
µM C3G equivalents). 
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reduce inflammation and inhibit enzymes that are current targets of pharmaceutical therapy, and 
thus highlight their potential to impact type-2 diabetes. 
 
Aim 4 Conclusions: Anthocyanins (ANC) from 50%blueberry: 50%blackberry and 
100%blackberry fermented beverages at 50 µM cyanidin-3-glucoside equivalents were able to 
increase glucose-stimulated insulin secretion from iNS-1E cells by 233 and 100 µIU insulin/mL 
directly and after Caco-2 transport, respectively. ANCs from both 50% and 100% blackberry 
increased the relative protein expression of IGF-II, IGFBP-2 and 3, and VEGF in iNS-1E cells. 
ANC also up-regulated the gene expression of the incretin hormone GLP-1 (fold-change 3.0 ± 
1.4 and 2.0 ± 0.3) and of genes in the insulin secretory pathway, including iGF1R (2.3 ± 0.6 and 
1.6 ± 0.3) for ANC50% and ANC100%, respectively. Also, PTP1B gene expression was down-
regulated by ANC 100% (-1.9 ± 0.1), a potential therapeutic target of type-2 diabetes.  
 
Aim 5 Conclusions: Daily consumption of anthocyanins was 8.4, 1.1, 9.0, and 19.0 mg 
C3G/kg BW/d for AFFB, 0.1X, 1X, and 2X, respectively, with anthocyanins present 
predominantly C3G (65.8%). The body weight/food intake ratio and sucrose consumption were 
similar (p > 0.05). Mice in the 3x group had the lowest body weight gain (10.3 ± 0.3 g) and the 
water group the most weight gain (16.7 ± 1.2 g, p < 0.05). The weight increase was attributed to 
a gain in fat mass (18.0 ± 0.8 % BW for 2X vs. 31.3 ± 1.1 % BW for water) which was 
correlated with visceral fat (0.8 ± 0.1 g for 2X vs. 2.4 ± 0.2 g for water), while absolute lean 
mass did not differ (p > 0.05). After 3 weeks of treatment, all groups had fasting blood glucose 
(FBG) above 126 mg/dL. At the end of the study (week 12), FBG for 1X and 2X groups was 
significantly lower (168 and 184 mg/dL, respectively) than the water (222 mg/dL), and the 
sitagliptin group (217 mg/dL, p < 0.05). These two highest doses, however, had an increase in 
liver weights and liver lipids, indicating that adverse effects need to be further evaluated. 
Overall, phenolic compounds, mainly anthocyanins, from a fermented blueberry-blackberry 
beverage reduced BW gain, fat mass accumulation, and FBG in diet-induced obese mice. Future 
studies to evaluate the mechanistic targets will add to the understanding of the reduction in fat 
mass and fasting blood glucose in the mice consuming anthocyanins. At the completion of this 
research we expect to understand the effect and mechanism of action of berry phenolic ANC and 
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PAC to reduce hyperglycemia, and therefore reduce the progression and onset of type-2 diabetes, 
through the mechanisms as indicated in the diagram below.  
 
 
Figure 11.5: Research findings integration pathway. Blue arrows indicate an 
increase/up-regulation or a decrease/reduction of specific measurements evaluated.  
The results of this research will allow better understanding of the anti-diabetic 
mechanisms of dietary bioactive compounds found in fermented berry beverages to prevent 
chronic inflammatory diseases such as type-2 diabetes using animal, cellular and molecular 
approaches, and establish physiological relevance by determining a dose that is translatable to 
human consumption. Further, the role of phenolic compounds to increase proliferation and 
response to glucose of pancreatic β-cells could reduce the rate of progression of patients with 
type-2 diabetes to become dependent on insulin therapy. Translation of our results to future 
clinical trials will be needed to attribute any reduction of onset of type-2 diabetes to specific 
compounds in berries. Potential synergism of compounds may provide additional evidence 
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behind reduced hyperglycemia following consumption of berries seen in future and previous 
epidemiological and clinical trials. It is important to determine the effective dose of phenolics 
needed to reduce blood glucose in humans in order to reduce the onset and progression of obesity 
or hyperglycemia. The animal study suggests consumption of the 1x dose of anthocyanins from 
fermented berry beverages per day (9 mg/kg BW) mg would be able to have an effect to reduce 
the onset of obesity and hyperglycemia, even when consuming a high-fat diet, however at the 
doses provided there were some adverse effects in the liver that warrant further investigation. 
Importantly, this amount of anthocyanins is feasibly achieved by humans consuming 2 cups of 
blueberries per day (8 mg/kg BW) and is associated with no known toxicity, but the 
concentration of other phenolic compounds present may be reaching a dose at which they exert 
adverse effects. Further investigation into the optimum dose and toxicity observed will help to 
add to the discussion of a recommended dose of phenolic compounds and dietary flavonoids that 
will be beneficial without safety concerns. With the knowledge gained from this research, the 
role of bioactive compounds from dealcoholized fermented berry beverages to reduce type-2 
diabetes will be expanded, thus contributing to the field of research on flavonoids and nutrition 
to improve human health. 
Future directions of this research will provide mechanistic evidence, effective dose, and 
potential new targets of DPP-IV inhibition and incretin action for future animal and clinical trials 
or drug discovery. This research could impact both current practices and dietary 
recommendations, and suggest future targets of type-2 diabetes therapy, and will provide 
understanding of the role of phenolic compounds to affect insulin secretion. This study will add 
to the growing field of research investigating health effects of flavonoids by understanding of the 
mechanisms of dietary bioactives found in fermented berry beverages to increase insulin 
secretion and reduce chronic diseases such as type-2 diabetes using both in vitro and in vivo 
models. Future studies are needed to address the diverse roles of the complex mixtures of 
chemical components in blueberries and blackberries and phenolic-rich products produced from 
these fruits and their potential to reduce obesity-associated inflammation and type-2 diabetes.  
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